000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1093|2909|lyfalmen|||1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1093||1093|2909||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 000049|N05CD0801|Dormicum|töflur|7,5|mg|100|stk|1|pakki||N05CD08|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4565|7688|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Mídazólam||||4565|7688||2 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|24307|33814|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||24307||24307|33814||2 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|6021|9692|lyfalmen|V0457|8667|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||6021||6021|9692||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|18487|26850|lyfalmen|V0475|9359|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||18487||18487|26850||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|23879|33272|lyfalmen|V0540|20531|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||23879||23879|33272||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|3700|6498|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||3700||3700|6498||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|3604|7008|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||3604||3604|7008||1 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|9911|15046|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||9911||9911|15046||1 000299|N06AB0311|Fluoxetin Mylan|hylki|20|mg|250|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2805|5266|lyfalmen|||2|250|0|250,0000|Icepharma hf|Mylan AB|Flúoxetín||2805||2805|5266||2 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|2271|4531|lyfsjukr|||1|5|0|1,6700|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||2271||2271|4531||1 000546|G03DA0406|Crinone|sk-hlaup|8|%|6|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|2439|4762|lyfalmen|V0942|4279|1|6|0||Icepharma hf|Merck AB|Prógesterón||2439||2439|4762||2 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|3791|6623|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3791||3791|6623||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2320|4598|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2320||2320|4598||1 000613|G03DA0406|Crinone|sk-hlaup|8|%|15|stk|1|sk-ílá||G03DA04|01.02.2018||R|0|0|0|1|G|0|MEC|0|0|0|100|SEK|6751|10697|lyfalmen|V0942|10697|1|15|0||Icepharma hf|Merck AB|Prógesterón||6751||6751|10697||2 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|pokar||B05BA02|01.04.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|9080|13903|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||9080||9080|13903||1 000663|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|pokar||B05BA02|01.12.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|29360|40205|lyfsjukr|||1|6000|0||Vistor hf|Fresenius Kabi AB|Fitusambönd||29360||29360|40205||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|2819|5285|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||2819||2819|5285||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSF|0|0|0|100|SEK|76415|99720|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd*|Interferón beta-1a||76415||76415|99720||2 001008|M03BX0201|Sirdalud|töflur|2|mg|100|stk|1|þpakki||M03BX02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|3401|6086|lyfalmen|||0|100|1|17,0000|Distica|Distica - óskráð lyf|tizanidine||||3401|6086||1 001066|N06AB0312|Prozac|hylki|20|mg|30|stk|1|pakki||N06AB03|01.06.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4023|6942|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Flúoxetín||||4023|6942||2 001115|M03BX0201|Sirdalud|töflur|4|mg|100|stk|1|þpakki||M03BX02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5605|9120|lyfalmen|||0|100|1|33,0000|Distica|Distica - óskráð lyf|tizanidine||||5605|9120||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12485|18589|lyfalmen|V0115|11638|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12485||12485|18589||1 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1564|3558|lyfalmen|V0050|2079|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1564||1564|3558||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4747|7939|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4747||4747|7939||1 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2215|4454|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||2215||2215|4454||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|17140|24996|lyfsjukr|||1|4104|0||Vistor hf|Fresenius Kabi AB|Blöndur||17140||17140|24996||1 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|11411|17111|lyfalmen|V0637|16241|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||11411||11411|17111||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|23479|32766|lyfsjukr|||1|6160|0||Vistor hf|Fresenius Kabi AB|Blöndur||23479||23479|32766||1 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|1890|4006|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||1890||1890|4006||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3857|6714|lyfalmen|V0444|6486|1|15|0|75,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||3857||3857|6714||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1395|2644|lyfalmen|V0291|2231|2|60|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||900||900|2644||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|2838|5311|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||2838||2838|5311||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|2371|4089|lyfalmen|V0292|3470|2|60|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||1950||1950|4089||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1437|3383|lyfalmen|V0004|2785|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1437||1437|3383||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|2927|5434|lyfalmen|V0005|1953|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2927||2927|5434||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20017|28388|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||20017||20017|28388||2 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2432|4752|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2432||2432|4752||1 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|11660|17454|lyfalmen|||0|120|1|120,0000|Distica|Distica - óskráð lyf|Kalcípótríól||||11660|17454||1 002320|P01BB5102|Malarone Pead|töflur|62,5|mg|12|stk|1|pakki||P01BB51|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|955|2719|lyfalmen|||0|12|1||Distica|Distica - óskráð lyf|Prógúaníl í blöndum||||955|2719||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|10885|16387|lyfalmen|||1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||10885||10885|16387|28.02.2018|1 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|GPA|0|0|1|100|IKR|||lyfalmen|V0362|1863|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Lóratadín|||||2635||1 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2017||R|0|0|0|1|0|1|OSK|0|0|0|100|DKK|194306|247769|lyfsjukr|||0|1|1||Distica|Distica - óskráð lyf|Verteporfin||||194306|247769||1 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|827|2543|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||827||827|2543||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|22533|31570|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||22533||22533|31570||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|10283|12715|lyfalmen|V0089|2505|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||8217||8217|12715||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6138|9853|lyfalmen|V0515|3929|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||6138||6138|9853||1 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|10020|15196|lyfalmen|V0253|6180|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||10020||10020|15196||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|19279|27941|lyfalmen|V0516|5697|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||19279||19279|27941||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|7010|11053|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||7010||7010|11053||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|10351|15652|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10351||10351|15652||1 003192|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2015||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|6434|12377|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||6434||6434|12377||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4994|8279|lyfalmen|V0356|7084|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4994||4994|8279||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|innö.t|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4683|7851|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4683||4683|7851||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2435|4756|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||2435||2435|4756||1 003527|G04BE0106|Bondil|þvst|500|mcg|6|stk|1|pakki||G04BE01|01.07.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|11586|17352|lyfalmen|||0|6|1||Distica|Distica - óskráð lyf|Alprostadíl||11586||11586|17352||1 003687|V03AC0202|Ferriprox|töflur|500|mg|100|stk|1|pakki||V03AC02|01.03.2016||R|0|0|0|1|0|0|LVE|0|0|0|100|DKK|41388|55418|lyfalmen|||0|100|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|deferiprone||||41388|55418||3 003775|V03AF0701|Fasturtec|st/irþ|1,5|mg/ml|1,5|mg|3|hgl|+leysir|V03AF07|01.12.2015||R|0|0|0|1|0|1|SGB|0|0|0|100|XEU|27933|38400|lyfsjukr|||1|4,5|0|0,1500|Vistor hf|Sanofi-aventis groupe|Rasburicase||27933||27933|38400||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|1727|3782|lyfalmen|||2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1727||1727|3782||1 003880|N05AH0205|Clozapine Actavis|töflur|100|mg|500|stk|1|glas||N05AH02|01.06.2015||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|23488|32778|lyfalmen|||2|500|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||23488||23488|32778||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|0|0|GPA|0|0|0|100|IKR|827|2353|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||689||689|2353||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|2389|2889|lyfalmen|V0322|2889|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||1078||1078|2889||1 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|14874|21877|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||14874||14874|21877||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|6219|9965|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||6219||6219|9965||1 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|||lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||||||30.11.2017|1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3581|6334|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||3581||3581|6334||1 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4684|7852|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4684||4684|7852||1 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|6542|10409|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||6542||6542|10409||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|16553|24188|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||16553||16553|24188||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|þpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|5101|5041|lyfalmen|V0381|4144|1|10|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||2642||2642|5041||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6046|11641|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6046||6046|11641||1 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|2551|4916|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||2551||2551|4916||2 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3403|6089|lyfalmen|V0226|2531|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||3403||3403|6089||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|1624|3640|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||1624||1624|3640||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2280|2613|lyfalmen|V0494|2093|1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||878||878|2613||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|2323|4602|lyfalmen|V0318|4602|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||2323||2323|4602||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2398|4706|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-B, hreinsaðir mótefnavakar||2398||2398|4706||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|4137|4715|lyfalmen|V0320|2781|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||2405||2405|4715||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1534|3516|lyfalmen|V0317|3516|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Cítalópram||1534||1534|3516||1 004676|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|200|stk|1|glas||A02AA04|01.03.2018||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|200|0|33,3333|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||3087||2 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MEA|0|0|0|100|IKR|||lyfalmen|||0|100|0|16,6700|Icepharma hf|Meda AB|Magnesíum hýdroxíð|||||2206||2 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|29381|40231|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||29381||29381|40231||3 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan||||||31.12.2017|1 004713|A07EB0101|Lomudal|mixtúra|20|mg/ml|100|skammtar|10|lykjur||A07EB01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|37523|50529|lyfalmen|||0|1000|1||Distica|Distica - óskráð lyf|cromoglicic acid ||||37523|50529||1 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|Clikstar/JuniorStar pennar|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|6764|10715|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||6764||6764|10715||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|660|2313|lyfalmen|||2|24|0|3,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||660||660|2313||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|4256|7263|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||4256||4256|7263||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|283|1794|lyfalmen|||2|8|0|2,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||283||283|1794||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|726|2404|lyfalmen|||2|14|0|3,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||726||726|2404||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|1242|3114|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól||1242||1242|3114||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2024|4191|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Kíghósti, í blöndum með öðrum toxóíðum||2024||2024|4191||1 005108|G04CA0201|Omnic|hylki|0,4|mg|90|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6889|6233|lyfalmen|V0148|3110|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3508||3508|6233||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2602|4225|lyfalmen|V0353|3983|2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2049||2049|4225|| 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2005|4165|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2005||2005|4165||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|TCA|0|0|1|100|DKK|2252|4061|lyfalmen|V0337|3470|2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1930||1930|4061||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|14983|22028|lyfalmen|V0356|21251|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||14983||14983|22028||1 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|2365|4660|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2365||2365|4660||1 005330|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|42044|55050|lyfalmen|V0451|46698|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||41097||41097|55050||1 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1406|3340|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1406||1406|3340||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímþynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4558|7679|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4558||4558|7679||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4622|7767|lyfalmen|||1|30|0|54,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||4622||4622|7767||1 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1468|3425|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||1468||1468|3425||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|2936|5446|lyfalmen|V0020|1248|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||2936||2936|5446||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4620|7764|lyfalmen|V0020|3745|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||4620||4620|7764||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3375|6050|lyfalmen|V0020|1873|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíð||3375||3375|6050||2 005766|H01CC0201|Cetrotide|sts|0,25|mg|1|hgl|1|pakki||H01CC02|01.12.2016||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3800|6635|lyfalmen|||1|1|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Cetrorelix||3800||3800|6635||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4276|7290|lyfalmen|V0324|1995|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4276||4276|7290||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|14101|24304|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||14101||14101|24304||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6863|10851|lyfalmen|V0325|2653|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6863||6863|10851||1 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|pakkar||P01BC02|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|||lyfalmen|||0|8|1||Parlogis hf|Parlogis - óskráð lyf|Meflókvín||||||30.11.2017|2 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2157|4374|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2157||2157|4374||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12066|17189|lyfalmen|V0326|4644|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11468||11468|17189||1 005932|C09CA0301|Diovan|töflur|80|mg|98|mg|1|pakki|lausn|C09CA03|01.04.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|8267|12784|lyfalmen|||0|98|1||Distica|Distica - óskráð lyf|Valsartan||||8267|12784||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|þpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RHA|0|0|1|100|IKR|1816|2231|lyfalmen|V0169|2231|2|14|0|12,2500|Alvogen|ratiopharm Oy|Amoxicillín og beta-laktamasa hemill ||600||600|2231||2 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4537|7650|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||4537||4537|7650||1 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|78802|102739|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||78802||78802|102739||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4344|7384|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4344||4344|7384||1 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|60203|79215|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||60203||60203|79215||1 006172|S01XA2007|Simplex|augnsm|||4|g|1|túpa||S01XA20|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1384|3310|lyfalmen|||0|4|1||Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||||1384|3310||2 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|MEA|0|0|1|100|SEK|2353|4644|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Flúkloxacillín||2353||2353|4644||2 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|2800|5483|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||2800|5483||1 006542|S01EB0901|Miochol E|duft|20|mg|1|stk|1|pakki|+ leysir|S01EB09|01.03.2016||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|2972|5496|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Acetylcholine||||2972|5496||2 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|10953|16481|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10953||10953|16481|28.02.2018|1 006732|A16AB0401|Fabrazyme|irþ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEB|0|1|0|100|XEU|396612|449397|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||356423||356423|449397||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|11503|17238|lyfalmen|V0099|6809|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||11503||11503|17238||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9667|14711|lyfalmen|V0117|5423|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||9667||9667|14711||1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|14144|20873|lyfalmen|V0118|8796|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14144||14144|20873||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|þpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1898|4017|lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Kaptópríl||1898||1898|4017||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|17311|25232|lyfalmen|V0195|19586|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||17311||17311|25232||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|75171|98147|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||75171||75171|98147||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|194773|248350|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||194773||194773|248350||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|2263|4520|lyfalmen|V0374|3571|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||2263||2263|4520||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6077|9769|lyfsjukr|||1|50|0||Icepharma hf|Baxter Medical AB|Vítamín||6077||6077|9769||2 007449|V03AB3401|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|88298|114750|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||88298||88298|114750||3 007462|N01AB0801|Sevorane|innö.guf|100|%|250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|18130|26359|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||18130||18130|26359||1 007505|G04BD0702|Detrusitol Retard|forðahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4757|7952|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||4757||4757|7952||1 007601|A16AB0301|Replagal|irþ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|1|0|100|XEU|194399|247885|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||194399|247885||3 007760|G04BD0702|Detrusitol Retard|forðahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3864|6723|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||3864||3864|6723||1 007769|G04BD0702|Detrusitol Retard|forðahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|12951|19231|lyfalmen|V0589|7584|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||12951||12951|19231||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1350|2781|lyfalmen|V0290|2231|2|60|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Risperídón||1000||1000|2781||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|3143|5731|lyfalmen|||1|3|0|84,0000|Vistor hf|Merck Sharp & Dohme|Skeiðarinnleg með progestógeni og östrógeni||3143||3143|5731||1 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|1104|2924|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Ólópatadín||1104||1104|2924||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|þpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LVE|0|0|1|100|IKR|729|2408|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|2408||3 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|281|1792|lyfalmen|V0502|970|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||281||281|1792||2 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1176|3024|lyfalmen|V0915|3024|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón||1176||1176|3024||1 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|703|2373|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||703||703|2373||1 008326|D07AC0101|Betnovat|húðlausn|1|mg/g|100|ml|1|plglas|í hársvörð|D07AC01|01.07.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|825|2540|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Betametasón||825||825|2540||1 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|2263|4520|lyfalmen|V0226|4520|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2263||2263|4520||1 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|3337|5998|lyfalmen|V0227|5998|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||3337||3337|5998||1 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|IVS|0|0|1|100|XEU|4618|7761|lyfalmen|V0228|7610|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||4618||4618|7761||1 008370|H01AB0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|H01AB01|01.01.2006||R|0|0|0|1|0|1|GEB|0|0|0|100|XEU|109839|142716|lyfsjukr|||1|2|0||Vistor hf|Genzyme Europe B.V.|Thyrotropin alfa||109839||109839|142716||1 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|6221|10723|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||6221||6221|10723||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|9323|17858|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||9323||9323|17858||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RTH|0|0|1|100|XEU|||lyfalmen|V0575|2389|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||2389||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2270|4529|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2270||2270|4529||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|81229|105809|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||81229||81229|105809||2 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|84266|109650|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||84266||84266|109650||2 008904|D10AF0101|Dalacin|húðlausn|10|mg/ml|60|ml|1|glas||D10AF01|01.01.1994||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1703|3749|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1703||1703|3749||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5548|9041|lyfalmen|V0145|4598|1|4|0|8,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||5548|9041||2 008938|H02AB0104|Betapred|stl|4|mg/ml|5|ml|1|pakki||H02AB01|01.03.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|IKR|1197|3052|lyfsjukr|||0|5|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||||1197|3052||3 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|11002|16548|lyfalmen|V0145|9195|1|8|0|16,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||11002|16548||2 008959|R01AA0706|Naso-ratiopharm|nefúði|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|þpakki||N06AG02|01.02.2013|28.02.2018|R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1378|2911|lyfalmen|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||1094||1094|2911||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|þpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4383|5809|lyfalmen|||2|60|0|60,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||3200||3200|5809||2 009113|B05DB0005|Balance|kvið.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6155|9877|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6155||6155|9877||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|þpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2769|4344|lyfalmen|V0063|4344|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Móklóbemíð||2135||2135|4344||2 009213|B05DB0005|Balance|kvið.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6155|9877|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6155||6155|9877||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|9421|14372|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||9421||9421|14372||1 009216|B05DB0005|Balance|kvið.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6155|9877|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6155||6155|9877||2 009270|R01AA0706|Naso-ratiopharm|nefúði|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Alvogen|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|40963|54880|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||40963||40963|54880||1 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|4076|7015|lyfalmen|V0906|7015|1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||4076||4076|7015||1 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|896|2638|lyfalmen|||1|8|0|21,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||896||896|2638||1 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|988|2765|lyfalmen|||1|8|0|28,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||988||988|2765||1 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1143|2978|lyfalmen|||1|8|0|42,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1143||1143|2978||1 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|1432|3376|lyfalmen|||1|8|0|56,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||1432||1432|3376||1 009525|B05DB0005|Balance|kvið.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|5548|9041|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5548||5548|9041||2 009560|B05DB0005|Balance|kvið.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5824|9421|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5824||5824|9421||2 009591|B05DB0005|Balance|kvið.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|5548|9041|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5548||5548|9041||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|1|1|0|0|0|1|PHH|0|0|0|100|DKK|146612|188451|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||146612||146612|188451||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|3949|6840|lyfalmen|V0921|6840|1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||3949||3949|6840||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|1|0|1|0|1|GSL|0|0|0|100|DKK|44393|59219|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||44393||44393|59219||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7748|10934|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||6923||6923|10934||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8396|12033|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7722||7722|12033||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6675|10592|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||6675||6675|10592||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8396|12033|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||7722||7722|12033||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|6767|10719|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||6767||6767|10719||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7748|10276|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||6445||6445|10276||1 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|1689|3730|lyfalmen|V0329|2602|1|30|0|15,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||1689||1689|3730||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|117979|152840|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||117979||117979|152840||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|5306|8708|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||5306||5306|8708||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|10083|15283|lyfalmen|V0331|2919|1|96|0|96,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||10083||10083|15283||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|||lyfalmen|||1|96|0|144,0000|Vistor hf|Merck Sharp & Dohme|Mirtazapín||||||30.11.2017|1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|13799|20398|lyfalmen|V0605|3607|1|100|0|50,0000|Vistor hf|H. Lundbeck A/S|Memantín||13799||13799|20398||1 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|8865|13607|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og þvagræsilyf||8865||8865|13607||1 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7237|11366|lyfsjukr|||1|1000|0||Vistor hf|Fresenius Kabi AB|Amínósýrur||7237||7237|11366||1 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|980|2754|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||980||980|2754||2 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|254293|322376|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||254293||254293|322376||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|254293|322376|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||254293||254293|322376||3 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|434095|546000|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||434095||434095|546000||1 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir, lausn|H01AX01|01.11.2016||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|578380|725450|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||578380||578380|725450||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|34528|46741|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||34528||34528|46741||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|MEA|0|0|0|100|DKK|2174|4397|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Meda AB|Kloxacillín||2174||2174|4397||2 010947|C08CA0203|Felodipin ratiopharm|forðatfl|5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2231|2231|lyfalmen|V0058|2231|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Felódipín||600||600|2231||2 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|15891|23277|lyfalmen|V0204|5809|1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||15891||15891|23277||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|G|0|OTS|0|0|0|100|DKK|10955|16483|lyfalmen|V0716|4846|1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||10955||10955|16483||1 010980|C08CA0203|Felodipin ratiopharm|forðatfl|10|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2980|2644|lyfalmen|V0059|2644|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Felódipín||900||900|2644||2 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|24411|33945|lyfalmen|V0683|4502|1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24411||24411|33945||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|1|0|0|0|G|0|OTS|0|0|0|100|DKK|19724|28553|lyfalmen|V0684|4502|1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19724||19724|28553||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3553|6295|lyfalmen|V0825|2789|1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||3553||3553|6295||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3692|6487|lyfalmen|V0826|2853|1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||3692||3692|6487||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12582|18723|lyfalmen|V0327|3840|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12582||12582|18723||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|942|2701|lyfalmen|V0827|1034|1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||942||942|2701||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1927|2978|lyfalmen|V0069|2456|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1143||1143|2978||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4928|8188|lyfalmen|V0357|7252|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||4928||4928|8188||1 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4716|7611|lyfalmen|V0691|4100|1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4509||4509|7611||1 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|6039|7056|lyfalmen|V0624|3759|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4106||4106|7056||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1518|2983|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1518||1518|2983||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PLS|0|0|0|100|DKK|3711|6513|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||3711||3711|6513||1 011690|J05AP0101|Copegus|töflur|200|mg|168|stk|1|plglas||J05AP01|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|50028|66346|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||50028||50028|66346||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2467|4849|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2467||2467|4849||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|0|0|GPA|0|0|0|100|IKR|842|2452|lyfalmen|V0152|2298|2|28|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||761||761|2452||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|2793|4238|lyfalmen|V0323|4075|2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Sertralín||2058||2058|4238||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|3186|5790|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||3186||3186|5790||2 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|1763|3832|lyfsjukr|||1|20|0||Icepharma hf|Aspen Pharma|Búpívakaín||1763||1763|3832||2 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|22206|31156|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||22206||22206|31156||1 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2923|5428|lyfalmen|V0909|4619|1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð||2923||2923|5428||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5339|8754|lyfalmen|V0924|4598|1|4|0|4,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||5339||5339|8754||2 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|7584|9008|lyfalmen|V0622|4489|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||5524||5524|9008||1 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992|31.12.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Alvogen|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|750|2437|lyfalmen|||1|80|0|4,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||750||750|2437||1 012921|G03AA1301|Evra|forðapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|3315|5968|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||3315||3315|5968||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|4916|8171|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||||4916|8171||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1995|2596|lyfalmen|V0250|1985|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Gabapentín||865||865|2596||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2617|2666|lyfalmen|V0251|2203|2|100|0|22,2200|Alvogen|ratiopharm GmbH|Gabapentín||916||916|2666||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5211|8577|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5211||5211|8577||1 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|7505|11735|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7505||7505|11735||1 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|4969|8244|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||4969||4969|8244||2 013302|C02CA0405|Cardosin Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1690|3731|lyfalmen|V0042|3731|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxazósín||1690||1690|3731||1 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|þpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|258814|286327|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||225308||225308|286327||1 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1003|2785|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1003||1003|2785||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008|28.02.2018|L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Blöndur|||||1939||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|600|1869|lyfalmen|V0562|1869|2|100|0|33,3300|Alvogen|ratiopharm Oy|Íbúprófen||337||337|1869||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1927|4057|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||1927||1927|4057||2 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|1548|3536|lyfalmen|||0|40|1|5,0000|Distica|Distica - óskráð lyf|Valpróínsýra||||1548|3536||1 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|294|1810|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Lídókaín||294||294|1810||2 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4851|8082|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4851||4851|8082||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1912|4037|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1912||1912|4037||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3645|6422|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||3645||3645|6422||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|146188|187924|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||146188||146188|187924||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|266075|337030|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||266075||266075|337030||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1891|4008|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||1891||1891|4008||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5680|9223|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5680||5680|9223||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|G|0|UCB|0|0|0|100|DKK|14296|21082|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||14296||14296|21082||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|44495|59348|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíð||44495||44495|59348||2 014147|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1261|2860|lyfalmen|V0479|2644|2|60|0|6,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1057||1057|2860||1 014158|J01CA0417|Amoxicillin Sandoz|mixtduft|100|mg/ml|100|ml|1|glas||J01CA04|01.08.2015||R|0|0|0|0|0|0|SHS|0|0|1|100|DKK|1604|3613|lyfalmen|||2|100|0|10,0000|Artasan ehf|Sandoz A/S|Amoxicillín||1604||1604|3613||1 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|14785|21755|lyfalmen|V0357|21755|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||14785||14785|21755||1 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|289|1683|lyfalmen|V0563|1683|2|30|0|15,0000|Alvogen|ratiopharm Oy|Íbúprófen||202||202|1683||2 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|1770|3626|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Metrónídazól||1614||1614|3626||1 014424|N01BB0205|Xylocain viskös|mixtúra|20|mg/ml|100|ml|1|fl||N01BB02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|1559|3551|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Lídókaín||||1559|3551||1 014435|QM01AE0303|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|1994|3919|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||1994||1994|3919||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|65190|85523|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||65190|85523||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|728|2061|lyfalmen|V0564|2061|2|100|0|50,0000|Alvogen|ratiopharm Oy|Íbúprófen||477||477|2061||2 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|739|2422|lyfalmen|V0596|2064|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||739||739|2422||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|20863|29458|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||20863||20863|29458||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|54064|71450|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||54064||54064|71450||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|36230|48894|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||36230||36230|48894||1 014889|A16AA0501|Carbaglu|dreifit.|200|mg|60|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|569675|714623|lyfalmen|||1|60|0|60,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||569675||569675|714623||3 015072|V04CX0005|Hexvix|stofn|85|mg|1|hgl|1|pakki|og leysir|V04CX|01.08.2016||R|0|0|0|0|0|1|CUR|0|0|0|100|XEU|59269|78034|lyfsjukr|||0|1|0||PhotoCure ASA|PhotoCure ASA|Önnur sjúkdómsgreiningarefni||||59269|78034||0 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2072|4093|lyfalmen|V0673|3057|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1953||1953|4093||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6308|10087|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||6308||6308|10087||1 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LVE|0|0|1|100|IKR|2760|5204|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|5204||3 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|NAA|0|0|0|100|DKK|859|2587|lyfalmen|||1|8|0|14,0000|Artasan ehf|Novartis Healthcare A/S|Estradíól||859||859|2587||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1433|2525|lyfalmen|V0234|1478|1|6|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||814||814|2525||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2045|2525|lyfalmen|V0233|1946|1|12|0|12,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||814||814|2525||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|7409|11603|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||7409||7409|11603||1 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|250621|317809|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||250621||250621|317809||3 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|71167|93082|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||||71167|93082||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4027|6948|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4027||4027|6948||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|10646|16058|lyfalmen|V0828|13688|1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||10646||10646|16058||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4057|6989|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4057||4057|6989||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|11216|16843|lyfalmen|V0900|14682|1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||11216||11216|16843||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|4057|6989|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||4057||4057|6989||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|9799|14892|lyfalmen|V0829|12671|1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9799||9799|14892||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|55542|73320|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||55542||55542|73320||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|17344|25277|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||17344||17344|25277||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|0|1|0|1|G|0|HES|0|0|0|100|DKK|34689|46945|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||34689||34689|46945||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3115|5369|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||3115||3115|5369||2 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4788|8253|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||4788||4788|8253||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2590|4464|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2590||2590|4464||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2628|4530|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||2628||2628|4530||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4596|7922|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4596||4596|7922||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|100|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1624|3640|lyfalmen|V0918|3640|1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||1624||1624|3640||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1817|3906|lyfalmen|V0905|3906|1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||1817||1817|3906||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1164|3007|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1164||1164|3007||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2527|4356|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2527||2527|4356||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||0|60|0||Alvogen|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|1315|3215|lyfalmen|||1|28|0|14,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1315||1315|3215||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|865|2596|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||865||865|2596||2 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|917|2667|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||917||917|2667||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2156|4372|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2156||2156|4372||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|5378|8807|lyfalmen|V0686|2097|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||5378||5378|8807||1 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8151|12624|lyfalmen|V0687|3099|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||8151||8151|12624||1 016317|C03CA0110|Impugan|töflur|40|mg|1000|stk|1|glas||C03CA01|01.01.2016||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|4039|6964|lyfalmen|||2|1000|0|1000,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||4039||4039|6964||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1424|3365|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1424||1424|3365||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|11500|17234|lyfalmen|V0689|4086|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||11500||11500|17234||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|1|0|0|0|1|PHH|0|0|0|100|DKK|75913|99085|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||75913||75913|99085||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|2969|5491|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||2969||2969|5491||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2093|4286|lyfalmen|V0685|1508|1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2093||2093|4286||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016527|J01CE0206|Apocillin|mixt.kyr|50|mg/ml|200|ml|1|glerfl||J01CE02|01.06.2015||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|1035|2829|lyfalmen|||2|200|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fenoxýmetýlpenicillín||1035||1035|2829||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|13025|19333|lyfalmen|V0690|4571|1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||13025||13025|19333||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||6814||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|24884|34544|lyfalmen|V0682|4502|1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24884||24884|34544||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1397|2169|lyfalmen|V0169|1912|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||555||555|2169||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007|28.02.2018|R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|114570|148600|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||114570||114570|148600||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|5925|9560|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5925||5925|9560||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2420|4736|lyfalmen|V0240|4736|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2420||2420|4736||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|4466|7552|lyfalmen|V0433|7552|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||4466||4466|7552|| 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|40591|54410|lyfalmen|V0721|14463|1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||40591||40591|54410||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|59801|78707|lyfalmen|V0722|24065|1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||59801||59801|78707||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|22233|31191|lyfalmen|V0720|11407|1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||22233||22233|31191||1 016930|A16AB0401|Fabrazyme|irþ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEB|0|1|0|100|XEU|58668|69680|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||52664||52664|69680||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|þpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1410|3346|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||1410|3346||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|31256|42207|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||30943||30943|42207||2 016979|N02AE0103|Norspan|forðapl|5|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|2438|4761|lyfalmen|V0943|2937|1|4|0|16,6700|Icepharma hf|Mundipharma A/S|Búprenorfín||2438||2438|4761||2 017020|G03AC0601|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03AC06|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1210|3070|lyfalmen|||1|3|0|89,8204|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1210||1210|3070||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|208916|265940|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||208916||208916|265940||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|GRP|0|0|0|100|XEU|5400|8837|lyfalmen|||2|500|0|333,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5400||5400|8837||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|GRP|0|0|0|100|SEK|5870|9484|lyfalmen|||2|500|0|500,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zópíklón||5870||5870|9484||1 017217|N02AB0308|Abstral Sublingval|töflur|300|mcg|30|stk|1|glas||N02AB03|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|35475|47939|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Fentanýl||||35475|47939||2 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|84349|109755|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||84349||84349|109755||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|0|0|0|1|0|0|ROC|0|0|0|100|IKR|33527|45475|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||33527||33527|45475||2 017266|N02AE0103|Norspan|forðapl|10|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|4435|7509|lyfalmen|V0944|4108|1|4|0|33,3300|Icepharma hf|Mundipharma A/S|Búprenorfín||4435||4435|7509||2 017326|N02AE0103|Norspan|forðapl|20|mcg/klst|4|stk|1|þpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|MUP|0|0|0|100|DKK|8063|12503|lyfalmen|V0945|6456|1|4|0|66,6600|Icepharma hf|Mundipharma A/S|Búprenorfín||8063||8063|12503||2 017331|A04AD1201|Emend|hylki|||3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|6892|10891|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||6892||6892|10891||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|þpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|930|2685|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||930||930|2685||1 017377|C01DA0208|Nitrangin|úðalyf|0,4|mg/sk|300|skammtar|1|glas||C01DA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2256|4510|lyfalmen|||0|300|1||Parlogis hf|Parlogis - óskráð lyf|Glýcerýltrínítrat||||2256|4510||2 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|2144|4356|lyfalmen|||1|30|0|150,0000|Icepharma hf|Meda AB|Prednisón||2144||2144|4356||2 017388|H03AA0108|Tirosint|hylki|75|mcg|100|stk|1|pakkar||H03AA01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3982|6886|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Levótýroxínnatríum||||3982|6886||2 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1047|2768|lyfalmen|V0168|2428|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||990||990|2768||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|5304|10233|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||5304||5304|10233||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|7026|11076|lyfalmen|V0107|2781|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||7026||7026|11076||1 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.12.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3813|6653|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||||3813|6653||2 018420|C07AG0207|Carvedilol STADA|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1544|3332|lyfalmen|V0946|3332|2|100|0|16,6700|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1400||1400|3332||2 018431|C07AG0207|Carvedilol STADA|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2300|4571|lyfalmen|V0947|4571|2|100|0|33,3300|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||2300||2300|4571||2 018442|C07AG0207|Carvedilol STADA|töflur|25|mg|100|stk|1|pakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2975|5121|lyfalmen|V0948|5121|0|100|0|66,6666|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||2700||2700|5121||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|784|2064|lyfalmen|V0243|1642|1|42|0|3,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||479||479|2064||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5751|9321|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5751||5751|9321||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|10831|16313|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||10831||10831|16313||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|14621|21529|lyfalmen|V0441|17192|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||14621||14621|21529||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|686|2349|lyfalmen|V0414|2317|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||686||686|2349||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4631|7779|lyfalmen|V0438|6482|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||4631||4631|7779||1 018689|J01EA0108|Idotrim|filmhtfl|100|mg|100|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|864|2594|lyfalmen|||2|100|0|25,0000|Vistor hf|Orion Corporation|Trímetóprím||864||864|2594||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|12038|17974|lyfalmen|V0440|14245|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||12038||12038|17974||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|25336|35115|lyfalmen|V0111|8287|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||25336||25336|35115||1 018718|L03AX0302|BCG-medac|duft|||3|hgl|1|pakki|+ leysir|L03AX03|01.01.2016||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|38105|51265|lyfsjukr|||1|3|0||Williams & Halls efh|medac Gesellschaft|BCG bóluefni||38105||38105|51265||2 018726|J06BA0209|Nanogam|irl|50|mg/ml|20|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|7080|11150|lyfsjukr|||1|20|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||7080||7080|11150||2 018770|J01EA0108|Idotrim|filmhtfl|160|mg|14|stk|1|glas||J01EA01|01.08.2015||R|1|0|0|0|0|0|COR|0|0|1|100|DKK|243|1739|lyfalmen|||2|14|0|5,6000|Vistor hf|Orion Corporation|Trímetóprím||243||243|1739||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEI|0|0|0|100|NOK|69395|90841|lyfsjukr|||1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Teva Pharmaceuticals Limited|Glatíramer acetat||69395||69395|90841||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|44447|59287|lyfsjukr|||1|60|0|30,0000|Vistor hf|Viiv Healthcare UK Ltd|Fosamprenavír||44447||44447|59287||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|818|1608|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||818||818|1608||2 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|4417|7484|lyfalmen|V0221|7055|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4417||4417|7484||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|4941|8206|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||4941||4941|8206||2 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3196|5804|lyfalmen|V0220|5224|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||3196||3196|5804||1 019098|J06BA0209|Nanogam|irl|50|mg/ml|400|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|141598|182215|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||141598||141598|182215||2 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|15020|22078|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||15020||15020|22078||2 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1760|3827|lyfalmen|V0219|3699|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||1760||1760|3827||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|17964|26131|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||17964||17964|26131||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|16152|23637|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||16152||16152|23637||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21737|30563|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||21737||21737|30563||2 019150|J06BA0209|Nanogam|irl|50|mg/ml|200|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|70799|92617|lyfsjukr|||1|200|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||70799||70799|92617||2 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|5428|8876|lyfalmen|V0223|7530|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||5428||5428|8876||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8451|13037|lyfalmen|V0215|8734|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||8451||8451|13037||1 019214|J06BA0209|Nanogam|irl|50|mg/ml|100|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|35399|47843|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||35399||35399|47843||2 019221|J06BA0209|Nanogam|irl|50|mg/ml|50|ml|1|hgl||J06BA02|01.08.2015||R|0|0|0|0|0|1|SPP|0|1|0|100|XEU|17700|25767|lyfsjukr|||1|50|0||Williams & Halls efh|Sanquin Plasma Product|Immúnóglóbúlín, normal, manna, gefin í æð||17700||17700|25767||2 019282|B05BA0203|Smof-lipid|irl|200|mg/ml|250|ml|10|flösku||B05BA02|01.02.2017||R|0|0|0|0|0|1|PCO|0|0|0|100|DKK|21834|30686|lyfsjukr|||0|2500|1||Distica|Distica - óskráð lyf|Fitusambönd||||21834|30686||1 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005|31.12.2017|R|0|1|0|1|0|1|THE|0|0|0|100|XEU|576022|722517|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||576022||576022|722517||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|3867|7507|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||3867||3867|7507||1 019338|B05BA0203|Smof-lipid|irl|200|mg/ml|500|ml|10|flösku||B05BA02|01.02.2017||R|0|0|0|0|0|1|PCO|0|0|0|100|DKK|37288|50232|lyfsjukr|||0|5000|1||Distica|Distica - óskráð lyf|Fitusambönd||||37288|50232||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|304|1783|lyfalmen|V0633|1783|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||275||275|1783||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dælur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|CAR|0|0|0|100|DKK|25818|49152|vetalmen|||0|1000|0||Vistor hf|Vetcare Ltd.|Benzylpenicillínprokaín||25818||25818|49152||1 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5402|8840|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5402||5402|8840||2 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|40034|53705|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||40034||40034|53705||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|5402|8840|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5402||5402|8840||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|829|2300|lyfalmen|V0496|2300|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Ramipríl||650||650|2300||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006|31.12.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019666|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|8571|13202|lyfalmen|||0|98|1|98,0000|Distica|Distica - óskráð lyf|Irbesartan||||8571|13202||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|766|2258|lyfalmen|V0648|2258|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ramipríl||620||620|2258||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1160|2781|lyfalmen|V0649|2781|2|100|0|400,0000|Alvogen|ratiopharm GmbH|Ramipríl||1000||1000|2781||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999|28.02.2018|R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|2941|5453|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||2941||2941|5453||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019754|C09DA0401|CoAprovel|töflur|162,5|mg|98|stk|1|þpakki||C09DA04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|15319|22490|lyfalmen|||0|98|1|98,0000|Distica|Distica - óskráð lyf|Irbesartan og þvagræsilyf||||15319|22490||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|DAN|0|0|0|100|XEU|12907|19170|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||12907||12907|19170||2 019776|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki||C09DA04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|11032|16589|lyfalmen|||0|98|1||Distica|Distica - óskráð lyf|Irbesartan og þvagræsilyf||||11032|16589||1 019777|A10AB0601|Apidra|stl|100|ein/ml|10|ml|1|hgl||A10AB06|01.12.2015||R|0|0|0|0|G|0|PCO|0|0|0|100|NOK|||lyfalmen|||0|10|1|38,0000|Distica|Distica - óskráð lyf|Insúlín glúlisín||||||30.11.2017|1 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|147584|189660|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||147584||147584|189660||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006|31.12.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|789|2253|lyfalmen|V0159|2066|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||616||616|2253||2 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006|31.12.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|NED|0|1|0|100|XEU|134349|173200|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||134349||134349|173200||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10195|15437|lyfalmen|V0812|7494|1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10195||10195|15437||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10195|15437|lyfalmen|V0813|7494|1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10195||10195|15437||2 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10195|15437|lyfalmen|V0814|8623|1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10195||10195|15437||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10195|15437|lyfalmen|V0815|7494|1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10195||10195|15437||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.08.2006||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|10195|15437|lyfalmen|V0816|7494|1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||10195||10195|15437||2 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|258|1760|lyfalmen|||1|12|0|0,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||||258|1760||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|0|1|0|1|0|1|RGO|0|0|0|100|DKK|48517|64435|lyfsjukr|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Lamívúdín og abacavír||48517||48517|64435||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|980|2564|lyfalmen|V0160|2368|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||842||842|2564||2 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020053|N02CC0701|Migard|töflur|2,5|mg|6|stk|1|þpakki||N02CC07|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|4777|7980|lyfalmen|||0|6|1||Distica|Distica - óskráð lyf|frovatriptan||||4777|7980||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|2212|4450|lyfalmen|||2|100|0|25,0000|Alvogen|ratiopharm GmbH|Diltíazem||2212||2212|4450||2 020180|C03CC0101|Edecrin|sts|50|mg/hgl|1|hgl|1|pakki||C03CC01|01.01.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|146665|188517|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Etacrínsýra||||146665|188517||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3098|5669|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Barnaveiki, kíghósti, mænusótt, stífkrampi||3098||3098|5669||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|25039|34740|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|barnaveiki, kíghósti, mænusótt, stífkrampi||25039||25039|34740||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stíll|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|1739|3798|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||1739||1739|3798||3 020282|L01XX2301|Lysodren|töflur|500|mg|100|stk|1|glas||L01XX23|01.04.2015||R|0|0|0|1|0|1|LHR|0|0|0|100|XEU|76870|100295|lyfsjukr|||1|100|0||Laboratoire HRA Pharma|Laboratoire HRA Pharma|Mitotanum||76870||76870|100295||0 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|40108|53799|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||40108||40108|53799||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2770|3918|lyfalmen|||1|84|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||1826||1826|3918||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5262|4451|lyfalmen|||1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||2213||2213|4451||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|18647|27071|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||18647||18647|27071||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|461|2039|lyfalmen|V0913|2039|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||461||461|2039||1 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1429|3372|lyfalmen|V0820|3372|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1429||1429|3372||1 020586|A03BA0302|Egazil duretter|forðatfl|0,2|mg|100|stk|1|glas||A03BA03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|2062|4243|lyfalmen|||0|100|1|17,0000|Distica|Distica - óskráð lyf|hyoscyamine||||2062|4243||1 020662|C01EB1601|Pedea|stl|5|mg/ml|8|ml|1|pakkar||C01EB16|01.03.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|XEU|81788|106516|lyfsjukr|||0|8|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|ibuprofen||||81788|106516||3 020685|C08DB0109|Dilmin|forðatfl|120|mg|100|stk|1|þpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|5194|3498|lyfalmen|V0599|3498|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Diltíazem||1521||1521|3498||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|1755|3025|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||1755||1755|3025||1 020845|N07XX0401|Xyrem|mixtúra|500|mg/ml|180|ml|1|glas|millist., mælispr. + 2 bollar|N07XX04|01.02.2016||R|0|1|1|1|0|0|UCP|0|0|0|100|DKK|47106|62650|lyfalmen|||1|180|0||Vistor hf|UCB Pharma Ltd.|sodium oxybate||||47106|62650||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2053|3539|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2053||2053|3539||2 020924|J01FA1003|Zithromax (Lyf og heilsa)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1359|3275|lyfalmen|V0174|2038|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1359||1359|3275||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2172|4394|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2172||2172|4394||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|1801|3884|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||1801||1801|3884||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|505|1920|lyfalmen|V0188|1840|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1920||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|HEG|0|0|0|100|XEU|1757|3823|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||||1757|3823||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|TCA|0|0|1|100|IKR|1086|2479|lyfalmen|V0189|2414|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||780||780|2479||1 021288|G03BA0309|Testim|hlaup|50|mg|30|skpokar|1|pakki||G03BA03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|6535|10400|lyfalmen|||0|30|1||Distica|Distica - óskráð lyf|Testósterón||||6535|10400||1 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|11062|16631|lyfalmen|V0490|2432|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||11062||11062|16631||1 021428|A06AB0201|Dulcolax|eþ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Bisakódýl|||||||1 021465|A16AX0501|Wilzin|hylki|25|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|26047|36014|lyfalmen|||1|250|0|41,6700|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||26047||26047|36014||3 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1248|3123|lyfsjukr|||2|100|0||Vistor hf|Fresenius Kabi AB|Própófól||1248||1248|3123||1 021520|N04BX0101|Tasmar|töflur|100|mg|100|stk|1|glas||N04BX01|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|SEK|24000|33425|lyfalmen|||0|100|1|22,0000|Distica|Distica - óskráð lyf|tolcapone||||24000|33425||1 021589|A16AX0501|Wilzin|hylki|50|mg|250|stk|1|glas||A16AX05|01.10.2016||R|1|0|0|0|G|0|URE|0|0|0|100|XEU|47724|63432|lyfalmen|||1|250|0|83,3300|Orphan Europe Nordic AB|Orphan Europe|zinc acetate||47724||47724|63432||3 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3402|6087|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3402||3402|6087||1 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|10558|15937|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||10558||10558|15937||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10250|15513|lyfalmen|V0214|9512|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||10250||10250|15513||1 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5612|9129|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5612||5612|9129||1 021624|B01AE0301|Novastan|irþ|100|mg/ml|2,5|ml|1|pakki||B01AE03|01.06.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|DKK|52453|69413|lyfsjukr|||0|2,5|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Argatrobanum||||52453|69413||3 021625|A07EC0203|Pentasa Sachet|forðakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|11925|17818|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||11925||11925|17818||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|12484|18588|lyfsjukr|||2|1000|0||Vistor hf|Fresenius Kabi AB|Própófól||12484||12484|18588||1 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|16260|23785|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16260||16260|23785||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|14357|21166|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||14357||14357|21166||1 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19217|27855|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||19217||19217|27855||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7178|11285|lyfsjukr|||2|500|0||Vistor hf|Fresenius Kabi AB|Própófól||7178||7178|11285||1 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3623|6392|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||3623||3623|6392||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15385|22581|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||15385||15385|22581||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|2746|5185|lyfalmen|V0692|2275|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||2746||2746|5185||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|4456|7538|lyfalmen|V0693|3110|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||4456||4456|7538||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|11039|16599|lyfalmen|V0694|5196|1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||11039||11039|16599||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|60715|79863|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||60715||60715|79863||3 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|65383|85767|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||65383||65383|85767||2 022050|J01CF0202|Cloxacillin Villerton|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.03.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|XEU|2127|4333|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Villerton Invest SA|Kloxacillín||2127||2127|4333||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|87645|113924|lyfsjukr|||1|1200|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||87645||87645|113924||2 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|Clikstar/JuniorStar pennar|A10AB06|01.07.2010||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|3518|6247|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||3518||3518|6247||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|228408|290183|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||228408||228408|290183||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|237419|301390|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||237419||237419|301390||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|þpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9988|17215|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||9988||9988|17215||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|IRE|0|0|0|100|XEU|12745|18947|lyfalmen|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||12745||12745|18947||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1793|3090|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||1793||1793|3090||2 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|þpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1133|1953|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1133||1133|1953||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3002|2785|lyfalmen|V0056|2320|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1003||1003|2785||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|5323|3588|lyfalmen|V0057|2320|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1586||1586|3588||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1698|2927|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||1698||1698|2927||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|480|2066|lyfalmen|V0914|2066|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||480||480|2066||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1446|3395|lyfalmen|V0949|3395|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1446||1446|3395||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1099|1894|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1099||1099|1894||2 022517|H01BA0207|Minirin Lyfjaver|nefúði|2,5|mcg/sk|5|ml|1|glas||H01BA02|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|0|100|NOK|2572|4945|lyfalmen|||0|5|1|5,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Desmópressín||||2572|4945||3 022533|J01FA0104|Abboticin|mixt.kyr|40|mg/ml|100|ml|1|glas||J01FA01|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|970|2740|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Erýtrómýcín||||970|2740||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|IKR|1540|3431|lyfalmen|V0321|3431|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3431||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5409||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|áf.spr||B01AX05|01.10.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|19565|28334|lyfalmen|||1|8|0|40,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||19565||19565|28334||2 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||3599||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|IKR|1407|3342|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|3342||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|TCA|0|0|0|30|IKR|2450|3731|lyfalmen|V0125|2285|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1690||1690|3731||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|63251|83070|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||63251||63251|83070||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|20337|28792|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||20337||20337|28792||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|31752|43230|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||31752||31752|43230||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|3000|3057|lyfalmen|V0125|2285|2|30|0|20,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||1200||1200|3057||2 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|15455|22677|lyfalmen|||1|98|0|98,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||15455||15455|22677||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|þpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RTH|0|0|0|30|IKR|5231|4571|lyfalmen|V0125|4571|2|60|0|40,0000|Alvogen|ratiopharm GmbH|Ísótretínóín||2300||2300|4571||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|13213|16132|lyfalmen|V0256|16132|2|100|0|44,4400|Alvogen|ratiopharm GmbH|Gabapentín||10700||10700|16132||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|6514|9663|lyfalmen|V0254|9663|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Gabapentín||6000||6000|9663||2 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|0|0|0|0|G|0|LUX|0|0|0|100|DKK|16243|23762|lyfalmen|||1|98|0|196,0000|POA Pharma Scandinavia AB|Merus Labs Luxco S.à R.L.|Darífenacín||16243||16243|23762||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1929|2684|lyfalmen|V0250|1985|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||929||929|2684||2 023347|L01XX2501|Targretin|hylki|75|mg|100|stk|1|pakki||L01XX25|01.12.2015||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|282079|356934|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|bexarotene||||282079|356934||2 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2489|3030|lyfalmen|V0251|2203|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||1181||1181|3030||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|15183|22303|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||15183||15183|22303||1 023485|D08AC0301|Brolene|augndr|0,1|%|10|ml|1|dr.gl.||D08AC03|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2943|5456|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Propamidine||||2943|5456||2 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SND|0|0|0|100|XEU|13605|20131|lyfalmen|V0029|5719|1|100|0|100,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||13605||13605|20131||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1620|3635|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||1620||1620|3635||2 023608|N01AB0802|Sevofluran Baxter|innö.guf|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|103838|135252|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||103838||103838|135252||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2644|lyfalmen|V0066|2400|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2644||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2850|lyfalmen|V0449|2752|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2850||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|536|2143|lyfalmen|V0448|2081|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||536||536|2143||2 023847|N06AX1106|Mirtazapin Krka|filmhtfl|45|mg|100|stk|1|þpakki||N06AX11|01.04.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4049|6222|lyfalmen|||2|100|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||3500||3500|6222||2 023897|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2327|3057|lyfalmen|V0673|3057|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1200||1200|3057||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|58780|77415|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||58780||58780|77415||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2204|4439|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2204||2204|4439||1 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|1749|3812|lyfalmen|V0222|3215|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||1749||1749|3812||1 024112|A16AA0501|Carbaglu|dreifit.|200|mg|5|stk|1|glas||A16AA05|01.12.2016||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|49207|65307|lyfalmen|||1|5|0|5,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Carglumicsýra||49207||49207|65307||3 024198|C07AB0213|Metoprololsuccinat Hexal|forðatfl|50|mg|100|stk|1|plglas|47,5 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1106|2688|lyfalmen|V0048|2300|2|100|0|31,6600|Artasan ehf|Hexal A/S|Metóprólól||932||932|2688||1 024231|C07AB0213|Metoprololsuccinat Hexal|forðatfl|100|mg|100|stk|1|plglas|95 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|1824|3582|lyfalmen|V0049|3057|2|100|0|63,3300|Artasan ehf|Hexal A/S|Metóprólól||1582||1582|3582||1 024253|C07AB0213|Metoprololsuccinat Hexal|forðatfl|200|mg|100|stk|1|plglas|190 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|3214|5542|lyfalmen|V0054|4571|2|100|0|126,6600|Artasan ehf|Hexal A/S|Metóprólól||3006||3006|5542||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18854|27356|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||18854||18854|27356|31.12.2017|1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6049|9731|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6049||6049|9731||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6049|9731|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6049||6049|9731||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauðölur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10193|15435|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10193||10193|15435||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviður|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10210|15458|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10210||10210|15458||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4362|7409|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4362||4362|7409||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|OPH|0|0|0|100|DKK|42932|57371|lyfalmen|||1|100|0|1,2500|Artasan ehf|Novartis Europharm Ltd|Zoledronsýra||42932||42932|57371||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|10315|15602|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||10315||10315|15602||1 024603|V04CL0001|Soluprick Negativ Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1242|3114|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1242||1242|3114||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|4362|7409|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||4362||4362|7409||1 024626|V04CL0035|SOLUPRICK 620 Gulrætur|lausn|||1|hgl|1|pakki||V04CL|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|15869|23247|lyfalmen|||0|1|1||Distica|Distica - óskráð lyf|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||||15869|23247||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossaværur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6049|9731|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6049||6049|9731||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|6049|9731|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||6049||6049|9731||1 024681|V04CL0002|Soluprick Positiv Kontrol|húðst.pr|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1242|3114|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1242||1242|3114||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1848|3949|lyfalmen|||2|100|0|66,6660|Alvogen|ratiopharm GmbH|Metóprólól||1848||1848|3949||2 025142|D07AB0202|Locoid Crelo|húðfl|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|490|2079|lyfalmen|V0950|2079|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||490||490|2079||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15385|22581|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||15385||15385|22581||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1212|2093|lyfalmen|V0051|2093|2|100|0|33,3333|Alvogen|ratiopharm GmbH|Metóprólól||500||500|2093||2 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|58834|77483|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||58834||58834|77483||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|7623|14633|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||7623||7623|14633||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|12374|18436|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||12374||12374|18436||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|4175|7151|lyfalmen|V0205|1290|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||4175||4175|7151||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|11187|16803|lyfalmen|V0205|3869|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||11187||11187|16803||2 025700|N07AX0101|Salagen|töflur|5|mg|84|stk|1|pakki||N07AX01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|12373|18435|lyfalmen|||0|84|1|28,0000|Distica|Distica - óskráð lyf|pilocarpine||||12373|18435||1 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|35778|48322|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||35778||35778|48322||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|MAR|0|0|0|100|DKK|5360|8782|lyfsjukr|||1|25|0|0,1667|Icepharma hf|Aspen Pharma|Lídókaín||5360||5360|8782||2 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19217|27855|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||19217||19217|27855||1 025895|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|800|2440|lyfalmen|V0597|2440|2|28|0|3,7300|Alvogen|ratiopharm GmbH|Oxýcódon||752||752|2440||2 025906|N02AA0505|Oxycodone ratiopharm|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|2679|4608|lyfalmen|V0598|4608|2|98|0|13,0700|Alvogen|ratiopharm GmbH|Oxýcódon||2327||2327|4608||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|þpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|41048|54988|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||41048|54988||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|27627|38013|lyfalmen|||1|98|0|196,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||27627||27627|38013||1 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|3090|5326|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||3090||3090|5326||1 025978|L03AX1302|Remurel|stl|20|mg/ml|28|áf.spr|1|pakki||L03AX13|01.07.2017||R|0|0|0|1|0|1|IPC|0|0|0|100|XEU|73150|88212|lyfsjukr|||2|28|0|28,0000|Alvogen|Alvogen IPco S.á.r.l.|Glatíramer acetat||67316||67316|88212||1 025997|A07DA0303|Immex|töflur|2|mg|20|stk|1|þpakki||A07DA03|01.09.2015||L|1|0|0|0|0|0|GOV|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Alvogen|Alvogen ehf|Lóperamíð|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1740|3420|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1740||1740|3420||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.09.2015||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|812|2306|lyfalmen|V0447|2306|2|100|0|20,0000|Alvogen|Alvogen ehf|Lóperamíð||655||655|2306||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|7372|12706|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||7372||7372|12706||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15385|22581|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||15385||15385|22581||1 026101|L01CA0501|Javlor|irþ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|33933|45989|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||33933||33933|45989||1 026114|L01CA0501|Javlor|irþ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|169667|217125|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||169667||169667|217125||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1446|3395|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíð||||1446|3395||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5478|8945|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíð||||5478|8945||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|2856|5336|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíð||||2856|5336||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11312|16975|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíð||||11312|16975||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|16951|24736|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíð||||16951|24736||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|þpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|22591|31643|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíð||||22591|31643||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|1044|2842|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Nítrófúrantóín||1044||1044|2842||2 026692|L01XE2701|IMBRUVICA|filmhtfl|140|mg|120|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|873422|1092399|lyfsjukr|||1|120|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||873422|1092399||1 026698|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|4027|6948|lyfalmen|V0099|6948|2|100|0|200,0000|Alvogen|ratiopharm GmbH|Lósartan||4027||4027|6948||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|844|2567|lyfalmen|V0160|2368|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||844||844|2567||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|584|2209|lyfalmen|V0159|2066|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||584||584|2209||2 027017|N06BA0202|Attentin|töflur|5|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|4622|7767|lyfalmen|||1|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||4622|7767||2 027051|A10BK0301|Jardiance|filmhtfl|10|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|16359|23921|lyfalmen|||1|90|0|51,4300|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16359||16359|23921||1 027058|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|100|stk|1|þpakki||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2043|2988|lyfalmen|V0823|2988|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||1150||1150|2988||2 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|589|2216|lyfalmen|||2|50|0|1,2500|Icepharma hf|Meda AB|Nítrófúrantóín||589||589|2216||2 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1727|3782|lyfalmen|||1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||1727||1727|3782||1 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|9673|6829|lyfalmen|||2|100|0|66,6600|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3941||3941|6829||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|11195|6829|lyfalmen|V0342|6829|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||3941||3941|6829||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2030|4199|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2030||2030|4199||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|5218|8587|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíð||5218||5218|8587||1 027627|N02AE0101|Bupremyl|forðapl|20|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|SEK|3670|6456|lyfalmen|V0945|6456|2|4|0|66,6600|Icepharma hf|Mylan AB|Búprenorfín||3670||3670|6456||2 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|480|2066|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||480||480|2066||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|553|2166|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||553||553|2166||1 027680|V01AA0703|Alutard SQ, býflugur|stl|||5|ml|4|hgl||V01AA07|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|DKK|50941|67500|lyfalmen|||0|20|1||Distica|Distica - óskráð lyf|insects||||50941|67500||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|16315|23861|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16315||16315|23861||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|18757|27222|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||18757|27222||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|18502|26871|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18502||18502|26871||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|25620|35474|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||25620||25620|35474||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|NED|0|0|0|100|XEU|37857|50952|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||37857|50952||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|þpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3417|6108|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Kaflaskipt lyf, prógestógen og östrógen||3417||3417|6108||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|18069|26275|lyfalmen|V0387|26275|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||18069||18069|26275||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyfalmen|||0|30|0|30,0000|Icepharma hf|Mylan AB|Fexófenadín|||||2850||2 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|þpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|15998|23425|lyfalmen|V0386|23425|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||15998||15998|23425||1 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|40264|53996|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||40264||40264|53996||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2092|4284|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Taugaveiki, hreinsaðir mótefnavakar||2092||2092|4284||1 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|33608|45578|lyfalmen|||1|5|0||Vistor hf|Sanofi Pasteur Europe|Gulusótt, veikluð veira||||33608|45578||1 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1348|3260|lyfalmen|V0202|3260|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1348||1348|3260||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1511|3485|lyfalmen|V0428|2763|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1511||1511|3485||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|1335|3242|lyfalmen|||1|56|0|0,9334|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||1335||1335|3242||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|5426|4337|lyfalmen|V0245|3804|1|98|0|32,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||2130||2130|4337||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|10026|9396|lyfalmen|V0232|7447|1|98|0|65,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||5806||5806|9396||1 028599|N04BC0508|Pramipexole Alvogen|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|634|2272|lyfalmen|V0266|2272|2|30|0|1,0600|Alvogen|Alvogen|Pramipexól||630||630|2272||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|6327|12174|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||6327||6327|12174||2 028610|N04BC0508|Pramipexole Alvogen|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2585|3986|lyfalmen|V0267|3650|2|100|0|7,2000|Alvogen|Alvogen|Pramipexól||1875||1875|3986||1 028621|N02BE5105|Citadon Minor|eþ-stíll|365|mg|20|stk|1|pakki||N02BE51|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|4133|7094|lyfalmen|||0|20|1||Distica|Distica - óskráð lyf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||||4133|7094||1 028878|V01AA0703|Alutard SQ, býflugur|stl|||5|ml|1|hgl||V01AA07|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|DKK|39605|53163|lyfalmen|||0|5|1||Distica|Distica - óskráð lyf|insects||||39605|53163||1 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|SDF|0|0|1|100|IKR|1084|2781|lyfalmen|V0625|2005|1|120|0|30,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Flútíkasón||1000||1000|2781||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|5240|8617|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||5240||5240|8617||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|þpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|13060|19381|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||13060||13060|19381||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2305|4578|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2305||2305|4578||1 029211|N02AB0309|Abstral|tungur.t|200|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29805|40768|lyfalmen|V0802|40768|1|30|0|10,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29805||29805|40768||2 029222|N02AB0309|Abstral|tungur.t|400|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29839|40811|lyfalmen|||1|30|0|20,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29839||29839|40811||2 029255|N02AB0309|Abstral|tungur.t|800|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29839|40811|lyfalmen|||1|30|0|40,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29839||29839|40811||2 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|þpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|UAK|0|0|0|100|XEU|1162|3004|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1162||1162|3004||1 029277|N02AB0309|Abstral|tungur.t|100|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|9844|14954|lyfalmen|V0801|13474|1|10|0|1,6700|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||9844||9844|14954||2 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|UAK|0|0|0|100|GBP|246|1744|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríð||246||246|1744||1 029292|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.07.2016||L|1|0|0|0|0|0|TER|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|TERALI PRODUCTS|Meklózín|||||||1 029300|N02AB0309|Abstral|tungur.t|100|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29531|40421|lyfalmen|V0801|40421|1|30|0|5,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29531||29531|40421||2 029311|N02AB0309|Abstral|tungur.t|200|mcg|10|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|9935|15079|lyfalmen|V0802|13589|1|10|0|3,3300|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||9935||9935|15079||2 029335|N02AB0309|Abstral|tungur.t|300|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29805|40768|lyfalmen|||1|30|0|15,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29805||29805|40768||2 029357|N02AB0309|Abstral|tungur.t|600|mcg|30|stk|1|þpakki||N02AB03|01.08.2016||R|0|1|1|0|0|0|KYO|0|0|0|100|DKK|29839|40811|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Ltd|Fentanýl||29839||29839|40811||2 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|1|0|100|SEK|46329|61667|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||46329||46329|61667||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|15640|22932|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||15640||15640|22932||1 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|3403|6089|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||3403||3403|6089||1 029596|N03AX1701|Diacomit|hylki|250|mg|60|stk|1|pakki||N03AX17|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|NOK|35456|47915|lyfalmen|||0|60|1||Distica|Distica - óskráð lyf|stiripentol||||35456|47915||1 029619|N03AX1702|Diacomit mixtúra|mixtduft|250|mg|60|pokar|1|pakki||N03AX17|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|NOK|42370|56660|lyfalmen|||0|60|1||Distica|Distica - óskráð lyf|stiripentol||||42370|56660||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|þpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9713|14774|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||9713|14774||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|þpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9423|14375|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||||9423|14375||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|þpakki|með br.losunarhraða|J01AA02|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|4696|7868|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||4696||4696|7868||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|75791|98931|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||75791||75791|98931||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|151582|194633|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||151582||151582|194633||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029867|N07BA0152|Zonnic Mint|munnh.du|4|mg|20|stk|1|krukka|munnh.duft í posa|N07BA01|01.09.2017||L|0|0|0|0|0|0|NIC|0|0|1|100|IKR|||lyflausa|||0|20|0|2,6666|LYFIS ehf|Niconovum AB|Nikótín|||||||2 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030136|J01CR0205|Spectracillin|filmhtfl|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|1096|2428|lyfalmen|V0168|2428|2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||743||743|2428||2 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|6534|10398|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6534||6534|10398||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|PGB|0|0|0|100|IKR|12900|19160|lyfalmen|V0277|5231|1|100|0|33,3333|Icepharma hf|BGP Products ApS|Klózapín||12900||12900|19160||2 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|0|0|PGB|0|0|0|100|IKR|4000|6911|lyfalmen|V0276|3432|1|100|0|8,3333|Icepharma hf|BGP Products ApS|Klózapín||4000||4000|6911||2 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|13095|22571|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||13095||13095|22571||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|999|2627|lyfalmen|V0051|2093|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||888||888|2627||2 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2755||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|2317|4594|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2317||2317|4594||2 031161|V01AA0702|Alutard SQ, geitungar|stl|||5|ml|4|hgl||V01AA07|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|DKK|52140|69017|lyfalmen|||0|20|1||Distica|Distica - óskráð lyf|insects||||52140|69017||1 031201|L04AX0307|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2095|4288|lyfalmen|||1|0,25|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2095||2095|4288||2 031500|V01AA0702|Alutard SQ, geitungar|stl|||5|ml|1|hgl||V01AA07|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|DKK|39605|53163|lyfalmen|||0|5|1||Distica|Distica - óskráð lyf|insects||||39605|53163||1 031623|N02AB0308|Abstral Sublingval|töflur|100|mcg|10|stk|1|glas||N02AB03|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|11900|17784|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Fentanýl||||11900|17784||2 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4628|7775|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||4628||4628|7775||1 031856|S01XA2003|Lacrisert|augnfl|5|mg|60|stk|1|sett||S01XA20|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|66192|86790|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||||66192|86790||2 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|17377|25323|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lægemidler A/S|Terlípressín||17377||17377|25323||1 032175|N03AX1606|Pregabalin Mylan|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|3675|3025|lyfalmen|V0686|2097|2|56|0|14,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1177||1177|3025||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|16821|24557|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||16821||16821|24557||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|XEU|11627|20040|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||11627||11627|20040||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|þpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|965|2733|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||965||965|2733||2 032745|V03AB0001|Trientine|hylki|300|mg|100|stk|1|pakki||V03AB|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|497863|625309|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|lyf gegn eitrunum||||497863|625309||2 032836|C09CA0107|Losartan Medical Valley|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.06.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2100|2713|lyfalmen|V0069|2506|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan||950||950|2713||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|17049|24871|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||17049|24871||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|34005|46080|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||34005|46080||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|976|1682|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||976||976|1682||2 033195|N02AA5501|Targin|forðatfl|15|mg|28|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|2457|4787|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||2457||2457|4787||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|7307|14033|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríð||||7307|14033||2 033206|N02AA5501|Targin|forðatfl|15|mg|98|stk|1|þpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|8373|12930|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||8373||8373|12930||2 033218|N02AA5501|Targin|forðatfl|30|mg|28|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4917|8173|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||4917||4917|8173||2 033229|N02AA5501|Targin|forðatfl|30|mg|98|stk|1|þpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|14514|21382|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||14514||14514|21382||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1126|2955|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||1126||1126|2955||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|1188|2414|lyfalmen|V0189|2414|2|100|0|50,0000|Alvogen|ratiopharm Oy|Díklófenak||733||733|2414||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|528|1840|lyfalmen|V0188|1840|2|30|0|15,0000|Alvogen|ratiopharm Oy|Díklófenak||316||316|1840||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|13451|12269|lyfalmen|V0185|12269|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||7893||7893|12269||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|66719|87456|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||66719||66719|87456||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1978|3888|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||1978|3888||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|þpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|XEU|1512|2337|lyfalmen|V0098|2337|2|100|0|100,0000|Alvogen|ratiopharm Oy|Enalapríl og þvagræsilyf||677||677|2337||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|13318|19736|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||13318||13318|19736||2 034494|N05CM1801|Dexdor|irþ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|53827|71151|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||53827||53827|71151||1 034553|M03CA0101|Dantrium|hylki|25|mg|100|stk|1|pakki||M03CA01|01.01.2017||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|5670|9209|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Dantrolene||||5670|9209||2 034616|N05CM0202|Heminevrin mixtúra|mixtúra|50|mg/ml|300|ml|1|fl||N05CM02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|3654|6434|lyfalmen|||0|300|1||Distica|Distica - óskráð lyf|Clómetíazól||||3654|6434||1 034796|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.10.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|3278|4158|lyfalmen|V0323|4158|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|4158||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1180|3029|lyfalmen|V0367|3029|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1180||1180|3029||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2129|4335|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2129||2129|4335||1 034988|L03AB0702|Rebif|stl|44|mcg/,5ml|1,5|ml|4|rörlyk|132 mcg pr. rörlykju|L03AB07|01.03.2010||R|0|0|0|1|0|1|MSF|0|0|0|100|SEK|87877|114217|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd*|Interferón beta-1a||87877||87877|114217||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|6118|9826|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||6118||6118|9826||1 035113|B05XA0501|Addex-Magnesium|irþ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1793|3873|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Magnesíum súlfat||1793||1793|3873|28.02.2018|1 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|1992|4147|lyfalmen|||1|14|0|7,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||1992|4147||1 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|12491|18598|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||12491||12491|18598||1 035494|C07AB0211|Metoprolol ratiopharm|forðatfl|23,75|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|876|2267|lyfalmen|V0050|2079|2|100|0|15,8300|Alvogen|ratiopharm GmbH|Metóprólól||626||626|2267||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|0|0|0|0|G|0|GPA|0|0|0|100|IKR|1844|2330|lyfalmen|V0244|2330|2|56|0|9,3300|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||672||672|2330||1 035528|C07AB0211|Metoprolol ratiopharm|forðatfl|47,5|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1064|2525|lyfalmen|V0048|2300|2|100|0|31,6600|Alvogen|ratiopharm GmbH|Metóprólól||814||814|2525||2 035563|C07AB0211|Metoprolol ratiopharm|forðatfl|95|mg|100|stk|1|þpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|1900|3087|lyfalmen|V0049|3057|2|100|0|63,3300|Alvogen|ratiopharm GmbH|Metóprólól||1222||1222|3087||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6589|10474|lyfalmen|V0080|5259|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||6589||6589|10474||1 035597|C07AB0211|Metoprolol ratiopharm|forðatfl|190|mg|100|stk|1|þpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|4152|4626|lyfalmen|V0054|4571|2|100|0|126,6600|Alvogen|ratiopharm GmbH|Metóprólól||2340||2340|4626||2 035722|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|4409|2919|lyfalmen|V0233|2919|2|18|0|18,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||1100||1100|2919||1 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.12.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|DKK|919|2670|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Digoxín||||919|2670||2 035926|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|0|0|0|0|0|0|GEB|0|0|0|100|XEU|22720|31806|lyfalmen|V0680|12141|1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||22720||22720|31806||1 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5856|9465|lyfalmen|V0081|5259|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||5856||5856|9465||1 036261|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|6626|10525|lyfalmen|||1|28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||6626|10525||2 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|592|2220|lyfalmen|V0929|2162|1|20|0|8,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||592||592|2220||2 036502|N06DA0301|Exelon|forðapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|15799|23151|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15799||15799|23151||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|1042|2839|lyfalmen|||1|60|0|3,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||1042||1042|2839||2 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|1142|1968|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||1142||1142|1968||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036558|B01AC0902|Flolan|sts|1,5|mg|1|hgl|1|pakki||B01AC09|01.03.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|NOK|23900|33299|lyfsjukr|||0|1|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Epoprostenol||||23900|33299||3 036577|L01XE0104|Imatinib Mylan|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|140239|87226|lyfsjukr|||2|30|0||Icepharma hf|Mylan AB|Imatiníb||66537||66537|87226||2 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|2056|4235|lyfalmen|||1|125|0|6,2500|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||2056||2056|4235||2 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|623|2262|lyfalmen|||1|30|0|12,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||623||623|2262||2 036754|N03AX1608|Pregabalina Tecnigen|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|8601|4272|lyfalmen|V0689|4086|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||2083||2083|4272||2 036968|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|60|stk|1|glas|hart|A02BC01|01.03.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|1955|lyfalmen|V0006|1173|2|60|0|60,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|1955||2 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|6045|6356|lyfalmen|V0532|6147|1|84|0|28,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||3597||3597|6356||1 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|10287|8813|lyfalmen|V0533|8743|1|84|0|56,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||5382||5382|8813||1 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|þpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|15401|16320|lyfalmen|V0534|16170|1|84|0|112,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Rópíníról||10836||10836|16320||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1979|4129|lyfalmen|V0434|4129|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1979||1979|4129||2 037471|C07AB0214|Bloxazoc|forðatfl|200|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3533|4571|lyfalmen|V0054|4571|2|100|0|126,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||2300||2300|4571||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.02.2013|28.02.2018|R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1796|2781|lyfalmen|||2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2781||1 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2428||1 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3549||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5826|9424|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||5826|9424||1 038305|N06AX1611|Duofaxin|forðatfl|150|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2426|2686|lyfalmen|V0335|2686|2|98|0|147,0000|Vistor hf|MediLink A/S|Venlafaxín||931||931|2686||1 038386|R06AE0706|Zensitin|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2785|3694|lyfalmen|V0321|3431|1|100|0|100,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Paroxetín||1663||1663|3694||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1347|2456|lyfalmen|V0110|2368|2|100|0|133,3333|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2456||1 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|821|2535|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||821||821|2535||2 038540|G04BE0808|Tadalafil Sandoz|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|3852|5697|lyfalmen|V0924|4598|2|4|0|4,0000|Artasan ehf|Sandoz A/S|Tadalafíl||3118||3118|5697||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|11464|17184|lyfalmen|||1|42|0|31,5000|Icepharma hf|Bayer AG|Rivaoxaban||||11464|17184||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|24128|33587|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||24128||24128|33587||2 039395|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|13831|13930|lyfalmen|||2|50|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||9100||9100|13930||1 039413|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1350|3263|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1350||1350|3263||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|4727|7911|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||4727||4727|7911||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|þpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGB|0|0|0|100|XEU|15621|22906|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||15621||15621|22906||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|þpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2526|4882|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||2526||2526|4882||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|321|1847|lyfalmen|V0541|1833|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||321||321|1847||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|463|1856|lyfalmen|V0542|1829|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||328||328|1856||2 039776|J01FA1001|Zitromax|mixtduft|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|847|2571|lyfalmen|V0821|2162|1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||847||847|2571||1 039784|J01FA1001|Zitromax|mixtduft|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|1485|3449|lyfalmen|V0822|2781|1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1485||1485|3449||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1630|2456|lyfalmen|V0110|2321|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2456||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|5415|3774|lyfalmen|V0182|3774|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||1721||1721|3774||1 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|GPA|0|0|1|100|GBP|1383|1973|lyfalmen|V0033|1973|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||413||413|1973||1 040148|C07AB0702|Bisoprolol ratiopharm|töflur|5|mg|98|stk|1|pakki||C07AB07|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1950|4089|lyfalmen|||0|98|1||Parlogis hf|Parlogis - óskráð lyf|bisoprolol||||1950|4089||2 040313|N02AB0306|Instanyl|nefúði|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|7764|12091|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||7764||7764|12091||1 040323|J01GB0601|Biklin|stl|250|mg/ml|5|lykjur|1|þpakki||J01GB06|01.12.2015||R|0|0|0|0|0|1|PCO|0|0|0|100|DKK|22850|31971|lyfsjukr|||0|5|1||Distica|Distica - óskráð lyf|amikacin||||22850|31971||1 040484|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|þpakki||N07BA01|01.11.2016|31.12.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|HES|0|0|0|100|DKK|||lyfalmen|||0|15|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||2218||1 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|71267|93209|lyfsjukr|||1|5|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Misóprostól||||71267|93209||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|775|2068|lyfalmen|V0174|2038|2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||482||482|2068||1 040742|C08CA0203|Felodipin ratiopharm|forðatfl|2,5|mg|100|stk|1|þpakki||C08CA02|01.11.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2339|4158|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Felódipín||2000||2000|4158||2 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|7114|11197|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7114||7114|11197||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|þpakki||C01EB17|01.04.2014||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|7263|11402|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||7263||7263|11402||2 041693|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.07.2016||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|45947|87341|vetalmen|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||45947||45947|87341||2 041731|C01EA0101|Prostivas|irþ|0,5|mg/ml|1|ml|5|stk||C01EA01|01.05.2014||R|0|0|0|0|0|1|PCO|0|0|0|100|IKR|124888|161433|lyfsjukr|||0|5|1||Distica|Distica - óskráð lyf|Alprostadil ||||124888|161433||1 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2844|4902|vetorma|||0|100|0||Vistor hf|Intervet International BV|||2844||2844|4902||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|852|2578|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||852||852|2578||2 041942|N06AX1106|Mirtazapin Krka|filmhtfl|15|mg|300|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7000|9663|lyfalmen|||2|300|0|150,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9663||2 041951|N06AX1106|Mirtazapin Krka|filmhtfl|30|mg|250|stk|1|glas||N06AX11|01.01.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|7926|9663|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Mirtazapín||6000||6000|9663||2 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1095|2912|lyfalmen|V0922|2912|1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1095||1095|2912||1 042270|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|6000|9113|lyfalmen|||2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||5600||5600|9113||2 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1913|4038|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1913||1913|4038||1 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3187|5792|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3187||3187|5792||1 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1731|3787|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||1731||1731|3787||1 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2289|4555|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||2289||2289|4555||1 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1672|3706|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1672||1672|3706||1 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1894|4012|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1894||1894|4012||1 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|með nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|1818|3907|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Mænusótt, dauð veira||1818||1818|3907||1 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2612|5000|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2612||2612|5000||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1825|3917|lyfsjukr|||2|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með kol­vetnum||1825||1825|3917||1 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyflausa|||0|4000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||||1 042678|B03BA0303|Vitamin B12 depot|stl|1500|mcg/ml|1|ml|10|stk||B03BA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3415|6105|lyfalmen|||0|10|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Hýdroxókóbalamín||||3415|6105||2 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|2843|5318|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||2843||2843|5318||2 042865|N01BB0204|Lidokain Mylan|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1120|2946|lyfalmen|V0560|2946|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1120||1120|2946||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|411|1971|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||411||411|1971||2 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|12539|5697|lyfalmen|V0516|5697|2|100|0|66,6700|Alvogen|Pharmathen S.A.|Levetíracetam||3118||3118|5697||1 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|3045|5596|lyfalmen|||1|120|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||3045||3045|5596||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|419|1982|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||419||419|1982||1 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúðaðar|B03AA07|01.09.2009||L|1|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|1|0|0|G|0|LVR|0|0|1|100|CHF|10779|16241|lyfalmen|V0637|16241|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||10779||10779|16241||3 044492|G02AD0602|Angusta|töflur|25|mcg|8|stk|1|pakki||G02AD06|01.06.2017||R|0|0|0|1|0|1|ZAA|0|0|0|100|DKK|11934|17831|lyfsjukr|||1|8|0|1,0000|Azanta Danmark A/S|Azanta Danmark A/S|Misóprostól||11934||11934|17831||2 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|264919|335592|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||264919||264919|335592||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|þpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|375302|472878|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||375302||375302|472878||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|4427|7498|lyfalmen|||1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4427||4427|7498||2 044739|N04BC0502|Sifrol|forðatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|13014|19317|lyfalmen|V0635|13539|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||13014||13014|19317||1 044752|N04BC0502|Sifrol|forðatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|34670|46921|lyfalmen|V0636|37379|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||34670||34670|46921||1 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045475|A10BK0301|Jardiance|filmhtfl|25|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|5541|9032|lyfalmen|||1|30|0|42,8600|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||5541||5541|9032||1 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1050|2220|lyfalmen|V0109|2081|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||592||592|2220||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|868|2079|lyfalmen|V0108|2051|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||490||490|2079||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg|10|hgl|1|pakki|lausn / dreifa|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|1643|3666|lyfsjukr|||2|10|0|2,5000|Icepharma hf|Villerton Invest SA|Cefúroxím||||1643|3666||2 045599|J01DC0204|Cefuroxim Villerton|sts/irs|1500|mg|10|hgl|1|pakki|lausn|J01DC02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2359|4652|lyfsjukr|||2|10|0|5,0000|Icepharma hf|Villerton Invest SA|Cefúroxím||||2359|4652||2 045634|N02AJ0603|Pinex Comp Forte|eþ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AJ06|01.01.2011||R|0|0|0|0|0|0|GRP|0|0|1|100|XEU|317|1841|lyfalmen|||2|10|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Kódein og Paracetamól||317||317|1841||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|GRP|0|0|0|100|SEK|1574|3571|lyfalmen|||2|30|0|7,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||1574||1574|3571||1 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1179|3028|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||||1179|3028||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|663|2317|lyfalmen|V0648|2258|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||663||663|2317||1 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|524|1777|lyfalmen|V0021|1777|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríð||270||270|1777||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|636|1964|lyfalmen|V0022|1964|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríð||406||406|1964||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|815|2203|lyfalmen|V0023|2093|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríð||580||580|2203||1 046485|L01BC0502|Gemcitabin Hospira|irþ|38|mg/ml|1|hgl|1|pakki||L01BC05|01.12.2015||R|0|0|0|1|0|1|PIS|0|0|0|100|SEK|6011|9678|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Gemcitabín||6011||6011|9678||1 046724|R01AD0802|Nasofan|nefúði|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSA|0|0|1|100|IKR|1264|2506|lyfalmen|V0625|2506|2|150|0|37,5000|Alvogen|Teva Sweden AB|Flútíkasón||800||800|2506||2 046797|N03AG0109|Orfiril Long|forðahlk|300|mg|100|stk|1|pakki||N03AG01|01.04.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|2726|5157|lyfalmen|||0|100|1|20,0000|Distica|Distica - óskráð lyf|Valpróínsýra||||2726|5157||1 046812|M05BA0605|Ibandronic acid Alvogen|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.02.2012||R|0|1|0|0|G|0|POF|0|0|0|100|IKR|4372|3951|lyfalmen|V0205|3869|2|3|0|90,0000|Alvogen|Alvogen|Íbandrónsýra||1850||1850|3951||1 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|730|2410|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||730||730|2410||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|19832|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|19832||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|63218|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|63218||5 047986|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|8530|4112|lyfalmen|V0420|3359|2|30|0|30,0000|Alvogen|Alvogen ehf|Bíkalútamíð||1967||1967|4112||1 047998|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|GOV|0|0|0|100|XEU|12032|5834|lyfalmen|V0421|5056|2|30|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||3218||3218|5834||1 048015|B05AA0115|Albumin Baxalta|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|3691|6485|lyfsjukr|||1|250|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||3691||3691|6485||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6884|10880|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||6884||6884|10880||1 048043|B05AA0115|Albumin Baxalta|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAG|0|0|0|100|SEK|5988|9647|lyfsjukr|||1|100|0||Shire Sweden AB |Baxalta Innovations GmbH|Albúmín||5988||5988|9647||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2096|2602|lyfalmen|V0324|1995|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||870||870|2602||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|899|2642|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||899||899|2642||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2368|2653|lyfalmen|V0325|2653|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||907||907|2653||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2948|4644|lyfalmen|V0326|4644|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2353||2353|4644||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|3251|3840|lyfalmen|V0327|3840|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1769||1769|3840||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|906|2652|lyfalmen|||1|100|0||Icepharma hf|Meda AB|Klídín og geðlyf||906||906|2652||2 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9721|14785|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||9721||9721|14785||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|þpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1427|3369|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1427||1427|3369||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999|28.02.2018|R|0|1|0|1|G|0|ROC|0|0|0|100|DKK|46652|62076|lyfalmen|||1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||46652||46652|62076||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GEB|0|1|0|100|XEU|684364|857264|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||684364||684364|857264||1 048744|N02BE0101|Panodil|filmhtfl|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|326|1854|lyfalmen|V0230|1852|1|100|0|16,6667|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||326||326|1854||1 048770|B05ZB0001|Hemosol BO|blóð.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GAA|0|0|0|100|SEK|3235|5858|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3235||3235|5858||2 048784|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|33513|45457|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||33513||33513|45457||3 048797|G04CA0208|Tamsulosin Mylan|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.11.2016||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3807|3307|lyfalmen|V0148|3110|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1382||1382|3307||2 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1590|3593|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||1590||1590|3593||1 049033|C08DB0108|Cardil|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3582|3570|lyfalmen|V0599|2099|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||1573||1573|3570||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|4217|7209|lyfalmen|V0376|2737|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||4217|7209||1 049116|H01CB0501|Signifor|sts|20|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|311424|393431|lyfsjukr|||1|1|0|16,6700|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||311424||311424|393431||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|12387|18454|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||12387||12387|18454||2 049319|H02AB0910|Hydrokortison Orion|töflur|10|mg|30|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|822|2536|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Hýdrókortisón||822||822|2536||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2718|5146|lyfalmen|V0655|4026|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||2718||2718|5146||2 049579|C10AA0104|Simvastatin Alvogen|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1154|2220|lyfalmen|V0109|2081|2|98|0|65,3400|Alvogen|Alvogen ehf|Simvastatín||592||592|2220||1 049597|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006|31.12.2017|R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1780|2653|lyfalmen|||2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||907||907|2653||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|701|2370|lyfalmen|V0496|2300|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||701||701|2370||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|DKK|||lyflausa|||0|30|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1122|2949|lyfalmen|V0649|2781|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1122||1122|2949||1 049834|N02BE0113|Pinex Junior|eþ-stíll|125|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,4167|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1748||1 049845|N02BE0113|Pinex Junior|eþ-stíll|250|mg|10|stk|1|þpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|0,8333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1748||1 049856|N02BE0114|Pinex|eþ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1845||1 049894|N02BG1001|Sativex|munnhúði|52|mg|10|ml|3|úðagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|64777|85000|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||64777||64777|85000||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|140129|180388|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||140129||140129|180388||3 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|7007|11049|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||7007||7007|11049||3 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|17516|25514|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||17516||17516|25514||3 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|35032|47379|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||35032||35032|47379||3 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|69935|91524|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||69935||69935|91524||3 049964|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 050068|J05AP5401|Zepatier|filmhtfl|150|mg|28|stk|1|þpakki|100mg/50mg|J05AP54|01.05.2017||R|0|0|0|1|0|1|MLD|0|1|0|100|DKK|1662857|2074236|lyfsjukr|||1|28|0||Vistor hf|Merck Sharp & Dohme Limited|Elbasvir og grazoprevir||1662857||1662857|2074236||1 050117|G04BE0309|Vizarsin|munndr.t|100|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|7599|lyfalmen|||2|24|0|48,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||4500||4500|7599||2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3536||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2959|5478|lyfalmen|||2|90|0|120,0000|Alvogen|ratiopharm GmbH|Alfúzósín||2959||2959|5478||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|55848|73707|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||55848|73707||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050563|N03AX1606|Pregabalin Mylan|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|980|2104|lyfalmen|V0685|1508|2|56|0|4,6667|Mylan AB|Generics (UK) Ltd.|Pregabalín||508||508|2104||2 050577|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3000|5534|lyfalmen|||2|100|0|37,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||3000||3000|5534||2 050604|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.01.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1899|2242|lyfalmen|V0088|2242|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||608||608|2242||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|9976|15136|lyfalmen|V0688|4635|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||9976||9976|15136||1 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|4378|4751|lyfalmen|V0042|3731|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2431||2431|4751||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4615|5259|lyfalmen|V0002|5259|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2800||2800|5259||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|4360|2231|lyfalmen|V0006|1955|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||600||600|2231||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|6304|2919|lyfalmen|V0001|2781|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1100||1100|2919||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051227|G03HA0101|Androcur|stl|100|mg/ml|3|ml|3|hgl||G03HA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|13742|20319|lyfalmen|||0|9|1|9,0000|Parlogis hf|Parlogis - óskráð lyf|Cýpróterón||||13742|20319||2 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|903|2484|lyfalmen|V0363|2484|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||784||784|2484||2 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2779|4401|lyfalmen|V0365|4401|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||2177||2177|4401||2 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|17481|25466|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||17481||17481|25466||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|662|2316|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||662||662|2316||1 052160|N02CA5202|Anervan Novum|töflur|160,5|mg|100|stk|1|pakki||N02CA52|01.10.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|1966|4111|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Blönduð ergótamínlyf||1966||1966|4111||2 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|153|1616|lyfalmen|||2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||153||153|1616||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|361|1902|lyfalmen|V0305|1053|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||361||361|1902||2 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|229|1720|lyfalmen|V0439|1720|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||229||229|1720||2 052317|R02AX0101|Strefen|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|527|2130|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||527||527|2130||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|509|2106|lyfalmen|V0305|2106|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||509||509|2106||2 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BMS|0|1|0|100|DKK|461468|580044|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Dasatíníb||461468||461468|580044||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2686|5102|lyfalmen|||1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Tímólól í blöndum||2686||2686|5102||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|27804|38237|lyfsjukr|||1|8212|0||Vistor hf|Fresenius Kabi AB|Blöndur||27804||27804|38237||1 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22604|31660|lyfsjukr|||1|7698|0||Vistor hf|Fresenius Kabi AB|Blöndur||22604||22604|31660||1 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|23260|32489|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||23260||23260|32489||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|20395|28866|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||20395||20395|28866||2 052737|N05AX1205|Aripiprazol Krka|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|4946|4571|lyfalmen|V0682|4502|2|56|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||2300||2300|4571||2 052790|N06BA0904|Atomoxetine Sandoz|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9168|7494|lyfalmen|V0815|7494|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Atomoxetín||4424||4424|7494||1 052838|A10BJ0201|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|11933|17830|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||11933||11933|17830||1 053055|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|þpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|4330|7365|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||4330||4330|7365||1 053155|N02AA5501|Targin|forðatfl|60|mg|28|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|9659|14700|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||9659||9659|14700||2 053166|N02AA5501|Targin|forðatfl|60|mg|98|stk|1|þpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|28769|39457|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||28769||28769|39457||2 053200|N02AA5501|Targin|forðatfl|7,5|mg|98|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|4816|8034|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||4816||4816|8034||2 053211|N02AA5501|Targin|forðatfl|7,5|mg|28|stk|1|þpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1412|3343|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1408||1408|3343||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4596|7731|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||4596||4596|7731||1 053304|C10AA0508|Lipistad|filmhtfl|80|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|7435|11638|lyfalmen|V0115|11638|2|100|0|400,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||7435||7435|11638||2 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDH|0|0|0|100|XEU|23261|32491|lyfalmen|V0453|30180|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíð||23261||23261|32491||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|8729|13420|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||8729||8729|13420||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1235|3105|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1235||1235|3105||1 053991|D10AF0101|Dalacin|húðlausn|10|mg/ml|30|ml|1|glas||D10AF01|01.07.1985||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|921|2673|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||921||921|2673||1 054122|C05CA0201|Venoruton|hylki|300|mg|100|stk|1|glas||C05CA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|2557|4924|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Monoxerutin||||2557|4924||1 054157|N02BE0121|Paracetamol|irl|10|mg/ml|100|ml|10|hgl||N02BE01|01.03.2016||R|0|0|0|0|0|1|PCO|0|0|0|100|DKK|911|2659|lyfsjukr|||0|1000|1||Distica|Distica - óskráð lyf|Paracetamól||||911|2659||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|2876|5363|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Haemophilus influenzae B||2876||2876|5363||1 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|4|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1909|4032|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||1909||1909|4032||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|þpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2618|5008|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||2618||2618|5008||1 054369|J05AP0101|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AP01|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|33487|45425|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||33487||33487|45425||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 054506|N05BB0101|Atarax|filmhtfl|10|mg|100|stk|1|þpakki||N05BB01|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2706|5129|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Hýdroxýzín||||2706|5129||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|SEK|987|2763|lyfalmen|V0907|2319|1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||987||987|2763||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|908|2655|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||908||908|2655||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|TCA|0|0|0|100|XEU|1157|2997|lyfalmen|V0061|2997|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1157||1157|2997||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|CES|1|0|0|100|DKK|4493|8695|vetalmen|||0|10|0||Icepharma hf|Ceva Sante Animale|Buprenorphinhýdróklóríð||4493||4493|8695||2 054896|C05AE0101|Rectogesic|eþ-krem|4|mg/g|30|g|1|túpa||C05AE01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|12805|14113|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|glyceryl trinitrate||9233||9233|14113||2 054960|N04BC0902|Neupro - Distica/Vistor|forðapl|4|mg/sólh|7|stk|1|pakki||N04BC09|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|7280|11425|lyfalmen|||0|7|1|5,0000|Distica|Distica - óskráð lyf|rotigotine||||7280|11425||1 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TAB|0|0|0|100|XEU|16317|23864|lyfalmen|||2|100|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||16317||16317|23864||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|þpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TAB|0|0|0|100|XEU|5753|4843|lyfalmen|V0187|4114|2|50|0|12,5000|Alvogen|Teva Pharma B.V.|Mýcófenólsýra||2498||2498|4843||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|1647|3672|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Moxífloxacín||||1647|3672||1 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|7431|11633|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||7431||7431|11633||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|IKR|1470|3359|lyfalmen|V0467|2218|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1420||1420|3359||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 055889|R03DA0404|Theo-Dur|forðatfl|200|mg|100|stk|1|glas||R03DA04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|3366|6038|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráð lyf|theophylline||||3366|6038||1 055968|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2177|4401|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2177||2177|4401||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|2217|3052|lyfalmen|V0112|2781|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1197||1197|3052||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|3113|3139|lyfalmen|V0113|2781|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1260||1260|3139||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|4522|3139|lyfalmen|V0114|2781|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Atorvastatín||1260||1260|3139||1 056308|N07XX0701|Fampyra|forðatfl|10|mg|28|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|25841|35754|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||25841||25841|35754||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|21738|37468|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||21738||21738|37468||2 056500|B01AF0301|Lixiana|filmhtfl|15|mg|10|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|2715|5142|lyfalmen|||1|10|0|2,5000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||2715||2715|5142||1 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|1169|3014|lyfalmen|||1|40|0|10,0000|Icepharma hf|Meda AB|Erýtrómýcín||1169||1169|3014||2 056664|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|GPA|0|0|0|100|XEU|2997|3463|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1495||1495|3463||1 056675|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|GPA|0|0|0|100|XEU|2940|3423|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1466||1466|3423|31.12.2017|1 056763|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|2139|4349|lyfalmen|||1|15|0||Icepharma hf|Meda AB|Pímekrólímus||2139||2139|4349||2 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|173320|221669|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||173320||173320|221669||2 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7135|11226|lyfalmen|V0095|6312|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||7135||7135|11226||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2859|5340|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2859||2859|5340||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3042|5592|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíð||3042||3042|5592||1 057365|N06AX1614|Venlafaxin Krka|forðahlk|75|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2859|2781|lyfalmen|V0334|2741|2|100|0|750,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2781||2 057376|N06AX1614|Venlafaxin Krka|forðahlk|150|mg|100|stk|1|tfílát|hart|N06AX16|01.02.2018||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3700|2781|lyfalmen|V0335|2741|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||1000||1000|2781||2 057401|N06DA0404|Galantamine Portfarma|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|16230|23744|lyfalmen|||2|84|0|84,0000|Alvogen|Alvogen|Galantamín||16230||16230|23744||1 057422|B05XA3102|Tracel|irþ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3941|6829|lyfsjukr|||1|200|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||3941||3941|6829||1 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2143|4355|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||2143||2143|4355||1 057492|L01XC1001|Arzerra|irþ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|251443|318832|lyfsjukr|||1|50|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||251443||251443|318832||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011|31.12.2017|R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|329770|416249|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||329770||329770|416249||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|8437|6221|lyfalmen|V0607|4984|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||3499||3499|6221||2 057979|L01BC5901|Lonsurf|filmhtfl|21,14|mg|20|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|87811|114134|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||87811|114134||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|16256|23780|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||16256|23780||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|339|1872|lyfalmen|||1|5|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Bútýlskópólamín||339||339|1872||1 058207|H01CB0501|Signifor|sts|40|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|332946|420199|lyfsjukr|||1|1|0|33,3300|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||332946||332946|420199||1 058283|QI01AD0401|Avipro Thymovac|frþlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|130602|225106|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||130602|225106||2 058294|QI01AD0401|Avipro Thymovac|frþlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|198397|341957|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||198397|341957||2 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|1043|2841|lyfalmen|||1|100|0|2,5000|Icepharma hf|Meda AB|Trímetóprím||1043||1043|2841||2 058609|N05AX1302|Xeplion|stl|50|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|29332|40169|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||29332||29332|40169||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4203|7190|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||4203||4203|7190||2 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|964|2732|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||964||964|2732||1 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1388|3315|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1388||1388|3315||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|þpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGH|0|0|0|100|IKR|2374|2644|lyfalmen|V0006|1095|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||900||900|2644||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|8900|13655|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||8900||8900|13655||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|75838|98990|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||75838||75838|98990||1 059644|J02AX0601|Ecalta|st/irþ|100|mg|30|ml|1|hgl||J02AX06|01.11.2015||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|51373|68047|lyfsjukr|||1|30|0|30,0000|Icepharma hf|Pfizer Limited|Anidulafungin||51373||51373|68047||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|þpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|20915|29524|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||20915||20915|29524||1 059803|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|4412|7478|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AB|Nífedipín||||4412|7478||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|7201|11316|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||7201||7201|11316||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|36008|48613|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||36008||36008|48613||1 060114|N02AB0305|Fentanyl ratiopharm|forðapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|1671|3699|lyfalmen|V0219|3699|2|5|0|7,5000|Alvogen|ratiopharm GmbH|Fentanýl||1667||1667|3699||2 060123|N02AB0305|Fentanyl ratiopharm|forðapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|2965|5224|lyfalmen|V0220|5224|2|5|0|15,0000|Alvogen|ratiopharm GmbH|Fentanýl||2775||2775|5224||2 060132|N02AB0305|Fentanyl ratiopharm|forðapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|4274|7055|lyfalmen|V0221|7055|2|5|0|22,5000|Alvogen|ratiopharm GmbH|Fentanýl||4105||4105|7055||2 060141|N02AB0305|Fentanyl ratiopharm|forðapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|4542|7530|lyfalmen|V0223|7530|2|5|0|30,0000|Alvogen|ratiopharm GmbH|Fentanýl||4450||4450|7530||2 060581|A10BD2001|Synjardy|filmhtfl|1012,5|mg|180|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|16680|24363|lyfalmen|V0713|24363|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||16680||16680|24363||1 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|6061|9747|lyfalmen|||0|100|1|75,0000|Distica|Distica - óskráð lyf|Klómípramín||||6061|9747||1 061112|L04AA3101|AUBAGIO|filmhtfl|14|mg|28|stk|1|þpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGB|0|1|0|100|XEU|108358|140874|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíð||108358||108358|140874||1 061218|D10AE0104|Basiron AC|hlaup|5|%|40|g|1|túpa||D10AE01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1592|3596|lyfalmen|||0|40|1||Parlogis hf|Parlogis - óskráð lyf|benzoyl peroxide||||1592|3596||2 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|85174|53897|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||40186||40186|53897||2 061388|C10AA0508|Lipistad|filmhtfl|10|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1994|2781|lyfalmen|V0112|2781|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||1000||1000|2781||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|4918|8174|lyfalmen|V0133|6725|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||4918||4918|8174||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|MBV|0|0|0|100|DKK|4602|7739|lyfalmen|V0133|6725|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Tíbólón||4602||4602|7739||1 061775|A06AH0301|Moventig|filmhtfl|25|mg|30|stk|1|þpakki||A06AH03|01.11.2017||R|1|0|0|0|0|0|KYO|0|0|0|100|XEU|10470|15816|lyfalmen|||1|30|0|30,0000|Icepharma hf|Kyowa Kirin Ltd|Naloxegol||10470||10470|15816||2 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|3339|6001|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||3339||3339|6001||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|12772|18984|lyfsjukr|||1|1|0|1,2500|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||12772||12772|18984||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|1|0|1|0|1|MLD|0|0|0|100|DKK|17774|25869|lyfsjukr|||1|1|0|1,7900|Vistor hf|Merck Sharp & Dohme Limited|Daptomýcín||17774||17774|25869||1 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|þpakki||L04AA06|01.08.2010||R|0|1|0|1|G|0|GPA|0|0|0|100|XEU|11767|12342|lyfalmen|V0187|12342|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||7946||7946|12342||1 062347|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|15000|13793|lyfalmen|V0924|13793|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||9000||9000|13793||2 062575|J05AP0801|Sovaldi|filmhtfl|400|mg|28|stk|1|glas||J05AP08|01.09.2015||R|0|0|0|1|0|1|GIL|0|1|0|100|XEU|1716692|2141191|lyfsjukr|||1|28|0|28,0000|Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir||||1716692|2141191||1 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|þpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|746|2432|lyfalmen|V0308|2342|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||746||746|2432||1 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|14503|24997|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||14503||14503|24997||2 062793|J05AE1002|Darunavir Alvogen|filmhtfl|600|mg|60|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|62769|82460|lyfsjukr|||2|60|0|30,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||62769||62769|82460||1 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|10090|12917|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||8364||8364|12917||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|4609|7749|lyfalmen|||1|10|0|1,6667|Artasan ehf|Novartis Healthcare A/S|Famcíclóvír||4609||4609|7749||1 063180|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.05.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1473|3432|lyfalmen|V0276|3432|2|100|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||1473||1473|3432||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4547|5231|lyfalmen|V0277|5231|2|100|0|33,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Klózapín||2780||2780|5231||1 063514|C07AB0214|Bloxazoc|forðatfl|50|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|500|2024|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||450||450|2024||2 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Icepharma hf|Meda AB|Laktúlósa|||||3000||2 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1751|3153|lyfalmen|V0123|3153|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Terbínafín||1270||1270|3153||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|3346|6010|lyfalmen|V0458|2919|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3346||3346|6010||2 063926|L04AC0701|RoActemra|stl|162|mg|4|áf.spr|1|pakki||L04AC07|01.12.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|119249|154419|lyfsjukr|||1|4|0|32,4000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||119249||119249|154419||2 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1642|3665|lyfalmen|V0310|3176|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||1642||1642|3665||1 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|FEI|0|0|0|100|XEU|754585|944599|lyfsjukr|||1|20|0|11,6300|Icepharma hf|Ferrer Internacional S.A.|Treprostiníl natríum||||754585|944599||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|FEI|0|0|0|100|XEU|349332|440578|lyfsjukr|||1|20|0|4,6500|Icepharma hf|Ferrer Internacional S.A.|Treprostiníl natríum||||349332|440578||2 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|FEI|0|0|0|100|XEU|3083893|3841606|lyfsjukr|||1|20|0|46,5100|Icepharma hf|Ferrer Internacional S.A.|Treprostiníl natríum||||3083893|3841606||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|1|0|1|0|1|FEI|0|0|0|100|XEU|1371973|1712457|lyfsjukr|||1|20|0|23,2600|Icepharma hf|Ferrer Internacional S.A.|Treprostiníl natríum||||1371973|1712457||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1648|3598|lyfalmen|V0009|3598|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1593||1593|3598||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|þpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|5256|5719|lyfalmen|V0029|5719|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||3134||3134|5719||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|953|1873|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||953||953|1873||1 064488|G03BA0310|Tostran|hlaup|2|%|60|mg|1|pakki||G03BA03|01.10.2017||R|0|0|0|0|G|0|LDR|0|0|0|100|SEK|5707|9260|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|Testósterón||5707||5707|9260||2 064727|QI09AE0401|Enterisol Ileitis vet.|frþlyf|||50|skammtar|1|hgl|+100 ml leysir, dreifa|QI09AE04|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5439|9375|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|lawsonia||||5439|9375||1 064732|A03BB0101|Buscopan|húðuðtfl|10|mg|100|stk|1|þpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1665|3697|lyfalmen|||1|100|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Bútýlskópólamín||1665||1665|3697||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|808|2275|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Inflúensa, hreinsaðir mótefnavakar||632||632|2275||1 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|32724|44460|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||32724||32724|44460||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|ASS|0|0|1|100|DKK|669|2326|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda AS|Metóklópramíð||669||669|2326||1 064939|G04BD0804|Solifenacin Actavis|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.03.2015|31.12.2017|R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|14260|17602|lyfalmen|||2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||11768||11768|17602||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|ASS|0|0|1|100|DKK|385|1935|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda AS|Metóklópramíð||385||385|1935||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|STE|0|0|0|100|DKK|1545|3531|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||1545||1545|3531|31.01.2018|1 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065339|A07EA0604|Cortiment|forðatfl|9|mg|30|stk|1|þpakki||A07EA06|01.09.2015||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|12733|18931|lyfalmen|||1|30|0|30,0000|Vistor hf|Ferring Lægemidler A/S|Búdesóníð||12733||12733|18931||1 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|8695|13373|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||8695||8695|13373||2 065468|M01AH0503|Coxerit|filmhtfl|60|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8600|7458|lyfalmen|V0830|7177|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4398||4398|7458||2 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|42011|56206|lyfalmen|V0451|46698|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||42011||42011|56206||3 065729|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forðapl|15|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|954|2297|lyfalmen|V0163|2297|2|70|0|5,6000|Alvogen|ratiopharm GmbH|Amoxicillín og beta-laktamasa hemill ||648||648|2297||2 065752|N07BA0142|Nicorette Invisi|forðapl|10|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065753|N02AB0303|Fentanyl Actavis|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.05.2016||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1315|3215|lyfalmen|V0222|3215|2|5|0|3,6000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1315||1315|3215||1 065775|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|14|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forðapl|25|mg/16kls|7|stk|1|þpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065827|N02AJ0601|Parkodin|filmhtfl|510|mg|200|stk|1|pakki|þp 10+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|2141|4352|lyfalmen|||2|200|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||2141||2141|4352||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|2747|5186|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||2747||2747|5186||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|588|2214|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||588||588|2214||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|1609|3620|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1609||1609|3620||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|GPA|0|0|0|100|SEK|2827|5296|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||2827||2827|5296||1 066013|A11HA0801|Vedrop|mixtúra|50|mg/ml|20|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|8679|13351|lyfalmen|||0|20|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||8679||8679|13351||3 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|3618|7035|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||3618||3618|7035||2 066235|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|3792|4912|lyfalmen|V0716|4846|2|28|0|28,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||2548||2548|4912||1 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|4596|7731|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||4596||4596|7731||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|24701|34312|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Hýdróxyetýl sterkja||24701||24701|34312||1 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|758|2448|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||758||758|2448||2 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|XEU|1162|3004|lyfalmen|V0006|1955|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||1162||1162|3004||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|757|2447|lyfalmen|V0036|2447|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||757||757|2447||2 066760|L02AB0101|Megace|töflur|160|mg|30|stk|1|pakki||L02AB01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|9450|14412|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Megestról||||9450|14412||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGH|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|3140|5727|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||3140||3140|5727||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|7092|11166|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||7092||7092|11166||1 067215|C01BC0402|Flecainid STADA|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.01.2018||R|1|0|0|1|G|0|ASR|0|0|0|100|IKR|3320|5975|lyfalmen|V0933|5975|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Flekaíníð||3320||3320|5975||2 067229|J05AR1901|Odefsey|filmhtfl|250|mg|30|stk|1|glas|200+25+25 mg|J05AR19|01.09.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|104509|136087|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtricitabine, tenofovir alafenamide og rilpivirine||||104509|136087||2 067877|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2010|4171|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||2010|4171||2 068358|L01XC1001|Arzerra|irþ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|86748|112789|lyfsjukr|||1|15|0||Vistor hf|Novartis Europharm Ltd|Ofatúmúmabi||86748||86748|112789||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEA|0|0|0|100|DKK|1193|3047|lyfalmen|||1|20|0|10,0000|Icepharma hf|Meda AB|Flekaíníð||1193||1193|3047||2 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEA|0|0|0|100|DKK|4072|7010|lyfalmen|V0933|5975|1|100|0|50,0000|Icepharma hf|Meda AB|Flekaíníð||4072||4072|7010||2 068509|R01AD0902|Kalmente|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.11.2015||L|0|0|0|0|G|0|IPC|0|0|1|100|IKR|||lyfalmen|V0677|2304|2|140|0|35,0000|Alvogen|Alvogen IPco S.á.r.l.|Mómetasón|||||3030||1 068555|J05AB1106|Valablis|filmhtfl|500|mg|40|stk|1|þpakki||J05AB11|01.06.2017||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|5483|3659|lyfalmen|V0182|3594|2|40|0|6,6700|Alvogen|Alvogen|Valacíklóvír||1638||1638|3659||1 068629|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.02.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|5689|6082|lyfalmen|||2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||3398||3398|6082||1 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2 068811|L04AX0307|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2597|4979|lyfalmen|||1|0,55|0|11,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2597||2597|4979||2 068896|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2023|4189|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||2023||2023|4189||1 068905|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1891|4008|lyfsjukr|||2|400|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||1891||1891|4008||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3529||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3712||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|200|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3483||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|400|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3662||1 069106|H01BA0201|Minirin|frþ.tfl|240|mcg|30|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|11395|17089|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||11395||11395|17089||1 069115|H01BA0201|Minirin|frþ.tfl|240|mcg|100|stk|1|þpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|35968|48563|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||35968||35968|48563||1 069347|C02KX0501|Adempas|filmhtfl|1|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|324443|409623|lyfsjukr|||1|84|0|18,6700|Vistor hf|Bayer AG|Riociguatum||324443||324443|409623||1 069423|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|CON|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|GlaxoSmithKline Consumer Healthcare A/S|Terbínafín|||||||1 069912|J05AF1301|Vemlidy|filmhtfl|25|mg|30|stk|1|þpakki||J05AF13|01.08.2017||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|53887|71227|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír alafenamíð||||53887|71227||2 070113|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forðahlk|4|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4489|7584|lyfalmen|V0589|7584|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||4489||4489|7584||1 070563|B02BD0208|Afstyla|sts|250|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|18118|26343|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||18118||18118|26343||2 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|8252|12763|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||8252||8252|12763||1 070921|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2016||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|5631|9706|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||5631||5631|9706||1 071029|C07AB0214|Bloxazoc|forðatfl|25|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|445|2017|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||445||445|2017||2 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|47076|62612|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíð||47076||47076|62612||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|238086|302219|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíð||238086||238086|302219||1 071359|A07AA0202|Nystimex|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.09.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|4701|7875|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Nýstatín||||4701|7875||1 071528|N03AX1608|Pregabalina Tecnigen|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|3905|2558|lyfalmen|V0686|2097|2|56|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||838||838|2558||2 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GEB|0|0|0|100|XEU|61384|80709|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||61384|80709||1 071998|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|504|2099|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||504||504|2099||2 072021|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.06.2015||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|384|1933|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||384||384|1933||2 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|5653|10895|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||5653||5653|10895||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|þpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|5256|5750|lyfalmen|V0029|5719|2|100|0|100,0000|Alvogen|Pharmathen S.A.|Klópídógrel||3157||3157|5750||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184552|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184552||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir þrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|184552|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Önnur sjúkdómsgreiningarefni||143477||143477|184552||5 072701|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|200|stk|1|glas|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|6000|6911|lyfalmen|V0148|6911|2|200|0|200,0000|Medical ehf|Medical ehf|Tamsúlósín||4000||4000|6911||2 072735|L04AX0306|Metojectpen|stl|20|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2783|5235|lyfalmen|||1|1|0|8,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2783||2783|5235||2 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|447|2020|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||447||447|2020||1 072918|N01AH0301|Sufenta|stl|50|mcg/ml|5|ml|5|stk||N01AH03|01.01.2016||R|0|0|1|0|0|1|PCO|0|0|0|100|IKR|13810|20413|lyfsjukr|||0|25|1||Distica|Distica - óskráð lyf|Súfentaníl||||13810|20413||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|47051|62580|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||47051||47051|62580||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7135|6565|lyfalmen|V0286|6265|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||3749||3749|6565||1 073178|A10BA0204|Metformin Sandoz|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.01.2016||R|0|0|0|0|G|0|SHS|0|0|0|100|DKK|373|1888|lyfalmen|V0500|1873|2|100|0|25,0000|Artasan ehf|Sandoz A/S|Metformín||351||351|1888||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|þpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|293213|370782|lyfsjukr|||1|30|0|30,0000|Vistor hf|Actelion Registration Ltd.|Macitentan||||293213|370782||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|541413|679473|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||541413||541413|679473||1 073520|N02AE0101|Bupremyl|forðapl|10|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|SEK|1964|4108|lyfalmen|V0944|4108|2|4|0|33,3300|Icepharma hf|Mylan AB|Búprenorfín||1964||1964|4108||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2738|5174|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Dútasteríð og tamsúlósínhýdroklóríð||2738||2738|5174||1 073682|L01XE1301|Giotrif|filmhtfl|50|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|235113|298522|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||235113||235113|298522||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|þpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|13451|12269|lyfalmen|V0185|12269|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||7893||7893|12269||1 073803|G04BE0806|Tadalafil Krka|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4700|5534|lyfalmen|V0924|4598|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||3000||3000|5534||2 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|415|1976|lyfalmen|V0439|1720|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||415||415|1976||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|1128|2957|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1128||1128|2957||1 073879|A10AB0601|Apidra|stl|100|ein/ml|10|ml|1|hgl||A10AB06|01.12.2017||R|0|0|0|0|G|0|OSK|0|0|0|100|NOK|2251|4503|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Insúlín glúlisín||||2251|4503||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|þpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|926|2679|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||926||926|2679||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|2825|4869|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||2825||2825|4869||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|778|2476|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||778||778|2476||2 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|2563|4933|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||2563||2563|4933||1 074364|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|40|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|917|2616|lyfalmen|V0932|2616|2|40|0|20,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||880||880|2616||2 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|627|2268|lyfalmen|||2|25|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||627||627|2268||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Alvogen|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|494|2085|lyfalmen|||2|50|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||494||494|2085||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|803|2510|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||803||803|2510||1 074608|N03AX1606|Pregabalin Mylan|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5717|5658|lyfalmen|V0689|4086|2|56|0|56,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||3090||3090|5658||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|þpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|588|2129|lyfalmen|V0923|2046|2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||526||526|2129||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|þpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|741|2389|lyfalmen|V0510|2287|2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||715||715|2389||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|613|2249|lyfalmen|||1|60|0|12,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||613||613|2249||2 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|309|1830|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||309||309|1830||2 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1795|3876|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Azatíóprín||1795||1795|3876||2 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|4422|7491|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4422||4422|7491||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|12965|19250|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||12965||12965|19250||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|4671|7834|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4671||4671|7834||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1540|3525|lyfalmen|V0363|2484|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1540||1540|3525||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|13676|20229|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||13676||13676|20229||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02AJ0601|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02AJ06|01.07.2007||R|2|0|1|0|0|0|GPA|0|0|1|100|IKR|3144|5732|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||3144||3144|5732||1 075096|N02AJ0602|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AJ06|01.07.2007||R|2|0|1|0|0|0|GPA|0|0|1|100|IKR|4555|7674|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||4555||4555|7674||1 075140|R03AL0601|Spiolto Respimat|innöndl|5|mcg|1|rörlyk|1|pakki|2,5+2,5 mcg|R03AL06|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|6771|10725|lyfalmen|||1|1|0||Vistor hf|Boehringer Ingelheim International GmbH|Olodaterol og tiotropiumbromide||6771||6771|10725||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||L|0|0|0|0|0|0|NBV|0|0|0|100|DKK|||lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hægðalyf með osmótíska verkun|||||4144||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|þpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3299|4485|lyfalmen|V0445|4485|2|98|0|98,0000|Alvogen|Alvogen|Fínasteríð||2238||2238|4485||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|981|1928|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||981||981|1928||1 075865|G04BD0805|Solifenacin Alvogen|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|10276|14245|lyfalmen|V0440|14245|2|90|0|90,0000|Alvogen|Alvogen|Sólífenacín||9329||9329|14245||1 075869|B05DB0005|Balance|kvið.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|4440|7516|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4440||4440|7516||2 075888|B05DB0005|Balance|kvið.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|NOK|4440|7516|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4440||4440|7516||2 075906|B05DB0005|Balance|kvið.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|4873|8112|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||4873||4873|8112||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|þpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|UAK|0|0|0|100|GBP|573|2194|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||573||573|2194||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|þpakki|80+400 mg|J01EE01|01.12.2009|31.12.2017|R|0|0|0|0|0|0|TAV|0|0|1|100|XEU|501|2094|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||501||501|2094||1 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|þpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|5150|8493|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||5150||5150|8493||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15779|23123|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||15779|23123||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|þpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15829|23192|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||15829||15829|23192||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|þpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|15860|23235|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||15860||15860|23235||1 076166|G02AD0401|Prostinfenem|stl|0,25|mg/ml|1|lykja|1|pakki||G02AD04|01.01.2016||R|0|0|0|0|0|1|PCO|0|0|0|100|IKR|5693|9241|lyfsjukr|||0|1|1||Distica|Distica - óskráð lyf|Carboprost||||5693|9241||1 076237|G04BE0309|Vizarsin|filmhtfl|50|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1605|2368|lyfalmen|V0143|1106|2|4|0|4,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||700||700|2368||2 076248|G04BE0309|Vizarsin|filmhtfl|50|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2971|3478|lyfalmen|V0143|2212|2|8|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1506||1506|3478||2 076259|G04BE0309|Vizarsin|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3742|3607|lyfalmen|V0143|3317|2|12|0|12,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1600||1600|3607||2 076270|G04BE0309|Vizarsin|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1667|2520|lyfalmen|V0144|1267|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||810||810|2520||2 076282|G04BE0309|Vizarsin|filmhtfl|100|mg|8|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|3208|3804|lyfalmen|V0144|2533|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||1743||1743|3804||2 076293|G04BE0309|Vizarsin|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.07.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|7023|4158|lyfalmen|V0144|3800|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||2000||2000|4158||2 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076378|N05AX0805|Risperidon Alvogen|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1553|2713|lyfalmen|V0290|2231|2|60|0|6,0000|Alvogen|Alvogen ehf|Risperídón||950||950|2713||1 076387|N05AX0805|Risperidon Alvogen|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1604|2644|lyfalmen|V0291|2231|2|60|0|12,0000|Alvogen|Alvogen ehf|Risperídón||900||900|2644||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1217|3080|lyfalmen|||1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1217||1217|3080||1 076435|G04BE0313|Sildenafil Medical Valley|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|4200|4006|lyfalmen|V0144|3800|2|12|0|24,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1890||1890|4006||2 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2231|lyfalmen|V0290|2231|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||600||600|2231||2 076667|B02BD0207|ReFacto AF|sts|3000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|217166|276201|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||217166||217166|276201||1 076680|B02BD0207|ReFacto AF|sts|2000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|144778|186170|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||144778||144778|186170||1 076691|B02BD0207|ReFacto AF|sts|1000|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|72500|94768|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||72500||72500|94768||1 076702|B02BD0207|ReFacto AF|sts|500|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|36463|49189|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||36463||36463|49189||1 076781|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|98|stk|1|glas||N02AA05|01.09.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|2327|4608|lyfalmen|V0598|4608|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2327||2327|4608||1 076792|B02BD0208|Afstyla|sts|1000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|70070|91695|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||70070||70070|91695||2 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 077213|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|30|stk|1|þpakki||A02BC05|01.09.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|1933|2093|lyfalmen|V0005|2093|2|30|0|40,0000|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||500||500|2093||1 077324|B02BD0102|Cofact|sts|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.02.2015||R|0|0|0|1|0|1|SPP|0|0|0|100|XEU|42901|57331|lyfsjukr|||1|1|0||Williams & Halls efh|Sanquin Plasma Product|Storkuþættir lX,ll,Vll,X||42901||42901|57331||2 077420|N02AJ0601|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02AJ06|01.01.1985||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|367|1910|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||367||367|1910||1 077446|N02AJ0601|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02AJ06|01.01.1985||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|1042|2839|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1042||1042|2839||1 077606|N06BA0405|Medikinet|töflur|5|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|819|2532|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||819||819|2532||2 077615|N06BA0405|Medikinet|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|874|2300|lyfalmen|V0671|2300|2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||650||650|2300||2 077624|N06BA0405|Medikinet|töflur|20|mg|30|stk|1|þpakki||N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2324|4604|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2324||2324|4604||2 077633|N06BA0406|Medikinet CR|hylki|10|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|3300|5947|lyfalmen|||2|30|0|10,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||3300||3300|5947||2 077642|N06BA0406|Medikinet CR|hylki|20|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|5000|8287|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||5000||5000|8287||2 077652|N06BA0406|Medikinet CR|hylki|30|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|6300|10076|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||6300||6300|10076||2 077661|N06BA0406|Medikinet CR|hylki|40|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8120|12581|lyfalmen|||2|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||8120||8120|12581||2 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|594|2223|lyfalmen|||1|10|0|0,8333|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||594||594|2223||1 077881|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.05.2016||R|1|1|0|0|G|0|TVA|0|0|0|100|IKR|8800|6616|lyfalmen|V0275|6346|2|100|0|12,5000|Alvogen|Teva B.V.|Quetíapín||3786||3786|6616||2 078013|H03BB0210|Thiamazol|töflur|5|mg|100|stk|1|glas||H03BB02|01.06.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|8424|13000|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|thiamazole||||8424|13000||1 078145|B01AF0301|Lixiana|filmhtfl|30|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|8145|12616|lyfalmen|||1|30|0|15,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||8145||8145|12616||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078227|G03HA0105|Cyproteron|töflur|50|mg|50|stk|1|pakki||G03HA01|01.06.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7296|8386|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Cýpróterón||5072||5072|8386||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12324|lyfalmen|V0419|12230|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||7933||7933|12324||1 078457|QD11AH9001|Apoquel|töflur|16|mg|100|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|25272|48117|vetalmen|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||25272||25272|48117||2 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|539|2147|lyfalmen|||1|20|0|2,5000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||539||539|2147||2 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|818|2531|lyfalmen|||1|40|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||818||818|2531||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7148|5535|lyfalmen|V0069|2456|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3001||3001|5535||1 079109|J05AP0701|Daklinza|filmhtfl|60|mg|28|stk|1|þpakki||J05AP07|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1136577|1419691|lyfsjukr|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1136577||1136577|1419691||1 079272|N06DX0109|Marbodin|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2071|3882|lyfalmen|V0901|3882|2|30|0|15,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1800||1800|3882||2 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 079409|N03AX1604|Brieka|hylki|225|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|8833|10393|lyfalmen|V0688|8277|2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||6530||6530|10393||1 079410|N05AX1207|Lemilvo|töflur|10|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|10342|10367|lyfalmen|V0683|8039|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||6511||6511|10367||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|þpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2790|5245|lyfalmen|V0315|5245|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2790||2790|5245||1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|þpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSA|0|0|0|100|IKR|9500|5935|lyfalmen|V0184|5646|2|100|0|100,0000|Alvogen|Teva Sweden AB|Anastrózól||3291||3291|5935||2 079654|R05CB0106|Mucolysin|freyðit|600|mg|10|stk|1|pakki||R05CB01|01.04.2016||L|0|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|10|0|12,0000|Artasan ehf|Sandoz A/S|Acetýlcýstein|||||||1 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|1662|3692|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||1662||1662|3692||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|393|1946|lyfalmen|||2|10|0|2,5000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||393||393|1946||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|638|2283|lyfalmen|V0418|2283|2|20|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||638||638|2283||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|647|2295|lyfalmen|V0177|2295|2|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||647||647|2295||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|1164|3007|lyfalmen|V0411|3007|2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cíprófloxacín||1164||1164|3007||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9628|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9628||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3215|6270|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3215|6270||2 080162|N03AX1608|Pregabalina Tecnigen|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|6588|3376|lyfalmen|V0687|3099|2|56|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Pregabalín||1432||1432|3376||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|12032|6324|lyfalmen|V0421|5056|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||3574||3574|6324||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|þpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|8731|15049|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||8731||8731|15049||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|BFP|0|0|0|100|XEU|7763|5975|lyfalmen|||2|30|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Letrózól||3320||3320|5975||1 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1835|3931|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1835||1835|3931||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|4418|7486|lyfalmen|||1|30|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||4418||4418|7486||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhraða|N06AX12|01.07.2007||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2159|4377|lyfalmen|||1|30|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||2159||2159|4377||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010|31.12.2017|R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1326|2692|lyfalmen|||2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||935||935|2692||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|11994|17913|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||11994||11994|17913||1 080621|B01AF0301|Lixiana|filmhtfl|30|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|27151|37411|lyfalmen|||1|100|0|50,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||27151||27151|37411||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|23645|32976|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||23645||23645|32976||1 080987|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|þpakki||G03XB01|01.06.2015||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|2558|4917|lyfsjukr|||1|1|0|1,0000|Alvogen|Linepharma France|Mifepriston||2552||2552|4917||1 081185|N06BA0903|Atomoxetin Medical Valley|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8449|8623|lyfalmen|V0815|7494|2|28|0|14,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||5244||5244|8623||2 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|þpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|PHH|0|1|0|100|DKK|588491|738025|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||588491||588491|738025||1 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|BEE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|SmithKline Beecham Ltd.|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|4313|3929|lyfalmen|V0515|3929|2|100|0|16,6700|Alvogen|Pharmathen S.A.|Levetíracetam||1834||1834|3929||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|þpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|3695|6491|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lægemidler A/S|Prógesterón||3695||3695|6491||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1687|3727|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1687||1687|3727||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|3824|6668|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insúlín glúlisín||3824||3824|6668||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDH|0|0|0|100|XEU|5386|8818|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5386||5386|8818||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|13661|8002|lyfalmen|V0184|5533|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||4793||4793|8002||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kælt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082237|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.04.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|23223|32443|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||23223||23223|32443||2 082334|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|10213|17603|vetorma|||0|10|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||10213||10213|17603||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostþurrkað stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|44457|76626|vetorma|||0|50|0||Vistor hf|Virbac S.A|Bóluefni gegn nokkrum kattaveirum||44457||44457|76626||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|501|2094|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||501||501|2094||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|þpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RTH|0|0|1|100|XEU|589|2139|lyfalmen|V0229|2139|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Paracetamól||533||533|2139||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|2127|4333|lyfalmen|||1|60|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||2127||2127|4333||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3560|6305|lyfalmen|||1|60|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3560||3560|6305||1 082830|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.01.2016||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2828|5297|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2828||2828|5297||1 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3079|5643|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3079||3079|5643||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|4225|6489|lyfalmen|V0080|5366|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3694||3694|6489||1 083053|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.12.2015||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|2980|5507|lyfalmen|||1|100|0|16,6700|Icepharma hf|BGP Products ApS|Hvatablöndur (lípasi, próteasi o.s.frv.)||2980||2980|5507||2 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4178|7156|lyfalmen|V0701|6360|1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4178||4178|7156||1 083275|N03AX1604|Brieka|hylki|75|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5868|3880|lyfalmen|V0686|3745|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1798||1798|3880||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4938|9539|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||4938||4938|9539||2 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|713|2305|lyfalmen|V0231|2245|1|300|0|50,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||654||654|2305||1 083875|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|4116|5169|lyfalmen|V0624|3759|2|30|0|36,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2735||2735|5169||1 084182|V03AC0301|Exjade|filmhtfl|180|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|131936|170198|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||131936||131936|170198||1 084192|N05BA1206|Alprazolam Krka|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1623|3639|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1623||1623|3639||2 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|54964|72589|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||54964||54964|72589||1 084736|C08CA0601|Nimotop|stl|0,2|mg/ml|250|ml|1|glas||C08CA06|01.03.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|NOK|16799|24527|lyfsjukr|||0|250|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|nimodipine||||16799|24527||3 084744|C09CA0604|Kairasec|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|5488|8734|lyfalmen|V0215|8734|2|98|0|392,0000|Acare ehf|Medical Valley Invest AB|Candesartan||5325||5325|8734||2 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|34479|46679|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||34479||34479|46679||1 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|10162|15392|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||10162||10162|15392||1 085171|A10BJ0101|Byetta|stl|5|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|12174|18161|lyfalmen|||1|60|0|20,0000|Vistor hf|AstraZeneca AB|Exenatide||12174||12174|18161||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|XEU|29211|40016|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||29211||29211|40016||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2082|4271|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2082||2082|4271||2 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|703|2373|lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||703||703|2373||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3875|6738|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3875||3875|6738||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|16498|24113|lyfalmen|||1|375|0|5,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||16498||16498|24113||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001|31.12.2017|R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|31063|42359|lyfalmen|||1|750|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||31063||31063|42359||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|13878|19484|lyfalmen|V0652|19382|1|100|0|50,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||13135||13135|19484||1 085736|H02AB0703|Lodotra|töflur|5|mg|30|stk|1|glas||H02AB07|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|DKK|4739|7928|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Prednisón||||4739|7928||2 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|þpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|NED|0|0|0|100|XEU|72450|94705|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||72450||72450|94705||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|þpakki||N07XX02|01.11.2012||R|1|0|0|1|G|0|GPA|0|0|0|100|SEK|19880|23581|lyfalmen|V0579|23581|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||16112||16112|23581||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|1|0|0|0|0|AEB|0|0|0|100|DKK|25842|35755|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||25842||25842|35755||1 085829|S01EB0104|Pilokarpin|augndr|2|%|0,5|ml|20|skammt||S01EB01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3919|6799|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||||3919|6799||2 085830|L01XA0211|Carboplatin Actavis|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|3391|6072|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||3391||3391|6072||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|2144|4356|lyfalmen|V0465|3372|1|3|0|30,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||2144||2144|4356||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|6328|10115|lyfalmen|V0465|10115|1|9|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Bimatóprost||6328||6328|10115||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|þpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|304|1823|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||304||304|1823||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1567|3562|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1567||1567|3562||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|4695|7867|lyfalmen|V0365|4401|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||4695||4695|7867||1 086142|N07XX0701|Fampyra|forðatfl|10|mg|56|stk|1|þpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|45596|60740|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||45596||45596|60740||2 086191|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17653|25703|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17653||17653|25703||1 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|6187|9921|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||6187||6187|9921||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|6715|10647|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Ceftazidím||6715||6715|10647||1 086324|A02BC0501|Nexium|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9609|14631|lyfalmen|V0012|5530|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9609||9609|14631||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|23484|32773|lyfalmen|||1|600|0|8,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||23484|32773||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|42515|56843|lyfalmen|||1|1200|0|16,0000|Vistor hf|Ferring Lægemidler A/S|Menótrópín||||42515|56843||1 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|41030|54965|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||41030||41030|54965||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|13433|19894|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||||13433|19894||2 086553|C08CA0601|Nimotop|töflur|30|mg|100|stk|1|pakki||C08CA06|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|16819|24555|lyfalmen|||0|100|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|nimodipine||||16819|24555||2 086743|J01AA0210|Vibranord|mixtúra|10|mg/ml|60|ml|1|glas||J01AA02|01.03.2016||R|0|0|0|0|0|0|LVE|0|0|0|100|NOK|3308|5958|lyfalmen|||0|60|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Doxýcýklín||||3308|5958||3 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|39823|53438|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||39823||39823|53438||2 087046|R06AX2706|Flynise|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||||1 087094|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|30|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|680|2300|lyfalmen|V0931|2300|2|30|0|15,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||650||650|2300||2 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|þpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|282|1793|lyfalmen|V0060|1717|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||282||282|1793||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|97372|126226|lyfsjukr|||1|60|0|15,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||97372||97372|126226||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|191|1668|lyfalmen|V0312|545|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||191||191|1668||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|168|1636|lyfalmen|V0312|1636|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||168||168|1636||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|1414|3351|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1414||1414|3351||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|18467|16248|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||10784||10784|16248||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|GRP|0|0|0|100|XEU|16058|16248|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||10784||10784|16248||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||4028||1 087727|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1520|3497|lyfalmen|V0952|2942|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1520||1520|3497||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|þpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|27617|47601|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||27617||27617|47601||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|þpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húðúði|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3562|6928|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3562||3562|6928||1 088020|S01EE0105|Monoprost|augndr|50|mcg/ml|6|ml|1|glas|án rotvarnarefnis|S01EE01|01.01.2018||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3930|6814|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||3930||3930|6814||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|20058|34572|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||20058||20058|34572||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2494|4838|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2494||2494|4838||2 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|RGO|0|0|1|100|DKK|851|2576|lyfalmen|||1|120|0|30,0000|Vistor hf|Glaxo Group Limited|Flútíkasón fúróat||851||851|2576||1 088300|L04AX0306|Metojectpen|stl|17,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2572|4945|lyfalmen|||1|1|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2572||2572|4945||2 088445|N05AX1205|Aripiprazol Krka|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|9197|4571|lyfalmen|V0684|4502|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||2300||2300|4571||2 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|7334|11499|lyfalmen|||1|28|0|42,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||7334||7334|11499||1 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|3772|6597|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||3772||3772|6597||1 088697|N06AX1611|Duofaxin|forðatfl|75|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|2328|2686|lyfalmen|V0334|2686|2|98|0|73,5000|Vistor hf|MediLink A/S|Venlafaxín||931||931|2686||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|6518|10376|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||6518||6518|10376||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|12053|17995|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||12053||12053|17995||1 088737|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.12.2015||R|0|0|0|1|0|1|PCO|0|0|0|100|DKK|5395|8831|lyfsjukr|||0|30|1|3,0000|Distica|Distica - óskráð lyf|Ritonavír||||5395|8831||1 088917|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|378056|476303|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||378056||378056|476303||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|þpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1177|3025|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1177||1177|3025||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|18628|27044|lyfalmen|||1|10|0||Vistor hf|Sanofi Pasteur MSD|Mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||18628||18628|27044||1 089089|B02BX0501|Revolade|filmhtfl|25|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|105868|137777|lyfsjukr|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||105868||105868|137777||1 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|þpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||6129||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|97372|126226|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Maravíroc||97372||97372|126226||1 089190|H01AC0101|Genotropin|sts|5|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|17067|24896|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||17067||17067|24896||1 089212|H01AC0101|Genotropin|sts|12|mg|1|áf-penni|1|pakki||H01AC01|01.02.2015||R|0|0|0|1|0|1|PLS|0|1|0|100|DKK|40962|54879|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||40962||40962|54879||1 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|1863|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||1863||2 089692|C07AB0214|Bloxazoc|forðatfl|50|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|1419|2300|lyfalmen|V0048|2300|2|100|0|31,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||650||650|2300||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|19728|28559|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||19728||19728|28559||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|78911|102877|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||78911||78911|102877||1 090153|N05AH0414|Quetiapin Hexal|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|12753|14987|lyfalmen|V0261|14987|2|100|0|100,0000|Artasan ehf|Hexal A/S|Quetíapín||9868||9868|14987||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|1969|4115|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1969||1969|4115||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|3939|6827|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3939||3939|6827||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|596|2225|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||596||596|2225||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|4627|7774|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||4627||4627|7774||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|103686|135063|lyfalmen|||1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||103686||103686|135063||3 090607|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|1558|3549|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1558||1558|3549||1 090784|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|674|2333|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíð||674||674|2333||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|11984|17900|lyfsjukr|||1|60|0||Vistor hf|Novartis Healthcare A/S|Flúorescein||||11984|17900||1 091015|N06AX1614|Venlafaxin Krka|forðahlk|37,5|mg|28|stk|1|þpakki|hart|N06AX16|01.02.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|1084|2644|lyfalmen|V0333|2644|2|28|0|10,5000|LYFIS ehf|Krka d.d. Novo mesto|Venlafaxín||900||900|2644||2 091219|N05AH0414|Quetiapin Hexal|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|7148|8793|lyfalmen|V0273|8793|2|100|0|50,0000|Artasan ehf|Hexal A/S|Quetíapín||5368||5368|8793||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2080|4268|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2080||2080|4268||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|3599|6359|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||3599||3599|6359||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|10563|15944|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||10563||10563|15944||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|2825|5293|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||2825||2825|5293||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|5218|8587|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||5218||5218|8587||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|TRI|0|0|1|100|SEK|3048|5600|lyfalmen|||1|30|0||Vistor hf|Trimb Healthcare AB|Dexametasón||3048||3048|5600||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|824|1939|lyfalmen|V0021|1777|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||388||388|1939||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1425|2207|lyfalmen|V0022|1964|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||583||583|2207||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|926|2679|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||926||926|2679||1 092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|3092|5661|lyfalmen|||0|15|1|30,0000|Distica|Distica - óskráð lyf|Escítalópram||||3092|5661||1 092097|QD11AH9001|Apoquel|töflur|16|mg|20|stk|1|þpakki||QD11AH90|01.06.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5482|10571|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|Oclacitinib||5482||5482|10571||2 092176|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC05|01.05.2016||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||||2 092188|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC05|01.08.2017||L|1|0|0|0|0|0|KRK|0|0|0|100|IKR|||lyfalmen|||2|28|0|18,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól|||||2746||2 092199|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2065|4158|lyfalmen|V0011|2673|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4158||2 092210|A02BC0511|Esomeprazol Krka|sþ-hylki|20|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3453|4708|lyfalmen|V0011|4678|2|98|0|65,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||2400||2400|4708||2 092234|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|28|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|1510|2781|lyfalmen|V0005|1953|2|28|0|37,3300|LYFIS ehf|Krka Sverige AB|Esómeprazól||1000||1000|2781||2 092245|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|56|stk|1|þpakki||A02BC05|01.10.2016||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2400|4158|lyfalmen|V0012|3097|2|56|0|74,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2000||2000|4158||2 092256|A02BC0511|Esomeprazol Krka|sþ-hylki|40|mg|98|stk|1|glas||A02BC05|01.10.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4794|5527|lyfalmen|V0012|5419|2|98|0|130,6700|LYFIS ehf|Krka Sverige AB|Esómeprazól||2995||2995|5527||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SND|0|0|0|100|XEU|3859|6716|lyfalmen|V0009|3598|1|28|0|28,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||3859||3859|6716||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1804|3888|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||1804||1804|3888||1 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|653|2304|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||653||653|2304||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|þpakki||M01AB01|01.03.2010||R|0|0|0|0|G|0|UAK|0|0|1|100|GBP|1238|3109|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||1238||1238|3109||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|2660|2861|lyfalmen|V0203|2860|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1058||1058|2861||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|792|2495|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||792||792|2495||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1817|3906|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||1817||1817|3906||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|þpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|3533|6268|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||3533||3533|6268||2 093072|L01XE1101|Votrient|filmhtfl|200|mg|90|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|241011|305857|lyfsjukr|||1|90|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||241011||241011|305857||1 093083|L01XE1101|Votrient|filmhtfl|400|mg|60|stk|1|glas||L01XE11|01.01.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|351662|443476|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Pazópaníb||351662||351662|443476||1 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3911|6788|lyfalmen|||1|1|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||3911||3911|6788||1 093284|G04BD1201|Betmiga|forðatfl|50|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4688|7857|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4688||4688|7857||1 093306|M03AX0105|Xeomin|sts|100|ein/hgl|1|hgl|1|pakki||M03AX01|01.08.2015||R|0|0|0|1|0|1|ERZ|0|0|0|100|XEU|19564|28333|lyfsjukr|||1|1|0||Williams & Halls efh|Merz Pharmaceuticals GmbH|Clostridium botulinum toxín-A||19564||19564|28333||2 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1579|3578|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1579||1579|3578||1 093496|A07EC0204|Asacol|sþ-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4643|7796|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4643|7796||2 093514|A07EC0204|Asacol|sþ-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.03.2016||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|3438|6137|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||3438|6137||2 093668|N01BB0203|Xylocain|húðúði|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.2014||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1940|4075|lyfalmen|||1|50|0||Icepharma hf|Aspen Pharma|Lídókaín||1940||1940|4075||2 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|27981|38461|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||27981||27981|38461||2 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6777|10733|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||6777||6777|10733||2 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|17544|25552|lyfalmen|V0588|17170|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||17544||17544|25552||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|357184|450344|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||357184||357184|450344||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|357184|450344|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||357184||357184|450344||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAC|0|0|0|100|DKK|2767|5213|lyfalmen|V0236|5169|1|6|0|6,0000|Icepharma hf|Almirall S.A.|Almótriptan||2767||2767|5213||2 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|þpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAC|0|0|0|100|DKK|4612|7753|lyfalmen|V0236|7753|1|9|0|9,0000|Icepharma hf|Almirall S.A.|Almótriptan||4612||4612|7753||2 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1414|2779|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1414||1414|2779||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|XEU|839|2560|lyfalmen|||2|25|0|1,2500|Alvogen|ratiopharm GmbH|Acíklóvír||839||839|2560||2 094495|N06AB1007|Escitalopram Bluefish|filmhtfl|5|mg|98|stk|1|þpakki||N06AB10|01.08.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1955|1955|lyfalmen|V0324|1955|2|98|0|49,0000|Vistor hf|Bluefish Pharmaceuticals AB|Escítalópram||400||400|1955||1 094652|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forðatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13458|16170|lyfalmen|V0534|16170|2|84|0|112,0000|Alvogen|Alvogen|Rópíníról||10727||10727|16170||1 094800|S01FB0101|Phenylephrine Minims|augndr|10|%|0,5|ml|20|stk||S01FB01|01.08.2016||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|3990|6897|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Phenylephrine||||3990|6897||2 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|þpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|1|0|1|0|1|VIH|0|0|0|100|DKK|60310|79350|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||60310||60310|79350||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|HAL|0|0|0|100|DKK|37557|50572|lyfalmen|||1|1|0||Vistor hf|Grunenthal GmbH|Capsaicin||||37557|50572||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|5126|8835|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||5126||5126|8835||2 094843|D02AX0001|Oviderm|krem|250|mg/g|100|g|1|túpa||D02AX|01.03.2018||L|0|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|100|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1 095005|B02BC3001|TachoSil|vefjal.n|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|32036|43589|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||32036||32036|43589||1 095092|M03AX0101|Botox|sts|200|ae/hgl|1|hgl|1|pakki||M03AX01|01.04.2016||R|0|0|0|1|0|1|IRE|0|0|0|100|XEU|41260|52763|lyfsjukr|||1|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Clostridium botulinum toxín-A||39289||39289|52763||1 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1787|3865|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráð lyf|Magnesíum hýdroxíð||1787||1787|3865||1 095514|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|301585|381194|lyfalmen|V0919|381194|1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||||301585|381194||2 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|6942|10960|lyfalmen|||1|50|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Dísúlfíram||6942||6942|10960||1 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|12988|19282|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||12988||12988|19282||1 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|13182|19549|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||13182||13182|19549||1 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|15346|22527|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||15346||15346|22527||1 095715|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|1748|3811|lyfsjukr|||2|50|0|0,5000|Alvogen|Alvogen ehf|Flúkónazól||||1748|3811||1 095726|J02AC0105|Fluconazole Alvogen|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|GOV|0|0|0|100|XEU|2763|5208|lyfsjukr|||2|100|0|1,0000|Alvogen|Alvogen ehf|Flúkónazól||||2763|5208||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|779|1965|lyfalmen|V0225|1965|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||407||407|1965||1 095767|R03BA0203|Budesonide Teva|innúðal|0,5|mg/ml|2|ml|20|lykjur||R03BA02|01.07.2015||R|0|0|0|0|G|0|TAB|0|0|0|100|IKR|3740|6360|lyfalmen|V0701|6360|2|40|0|13,3400|Alvogen|Teva Pharma B.V.|Búdesóníð||3600||3600|6360||2 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|4156|8055|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4156||4156|8055||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|5733|11047|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||5733||5733|11047||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHP|0|0|0|100|IKR|9534|18258|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||9534||9534|18258||2 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|97664|126596|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||97664||97664|126596||1 096201|L01XC3201|Tecentriq|irþ|1200|mg|20|ml|1|hgl|lausn|L01XC32|01.01.2018||R|0|1|0|0|0|1|RRL|0|0|0|100|DKK|557241|699159|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Atezolizumab||557241||557241|699159||2 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|11767|17601|lyfalmen|V0347|15492|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||11767||11767|17601||1 096473|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|1|g|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|470|2011|lyfalmen|V0930|2011|2|20|0|10,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||440||440|2011||2 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|594854|745939|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||594854||594854|745939||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|551383|691873|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||551383||551383|691873||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|580402|727965|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||580402||580402|727965||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|636370|797573|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||636370||636370|797573||2 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|10703|16137|lyfalmen|V0349|16137|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||10703||10703|16137||1 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|837|2557|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíð||837||837|2557||2 096768|L02AE0102|Suprecur|nefúði|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNP|0|0|0|100|XEU|9813|14912|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||9813||9813|14912||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|58158|100241|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||58158||58158|100241||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|6404|12320|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||6404|12320||2 097152|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 097269|J01FF0103|Dalacin (Lyf og heilsa)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007|31.12.2017|R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1693|3735|lyfalmen|||3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||1693||1693|3735||2 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.12.2015||R|0|0|0|1|0|1|PCO|0|0|0|100|DKK|17136|24991|lyfsjukr|||0|20|1||Distica|Distica - óskráð lyf|Etoposíð||||17136|24991||1 097531|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8795|13510|lyfalmen|V0334|2686|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||8795||8795|13510||1 097577|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|16363|23927|lyfalmen|V0335|2686|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||16363|23927||1 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2265|4522|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráð lyf|Lórazepam||2265||2265|4522||1 097603|C10AX1301|Repatha|stl|140|mg|1|áf-penni|1|pakki||C10AX13|01.01.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|27663|38058|lyfalmen|||1|1|0|14,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||27663||27663|38058||1 097662|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4903|9472|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4903||4903|9472||2 097847|G03AC0803|Nexplanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.12.2016||R|0|0|0|0|0|0|DSM|0|0|0|100|DKK|16022|23458|lyfalmen|||1|1|0|1000,0000|Vistor hf|Merck Sharp & Dohme|Etónógestrel||16022||16022|23458||1 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2045|2432|lyfalmen|V0023|2093|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríð||746||746|2432||1 097889|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2398|4706|lyfsjukr|||2|2000|0|8,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2398|4706||2 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|870|2602|lyfalmen|V0329|2602|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||870||870|2602||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2450|3860|lyfalmen|V0678|2781|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan||1784||1784|3860||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3391|3860|lyfalmen|V0679|2781|2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan||1784||1784|3860||1 098074|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|3|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|VCL|0|0|0|100|DKK|4514|8734|vetalmen|||0|90|0||Icepharma hf|VETCOOL BV.|Vedaprófen||4514||4514|8734||2 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|487|2075|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||487||487|2075||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|487|2075|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||487||487|2075||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|953|1955|lyfalmen|V0243|1955|2|50|0|4,1600|Alvogen|ratiopharm GmbH|Lamótrigín||400||400|1955||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1609|2231|lyfalmen|V0244|2080|2|50|0|8,3300|Alvogen|ratiopharm GmbH|Lamótrigín||600||600|2231||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|4409|3882|lyfalmen|V0245|3882|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Lamótrigín||1800||1800|3882||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|þpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|9120|7599|lyfalmen|V0232|7599|2|100|0|66,6600|Alvogen|ratiopharm GmbH|Lamótrigín||4500||4500|7599||2 098469|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|2793|4144|lyfalmen|V0381|4144|2|10|0|2,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||1990||1990|4144||2 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1186|3037|lyfalmen|||0|5|1|25,0000|Distica|Distica - óskráð lyf|Betaxólól||||1186|3037||1 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|MPS|0|0|0|100|DKK|12769|18980|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||12769||12769|18980||1 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|0|0|1|ASZ|0|0|0|100|SEK|56827|74945|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||56827||56827|74945||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2020|2214|lyfalmen|V0284|2194|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||588||588|2214||2 099482|N05AH0414|Quetiapin Hexal|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|8757|10891|lyfalmen|V0272|10891|2|100|0|75,0000|Artasan ehf|Hexal A/S|Quetíapín||6892||6892|10891||1 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3775|3699|lyfalmen|V0285|3470|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||1667||1667|3699||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6591|6265|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||3531||3531|6265|31.01.2018|2 099705|D08AG0201|Betadine|húðlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099707|N03AX1604|Brieka|hylki|25|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3141|2693|lyfalmen|V0685|2693|2|100|0|8,3300|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||936||936|2693||1 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1374|2030|lyfalmen|V0247|2030|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||454||454|2030||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2521|3319|lyfalmen|V0248|3319|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1391||1391|3319||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4548|3753|lyfalmen|V0249|3753|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||1706||1706|3753||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|þpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|138451|178301|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||138451||138451|178301||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|266862|338009|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||266862||266862|338009||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|þpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|533705|669887|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||533705||533705|669887||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|629|2271|lyfalmen|V0414|2271|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||629||629|2271||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|4461|7191|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||4461||4461|7191||1 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|NED|0|0|0|100|XEU|9182|14043|lyfalmen|V0935|10639|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||||9182|14043||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1589|3355|lyfalmen|V0823|2988|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1417||1417|3355||1 100441|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|30|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|322|1683|lyfalmen|V0563|1683|2|30|0|15,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||202||202|1683||2 100685|P02BA0101|Biltricide|töflur|600|mg|6|stk|1|pakki||P02BA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|5961|9610|lyfalmen|||0|6|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|praziquantel||||5961|9610||2 100807|N03AX1603|Pregabalin Krka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|1746|2106|lyfalmen|V0685|1508|2|56|0|4,6667|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||509||509|2106||2 100830|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|15|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|700|2162|lyfalmen|V0821|2162|2|15|0|2,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||550||550|2162||2 100843|J01FA1007|Azithromycin STADA|mixtduft|40|mg/ml|22,5|ml|1|glas|dreifa|J01FA10|01.06.2017||R|0|0|0|0|0|0|ASR|0|0|1|100|IKR|1000|2781|lyfalmen|V0822|2781|2|22,5|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||1000||1000|2781||2 100884|J01AA0401|Lymecycline Actavis|hylki|300|mg|100|stk|1|þpakki||J01AA04|01.07.2015||R|0|0|0|0|0|0|GPA|0|0|1|100|XEU|3420|6112|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Lymecycline||3420||3420|6112||1 100910|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|pakki||N07CA01|01.09.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|2376|4675|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Betahistín||||2376|4675||2 101105|B06AB0001|Normosang|irþ|25|mg/ml|10|ml|4|lykjur||B06AB|01.08.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|377710|475872|lyfsjukr|||0|40|1||Parlogis hf|Parlogis - óskráð lyf|Human hemin||||377710|475872||2 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8673|11217|lyfalmen|V0254|9663|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||7129||7129|11217||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|12689|18870|lyfalmen|V0256|16132|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||12689||12689|18870||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|51259|82630|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||51259||51259|82630||1 101367|QM01AE9104|Canicaral vet|töflur|40|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5189|10015|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5189||5189|10015||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|1003|2328|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||671||671|2328||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|2202|3037|lyfalmen|V0331|2919|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1186||1186|3037||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2634|2796|lyfalmen|V0089|2556|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og þvagræsilyf||1011||1011|2796||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|9853|18864|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||9853||9853|18864||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4884|8127|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||4884||4884|8127||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|þpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|14488|21346|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||14488||14488|21346||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|849|2573|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||849||849|2573||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1281|3168|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1281||1281|3168||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|4777|7980|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||4777||4777|7980||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|þpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|331|1861|lyfalmen|V0230|1852|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||331||331|1861||1 102353|N06AX2108|Aritavi|sþ-hylki|60|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|2488|3240|lyfalmen|V0693|3110|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||1333||1333|3240||1 102518|N05AX1208|Aripiprazol W&H|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|7375|5300|lyfalmen|V0684|4502|2|56|0|56,0000|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||2830||2830|5300||2 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2658|5063|lyfalmen|V0041|2790|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2658||2658|5063||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|12629|17192|lyfalmen|V0441|17192|2|90|0|180,0000|Alvogen|Alvogen|Sólífenacín||11470||11470|17192||1 103050|N05CF0205|Zovand|filmhtfl|10|mg|30|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|321|1717|lyfalmen|V0060|1717|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||227||227|1717||2 103114|L04AX0306|Metojectpen|stl|7,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2088|4279|lyfalmen|||1|1|0|3,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2088||2088|4279||2 103197|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.01.2017||R|1|0|0|1|0|0|PMA|0|0|0|100|DKK|5919|7940|lyfalmen|V0657|7940|1|30|0|10,0000|Actavis hf|Teva Pharma B.V.|Modafinil||4748||4748|7940||1 103379|L03AA1401|Lonquex|stl|6|mg|0,6|ml|1|áfspr||L03AA14|01.10.2015||R|0|0|0|1|0|1|UAB|0|0|0|100|NOK|83019|108073|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|UAB Sicor Biotech|Lipegfilgrastim||83019||83019|108073||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2030|3068|lyfalmen|V0088|2242|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1208||1208|3068||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|2590|3654|lyfalmen|V0089|2505|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan og þvagræsilyf||1634||1634|3654||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1845|3841|lyfalmen|V0069|2456|2|98|0|98,0000|Alvogen|Alvogen ehf|Lósartan||1770||1770|3841||1 103678|N06AX1604|Venlafaxin (Portfarma)|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2859|3882|lyfalmen|V0334|2741|2|100|0|75,0000|Alvogen|Alvogen|Venlafaxín||1800||1800|3882||1 103687|N06AX1604|Venlafaxin (Portfarma)|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4715|3975|lyfalmen|V0335|2741|2|100|0|150,0000|Alvogen|Alvogen|Venlafaxín||1867||1867|3975||1 103791|M01AE0115|Alvofen Express|hylki|400|mg|10|stk|1|þpakki||M01AE01|01.01.2015||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 103806|N02AB0305|Fentanyl ratiopharm|forðapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RTH|0|0|0|100|XEU|1429|3215|lyfalmen|V0222|3215|2|5|0|3,6000|Alvogen|ratiopharm GmbH|Fentanýl||1315||1315|3215||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|245350|311254|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||245350||245350|311254||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|97488|126373|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||97488||97488|126373||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3149|6145|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníð og amídín-Klórhexidín í blöndum||3149||3149|6145||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||2145||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|7430|11632|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||7430||7430|11632||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2246|4496|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2246||2246|4496||1 104489|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|1|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|5384|8815|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||5384||5384|8815||1 104503|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 104593|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.08.2017||L|0|0|0|0|G|0|BOI|0|0|1|100|NOK|||lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð|||||2648||1 104675|C09DX0401|Entresto|filmhtfl|50|mg|28|stk|1|þpakki|24 + 26 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|8414|12986|lyfalmen|||1|28|0|14,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||8414||8414|12986||1 104760|A07EC0202|Pentasa|eþ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|6208|9950|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6208||6208|9950||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|3217|5833|lyfalmen|V0017|5101|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||3217||3217|5833||1 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|4169|7143|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4169||4169|7143||1 104856|R03AK1101|Flutiform|innúðal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|3605|6367|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||3605||3605|6367||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|87406|113621|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||87406|113621||1 105306|A02BC0505|Nexium (Lyf og heilsa)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|23.09.2007||R|1|0|0|0|0|0|HOL|0|0|0|100|SEK|10228|15483|lyfalmen|V0012|5530|3|100|0|133,3300|Lyf og heilsa|Lyf og heilsa|Esómeprazól||10228||10228|15483||2 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|þpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1023|2813|lyfalmen|V0545|2012|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1023||1023|2813||2 105363|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|IKR|2983|2781|lyfalmen|V0107|2781|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||1000||1000|2781||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1762|3830|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||1762||1762|3830||2 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2083|4272|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín||2083||2083|4272||2 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1460|3414|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1460||1460|3414||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|þpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|2795|3412|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1458||1458|3412||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2792|5248|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||2792||2792|5248||2 106390|L01XE1801|Jakavi|töflur|10|mg|56|stk|1|þpakki||L01XE18|01.03.2016||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|362175|456551|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||362175||362175|456551||1 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|13939|20591|lyfsjukr|||1|5|0|0,6250|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||13939||13939|20591||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|7708|12014|lyfsjukr|||1|5|0|0,3125|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||7708||7708|12014||1 106978|C03DA0404|Kalspar|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|2870|2946|lyfalmen|V0107|2781|2|30|0|15,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||1120||1120|2946||2 107002|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|CHI|0|0|0|100|DKK|128149|165488|lyfsjukr|||1|3|0|1,5000|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||128149||128149|165488||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1245|3119|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1245||1245|3119||1 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3689|6482|lyfalmen|V0438|6482|2|30|0|30,0000|Alvogen|Alvogen|Sólífenacín||3689||3689|6482||1 107575|N01AB0803|Sevoflurane Piramal|innö.guf|100|%|250|ml|1|fl||N01AB08|01.03.2015||R|0|0|0|0|0|1|PIR|0|0|0|100|XEU|16981|21986|lyfsjukr|||1|250|0||Williams & Halls efh|Piramal Healthcare UK Limited|Sevóflúran||14953||14953|21986||2 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|732|2412|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||732||732|2412||1 107643|N06BA0902|Atomoxetin Actavis|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10180|8623|lyfalmen|V0814|8623|2|28|0|8,7500|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||5244||5244|8623||1 107657|N05AX1205|Aripiprazol Krka|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|20582|4571|lyfalmen|V0683|4502|2|56|0|37,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||2300||2300|4571||2 107935|QN01AX0304|Aniketam vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2015||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|7285|13992|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Ketaminum||||7285|13992||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|þpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1837|3933|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||1837||1837|3933||2 108205|QN02AC5201|Synthadon|stl|10|mg/ml|10|ml|1|pakki||QN02AC52|01.07.2016||R|0|0|1|0|0|0|VEB|1|0|0|100|IKR|3258|6352|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Metadón í blöndum nema með geðlyfjum||||3258|6352||2 108347|J05AP0701|Daklinza|filmhtfl|30|mg|28|stk|1|þpakki||J05AP07|01.10.2015||R|1|0|0|1|0|1|BMS|0|1|0|100|DKK|1136577|1419691|lyfsjukr|||1|28|0|14,0000|Vistor hf|Bristol-Myers Squibb Pharma EEIG|Daclatasvír||1136577||1136577|1419691||1 108413|C10AX1401|Praluent|stl|75|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|58078|76527|lyfalmen|||1|2|0|27,7778|Vistor hf|Sanofi-aventis groupe|Alirocumab||58078||58078|76527||1 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|43372|57927|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||43372||43372|57927||1 108455|N04BD0203|Rasagilin WH|töflur|1|mg|30|stk|1|þpakki||N04BD02|01.04.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|5828|8292|lyfalmen|V0726|8292|2|30|0|30,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||5004||5004|8292||2 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7752|12075|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||7752||7752|12075||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|58932|77607|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||58932||58932|77607||3 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1108|2930|lyfalmen|||1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1108||1108|2930||1 109338|M01AH0502|Coxient|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|987|2052|lyfalmen|V0827|1034|2|7|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||470||470|2052||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19217|27855|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||19217||19217|27855||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|15385|22581|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||15385||15385|22581||1 109569|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|1304|3131|lyfalmen|V0584|3131|2|28|0|7,4700|Alvogen|ratiopharm GmbH|Oxýcódon||1254||1254|3131||2 109578|N02AA0505|Oxycodone ratiopharm|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|4561|6079|lyfalmen|V0585|6079|2|98|0|26,1300|Alvogen|ratiopharm GmbH|Oxýcódon||3396||3396|6079||2 109588|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|2384|4686|lyfalmen|V0586|4686|2|28|0|14,9300|Alvogen|ratiopharm GmbH|Oxýcódon||2384||2384|4686||2 109597|N02AA0505|Oxycodone ratiopharm|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|7735|11644|lyfalmen|V0587|11644|2|98|0|52,2700|Alvogen|ratiopharm GmbH|Oxýcódon||7439||7439|11644||2 109615|N02AA0505|Oxycodone ratiopharm|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|12921|17170|lyfalmen|V0588|17170|2|98|0|104,5300|Alvogen|ratiopharm GmbH|Oxýcódon||11454||11454|17170||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Alvogen|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|282|1793|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||282||282|1793||2 110177|N06AX2108|Aritavi|sþ-hylki|60|mg|90|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6538|4772|lyfalmen|V0694|4772|2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||2446||2446|4772||1 110184|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1537|3520|lyfalmen|||1|5|0|25,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||1537||1537|3520||1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2231|lyfalmen|V0291|2231|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||600||600|2231||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2608|3470|lyfalmen|V0292|3470|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1500||1500|3470||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3684|6476|lyfalmen|||2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3684||3684|6476||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|þpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|8287|lyfalmen|||2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||5000||5000|8287||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|þpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1219|3083|lyfalmen|||1|63|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel og ethinylestradíól||1219||1219|3083||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi/LIV|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110421|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|áf.spr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|21099|29756|lyfalmen|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||21099||21099|29756||1 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|3398|6082|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3398||3398|6082||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|73010|95413|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||73010||73010|95413||1 110820|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|76494|47028|lyfsjukr|||2|60|0||Icepharma hf|Mylan AB|Imatiníb||34755||34755|47028||2 111295|G02BA0304|Levosert|leginnle|20|mcg/sólh|1|stk|1|poki||G02BA03|01.09.2015||R|0|1|0|0|0|0|GER|0|0|0|100|XEU|12732|16167|lyfalmen|||2|1|0||Actavis|Gedeon Richter Plc.|Plast lyfjalykkja (IUD) með prógestógen||10725||10725|16167||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2338|4266|lyfalmen|V0373|4266|2|15|0|75,0000|Alvogen|Alvogen|Tímólól í blöndum||2079||2079|4266||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|CAS|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Casen Recordati S.L.|Natríumpicosúlfat|||||||1 111955|N02BE0101|Panodil|filmhtfl|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|HCA|0|0|1|100|DKK|555|2169|lyfalmen|V0229|2139|1|100|0|33,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól||555||555|2169||1 112073|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|duft og sett ekki leysir|V03AB33|01.06.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|DKK|118775|153830|lyfsjukr|||0|1|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Hydroxocobalamin||||118775|153830||3 112191|C02KX0501|Adempas|filmhtfl|1|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|161061|206422|lyfsjukr|||1|42|0|9,3300|Vistor hf|Bayer AG|Riociguatum||161061||161061|206422||1 112873|J01CA0413|Amoxin|mixtduft|50|mg/ml|100|ml|1|glas||J01CA04|01.12.2015||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1627|3644|lyfalmen|||2|100|0|5,0000|Alvogen|ratiopharm GmbH|Amoxicillín||1627||1627|3644||2 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113143|N05AX1205|Aripiprazol Krka|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.03.2015||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|14883|16545|lyfalmen|||2|56|0|112,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||11000||11000|16545||2 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyfalmen|V0655|4026|2|5|0||Alvogen|ratiopharm Oy|Amorolfín|||||4984||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6137|9852|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||6137||6137|9852||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|5528|9014|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||5528||5528|9014||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|1799|3881|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||1799||1799|3881|31.12.2017|2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|2291|4558|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2291||2291|4558||1 113648|N06BA0404|Methylphenidate Sandoz|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4657|6886|lyfalmen|V0681|5614|2|30|0|27,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3982||3982|6886||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dæla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|3936|6822|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3936||3936|6822||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|396279|498967|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||396279||396279|498967||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|480|2066|lyfalmen|V0930|2011|1|20|0|10,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||480||480|2066||2 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|698|2366|lyfalmen|V0931|2300|1|30|0|15,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||698||698|2366||2 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|925|2678|lyfalmen|V0932|2616|1|40|0|20,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||925||925|2678||2 113982|B05AA0510|RescueFlow|irl|||250|ml|6|pokar|60/75 g/l|B05AA05|01.03.2017||R|0|0|0|0|0|1|ARM|0|0|0|100|DKK|38794|52137|lyfsjukr|||1|1500|0||Williams & Halls efh|Pharmanovia A/S|Dextran||38794||38794|52137||2 113993|N07AA5101|Robinul-Neostigmin|stl|||10|lykjur|1|pakki|0,5+2,5 mg/ml|N07AA51|01.03.2018||R|0|0|0|0|0|1|LDR|0|0|0|100|DKK|4496|7593|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Neostigmine í samsetingum||4496||4496|7593||2 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|577|2199|lyfalmen|||1|60|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||577||577|2199||1 114063|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5000|5396|lyfalmen|V0145|4598|2|4|0|8,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||2900||2900|5396||2 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|þpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíð|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|17349|25284|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||17349|25284||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|27973|38450|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||27973|38450||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|3271|5907|lyfalmen|V0824|2853|1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||3271||3271|5907||1 114512|D06BB0401|Condyline|húðlausn|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|1741|3801|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||1741||1741|3801||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Chlorambucíl||||||30.11.2017|2 114755|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2014||R|0|0|0|0|G|0|MED|0|0|0|100|IKR|14000|10076|lyfalmen|V0420|10076|2|90|0|90,0000|Medical ehf|Medical ehf|Bíkalútamíð||6300||6300|10076||2 114912|QP54AA0501|Stronghold|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4801|8275|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4801||4801|8275||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|1951|2689|lyfalmen|V0278|2689|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||933||933|2689||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2573|2751|lyfalmen|V0279|2751|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||978||978|2751||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|6675|4093|lyfalmen|V0280|4093|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1953||1953|4093||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|9225|3055|lyfalmen|V0282|3055|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1199||1199|3055||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5276|8667|lyfalmen|V0457|8667|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5276||5276|8667||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8022|12446|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||8022||8022|12446||2 115015|G03GA1001|REKOVELLE|stl|72|mcg|2,16|ml|1|pakki|+ 9 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|68281|89432|lyfalmen|||1|2,16|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||||68281|89432||1 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|5779|9359|lyfalmen|V0475|9359|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||5779||5779|9359||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|13896|20531|lyfalmen|V0540|20531|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13896||13896|20531||2 115126|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|75611|98703|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||75611||75611|98703||1 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1508|3481|lyfalmen|||1|10|0|2,5000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1508||1508|3481||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|7010|11053|lyfsjukr|||2|10|0||Actavis Group hf|B.Braun Melsungen AG|Naloxón||7010||7010|11053||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|951|2651|lyfalmen|V0158|2437|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||905||905|2651||2 115309|N05AH0206|Clozapin Medical|töflur|25|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1862|3968|lyfalmen|||2|100|0|8,3300|Medical ehf|Medical ehf|Klózapín||1862||1862|3968|31.01.2018|2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9044|13853|lyfalmen|||1|60|0|15,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||9044||9044|13853||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1508|3481|lyfalmen|||1|10|0|3,6700|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1508||1508|3481||1 115348|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|145|1604|lyfalmen|V0505|1604|1|25|0|12,5000|Vistor hf|TERALI PRODUCTS|Meklózín||145||145|1604||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|8262|12777|lyfalmen|||1|60|0|22,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||8262||8262|12777||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|41067|55012|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||41067||41067|55012||1 115613|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.03.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|2546|4909|lyfalmen|||0|5|1||Distica|Distica - óskráð lyf|Dorzólamíð||||2546|4909||1 115770|D10AF5101|Duac|hlaup|||30|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.03.2018||R|0|0|0|0|0|0|STE|0|0|0|100|DKK|2713|5139|lyfalmen|||1|30|0||Vistor hf|Stiefel Laboratories L.(Ireland) Ltd.|Klindamýcín í blöndum||2713||2713|5139||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|2674|5085|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról||2674||2674|5085||1 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|2781|5233|lyfsjukr|||1|5|0|2,5000|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||2781||2781|5233||1 116046|J01DC0202|Zinacef|sts|750|mg|5|hgl|1|pakki||J01DC02|01.09.1983||R|0|0|0|0|0|1|GPH|0|0|0|100|DKK|1454|3406|lyfsjukr|||1|5|0|1,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Cefúroxím||1454||1454|3406||1 116244|D11AF01|Verucid|áburður|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf við vörtum og líkþornum|||||||2 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|600|2129|lyfalmen|V0562|1869|2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||526||526|2129||1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|299|1816|lyfalmen|V0563|1683|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||299||299|1816||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|719|2375|lyfalmen|V0564|2061|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen||705||705|2375||1 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|12526|18646|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||12526||12526|18646||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|þpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3539|6276|lyfalmen|V0081|5366|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||3539||3539|6276||1 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|4882|8125|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||4882||4882|8125||1 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|5231|8605|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5231||5231|8605||1 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|PHH|0|0|0|100|DKK|13428|19887|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||13428||13428|19887||1 116841|D07AC1302|Ovixan|húðlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|440|2011|lyfalmen|V0951|2008|2|30|0||Vistor hf|Galenica AB|Mómetasón||||440|2011||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|XEU|7739|14853|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum með D-vítamíni/eða öðrum efnum||7739||7739|14853||2 117424|M01AE0303|Orudis|forðahlk|100|mg|100|stk|1|glas||M01AE03|01.12.2014||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1240|3112|lyfalmen|||1|100|0|66,6700|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||1240||1240|3112||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3492|6211|lyfalmen|V0435|5844|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3492||3492|6211||2 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|0|0|ASZ|0|0|0|100|SEK|9620|14014|lyfalmen|V0275|6346|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||9161||9161|14014||1 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|17721|23696|lyfalmen|V0273|8793|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||16195||16195|23696||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1171|3017|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1171||1171|3017||2 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|25434|35239|lyfalmen|V0272|10891|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||25434||25434|35239||1 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|1|1|0|0|G|0|ASZ|0|0|0|100|SEK|37227|50155|lyfalmen|V0261|14987|1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||37227|50155||1 117676|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|47193|62760|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||47193||47193|62760||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5811|10016|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||5811||5811|10016||2 117787|N06BA0904|Atomoxetine Sandoz|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9168|7494|lyfalmen|V0816|7494|2|28|0|21,0000|Artasan ehf|Sandoz A/S|Atomoxetín||4424||4424|7494||1 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|4625|8945|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||4625||4625|8945||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|XEU|9164|17556|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||9164||9164|17556||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1432|3376|lyfalmen|V0278|2689|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1432||1432|3376||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2349|3467|lyfalmen|V0279|2751|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1498||1498|3467||1 118074|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|20|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|600|2162|lyfalmen|V0929|2162|2|20|0|8,0000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||550||550|2162||2 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|8022|3402|lyfalmen|V0282|3055|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1451||1451|3402||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|1385|3311|lyfalmen|V0283|2871|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1385||1385|3311||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|14497|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|14497||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|6675|5059|lyfalmen|V0280|4093|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2655||2655|5059||1 118575|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|4264|8260|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||4264||4264|8260||2 118612|A07EC0203|Pentasa Sachet|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|17354|25291|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17354||17354|25291||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2395|4701|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2395||2395|4701||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|þpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|387|1938|lyfalmen|||1|120|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Digoxín||387||387|1938||2 118967|C03DA0405|Eplerenon Actavis|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.09.2015|28.02.2018|R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3138|3105|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Eplerenón||1235||1235|3105||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|1030|2823|lyfalmen|||1|50|0|8,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||1030||1030|2823||2 119520|M01AH0503|Coxerit|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|2800|3157|lyfalmen|V0824|2853|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1273||1273|3157||2 119528|D11AX2201|Soolantra|krem|10|mg/g|30|g|1|túpa||D11AX22|01.07.2016||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3230|5851|lyfalmen|||1|30|0||Icepharma hf|Galderma Nordic AB|Ivermectin||3230||3230|5851||2 119710|N03AX1603|Pregabalin Krka|hylki|100|mg|84|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|5500|5259|lyfalmen|||2|84|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2800||2800|5259||2 119825|N05BA1206|Alprazolam Krka|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|762|2454|lyfalmen|||2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||762||762|2454||2 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|267948|339359|lyfsjukr|||1|30|0|20,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||267948||267948|339359||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|RGO|0|1|0|100|DKK|248760|315495|lyfsjukr|||1|30|0|40,0000|Vistor hf|Glaxo Group Limited|Ambrisentanum||248760||248760|315495||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1436|3381|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Cýklópentólat||1436||1436|3381||1 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|NED|0|1|0|100|XEU|33992|46063|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||33992||33992|46063||2 120768|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2015||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|10373|8975|lyfalmen|V0118|8975|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||5500||5500|8975||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012|28.02.2018|R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|23230|32452|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||23230||23230|32452||1 121104|L01XC1401|Kadcyla|irþ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|358643|452158|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||358643||358643|452158||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|3647|6425|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3647||3647|6425||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|MBV|0|0|0|100|DKK|6009|9676|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme B.V.|Rókúrón, brómíð||6009||6009|9676||1 121302|N02BA5102|Treo|freyðit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MEA|0|0|1|100|DKK|||lyflausa|||0|60|0|10,0000|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|skammtar|1|stauk|dreifa|R03AC02|01.12.1972||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|371|1916|lyfalmen|||1|200|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||371||371|1916||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|404|1961|lyfalmen|||2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||404||404|1961||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|NAA|0|0|0|100|DKK|1351|3264|lyfalmen|V0314|2817|1|100|0|25,0000|Artasan ehf|Novartis Healthcare A/S|Klómípramín||1351||1351|3264||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|þpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|310|1832|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||310||310|1832||1 121792|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|232|1724|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||232||232|1724||1 121912|L04AX0306|Metojectpen|stl|25|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2938|5449|lyfalmen|||1|1|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2938||2938|5449||2 122133|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|SEK|3656|4975|lyfalmen|V0145|4598|2|4|0|8,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||2594||2594|4975||2 122301|R01AD0802|Nasofan|nefúði|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSA|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Alvogen|Teva Sweden AB|Flútíkasón|||||||2 122354|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|5971|4912|lyfalmen|V0682|4502|2|56|0|18,6600|Artasan ehf|Sandoz GmbH|Aripiprazól||2548||2548|4912||1 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7321|12618|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||7321||7321|12618||1 122471|L01XE1301|Giotrif|filmhtfl|30|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|235113|298522|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||235113||235113|298522||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|466|2046|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||466||466|2046||2 123216|N05BA0105|Stesolid|eþ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|680|2341|lyfalmen|||2|10|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||680||680|2341||1 123224|N05BA0105|Stesolid|eþ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|1124|2952|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1124||1124|2952||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|26063|44922|vetorma|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||26063||26063|44922||2 123435|N05AX1205|Aripiprazol Krka|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|5668|4846|lyfalmen|V0716|4846|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Aripiprazól||2500||2500|4846||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|þpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|AZA|0|0|0|100|SEK|16358|23920|lyfalmen|||1|90|0|90,0000|Vistor hf|AstraZeneca AB|Roflumílast||16358||16358|23920||1 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|18931|32629|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||18931||18931|32629||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|233|1726|lyfalmen|||2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||233||233|1726||1 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|1|0|0|1|G|0|AVS|0|0|0|100|XEU|18743|27203|lyfalmen|V0579|23581|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||18743||18743|27203||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1442|2834|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1442|2834||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|þpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SND|0|0|0|100|XEU|24842|34490|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Clir SNC|Klópídógrel||24842||24842|34490||1 124141|A11HA0801|Vedrop|mixtúra|50|mg/ml|60|ml|1|glas||A11HA08|01.07.2017||R|0|0|0|1|0|0|URE|0|0|0|100|XEU|25745|35633|lyfalmen|||0|60|0||Orphan Europe Nordic AB|Orphan Europe|Tocofersolanum||25745||25745|35633||3 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|7400|11590|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||7400||7400|11590||2 124356|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|7710|12017|lyfalmen|V0464|12017|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||7710||7710|12017||1 124908|D02AX0001|Oviderm|krem|250|mg/g|500|g|1|túpa|fjölskammtaílát m.dælu|D02AX|01.03.2018||L|0|0|0|0|0|0|GAB|0|0|0|100|IKR|||lyflausa|||0|500|0||Vistor hf|Galenica AB|Önnur húðverndandi efni|||||||1 125038|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|723|2400|lyfalmen|V0066|2400|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||723||723|2400||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|10051|15239|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Melphalan||10051||10051|15239|28.02.2018|2 125197|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|þpakki||R03DC03|01.08.2017||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|5210|2613|lyfalmen|V0490|2482|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||878||878|2613||1 125457|N05AH0411|Quetiapine Teva|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|4399|3470|lyfalmen|V0285|3470|2|100|0|25,0000|Alvogen|Teva Sweden AB|Quetíapín||1500||1500|3470||2 125661|G04BE0805|Tadalafil Actavis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|10245|10016|lyfalmen|V0145|9195|2|8|0|16,0000|Actavis Group hf|Actavis Group PTC ehf|Tadalafíl||6256||6256|10016||1 125688|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1817|3906|lyfalmen|V0905|3906|1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||||1817|3906||1 125705|P02CF0101|Stromectol|töflur|3|mg|4|stk|1|þpakki||P02CF01|01.03.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|8011|12431|lyfalmen|||0|4|1||Parlogis hf|Parlogis - óskráð lyf|ivermectin||||8011|12431||2 126374|L01XX1701|Hycamtin|hylki|1|mg|10|stk|1|pakki||L01XX17|01.01.2016||R|0|0|0|1|0|1|PCO|0|0|0|100|XEU|96116|124638|lyfsjukr|||0|10|1||Distica|Distica - óskráð lyf|Tópótecan||||96116|124638||1 126385|L01XX1701|Hycamtin|hylki|0,25|mg|10|stk|1|pakki||L01XX17|01.01.2016||R|0|0|0|1|0|1|PCO|0|0|0|100|XEU|27635|38023|lyfsjukr|||0|10|1||Distica|Distica - óskráð lyf|Tópótecan||||27635|38023||1 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|26635|36758|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||26635||26635|36758||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|53269|70445|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||53269||53269|70445||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|106540|138613|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||106540||106540|138613||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|1|0|1|0|1|FIN|0|1|0|100|DKK|107415|139701|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Aflibercept||107415||107415|139701||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|27179|37446|lyfalmen|||1|100|0|75,0000|Icepharma hf|Bayer AG|Rivaoxaban||||27179|37446||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|2976|5501|lyfalmen|||1|3|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||2976|5501||1 126955|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|þpakki||H02AB02|01.08.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|5841|9444|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||5841||5841|9444||2 127362|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|2641|4773|lyfalmen|V0011|4773|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2447||2447|4773||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|þpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127403|G04B00001|Lyngonia|filmhtfl|||60|stk|1|þpakki|425,25-519,75 mg|G04B000|01.11.2017||L|0|0|0|0|0|0|FLO|0|0|0|100|IKR|||lyflausa|||0|60|0||Florealis ehf|Florealis ehf|Dry Bearberry leaf extract|||||||1 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128003|N05CF0205|Zovand|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.04.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|IKR|944|2704|lyfalmen|V0313|2704|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Zolpidem||944||944|2704||2 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|5633|9158|lyfalmen|V0279|2751|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||5633||5633|9158||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|þpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|11443|21880|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíðar í blöndu með öðrum lyfjum||11443||11443|21880||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1042|2839|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1042||1042|2839||1 128625|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|3078|5641|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||3078||3078|5641||1 129024|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2506|lyfalmen|||2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2506|31.12.2017|2 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|NED|0|0|0|100|XEU|22060|30972|lyfalmen|V0282|3055|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22060||22060|30972||2 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|þpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|UAK|0|0|1|100|GBP|368|1911|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||368||368|1911||1 129188|V03AE0204|Sevelamerkarbonat WH|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.03.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|15688|13092|lyfalmen|V0680|12141|2|180|0|22,5000|Williams & Halls efh|Williams & Halls ehf|Sevelamer||8491||8491|13092||2 129668|A02AH0003|Natriumbikarbonat Meda|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyfalmen|||0|100|0||Icepharma hf|Meda AB|Natríumhýdrógenkarbonat|||||3017||2 129817|R03BB0101|Atrovent|lausn|0,25|mg/ml|60|sk-ílát|1|pakki|fyrir eimgjafa|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|2650|5052|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2650||2650|5052||1 129923|N06BA0903|Atomoxetin Medical Valley|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8449|8623|lyfalmen|V0812|7494|2|28|0|3,5000|Acare ehf|Medical Valley Invest AB|Atomoxetín||5244||5244|8623||2 129936|N06BA0406|Medikinet CR|hylki|50|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|9929|15071|lyfalmen|||2|30|0|50,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||9929||9929|15071||2 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|13175|19539|lyfalmen|||0|100|1|25,0000|Distica|Distica - óskráð lyf|Quetíapín||||13175|19539||1 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1656|3684|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||1656||1656|3684||2 130309|L01AB0102|Busilvex|irþ|6|mg/ml|10|ml|8|hgl||L01AB01|01.06.2016||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|252908|320654|lyfsjukr|||1|80|0||Vistor hf|Pierre Fabre Médicament|Búsúlfan||252908||252908|320654||1 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|16329|31150|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||16329||16329|31150||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1295|3187|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1295||1295|3187||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|0|0|0|0|0|0|PHH|0|0|1|100|DKK|9004|13798|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||9004|13798||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|40534|65341|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||40534|65341||1 131010|QN01BB0301|Mepidor vet.|stl|20|mg/ml|10|ml|6|hgl|lausn|QN01BB03|01.06.2017||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|5598|10791|vetalmen|||0|60|0||Icepharma hf|Richter Pharma AG|Mepivacaine||5598||5598|10791||2 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2374|4672|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríð||||2374|4672||2 131155|H05BX0104|Cinacalcet Mylan|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|35913|24065|lyfalmen|V0722|24065|2|28|0|42,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||16463||16463|24065||2 131334|N03AB0209|Fenantoin Meda|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|801|2507|lyfalmen|||2|100|0|33,3333|Icepharma hf|Meda AB|Fenýtóín||801||801|2507||2 131383|N03AA0207|Fenemal Meda|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1320|3222|lyfalmen|||2|100|0|15,0000|Icepharma hf|Meda AB|Fenemal||1320||1320|3222||2 131417|N03AA0207|Fenemal Meda|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|1495|3463|lyfalmen|||2|100|0|50,0000|Icepharma hf|Meda AB|Fenemal||1495||1495|3463||2 131441|N03AA0207|Fenemal Meda|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|2127|4333|lyfalmen|||2|100|0|100,0000|Icepharma hf|Meda AB|Fenemal||2127||2127|4333||2 132260|N06DA0404|Galantamine Portfarma|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|3160|5754|lyfalmen|||2|28|0|14,0000|Alvogen|Alvogen|Galantamín||3160||3160|5754||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4180|3141|lyfalmen|V0581|2231|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1261||1261|3141||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2599|3141|lyfalmen|V0580|2368|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||1261||1261|3141||1 132488|L01XC1201|ADCETRIS|irþ|50|mg|1|hgl|1|pakki||L01XC12|01.08.2016||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|373839|471058|lyfsjukr|||1|1|0||Vistor hf|Takeda Pharma A/S|Brentuximabum vedotinum||373839||373839|471058||1 132494|M01AX0503|Glucosamin LYFIS|mixtduft|1178|mg|30|skpokar|1|pakki||M01AX05|01.05.2016||L|0|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Glúkósamín|||||||2 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|7975|12382|lyfalmen|||1|28|0|28,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||7975||7975|12382||1 132635|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|125|mg|98|stk|1|þpakki|100 + 25 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|2163|2597|lyfalmen|V0089|2505|2|98|0|100,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||866||866|2597||2 132662|R05DA0403|Kodein Meda|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|MEA|0|0|1|100|DKK|1062|2867|lyfalmen|||2|100|0|25,0000|Icepharma hf|Meda AB|Kódein||1062||1062|2867||2 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|1|1|0|0|0|JAS|0|0|0|100|SEK|4599|7735|lyfalmen|V0681|5614|1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||4599||4599|7735||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|5221|10076|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||||5221|10076||2 132748|N06AX1610|Venlafaxine Bluefish|forðahlk|150|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|3700|3470|lyfalmen|V0335|2741|2|100|0|150,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3470||1 132761|D08AG0201|Betadine|húðlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Joð/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|DKK|407|1965|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Proxýmetakaín||407||407|1965||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|19251|27902|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||19251||19251|27902||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|25597|35445|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||25597||25597|35445||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|1|0|1|0|1|EIS|0|0|0|100|SEK|34807|47094|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||34807|47094||1 133371|C07AB0501|Kerlon|töflur|10|mg|98|stk|1|þpakki||C07AB05|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|XEU|5452|8909|lyfalmen|||0|98|1|49,0000|Parlogis hf|Parlogis - óskráð lyf|betaxolol||||5452|8909||2 133384|B05ZB0002|Phoxilium|blóð.sk|1,2|mmól/l|5000|ml|2|pokar|Blóðsk.- blóðsíunarlausn|B05ZB|01.10.2017||R|0|0|0|1|0|1|GAA|0|0|0|100|SEK|3538|6275|lyfsjukr|||1|10000|0||Baxter Medical AB|Gambro Lundia AB|Blóðsölt og stuðpúðalausn||3538||3538|6275||2 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|BVB|0|0|0|100|DKK|186234|237730|lyfsjukr|||1|2|0||Lyfjaver ehf|Shire Services BVBA|C1 hemill||||186234|237730||3 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0||Icepharma hf|Meda AB|Makrógól 3350|||||||2 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|20|0|10,0000|Icepharma hf|Meda AB|Makrógól 3350|||||||2 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|6742|10685|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||6742||6742|10685||1 133856|N06BA0904|Atomoxetine Sandoz|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9168|8624|lyfalmen|V0814|8623|2|28|0|8,7500|Artasan ehf|Sandoz A/S|Atomoxetín||5245||5245|8624||1 133949|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.02.2015||R|0|0|0|0|G|0|STI|0|0|0|100|NOK|2061|4242|lyfalmen|||1|5|0|13,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||2061||2061|4242||3 133974|N06AX1610|Venlafaxine Bluefish|forðahlk|37,5|mg|30|stk|1|þpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BFP|0|0|0|100|IKR|1084|2897|lyfalmen|V0333|2833|2|30|0|11,2500|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1084||1084|2897||1 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2410|4722|lyfalmen|V0378|3359|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||2410||2410|4722||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|6301|10078|lyfalmen|V0378|10078|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||6301||6301|10078||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|2146|4359|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Epírúbicín||2146||2146|4359||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|47462|63100|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||47462||47462|63100||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|95273|123572|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||95273||95273|123572||2 134920|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|13688|lyfalmen|V0828|13688|2|100|0|11,1100|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8924||8924|13688||2 135090|C02KX0501|Adempas|filmhtfl|1,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|324443|409623|lyfsjukr|||1|84|0|28,0000|Vistor hf|Bayer AG|Riociguatum||324443||324443|409623||1 135216|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|5|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|8344|12890|lyfalmen|||1|7,5|0|56,2500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8344||8344|12890||1 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1010|2795|lyfalmen|||1|60|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1010||1010|2795||1 135498|G04CB0202|Dutasteride Medical Valley|hylki|0,5|mg|30|stk|1|þpakki|hylki mjúk|G04CB02|01.09.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|DKK|2606|4619|lyfalmen|V0909|4619|2|30|0|30,0000|Acare ehf|Medical Valley Invest AB|Dútasteríð||2335||2335|4619||2 135624|H03BB0211|Thacapzol|töflur|5|mg|100|stk|1|pakki||H03BB02|01.05.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|8754|13454|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|thiamazole||||8754|13454||1 136181|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.01.2013||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|32009|43555|lyfalmen|||1|60|0|20,0000|Icepharma hf|Pfizer Limited|Sirolimus||32009||32009|43555||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|MEA|0|0|0|100|DKK|4962|8235|lyfalmen|||1|100|0|100,0000|Icepharma hf|Meda AB|Ísóníazíð||4962||4962|8235||2 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|54964|72589|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||54964||54964|72589||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|2555|4922|lyfalmen|||1|28|0|14,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||2555||2555|4922||1 136658|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|362|1903|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||362||362|1903||2 136887|L01AD0202|Lomustine|hylki|40|mg|20|stk|1|glas||L01AD02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|69616|91121|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|lomustine||||69616|91121||2 136953|D06BX0106|Rosazol|krem|10|mg/g|25|g|1|túpa||D06BX01|01.04.2016||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Metrónídazól|||||||1 137635|N05AH0413|Quetiapin ratiopharm|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|39000|15169|lyfalmen|V0261|14987|2|100|0|100,0000|Alvogen|Teva Pharma B.V.|Quetíapín||10000||10000|15169||2 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|XEU|16742|24449|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Pfizer ApS|Pamídrónsýra||16742||16742|24449|31.01.2018|1 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|XEU|4954|8224|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||4954||4954|8224||1 137831|M05BA0302|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|XEU|4327|7361|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Pfizer ApS|Pamídrónsýra||4327||4327|7361||1 137842|M05BA0302|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|1|0|0|0|1|PZA|0|0|0|100|XEU|4890|8136|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Pfizer ApS|Pamídrónsýra||4890||4890|8136||1 137881|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|9701|12310|lyfalmen|V0691|12301|2|90|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||7923||7923|12310||1 138302|N03AX1603|Pregabalin Krka|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|8293|4086|lyfalmen|V0689|4086|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1948||1948|4086||2 138318|L04AX0307|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2302|4573|lyfalmen|||1|0,35|0|7,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2302||2302|4573||2 138505|J05AP5601|Vosevi|filmhtfl|600|mg|28|stk|1|glas|400/100/100 mg|J05AP56|01.11.2017||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|2130198|2655477|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|sofosbuvir,velpatasvir,voxilaprevir||||2130198|2655477||2 138567|C10AA0509|Atorvastatin Xiromed|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2018||R|1|0|0|0|G|0|MVX|0|0|0|100|IKR|2500|2781|lyfalmen|V0114|2781|2|100|0|200,0000|Acare ehf|Medical Valley with subfirm Xiromed|Atorvastatín||1000||1000|2781||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1286|3175|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1286||1286|3175||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|13562|20072|lyfalmen|||1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||13562||13562|20072||1 138619|L04AX0306|Metojectpen|stl|22,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2888|5380|lyfalmen|||1|1|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2888||2888|5380||2 138687|N06BA0407|Metylfenidat Actavis|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|4087|5391|lyfalmen|V0691|4100|2|30|0|18,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||2896||2896|5391||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|2196|4418|lyfalmen|V0373|4266|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||2189||2189|4418||1 139604|L04AA3201|Otezla|filmhtfl|30|mg|56|stk|1|þpakki||L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|1|0|100|XEU|97234|126052|lyfsjukr|||1|56|0|28,0000|Celgene AB|Celgene Europe Limited|Apremilast||97234||97234|126052||2 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||4649||1 140013|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.12.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|461|2039|lyfalmen|V0927|2039|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||461||461|2039||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|904|2649|lyfalmen|V0266|2272|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||904||904|2649||1 140330|N02AA0506|Oxikodon Depot Actavis|forðatfl|80|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|12726|18921|lyfalmen|V0588|17170|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||12726||12726|18921||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|8679|13351|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8679||8679|13351||1 140500|N07BC0202|Metadon Abcur|töflur|40|mg|25|stk|1|glas||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|4467|7553|lyfalmen|||1|25|0|40,0000|Icepharma hf|Abcur AB|Metadón||4467||4467|7553||2 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|baðlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|64350|122255|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||64350||64350|122255||1 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141015|J05AR1401|REZOLSTA|filmhtfl|950|mg|30|stk|1|glas|800+150 mg|J05AR14|01.01.2016||R|0|0|0|1|0|1|JAS|0|0|0|100|SEK|44038|58770|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag AB|Darunavir og kóbísistat||44038||44038|58770||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|957|2722|lyfalmen|V0413|2527|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||957||957|2722||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|NEL|0|0|1|100|DKK|2845|5321|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Nepafenak||||2845|5321||1 141153|R01AB0601|Otrivin Comp|nefúði|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3095|5665|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3095||3095|5665||1 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|12314|18354|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||12314|18354||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|34445|46636|lyfalmen|||1|50|0|8,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||34445||34445|46636||3 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|3184|5787|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||3184|5787||2 141751|J01EE0106|Co-Trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2009||R|0|0|0|0|0|0|UAK|0|0|1|100|XEU|819|2532|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||819||819|2532||1 141856|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3164||1 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TVA|0|0|0|100|XEU|4759|7955|lyfalmen|||2|98|0|39,2000|Alvogen|Teva B.V.|Montelúkast||4759||4759|7955||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5240|8617|lyfalmen|V0267|3650|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||5240||5240|8617||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1396|3255|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1344||1344|3255||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|18342|26651|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||18342|26651||5 142266|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|3320|4041|lyfalmen|V0384|2992|2|10|0|5,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||1915||1915|4041||1 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|681|2342|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||681||681|2342||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|2508|4857|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Metenamín||2508||2508|4857||2 142410|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|434095|546000|lyfsjukr|||1|30|0|45,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||434095||434095|546000||1 142615|C07AG0205|Carveratio|töflur|6,25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1544|3530|lyfalmen|V0946|3332|2|100|0|16,6700|Alvogen|ratiopharm GmbH|Carvedílól||1544||1544|3530||2 142914|C07AB0214|Bloxazoc|forðatfl|100|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2043|3057|lyfalmen|V0049|3057|2|100|0|66,6600|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||1200||1200|3057||2 142927|C03CA0201|Burinex|töflur|1|mg|100|stk|1|þpakki||C03CA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|3660|6443|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|bumetanide||||3660|6443||1 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||16727||1 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|1321|3223|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1321||1321|3223||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1786|3863|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1786||1786|3863||1 143410|N03AX1604|Brieka|hylki|150|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|9837|5668|lyfalmen|V0687|5534|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||3097||3097|5668||1 143487|L01BC0204|Efudix|krem|50|mg/ml|20|g|1|túpa||L01BC02|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|DKK|5668|9206|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Flúóróúracíl||5668||5668|9206||2 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|2841|5315|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||2841||2841|5315||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|462|1866|lyfalmen|V0542|1866|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||335||335|1866||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|HES|0|0|0|100|DKK|867|2598|lyfalmen|||1|15|0||Vistor hf|Novartis Healthcare A/S|Trópíkamíð||867||867|2598||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1077|2887|lyfalmen|V0173|2038|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1077||1077|2887||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|þpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5173|8525|lyfalmen|V0387|7507|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5173||5173|8525||1 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|pakki||N02CX02|01.08.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|915|2664|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Klónidín||||915|2664||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|5205|8569|lyfalmen|V0386|6693|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||5205||5205|8569||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|461|2039|lyfalmen|V0927|2039|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||461||461|2039||1 143787|N06AX1611|Duofaxin|forðatfl|225|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|1281|3048|lyfalmen|||2|28|0|63,0000|Vistor hf|MediLink A/S|Venlafaxín||1194||1194|3048||1 143800|N05AN0101|Litarex|forðatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|GRP|0|0|0|100|DKK|2311|4586|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Litíum||2311||2311|4586||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1359|3275|lyfalmen|V0174|2038|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1359||1359|3275||1 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1645|3669|lyfalmen|V0938|3669|1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1645||1645|3669||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|NVO|0|0|0|100|DKK|21899|30768|lyfalmen|||1|60|0|30,0000|Vistor hf|N.V. Organon|Asenapíne||21899||21899|30768||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|54886|72490|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||54886||54886|72490||1 144419|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.01.2016||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2840|5314|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||2840||2840|5314||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|36596|49357|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||36596||36596|49357||1 144498|N02AA0506|Oxikodon Depot Actavis|forðatfl|40|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|7439|11644|lyfalmen|V0587|11644|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||7439||7439|11644||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|18298|26590|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||18298||18298|26590||1 144808|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|482|2068|lyfalmen|V0912|2068|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||482||482|2068||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|61844|81291|lyfsjukr|||1|1|0|26,6700|Vistor hf|Janssen Biologics B.V.|Infliximab||61844||61844|81291||1 145158|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.08.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|4076|7015|lyfalmen|V0906|7015|1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||||4076|7015||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2442|4800|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2442||2442|4800||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3519|6847|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||3519||3519|6847||1 145545|D07AD0101|Dermovat|krem|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|403|1960|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||||403|1960||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|8|0|1,1400|Icepharma hf|Meda AB|Pýrvín|||||||2 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|4706|9099|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4706||4706|9099||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|þpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5724|11030|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5724||5724|11030||1 145648|B05BB0121|Plasmalyte|irl|||500|ml|20|pokar|lausn|B05BB01|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7904|12284|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7904||7904|12284||2 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|4265|7275|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||4265||4265|7275||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|22088|31007|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||22088||22088|31007||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|RGO|0|1|0|100|DKK|22711|31795|lyfsjukr|||1|1|0|4,8000|Vistor hf|Glaxo Group Limited|Belimumab||22711||22711|31795||1 146229|L01XX1903|Irinotecan Hospira|irþ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.12.2015||R|0|0|0|1|0|1|PLS|0|0|0|100|XEU|6776|10731|lyfsjukr|||2|25|0||Icepharma hf|Pfizer Aps|Írinótekan||6776||6776|10731||1 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.01.2010||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|14063|20761|lyfalmen|V0817|9994|1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||14063||14063|20761||2 146529|B06AC0201|Firazyr|stl|30|mg|1|spr|1|pakki|+ leysir, lausn|B06AC02|01.01.2016||R|0|0|0|1|0|1|LVE|0|0|0|100|NOK|212723|270675|lyfsjukr|||1|1|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Icatibant ||212723||212723|270675||3 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|264|1768|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||264||264|1768||1 147263|L01BC0102|Arabine|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.09.2015||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|2526|4882|lyfsjukr|||2|20|0||Alvogen|Hospira Nordic AB|Cýtarabín||||2526|4882||1 147426|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.04.2015||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|3509|5384|lyfalmen|V0691|4100|2|30|0|18,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2891||2891|5384||1 147578|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3277||1 147605|J01CF0104|Dicloxacillin Bluefish|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|IKR|1873|3983|lyfalmen|V0353|3983|2|30|0|3,7500|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1873||1873|3983||1 147788|N03AX1603|Pregabalin Krka|hylki|150|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|6431|5534|lyfalmen|V0687|5534|2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||3000||3000|5534||2 147958|R07AX0201|Kalydeco|töflur|150|mg|56|stk|1|pakki||R07AX02|01.12.2015||R|0|0|0|1|0|1|LVE|0|0|0|100|XEU|2424816|3021899|lyfsjukr|||0|56|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|ivacaftor ||||2424816|3021899||3 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|1|0|0|ROA|0|0|0|100|DKK|88724|115288|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||88724||88724|115288||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|952|2485|lyfalmen|V0577|2485|2|20|0|6,6667|Vistor hf|Orion Corporation|Pívmecillínam||785||785|2485||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|þpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|1417|3355|lyfalmen|||2|30|0|10,0000|Vistor hf|Orion Corporation|Pívmecillínam||1417||1417|3355||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|COR|0|0|1|100|DKK|4870|7785|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Pívmecillínam||4635||4635|7785||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|48794|64785|lyfalmen|||1|30|0|15,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||48794||48794|64785||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|þpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLA|0|0|0|100|DKK|48794|64785|lyfalmen|||1|30|0|45,0000|Vistor hf|Stiefel Laboratories Ireland Ltd.|Alítretínóín||48794||48794|64785||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|SEK|327|1778|lyfalmen|V0601|1778|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Fúrósemíð||271||271|1778||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|907|2653|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||907||907|2653||1 148460|N03AX1201|Neurontin|hylki|100|mg|100|stk|1|pakki||N03AX12|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|9800|14894|lyfalmen|||0|100|1|6,0000|Distica|Distica - óskráð lyf|Gabapentín||||9800|14894||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|81611|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíð og súrefni||62097||62097|81611||5 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|10819|16296|lyfsjukr|||2|10|0||Alvogen|Hospira Nordic AB|Vínkristín||10819||10819|16296||1 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|ALV|0|0|0|100|XEU|23144|32343|lyfsjukr|||1|1|0||Alvogen|Hospira Nordic AB|Raltítrexed||23144||23144|32343||1 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|2867|5610|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||2867||2867|5610||2 149120|B02BD0601|Haemate|stl|1000|ae|1|hgl|1|pakki||B02BD06|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|93651|121520|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|von Willebrand factor og factor VIII||||93651|121520||2 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3050|5603|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráð lyf|Pímózíð||3050||3050|5603||1 149279|L01XC2401|Darzalex|irþ|20|mg/ml|20|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|231273|293746|lyfsjukr|||1|20|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||231273||231273|293746||1 149624|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1939|4074|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1939||1939|4074||1 149908|J02AC0303|Vortil|irs|200|mg|1|hgl|1|pakki|lausn|J02AC03|01.10.2017||R|0|0|0|0|0|1|WEH|0|0|0|100|IKR|14270|21046|lyfsjukr|||2|1|0|0,5000|Williams & Halls efh|Williams & Halls ehf|Voricónazól||14270||14270|21046||2 149963|R06AA0401|Tavegyl|stl|1|ml|2|ml|5|lykjur||R06AA04|01.01.2016||R|0|0|0|0|0|1|PCO|0|0|0|100|IKR|4804|8017|lyfsjukr|||0|10|1||Distica|Distica - óskráð lyf|Klemastín||||4804|8017||1 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3737|6549|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||3737||3737|6549||1 150448|L01XX4501|Kyprolis|irs|60|mg|1|hgl|1|pakki||L01XX45|01.10.2016||R|0|0|0|1|0|1|AEB|0|1|0|100|DKK|152087|195261|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Carfilzomibum||152087||152087|195261||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|34961|47289|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||34961|47289||1 151037|N06DX0109|Marbodin|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4300|4984|lyfalmen|V0607|4984|2|98|0|98,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2600||2600|4984||2 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|5049|8354|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||5049||5049|8354||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|1151|2989|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1151||1151|2989||1 151250|J05AP5301|Viekirax|filmhtfl|137,5|mg|56|stk|1|þpakki|12,5mg/75mg/50mg|J05AP53|01.10.2015||R|0|0|0|1|0|1|ABV|0|1|0|100|DKK|1560548|1946992|lyfsjukr|||1|56|0||Vistor hf|AbbVie Ltd.|Ombitasvir, paritaprevir og ritonavir||1560548||1560548|1946992||1 151266|R06AD0101|Vallergan|töflur|10|mg|25|stk|1|þpakki||R06AD01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|637|2282|lyfalmen|||0|25|1|8,0000|Distica|Distica - óskráð lyf|Alímemazín||||637|2282||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LUN|0|0|0|100|DKK|26564|36668|lyfalmen|V0607|4984|1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Memantín||26564||26564|36668||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|334|1865|lyfalmen|V0633|1783|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||334||334|1865||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|3558|6302|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||3558|6302||2 151682|N05AX1210|Aripiprazol Medical Valley|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|5688|4502|lyfalmen|V0682|4502|2|56|0|18,6670|Acare ehf|Medical Valley Invest AB|Aripiprazól||2250||2250|4502||2 151737|S01AA2601|Azyter|augndr|15|mg/g|0,25|g|6|sk-ílá||S01AA26|01.04.2016||R|0|0|0|0|0|0|LTH|0|0|1|100|SEK|932|2688|lyfalmen|||1|1,5|0||Vistor hf|Laboratoires THEA|azithromycin||932||932|2688||1 151810|QJ01CE9003|Penethaone vet.|sts|10|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1768|3475|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1768|3475||2 151873|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1512|2458|lyfalmen|V0234|1478|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||765||765|2458||1 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1237|3108|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1237||1237|3108||1 152197|C07AB0213|Metoprololsuccinat Hexal|forðatfl|25|mg|100|stk|1|plglas|23,75 mg metoprololsuccinat|C07AB02|01.04.2015||R|1|0|0|0|G|0|SSA|0|0|0|100|DKK|705|2375|lyfalmen|V0050|2079|2|100|0|15,8300|Artasan ehf|Hexal A/S|Metóprólól||705||705|2375||1 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1507|3479|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1507||1507|3479||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.12.2010|31.12.2017|R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|1716|3746|lyfalmen|||3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||1701||1701|3746||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PLS|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|2308|4582|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2308||2308|4582||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3704|6503|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3704||3704|6503||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|6773|10727|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||6773||6773|10727||1 152635|B01AC0601|Hjartamagnyl|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|GPA|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14866|21866|lyfalmen|||3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||14866||14866|21866||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|5140|3882|lyfalmen|V0182|3774|2|42|0|7,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||1800||1800|3882||1 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|þpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|5235|7599|lyfalmen|||2|90|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Valacíklóvír||4500||4500|7599||1 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|867|2598|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||867||867|2598||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1295|3187|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín í blöndum||1295||1295|3187||2 153190|S01EC0402|Brinzolamide ratiopharm|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.04.2016||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|1176|2162|lyfalmen|V0444|2162|2|5|0|25,0000|Alvogen|ratiopharm GmbH|Brinzólamíð||550||550|2162||2 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|26222|36236|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||26222|36236||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1636|3657|lyfalmen|V0561|3128|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1636||1636|3657||2 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1144|2980|lyfalmen|V0560|2946|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1144||1144|2980||2 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0575|2389|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Cetirizín|||||3648||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|169560|216992|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||169560||169560|216992||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|569|2188|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Própranólól||||569|2188||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|þpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|XEU|25508|35333|lyfalmen|V0452|35333|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||25508||25508|35333||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|3050|5603|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||3050||3050|5603||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1321|2103|lyfalmen|||2|24|0|8,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||507||507|2103||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|952|2715|lyfalmen|||2|24|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||952||952|2715||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|XEU|504|2024|lyfalmen|V0908|2024|2|30|0|30,0000|Alvogen|Teva B.V.|Deslóratadín||450||450|2024||2 154048|L02AE0307|Reseligo|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|18237|17111|lyfalmen|V0183|17111|2|1|0|27,9070|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||11411||11411|17111||1 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|7018|11064|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||7018||7018|11064||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|16050|23496|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||16050||16050|23496||1 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|18339|26647|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||18339||18339|26647||1 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|22941|32086|lyfsjukr|||1|7880|0||Vistor hf|Fresenius Kabi AB|Blöndur||22941||22941|32086||1 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20931|29544|lyfsjukr|||1|7389|0||Vistor hf|Fresenius Kabi AB|Blöndur||20931||20931|29544||1 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20968|29591|lyfsjukr|||1|3944|0||Vistor hf|Fresenius Kabi AB|Blöndur||20968||20968|29591||1 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|25413|35213|lyfsjukr|||1|5908|0||Vistor hf|Fresenius Kabi AB|Blöndur||25413||25413|35213||1 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|13684|20240|lyfsjukr|||1|4824|0||Vistor hf|Fresenius Kabi AB|Blöndur||13684||13684|20240||1 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.04.1993||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2405|4715|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2405||2405|4715||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|20222|28647|lyfsjukr|||1|7616|0||Vistor hf|Fresenius Kabi AB|Blöndur||20222||20222|28647||1 154728|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|28|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1088|2902|lyfalmen|V0336|2476|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1088||1088|2902||1 154739|N06AX1608|Venlafaxin Actavis|forðahlk|75|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2770|3178|lyfalmen|V0334|2686|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1288||1288|3178||1 154761|N06AX1608|Venlafaxin Actavis|forðahlk|150|mg|98|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4855|3452|lyfalmen|V0335|2686|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1487||1487|3452||1 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|2347|3926|lyfalmen|V0901|3882|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Memantín||1832||1832|3926||2 155219|N03AX1106|Topiramate Alvogen|filmhtfl|25|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|1374|2030|lyfalmen|V0247|2030|2|60|0|5,0000|Alvogen|Alvogen ehf|Tópíramat||454||454|2030||1 155230|N03AX1106|Topiramate Alvogen|filmhtfl|50|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|2521|3319|lyfalmen|V0248|3319|2|60|0|10,0000|Alvogen|Alvogen ehf|Tópíramat||1391||1391|3319||1 155241|N03AX1106|Topiramate Alvogen|filmhtfl|100|mg|60|stk|1|þpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|GOV|0|0|0|100|XEU|4548|3753|lyfalmen|V0249|3753|2|60|0|20,0000|Alvogen|Alvogen ehf|Tópíramat||1706||1706|3753||1 155246|C10BA0501|Atozet|filmhtfl|30|mg|90|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|13996|20669|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||13996||13996|20669||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1227|3094|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1227||1227|3094||1 155410|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1347|2506|lyfalmen|V0466|2183|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2506||2 155415|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|7414|6432|lyfalmen|V0253|6180|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3652||3652|6432||1 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|529|2133|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||529||529|2133||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|957|2722|lyfalmen|V0590|2722|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||957||957|2722||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|RHA|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Alvogen|ratiopharm Oy|Íbúprófen|||||||2 155628|V08CA0101|Magnevist|stl|0,5|mmol/ml|20|ml|5|áfspr|röntgenskuggaefni|V08CA01|01.06.2017|31.12.2017|R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|53444|70666|lyfsjukr|||1|100|0||Icepharma hf|Bayer AB|Gadópentetat||53444||53444|70666||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4646|7800|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4646||4646|7800||1 155903|J05AF0101|Retrovir|mixtúra|10|mg/ml|200|ml|1|fl||J05AF01|01.02.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|XEU|10272|15543|lyfsjukr|||0|200|1||Distica|Distica - óskráð lyf|Zídóvúdín||||10272|15543||1 156195|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|100|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|16000|23427|lyfalmen|V0383|23427|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||16000||16000|23427||1 156427|J02AC0106|Fungyn|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.11.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4589|3483|lyfalmen|V0552|3483|2|30|0|7,5000|Alvogen|Alvogen|Flúkónazól||1510||1510|3483||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4265|7275|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||4265||4265|7275||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|NED|0|0|0|100|XEU|4774|7976|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||4774||4774|7976||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|þpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|311|1833|lyfalmen|||2|15|0|3,7500|Icepharma hf|Meda AB|Nítrófúrantóín||311||311|1833||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|531|2136|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||531||531|2136||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|IKR|6850|13166|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|Ketaminum||6850||6850|13166||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 157054|N06BA0202|Attentin|töflur|10|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|8684|13358|lyfalmen|||1|30|0|20,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||8684|13358||2 157257|QJ01DB0101|Cefabactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|1|0|0|100|IKR|2589|5082|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||2589|5082||0 157331|QN03AA0201|Phenoleptil|töflur|100|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2895|5663|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2895||2895|5663||2 157594|G03BA0301|Testoviron Depot|stl|250|mg/ml|1|ml|3|lykjur||G03BA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|9256|14145|lyfalmen|||0|3|1|42,0000|Parlogis hf|Parlogis - óskráð lyf|Testósterón||||9256|14145||2 157745|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|20|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|59654|78521|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||59654||59654|78521||2 157756|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33742|45747|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33742|45747||1 157768|S01AA3001|Terramycin Polymyxin B|augnsm|100|mg|3,5|g|1|túpa||S01AA30|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|382|1931|lyfalmen|||0|3,5|1||Distica|Distica - óskráð lyf|Oxýtetracýklín||||382|1931||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|þpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1205|3063|lyfalmen|||1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1205||1205|3063||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|5310|8714|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||5310||5310|8714||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|809|2518|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||809||809|2518||1 158185|N05AH0405|Seroquel Prolong|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.10.2011||R|1|1|0|0|0|0|ASA|0|0|0|100|SEK|16485|24095|lyfalmen|V0910|9378|1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||16485|24095||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|35992|48593|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||35992|48593||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|47374|62989|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||47374||47374|62989||1 158639|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.12.2016||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3180|3607|lyfalmen|V0143|3317|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1600||1600|3607||1 158698|L01BC5901|Lonsurf|filmhtfl|21,14|mg|60|stk|1|þpakki|15 mg + 6,14 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|263434|333745|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||263434|333745||2 158725|M01AB0516|Diklofenak Mylan|sþ-tfl|50|mg|100|stk|1|glas||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|732|2375|lyfalmen|V0469|2231|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||705||705|2375||2 158849|N06BA0903|Atomoxetin Medical Valley|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|11503|11369|lyfalmen|V0817|9994|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||7239||7239|11369||2 158866|G03GA1001|REKOVELLE|stl|12|mcg|0,36|ml|1|pakki|+ 3 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|11380|17068|lyfalmen|||1|0,36|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||||11380|17068||1 158972|H01AA0201|Synachten depot|stl|1|mg/ml|1|ml|1|lykjur||H01AA02|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|27082|37324|lyfsjukr|||0|1|1|40,0000|Parlogis hf|Parlogis - óskráð lyf|tetracosactide||||27082|37324||2 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|1667|3699|lyfalmen|V0219|3699|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1667||1667|3699||1 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|2775|5224|lyfalmen|V0220|5224|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||2775||2775|5224||1 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4105|7055|lyfalmen|V0221|7055|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4105||4105|7055||1 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|GPA|0|0|0|100|XEU|4450|7530|lyfalmen|V0223|7530|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4450||4450|7530||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3218|2231|lyfalmen|V0581|2231|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||600||600|2231||2 159341|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.06.2015||R|0|0|0|0|G|0|LYF|0|0|0|100|IKR|27000|15169|lyfalmen|V0421|15169|2|90|0|270,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíð||10000||10000|15169||2 159454|L01XX3202|VORTEMYEL|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.12.2015||R|0|1|0|1|0|1|IPC|0|1|0|100|SEK|107764|140135|lyfsjukr|||2|1|0||Alvogen|Alvogen IPco S.á.r.l.|Bortezomíb||107764||107764|140135||1 159458|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.11.2016||L|1|0|0|0|0|0|VAL|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól|||||||2 159605|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.09.2017||R|0|0|0|0|0|1|ESS|0|0|0|100|DKK|4468|7555|lyfsjukr|||1|5|0|5,0000|Essential Pharma Ltd.|Essential Pharma Ltd.|Samtengt laxakalsítónín||4468||4468|7555||2 159672|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|375|1921|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||375||375|1921||2 159683|R05CB0105|Acetylcystein Mylan|freyðit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1137|2970|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1137||1137|2970||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|108476|141021|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||108476||108476|141021||1 159845|A02BC0509|Esomeprazole Alvogen|sþ-tfl|40|mg|100|stk|1|þpakki||A02BC05|01.10.2015||R|1|0|0|0|0|0|IPC|0|0|0|100|IKR|5271|5778|lyfalmen|||2|100|0|133,3300|Alvogen|Alvogen IPco S.á.r.l.|Esómeprazól||3177||3177|5778|31.01.2018|1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|3326|6481|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3326||3326|6481||2 160047|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|12000|8975|lyfalmen|||2|100|0|200,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||5500||5500|8975||2 160155|L04AB0102|Benepali|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAM|0|1|0|100|XEU|55227|72921|lyfsjukr|||2|4|0|14,2900|Biogen Idec Ltd.|Samsung Bioepis UK Ltd.|Etanercept||55227||55227|72921||2 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|IKR|4411|3503|lyfalmen|V0010|2218|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1524||1524|3503||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|5961|4869|lyfsjukr|||2|50|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2517||2517|4869||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|649|2298|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||649||649|2298||1 160531|C10AC0101|Questran|mixtduft|4|g|50|skammtar|1|skpoki||C10AC01|01.05.2016||R|0|0|0|0|0|0|BRS|0|0|0|100|DKK|3226|5845|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb|Kólestýramín||3226||3226|5845||1 160852|R01AX0301|Atrovent|nefúði|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009|31.12.2017|R|0|0|0|0|G|0|BOI|0|0|1|100|NOK|900|2644|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||900||900|2644||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|540|2148|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||540||540|2148||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|729|2408|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||729||729|2408||1 161113|J01CR0202|Augmentin|töflur|1|g|14|stk|1|þpakki|875+125 mg|J01CR02|01.11.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1164|3007|lyfalmen|V0169|2231|1|14|0|12,2500|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1164||1164|3007||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2010|4171|lyfalmen|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||2010||2010|4171||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|480|2066|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||480||480|2066||1 161180|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1339|2367|lyfalmen|V0143|1106|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||699||699|2367||1 161424|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|10000|9663|lyfalmen|V0145|9195|2|8|0|16,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||6000||6000|9663||2 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|45380|60467|lyfalmen|V0452|35333|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||45380||45380|60467||1 161592|J01DD0101|Cefotaxim Villerton|sts|1|g|10|ml|10|hgl|lausn|J01DD01|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|5152|8496|lyfsjukr|||2|100|0|2,5000|Icepharma hf|Villerton Invest SA|Cefotaximum||||5152|8496||2 161824|A06AX0401|Constella|hylki|290|mcg|90|stk|1|glas||A06AX04|01.12.2016||R|0|0|0|0|G|0|AIP|0|0|0|100|XEU|23583|32898|lyfalmen|||1|90|0|90,0000|Actavis ehf|Allergan Pharmaceuticals Ltd.|Linaclotídum||23583||23583|32898||1 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.08.2011|31.12.2017|R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|9547|14545|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||9547||9547|14545||1 161950|S01EA0301|Iopidine|augndr|0,5|%|5|ml|1|glas||S01EA03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|3726|6533|lyfalmen|||0|5|1|17,0000|Distica|Distica - óskráð lyf|apraclonidine||||3726|6533||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012|28.02.2018|R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|116151|150566|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||116151||116151|150566||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|432233|543684|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||432233||432233|543684||1 162276|A10BB0904|Zodediab|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.03.2015|31.01.2018|R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2658|4020|lyfalmen|||2|180|0|90,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||1900||1900|4020||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1601|3609|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1601||1601|3609||1 162440|G04BE0806|Tadalafil Krka|filmhtfl|20|mg|12|stk|1|þpakki||G04BE08|01.12.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|16000|13793|lyfalmen|V0145|13793|2|12|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Tadalafíl||9000||9000|13793||2 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|4478|8666|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||4478||4478|8666||2 162808|C01DA1404|Fem-Mono Retard|forðatfl|60|mg|100|stk|1|þpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2048|3112|lyfalmen|V0041|2847|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíð mónónítrat||1240||1240|3112||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|387|1873|lyfalmen|V0500|1873|2|100|0|25,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||340||340|1873||1 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|580|2203|lyfalmen|||2|100|0|42,5000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||580||580|2203||1 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|500|2093|lyfalmen|V0502|1940|2|60|0|30,0000|Vistor hf|Bluefish Pharmaceuticals AB|Metformín||500||500|2093||1 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1103|2923|lyfalmen|||1|120|0|20,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1103||1103|2923||1 163036|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|7999|12415|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíð||7999||7999|12415||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|972|2743|lyfalmen|V0671|2300|1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||972||972|2743||1 163239|L04AX0306|Metojectpen|stl|30|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|3297|5943|lyfalmen|||1|1|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||3297||3297|5943||2 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNP|0|0|1|100|XEU|1094|2911|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1094||1094|2911||1 163354|C10BA0501|Atozet|filmhtfl|30|mg|30|stk|1|þpakki|10 mg + 20 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5003|8291|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5003||5003|8291||1 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|9495|14474|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||9495||9495|14474||2 163453|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|8350|9663|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||6000||6000|9663||2 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|1924|4053|lyfalmen|||1|120|0|25,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1924||1924|4053||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|415485|522854|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||415485||415485|522854||2 163646|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|100|stk|1|þpakki||L04AX03|01.06.2016||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1566|3560|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Metótrexat||1566||1566|3560||1 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|482|1947|lyfalmen|||2|30|0|20,0000|Alvogen|ratiopharm Oy|Íbúprófen||394||394|1947||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|þpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|RHA|0|0|1|100|XEU|1329|2713|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Íbúprófen||950||950|2713||2 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|9384|14321|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráð lyf|Pólýstýren súlfónat||9384||9384|14321|31.01.2018|1 163967|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|800|2052|lyfalmen|V0827|1034|2|7|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||470||470|2052||2 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3139|5725|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3139||3139|5725||1 164324|L01BB0202|Xaluprine|mixtúra|20|mg/ml|100|ml|1|glas||L01BB02|01.05.2015||R|0|0|0|1|0|1|VON|0|0|0|100|DKK|31298|42656|lyfsjukr|||1|100|0||Williams & Halls efh|Nova Laboratories Limited|Merkaptópúrín||31298||31298|42656||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7615|14618|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||7615||7615|14618||1 164827|C02KX0501|Adempas|filmhtfl|2,5|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|324443|409623|lyfsjukr|||1|84|0|46,6700|Vistor hf|Bayer AG|Riociguatum||324443||324443|409623||1 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|835|2554|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||835||835|2554||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1026|2817|lyfalmen|V0314|2817|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1026||1026|2817||2 164871|A07EC0204|Asacol|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|4476|7566|lyfalmen|V0014|7566|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4476|7566||2 164944|M01AX0001|Harpatinum|hylki|225|mg|90|stk|1|þpakki||M01AX00|01.01.2018||L|0|0|0|0|0|0|FLO|0|0|1|100|IKR|||lyflausa|||0|90|0||Florealis ehf|Florealis ehf|Devil´s claw dry extrakt ethanolic 60%|||||||1 165019|C05AA0102|Proctosedyl|eþ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||||31.01.2018|1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1206|3065|lyfalmen|||2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Klórdíazepoxíð||1206||1206|3065||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|5479|10565|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||5479||5479|10565||2 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.08.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|4747|7939|lyfalmen|||0|98|1||Distica|Distica - óskráð lyf|Felódipín||||4747|7939||1 165522|D11AX0102|Regain forte|áburður|50|mg/ml|60|ml|1|glas||D11AX01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|3436|6134|lyfalmen|||0|60|1||Distica|Distica - óskráð lyf|Mínoxidíl||||3436|6134||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|137453|177060|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|Merck AB|Sómatrópín||137453||137453|177060||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010|31.12.2017|R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22752|31847|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||22752||22752|31847||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010|31.12.2017|R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|33128|44971|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||33128||33128|44971||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2017||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|500|2093|lyfalmen|V0904|2093|1|100|0|50,0000|Vistor hf|TERALI PRODUCTS|Meklózín||500||500|2093||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|145|1604|lyfalmen|V0505|1604|1|25|0|12,5000|Vistor hf|TERALI PRODUCTS|Meklózín||145||145|1604||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|TER|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|TERALI PRODUCTS|Meklózín|||||||1 165799|C02KX0501|Adempas|filmhtfl|2|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|161061|206422|lyfsjukr|||1|42|0|18,6700|Vistor hf|Bayer AG|Riociguatum||161061||161061|206422||1 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3317|5970|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||3317||3317|5970||1 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010|31.12.2017|R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44195|58968|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||44195||44195|58968||2 165903|QA03DB0401|Spasmium vet.|stl|504|mg/ml|100|ml|1|hgl|500 mg/ml+4 mg/ml, lausn|QA03DB04|01.02.2016||R|0|0|0|0|0|0|RPG|1|0|0|100|XEU|4740|9163|vetalmen|||0|100|0||Icepharma hf|Richter Pharma AG|Butylscopolamine og metamizolum||||4740|9163||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|3711|7211|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||3711|7211||1 166029|G04BE0309|Vizarsin|munndr.t|50|mg|24|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|8916|6635|lyfalmen|||2|24|0|24,0000|LYFIS ehf|Krka d.d. Novo mesto|Síldenafíl||3800||3800|6635||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1250|3125|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1250||1250|3125||1 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PLS|0|0|0|100|DKK|12373|18435|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||12373||12373|18435||1 166204|J07BB0205|Influvac|stl|||0,5|ml|10|áfspr||J07BB02|01.11.2017||R|0|0|0|0|0|0|PGB|0|0|0|100|DKK|6905|10909|lyfalmen|||1|5|0||Icepharma hf|BGP Products ApS|Inflúensa, hreinsaðir mótefnavakar||||6905|10909||2 166277|C10AA0508|Lipistad|filmhtfl|20|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2665|2781|lyfalmen|V0113|2781|2|100|0|100,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||1000||1000|2781||2 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1582|3428|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1470||1470|3428||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2994|5526|lyfalmen|V0428|5526|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||2994||2994|5526||2 166628|L04AB0401|Humira|stl|40|mg/penna|0,4|ml|2|áfpen|áfylltur penni|L04AB04|01.11.2016||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|117517|152265|lyfsjukr|||1|0,8|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||117517||117517|152265||1 166814|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|pakki||N03AX21|01.04.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|20215|28638|lyfalmen|||0|84|1||Distica|Distica - óskráð lyf|Retigabín||||20215|28638||1 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|0|0|0|0|0|0|UAK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forðahlk|37,5|mg|7|stk|1|þpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|314|1837|lyfalmen|||2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||314||314|1837|31.01.2018|1 167588|B02BD0208|Afstyla|sts|500|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|35716|48244|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||35716||35716|48244||2 167753|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2588|3057|lyfalmen|V0826|3057|2|30|0|45,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1200||1200|3057||2 167905|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1421|2783|lyfalmen|V0005|1953|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1001||1001|2783||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|140233|180518|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og kóbísistat||140233||140233|180518||2 168083|L02BB0305|Bicalutamide Alvogen|filmhtfl|50|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|19158|10076|lyfalmen|V0420|10076|2|90|0|90,0000|Alvogen|Alvogen ehf|Bíkalútamíð||6300||6300|10076||1 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|UAK|0|0|0|100|GBP|357|1896|lyfalmen|V0119|1887|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||357|1896||1 168309|A02BC0306|Lanser|sþ-hylki|30|mg|98|stk|1|þpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|3892|4944|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||2571||2571|4944||1 168423|R06AX2701|Aerius|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.10.2015||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|2719|5147|lyfalmen|V0458|2627|1|90|0|90,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||2719||2719|5147||1 168589|N02CC0402|Maxalt Smelt|frþ.tfl|10|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2212|4450|lyfalmen|V0621|1614|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||2212||2212|4450||1 168629|L04AX0307|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|1870|3979|lyfalmen|||1|0,2|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||1870||1870|3979|31.12.2017|2 168640|L04AX0307|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2074|4260|lyfalmen|||1|0,3|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2074||2074|4260||2 168662|L04AX0307|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2469|4803|lyfalmen|||1|0,5|0|10,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2469||2469|4803||2 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2421|4737|lyfalmen|V0240|4736|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2421||2421|4737||1 168778|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4468|7555|lyfalmen|V0433|7552|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||4468||4468|7555||1 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|22070|30984|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||22070||22070|30984||1 169175|N03AX1603|Pregabalin Krka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|7281|4635|lyfalmen|V0688|4635|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||2347||2347|4635||2 169287|M05BA0606|Ibandronic acid WH|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|0|0|0|WEH|0|0|0|100|IKR|54874|72475|lyfalmen|||2|84|0|840,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||54874||54874|72475||2 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|110349|143350|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||110349||110349|143350||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|16360|23923|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||16360||16360|23923||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3987|6893|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Hlaupabóla, veikluð veira||3987||3987|6893||1 169751|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|1168|3007|lyfalmen|V0411|3007|2|20|0|10,0000|Alvogen|Alvogen ehf|Cíprófloxacín||1164||1164|3007||1 169762|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|500|mg|10|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|647|2295|lyfalmen|V0177|2295|2|10|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||647||647|2295||1 169773|J01MA0204|Ciprofloxacin Alvogen|filmhtfl|250|mg|20|stk|1|þpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|GOV|0|0|1|100|IKR|638|2283|lyfalmen|V0418|2283|2|20|0|5,0000|Alvogen|Alvogen ehf|Cíprófloxacín||638||638|2283||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2145|4357|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2145||2145|4357||2 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2309|4583|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín||2309||2309|4583||2 169998|S01GA0101|Cleye|augndr|0,12|mg/ml|10|ml|1|glas||S01GA01|01.08.2017||L|0|0|0|0|0|0|CLE|0|0|0|100|IKR|||lyflausa|||1|10|0||LYFIS ehf|Clear Eyes Pharma Ltd.|Nafazólín|||||||2 170062|L04AC0701|RoActemra|irþ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|16963|24753|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||16963|24753||2 170085|L04AC0701|RoActemra|irþ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|42101|56320|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||42101|56320||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GBI|0|0|0|100|DKK|4187|7168|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4187||4187|7168||1 170107|L04AC0701|RoActemra|irþ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|83768|109020|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||83768||83768|109020||2 170486|C10AX1401|Praluent|stl|75|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|167260|214132|lyfalmen|||1|6|0|83,3333|Vistor hf|Sanofi-aventis groupe|Alirocumab||167260||167260|214132||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|þpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|10285|15561|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||10285||10285|15561||2 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|DKK|6349|10144|lyfalmen|||0|100|1|100,0000|Parlogis hf|Parlogis - óskráð lyf|Própafenón||||6349|10144||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1755|3821|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Mepívakaín í blöndum||1755||1755|3821||2 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|9060|13875|lyfsjukr|||2|1600|0|6,6700|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||9060||9060|13875||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|21795|30637|lyfsjukr|||2|1600|0|20,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||21795||21795|30637||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|32692|44419|lyfsjukr|||2|2400|0|30,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||32692||32692|44419||1 170672|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2015||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|28376|38960|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||28376|38960||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2660|2860|lyfalmen|V0203|2860|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||1057||1057|2860||1 170881|QM01AC0607|Meloxoral|mixtúra|0,5|mg/ml|5|ml|1|glas|handa köttum|QM01AC06|01.12.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1158|2276|vetalmen|||0|5|0||Dýraheilsa ehf|Le Vet B.V.|||1158||1158|2276||2 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|45600|60745|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||45600||45600|60745||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2172|4269|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2172||2172|4269||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2659|5065|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2659||2659|5065||2 171609|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.05.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1455|2919|lyfalmen|V0213|2781|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1100||1100|2919||2 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|2685|5101|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Búpívakaín í blöndum||2685||2685|5101||2 171645|C02DB0101|Nepresol|sts/irs|25|mg|2|ml|5|lykjur||C02DB01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|13613|20142|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Dihydralazine||||13613|20142||2 171762|A03AA0407|Duspatalin Retard|forðahlk|200|mg|30|stk|1|þpakki||A03AA04|01.11.2016||R|0|0|0|0|G|0|GBP|0|0|0|100|DKK|1005|2788|lyfalmen|||1|30|0|20,0000|Icepharma hf|BGP Produtcs B.V.|Mebeverín||1005||1005|2788||2 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2235|4481|lyfalmen|V0247|2030|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2235||2235|4481||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3884|6751|lyfalmen|V0248|3319|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3884||3884|6751||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007|31.12.2017|R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|34854|47154|lyfsjukr|||1|75|0||Icepharma hf|Bayer AB|Gadópentetat||34854||34854|47154||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007|31.12.2017|R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|23237|32460|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadópentetat||23237||23237|32460||2 172289|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|þpakki|hart|L04AX05|01.02.2016||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|89806|116657|lyfalmen|V0920|114932|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||||89806|116657||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|7190|11301|lyfalmen|V0249|3753|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7190||7190|11301||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|13085|19415|lyfalmen|||1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13085||13085|19415||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007|31.12.2017|R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|53444|70666|lyfsjukr|||1|100|0||Icepharma hf|Bayer AB|Gadópentetat||53444||53444|70666||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|37865|lyfalmen|||3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||27510||27510|37865||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|16045|23489|lyfalmen|||1|98|0|98,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||16045||16045|23489||1 172595|B01AC2701|Uptravi|filmhtfl|1600|mcg|60|stk|1|pakki||B01AC27|01.07.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|SEK|515692|647483|lyfsjukr|||0|60|1||Distica|Distica - óskráð lyf|Selexipagum||||515692|647483||1 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|7912|12295|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||7912||7912|12295||1 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2157|2207|lyfalmen|V0284|2194|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||583||583|2207||1 172742|M04AB0102|Probecid / Probenecid|töflur|500|mg|50|stk|1|glas||M04AB01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|1996|4152|lyfalmen|||0|50|1|25,0000|Distica|Distica - óskráð lyf|probenecid||||1996|4152||1 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|485516|609953|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||485516||485516|609953||1 173060|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl||R05CB01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|DKK|13449|19916|lyfalmen|||0|100|1|13,0000|Parlogis hf|Parlogis - óskráð lyf|Acetýlcýstein||13449||13449|19916||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MEA|0|0|1|100|DKK|302|1821|lyfalmen|||1|50|0|50,0000|Icepharma hf|Meda AB|Nítrazepam||302||302|1821||2 173284|C10AA0702|Rosuvastatin Actavis|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|8434|9557|lyfalmen|V0118|8796|2|98|0|196,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||5923||5923|9557||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2442|4766|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||2442||2442|4766||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3476||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|4182|7161|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríð||4182||4182|7161||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|10496|15852|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||10496||10496|15852||1 173895|N05AX1207|Lemilvo|töflur|15|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|14712|10367|lyfalmen|V0684|8039|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||6511||6511|10367||1 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|4459|7542|lyfalmen|||0|250|1|14,0000|Distica|Distica - óskráð lyf|Pyridostigmin||||4459|7542||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|11457|17174|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||11457||11457|17174||1 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|10583|15971|lyfalmen|||0|150|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|Pyridostigmin||10583||10583|15971||2 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1608|3618|lyfsjukr|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1608||1608|3618||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|451|2026|lyfalmen|V0928|1955|1|14|0|5,6000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||451||451|2026||2 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|460|2038|lyfalmen|||1|14|0|7,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||460||460|2038||2 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|1138|2971|lyfalmen|V0368|1977|1|5|0|25,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||1138||1138|2971||1 174522|N04BC0505|Oprymea|forðatfl|0,26|mg|30|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5396|lyfalmen|||2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5396||2 174532|B01AA0302|Marevan|töflur|2,5|mg|100|stk|1|glas||B01AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2230|4474|lyfalmen|||0|100|1|33,0000|Parlogis hf|Parlogis - óskráð lyf|Warfarín||||2230|4474||2 174615|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|30|stk|1|þpakki||N05CF01|01.01.2017||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|276|1785|lyfalmen|V0312|1636|2|30|0|30,0000|Icepharma hf|Mylan AB|Zópíklón||276||276|1785||2 174626|A10AE0601|Tresiba|stl|200|ae/ml|3|ml|3|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|9501|14482|lyfalmen|||1|9|0|45,0000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||9501||9501|14482||1 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|IRE|0|0|0|100|XEU|3289|5932|lyfalmen|V0368|5932|1|15|0|75,0000|Actavis ehf|Allergan Pharmaceuticals Ireland|Brímónidín||3289||3289|5932||1 174806|J05AE1002|Darunavir Alvogen|filmhtfl|800|mg|30|stk|1|glas||J05AE10|01.07.2017||R|1|0|0|1|0|1|ALO|0|0|0|100|XEU|42486|56807|lyfsjukr|||2|30|0|20,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Darunavír||42486||42486|56807||1 174935|L01XE1301|Giotrif|filmhtfl|20|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|235113|298522|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||235113||235113|298522||1 175058|N05AH0413|Quetiapin ratiopharm|forðatfl|50|mg|10|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|0|0|TVA|0|0|0|100|IKR|1262|3142|lyfalmen|||2|10|0|1,2500|Alvogen|Teva B.V.|Quetíapín||1262||1262|3142||2 175246|B02BD0205|Elocta|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|18823|27313|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||18823|27313||3 175253|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|6770|6525|lyfalmen|||1|10|0|1,2500|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3720||3720|6525||1 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|4235|8205|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||4235||4235|8205||2 175370|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|12592|18737|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||12592|18737||1 175398|S02CA0201|Locacorten-Vioform|eyrnadr|||7,5|ml|1|glas||S02CA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2244|4494|lyfalmen|||0|7,5|1||Distica|Distica - óskráð lyf|flumetasone and antiinfectives||||2244|4494||1 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|1896|2334|lyfalmen|V0033|1973|1|10|0|1,6667|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||675||675|2334||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|NED|0|0|0|100|XEU|3952|6844|lyfalmen|V0278|2689|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3952||3952|6844||2 176472|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1176|3024|lyfalmen|V0915|3024|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón||1176||1176|3024||1 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2104|4301|lyfalmen|V0429|4301|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2104||2104|4301||2 176616|N05CH0101|Circadin|forðatfl|2|mg|30|stk|1|þpakki||N05CH01|01.10.2012||R|0|0|0|0|0|0|RAD|0|0|1|100|DKK|2188|4416|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2188||2188|4416||1 176835|C09CA0106|Losatrix|filmhtfl|25|mg|100|stk|1|þpakki||C09CA01|01.01.2018||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1832|3926|lyfalmen|||2|100|0|50,0000|Alvogen|ratiopharm GmbH|Lósartan||1832||1832|3926||2 176889|QP53AC5501|Seresto|hálsband|1,81|g|1|stk|1|poki|1,25 + 0,56 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5231|10095|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5231||5231|10095||2 176955|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas|+spaði|D01AE16|01.12.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|1904|4026|lyfalmen|V0655|4026|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||||1904|4026||2 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|3039|5588|lyfalmen|||0|20|1|10,0000|Distica|Distica - óskráð lyf|Ófloxacín||||3039|5588||1 177099|L01XC1901|Blincyto|st/irþ|38,5|mcg/ml|1|hgl|1|pakki|lausn|L01XC19|01.04.2017||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|341625|430993|lyfsjukr|||1|1|0||Vistor hf|Amgen Europe B.V.|Blinatumomab||341625||341625|430993||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6464|10302|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||6464||6464|10302||2 177199|L01XE3301|Ibrance|hylki|125|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|441577|555305|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||441577||441577|555305||1 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|610|2245|lyfalmen|V0231|2245|2|300|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||610||610|2245||1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|3635|7067|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||3635||3635|7067||2 177652|V08CA0101|Magnevist|stl|0,5|mmol/ml|15|ml|5|áfspr|röntgenskuggaefni|V08CA01|01.06.2017|31.12.2017|R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|34854|47154|lyfsjukr|||1|75|0||Icepharma hf|Bayer AB|Gadópentetat||34854||34854|47154||2 177882|L04AX0501|Esbriet|filmhtfl|801|mg|84|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|301586|381196|lyfalmen|||1|84|0|28,0350|Icepharma hf|Roche Registration Limited|Pírfenidon||||301586|381196||2 177937|M04AC0102|Colrefuz|töflur|500|mcg|100|stk|1|þpakki||M04AC01|01.10.2015||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|7435|9648|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Kolkisín||5989||5989|9648||1 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|614|2250|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráð lyf|Tríamcínólón||||614|2250||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|27179|37446|lyfalmen|||1|100|0|50,0000|Icepharma hf|Bayer AG|Rivaoxaban||27179||27179|37446||2 178273|L01XE2501|Mekinist|filmhtfl|2|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|705238|883226|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||705238||705238|883226||1 178511|B02BD0205|Elocta|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|75294|98302|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||75294|98302||3 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|þpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|4998|2781|lyfalmen|V0320|2781|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Cítalópram||1000||1000|2781||1 179100|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|116050|150441|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||116050||116050|150441||1 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|112472|145991|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||112472||112472|145991||1 179207|N02BE0122|Dolorin|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|7672|11965|lyfalmen|||1|28|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||||7672|11965||2 179557|C10BA0501|Atozet|filmhtfl|50|mg|90|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|14190|20936|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||14190||14190|20936||1 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|92675|120286|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||92675||92675|120286||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|3933|6818|lyfalmen|||1|100|0|25,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||3933||3933|6818||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|2191|3470|lyfalmen|V0148|3456|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1500||1500|3470||2 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|632|2275|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||632||632|2275||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól||||||28.02.2018|2 181750|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|7760|12086|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||7760||7760|12086||1 181890|G03AD0102|Postinor|töflur|1,5|mg|1|stk|1|þpakki||G03AD01|01.11.2016||L|0|0|0|0|0|0|RIC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Gedeon Ricther Nordics AB|Gedeon Richter Plc.|Levonorgestrel|||||||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|4857|8090|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||4857||4857|8090||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||5555||2 182177|J02AC0106|Fungyn|hylki|150|mg|4|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|2189|lyfalmen|V0556|2189|2|4|0|3,0000|Alvogen|Alvogen|Flúkónazól||570||570|2189||1 182307|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|9546|14544|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||9546||9546|14544||1 182502|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12800|19023|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||12800||12800|19023||2 182569|N06BA0902|Atomoxetin Actavis|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|13641|11369|lyfalmen|V0817|9994|2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||7239||7239|11369||1 182763|QC01CE9001|Vetmedin vet.|tuggutfl|10|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|13089|25003|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||13089||13089|25003||1 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|16383|31252|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||16383|31252||2 182893|M05BA0806|Zoledronic Acid Accord|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.07.2016||R|0|1|0|1|0|1|AHL|0|0|0|100|IKR|9983|4740|lyfsjukr|||2|5|0|1,0000|Alvogen|Accord Healthcare Limited|Zoledronsýra||2423||2423|4740||1 183093|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|SEK|2857|5337|lyfalmen|||1|0,25|0||Icepharma hf|Pfizer ApS|Heilabólguveira óvirk, borin með blóðmaur||2857||2857|5337||1 183133|J01DD5201|Zavicefta|st/irþ|||20|ml|10|hgl|2g/0,5g|J01DD52|01.12.2017||R|0|0|0|1|0|1|PIP|0|0|0|100|DKK|141099|181595|lyfsjukr|||1|200|0|3,3333|Icepharma hf|Pfizer Ireland Pharmaceuticals|Ceftazidime og beta-laktamasa hemill||141099||141099|181595||1 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4279|8289|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||4279||4279|8289||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|þpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1512|2458|lyfalmen|V0234|1478|2|6|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||765||765|2458||1 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|4594|7728|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4594|7728||1 183825|QP53AC5501|Seresto|hálsband|6,53|g|1|stk|1|poki|4,50 +2,03 g|QP53AC55|01.06.2016||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5526|10654|vetalmen|||0|1|0||Icepharma hf|Bayer Animal Health GmbH|Flúmetrín í blöndum||5526||5526|10654||2 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|943|2703|lyfalmen|||1|100|0|100,0000|Icepharma hf|Aspen Pharma Trading Limited|Flúdrókortisón||943||943|2703||2 184046|L01XE2701|IMBRUVICA|filmhtfl|140|mg|90|stk|1|glas||L01XE27|01.02.2016||R|1|0|0|1|0|1|JCI|0|1|0|100|SEK|655066|820826|lyfsjukr|||1|90|0||Vistor hf|Janssen-Cilag International N.V.|Ibrutinib||||655066|820826||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|616|2253|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||616||616|2253||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|IKR|1517|2641|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||898||898|2641||1 184205|L04AC0501|Stelara|irþ|130|mg|26|ml|1|hgl|lausn|L04AC05|01.09.2017||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|292823|370297|lyfsjukr|||1|26|0|240,7407|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||292823||292823|370297||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|2685|5101|lyfalmen|V0017|5101|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||2685|5101||2 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|40350|54105|lyfalmen|V0185|12269|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||40350||40350|54105||1 184309|R03DA0404|Theo-Dur|forðatfl|200|mg|100|stk|1|glas||R03DA04|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|2473|4809|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráð lyf|theophylline||||2473|4809||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|þpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LDD|0|0|1|100|XEU|1276|2931|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d|Amoxicillín og beta-laktamasa hemill ||1109||1109|2931||1 184418|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|5|hgl|lausn|QB03AC|01.07.2017||R|0|0|0|0|0|0|PHM|0|0|0|100|XEU|10153|19433|vetalmen|||0|500|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||10153||10153|19433||2 184731|N05AX1205|Aripiprazol Krka|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|3362|4571|lyfalmen|V0690|4571|2|28|0|9,3300|LYFIS ehf|Krka Sverige AB|Aripiprazól||2300||2300|4571||2 185025|R01AC0102|Glinor|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.03.2015||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|15|0|1,9500|Alvogen|ratiopharm GmbH|Krómóglíkatsýra|||||||2 185248|G03AA0707|Microstad|húðuðtfl|||63|stk|1|þpakki|150/30 mcg|G03AA07|01.05.2017||R|0|0|0|0|0|0|ASR|0|0|0|100|IKR|985|2300|lyfalmen|V0545|2012|1|63|0|84,0000|LYFIS ehf|STADA Arzneimittel AG|Levónorgestrel og ethinylestradíól||650||650|2300||2 186026|B02BD0205|Elocta|sts|3000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|225882|287041|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||225882|287041||3 186073|B01AC2701|Uptravi|filmhtfl|800|mcg|60|stk|1|pakki||B01AC27|01.10.2016||R|0|0|0|1|0|1|PCO|0|0|0|100|SEK|495479|622344|lyfsjukr|||0|60|1||Distica|Distica - óskráð lyf|Selexipagum||||495479|622344||1 186259|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.02.2016||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|13753|13104|lyfalmen|V0419|13104|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||8500||8500|13104||1 186713|N02AA0506|Oxikodon Depot Actavis|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|739|2422|lyfalmen|||2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||739||739|2422|31.01.2018|1 186742|R03DA0404|Theo-Dur|forðatfl|300|mg|100|stk|1|glas||R03DA04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|5967|9618|lyfalmen|||0|100|1|75,0000|Distica|Distica - óskráð lyf|theophylline||||5967|9618||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|9901|5608|lyfalmen|V0607|5086|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Memantín||3054||3054|5608||2 186867|C10BA0501|Atozet|filmhtfl|20|mg|30|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|4945|8211|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||4945||4945|8211||1 187154|N06AX1611|Duofaxin|forðatfl|225|mg|98|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|3603|6028|lyfalmen|V0916|5288|2|98|0|220,5000|Vistor hf|MediLink A/S|Venlafaxín||3359||3359|6028||1 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2459|4789|lyfalmen|V0462|4789|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2459||2459|4789||2 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|5163|8511|lyfalmen|||0|100|1|20,0000|Distica|Distica - óskráð lyf|Díkúmaról||||5163|8511||1 187399|QP54AA0501|Stronghold|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|4632|7984|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||4632||4632|7984||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|3307|5957|lyfalmen|||1|30|0||Icepharma hf|Meda AB|Pímekrólímus||3307||3307|5957||2 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2788||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|PHH|0|0|0|100|DKK|61254|80544|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer Limited|Tigecýklín||61254||61254|80544||1 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|þpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1248|2677|lyfalmen|V0621|1614|2|6|0|6,0000|Alvogen|Alvogen|Rizatriptan||924||924|2677||1 188479|N04BD0201|Azilect|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|13648|20190|lyfalmen|V0726|7739|1|28|0|28,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||13648||13648|20190||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|1|0|0|G|0|DEA|0|0|0|100|XEU|2324|4604|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2324||2324|4604||1 188827|S01ED5117|DUOKOPT|augndr|25|mg/ml|5|ml|3|glas|5+20 mg/ml, án rotvarnar|S01ED51|01.06.2016||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|4611|7752|lyfalmen|||1|15|0|75,0000|Vistor hf|Laboratoires THEA|Tímólól í blöndum||4611||4611|7752||1 188829|R06AX2707|Dasselta|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|1400|2919|lyfalmen|V0458|2919|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||1100||1100|2919||2 188988|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|þpakki|stakskammtaþynna|H02AB02|01.02.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|3137|5723|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||||3137|5723||2 189052|M05BA0604|Iasibon|irþ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|1|0|1|PSA|0|0|0|100|DKK|7661|11950|lyfsjukr|||2|2|0|0,3400|Alvogen|Pharmathen S.A.|Íbandrónsýra||7661||7661|11950||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|34406|46587|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||34406||34406|46587||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5682|9226|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||5682||5682|9226||1 189235|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|áfspr||H01CC01|01.12.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|4219|7212|lyfalmen|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||4219||4219|7212||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|2244|4494|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2244||2244|4494||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|815|2527|lyfalmen|V0413|2527|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||815||815|2527||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|394|1947|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||394||394|1947||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|366|1909|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||366||366|1909||1 190042|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|1356|3271|lyfalmen|||1|90|0|45,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||1356||1356|3271|28.02.2018|2 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|214|1699|lyfalmen|||2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||214||214|1699||1 190425|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|6129|9841|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer AB|Nífedipín||||6129|9841||2 190889|G03XB0201|Esmya|töflur|5|mg|28|stk|1|þpakki||G03XB02|01.05.2016||R|0|1|0|0|G|0|CLP|0|0|0|100|XEU|18791|27269|lyfalmen|||1|28|0|28,0000|Vistor hf|Gedeon Ricther Plc.|Ulipristal||18791||18791|27269||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||3522||1 191064|B05XC03|Vitalipid Infant|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3065|5624|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3065||3065|5624||1 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|5552|5852|lyfalmen|V0117|5423|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||3231||3231|5852||1 191247|B05XC02|Vitalipid Adult|irþ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2888|5380|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||2888||2888|5380||1 191251|C09DA0108|Losartan/Hydrochlorothiazide Medical Val|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|XEU|1967|2739|lyfalmen|V0088|2242|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Lósartan og þvagræsilyf||969||969|2739||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3013|5552|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Vítamín||3013||3013|5552||1 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|414|1975|lyfalmen|V0936|1885|1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||414||414|1975||1 191986|N03AX1604|Brieka|hylki|300|mg|100|stk|1|glas||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|14830|9505|lyfalmen|V0689|7296|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||5885||5885|9505||1 192030|QD06AA0202|Cyclospray vet.|húðúði|78,6|mg/g|200|ml|1|úðaílá||QD06AA02|01.12.2016||R|0|0|0|0|0|0|ERO|0|0|0|100|XEU|907|1783|vetalmen|||0|200|0||Vistor hf|Eurovet Animal Health B.V.|Chlortetracycline||907||907|1783||1 192296|H05BX0103|Cinacalcet Sandoz|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.05.2016||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|33591|21056|lyfalmen|V0721|14463|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Cinacalcet||14277||14277|21056||1 192400|J05AB1106|Valablis|filmhtfl|500|mg|10|stk|1|þpakki||J05AB11|01.05.2017||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|10|0|1,6667|Alvogen|Alvogen|Valacíklóvír|||||||1 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|þpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|GPA|0|0|0|100|XEU|3038|5586|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3038||3038|5586||1 192514|M01AH0106|Celecoxib Actavis|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|2420|4301|lyfalmen|V0429|4301|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||2104||2104|4301||1 192558|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.07.2016||R|1|0|0|0|G|0|TER|0|0|1|100|SEK|500|2093|lyfalmen|V0904|2093|1|100|0|50,0000|Vistor hf|TERALI PRODUCTS|Meklózín||500||500|2093||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1838|3935|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1838||1838|3935||1 192644|C10BA0501|Atozet|filmhtfl|90|mg|30|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5184|8540|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5184||5184|8540||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5658|9193|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5658||5658|9193||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|IRE|0|1|0|100|XEU|139827|180013|lyfsjukr|||2|1|0||Actavis ehf|Allergan Pharmaceuticals Ireland|Dexametasón||139827||139827|180013||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|þpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|2159|2458|lyfalmen|V0233|1946|2|12|0|12,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||765||765|2458||1 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|þpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|735|2417|lyfalmen|V0447|2306|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíð||735||735|2417||1 193411|H05BX0104|Cinacalcet Mylan|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|22774|14463|lyfalmen|V0721|14463|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||9487||9487|14463||2 193432|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17653|25703|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17653||17653|25703||1 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2667||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|32540|52454|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||32540||32540|52454||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|2031|2189|lyfalmen|V0556|2189|2|4|0|3,0000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||570||570|2189||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4339|8402|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4339||4339|8402||2 194672|A02BC0508|Esomeprazol Actavis|sþ-tfl|40|mg|100|stk|1|glas||A02BC05|01.02.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|5035|5530|lyfalmen|V0012|5530|2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||2997||2997|5530||1 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1307|3204|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1307||1307|3204||2 195104|R01AA0707|Otrivin Junior ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyfalmen|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||13227||2 195518|N05AH0206|Clozapin Medical|töflur|100|mg|500|stk|1|glas||N05AH02|01.01.2018||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|23000|28366|lyfalmen|||2|500|0|166,6666|Medical ehf|Medical ehf|Klózapín||20000||20000|28366||2 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|45818|61021|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|Merck AB|Sómatrópín||45818||45818|61021||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|111556|144851|lyfsjukr|||1|1|0|30,1200|Vistor hf|Janssen Biologics B.V.|Golimumab||111556||111556|144851||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|785|2485|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||785||785|2485||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|519|2119|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||519||519|2119||1 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|703|2373|lyfalmen|V0917|2363|1|30|0|15,0000|Icepharma hf|Meda AB|Fenýlprópanólamín||703||703|2373||2 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|895|2637|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Fenýlprópanólamín||895||895|2637||2 195999|M05BA0606|Ibandronic acid WH|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2018||R|1|1|0|0|G|0|WEH|0|0|0|100|IKR|3842|3869|lyfalmen|V0205|3869|2|3|0|90,0000|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||1790||1790|3869||2 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1670|3704|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||1670||1670|3704||2 196106|C10AA0107|Simvastatin LYFIS|filmhtfl|40|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2047|2368|lyfalmen|V0110|2368|2|100|0|133,3333|LYFIS ehf|LYFIS ehf|Simvastatín||700||700|2368||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|þpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1681|3719|lyfalmen|||2|100|0|75,0000|Alvogen|ratiopharm GmbH|Allópúrinol||1681||1681|3719||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||2048||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|5658|9193|lyfalmen|||1|100|0|0,8333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||5658||5658|9193||2 196889|D07AB0202|Locoid Crelo|húðfl|0,1|%|30|g|1|glas|á húð|D07AB02|01.03.2018||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|490|2079|lyfalmen|V0950|2079|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||490||490|2079||1 196895|J07BC0203|Vaqta|stl|25|ein|0,5|ml|1|áfspr||J07BC02|01.02.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3177|5778|lyfalmen|||0|0,5|1||Distica|Distica - óskráð lyf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||||3177|5778||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|17481|25466|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||17481|25466||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|þpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|564|1887|lyfalmen|V0119|1887|2|100|0|25,0000|Alvogen|ratiopharm GmbH|Allópúrinol||350||350|1887||2 197320|L04AB0204|Inflectra|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2015||R|0|1|0|1|0|1|VOG|0|1|0|100|XEU|50258|66637|lyfsjukr|||2|1|0|26,6700|Alvogen HS|Hospira UK Ltd.|Infliximab||50258||50258|66637||1 197554|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|150|skammtar|1|fl|1 x 150 úðaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr|án rotvarnarefnis|N01BB02|01.10.2003||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1329|3234|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1329||1329|3234||2 197927|L01XE3101|Ofev|hylki|100|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|173021|221297|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||173021||173021|221297||1 198334|M02AA1502|Voltaren|hlaup|11,6|mg/g|150|g|1|túpa||M02AA15|01.02.2015||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|þpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1883|2506|lyfalmen|V0069|2506|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Lósartan||800||800|2506||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|5659|9194|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||5659||5659|9194||1 198665|H01BA0208|NOCDURNA|frþ.tfl|50|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2960|5479|lyfalmen|||1|30|0|3,7500|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2960||2960|5479||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|28556|39188|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||28556||28556|39188||1 199454|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|þpakki||B01AC22|01.11.2016||R|0|1|0|0|G|0|DSA|0|0|0|100|XEU|6626|10525|lyfalmen|||1|28|0|14,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Prasugrel||||6626|10525||2 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|499|2092|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||499||499|2092||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|74273|97011|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||74273|97011||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3682|6473|lyfalmen|||1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||3682||3682|6473||1 199940|L01XC1101|Yervoy|stþ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2036203|2538573|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2036203||2036203|2538573||1 229729|C02AC0102|Catapresan (Distica)|töflur|150|mcg|100|stk|1|þpakki||C02AC01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|5763|9337|lyfalmen|||0|100|1|33,0000|Distica|Distica - óskráð lyf|clonidine||||5763|9337||1 229746|N05CD0802|Epistatus Buccal|munnh.l|10|mg/ml|5|ml|1|glas||N05CD08|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|0|100|DKK|12597|18743|lyfalmen|||0|5|1|3,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|Mídazólam||||12597|18743||3 229752|N06AX0602|Nefazodone|töflur|200|mg|60|stk|1|glas||N06AX06|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|15811|23167|lyfalmen|||0|60|1||Distica|Distica - óskráð lyf|nefazodone||||15811|23167||1 236133|A12BA0205|Acalka|töflur|1080|mg|100|stk|1|glas||A12BA02|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|0|100|IKR|10727|16170|lyfalmen|||0|100|1|27,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|potassium citrate||||10727|16170||3 248328|L01AD0102|Bicnu|duft|100|mg|1|stk|1|pakki||L01AD01|01.01.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|225504|286571|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Carmustine ||||225504|286571||2 267631|C01CA0121|Effortil|töflur|5|mg|50|stk|1|glas||C01CA01|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1387|3314|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|etilefrine||||1387|3314||2 267933|A01AC0103|Volon A|munnh.pa|1|mg/g|10|g|1|túpa||A01AC01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|840|2561|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|triamcinolone||||840|2561||1 270414|N02AA0109|Morfin sulphate|stl|40|mg/ml|1|ml|10|lykjur||N02AA01|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|3404|6090|lyfalmen|||0|10|1|13,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||||3404|6090||2 272781|V03AB1301|Toxogonin|stl|250|mg/ml|5|ml|1|pakki||V03AB13|01.03.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|NOK|11979|17893|lyfsjukr|||0|5|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Obidoxime||||11979|17893||3 274290|A05AA0202|Ursofalk|hylki|250|mg|100|stk|1|pakki||A05AA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|8650|13311|lyfalmen|||0|100|1|33,0000|Parlogis hf|Parlogis - óskráð lyf|Úrsódeoxýkól sýra||||8650|13311||2 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|þpakki||A05AA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|4813|8030|lyfalmen|||0|60|1||Distica|Distica - óskráð lyf|Úrsódeoxýkól sýra||||4813|8030||1 322594|C01CA0602|Fenylefrinhydrokl|stl|10|mg/ml|1|ml|10|stk||C01CA06|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|8475|13070|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Phenylephrin||||8475|13070||2 331967|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|10|lykjur||C01CA24|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|11232|16865|lyfalmen|||0|100|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|Adrenalín tartrat||||11232|16865||2 332106|A06AA0108|Parafin Emulsion|mixtúra|||300|ml|1|fl||A06AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3122|5702|lyfalmen|||0|300|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|liquid paraffin||||3122|5702||2 332536|A12CX0002|Fosfat APL|mixtúra|120|mg/ml|300|ml|1|glas||A12CX00|01.09.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|11194|16812|lyfalmen|||0|300|1||Parlogis hf|Parlogis - óskráð lyf|Málmlyf ýmisleg||||11194|16812||2 335083|P01BC0105|Kinin|irl|600|mg|10|ml|1|hgl||P01BC01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|12402|18475|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Kínín||||12402|18475||2 337212|A01AB0201|Hydrogen Peroxide|skolvökv|30|mg/ml|250|ml|1|hgl||A01AB02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3680|6470|lyfsjukr|||0|250|1||Parlogis hf|Parlogis - óskráð lyf|Hydrogen Peroxide||||3680|6470||2 364488|H02AB0909|Cortef|töflur|5|mg|50|stk|1|glas||H02AB09|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|1|100|NOK|7465|11680|lyfalmen|||0|50|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Hýdrókortisón||||7465|11680||3 364569|P02CF0101|Stromectol|töflur|3|mg|20|stk|1|þpakki||P02CF01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|27147|37406|lyfalmen|||0|20|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|ivermectin||||27147|37406||2 364680|L01XX0201|Erwinase|stl|10000|ae|5|hgl|1|pakki||L01XX02|01.09.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|DKK|532693|668628|lyfsjukr|||0|5|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Asparaginase||||532693|668628||3 369463|G03EA0301|Gynodian depot|stl|||1|ml|1|pakki||G03EA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2996|5529|lyfalmen|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|prasterone og estrogen ||||2996|5529||2 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|487|2075|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||487||487|2075||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|30944|58877|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||30944||30944|58877||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1222|3072|lyfalmen|||2|20|0|7,5000|Alvogen|ratiopharm GmbH|Amoxicillín||1211||1211|3072||2 370901|L01XE0302|Varlota|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.07.2017||R|1|0|0|1|0|1|ALO|0|1|0|100|XEU|202379|257810|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||202379||202379|257810||1 371058|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.06.2016||L|0|0|0|0|0|0|MEA|0|0|0|100|SEK|||lyfalmen|V0592|5485|0|50|0|25,0000|Icepharma hf|Meda AB|Makrógól 3350|||||5485||2 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|7183|11292|lyfalmen|||1|60|0||Icepharma hf|Meda AB|Pímekrólímus||7183||7183|11292||2 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||8498||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|TCA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 371826|L01XE3601|Alecensa|hylki|150|mg|224|stk|1|þpakki|4 x 56|L01XE36|01.06.2017||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|673158|843327|lyfsjukr|||1|224|0||Icepharma hf|Roche Registration Limited|Alectinib hydrochloride||673158||673158|843327||2 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|2939|5450|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||2939||2939|5450||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2748|5187|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2748||2748|5187||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372180|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|25|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|8853|13590|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||8853||8853|13590||2 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372571|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|þpakki||G03CA04|01.08.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2545||2 373184|P01BB5103|Malastad|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.01.2018||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|3200|5534|lyfalmen|V0934|5534|2|12|0|3,0000|LYFIS ehf|STADA Arzneimittel AG|Prógúaníl í blöndum||3000||3000|5534||2 373234|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|5218|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|5218||2 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|10018|15194|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||10018||10018|15194||1 373251|L03AB1301|Plegridy|stl|||2|áf-penni|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|75918|99091|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||75918||75918|99091||2 373252|N05AX1205|Aripiprazol Krka|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.04.2017||R|1|1|0|0|G|0|KRK|0|0|0|100|IKR|3507|5809|lyfalmen|V0204|5809|2|28|0|18,6670|LYFIS ehf|Krka Sverige AB|Aripiprazól||3200||3200|5809||2 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50/100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3064|5622|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3064||3064|5622||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50/250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3681|6471|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||3681||3681|6471||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50/500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4708|7885|lyfalmen|||1|60|0|30,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salmeteról og fluticason||4708||4708|7885||1 373581|G03GA1001|REKOVELLE|stl|36|mcg|1,08|ml|1|pakki|+ 6 inndælingarnálar|G03GA10|01.08.2017||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|34141|46252|lyfalmen|||1|1,08|0||Vistor hf|Ferring Lægemidler A/S|Follitrópín delta||||34141|46252||1 373611|J07AL0103|Pneumovax|stl|25|mcg|0,5|ml|1|áfspr|lausn|J07AL01|01.06.2017||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|3346|6010|lyfalmen|||1|0,5|0||Vistor hf|Merck Sharp & Dohme B.V.|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||3346||3346|6010||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|4994|4414|lyfalmen|V0420|3359|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíð||2186||2186|4414||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|þpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|350|1870|lyfalmen|V0541|1870|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||338||338|1870||1 374036|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|6688|10610|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||6688||6688|10610||3 374077|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|286726|353954|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||279683||279683|353954||1 374194|L01XE2501|Mekinist|filmhtfl|0,5|mg|30|stk|1|glas||L01XE25|01.01.2016||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|176309|225386|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Trametinib||176309||176309|225386||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|402|1958|lyfalmen|V0500|1873|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||402||402|1958||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4613|7754|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Kolvetni||4613||4613|7754||1 374348|G04CA0201|Omnic|hylki|0,4|mg|30|stk|1|þpakki|með br.losunarhraða|G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|3023|5566|lyfalmen|V0926|3847|1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||3023||3023|5566||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|8548|13170|lyfalmen|||1|60|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||8548||8548|13170||1 374450|L01XE3301|Ibrance|hylki|100|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|441577|555305|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||441577||441577|555305||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|TRI|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 374527|J07CA0602|Pentavac|sts|||0,5|ml|1|hgl|leysir, dreifa|J07CA06|01.04.2015||R|0|0|0|0|0|0|SSS|0|0|0|100|XEU|3589|6345|lyfalmen|||1|0,5|0||Vistor hf|Sanofi Pasteur Europe|Barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||3589||3589|6345||1 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|5517|8999|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5517||5517|8999||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|6512|10368|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6512||6512|10368||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|7625|11900|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7625||7625|11900||1 374672|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|þpakki||A04AA01|01.09.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|8525|13139|lyfalmen|V0383|11714|2|50|0|12,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||8525||8525|13139||1 374906|B01AC2701|Uptravi|filmhtfl|200|mcg|140|stk|1|pakki||B01AC27|01.09.2016||R|0|0|0|1|0|1|PCO|0|0|0|100|SEK|1132917|1415139|lyfsjukr|||0|140|1||Distica|Distica - óskráð lyf|Selexipagum||||1132917|1415139||1 374941|QJ01CA0403|Amoxibactin vet.|töflur|50|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2720|5331|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2720||2720|5331||2 375304|N06DX0109|Marbodin|filmhtfl|10|mg|100|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|4000|3607|lyfalmen|V0605|3607|2|100|0|50,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||1600||1600|3607||2 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|22077|30993|lyfalmen|V0459|30993|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||22077||22077|30993||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|4965|8239|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||4965||4965|8239||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|14298|21085|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||14298||14298|21085||1 376510|R06AE0706|Zensitin|filmhtfl|10|mg|10|stk|1|þpakki||R06AE07|01.07.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||||2 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|73451|95971|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||73451||73451|95971||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|685109|858191|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||685109||685109|858191||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|10044|17312|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10044||10044|17312||2 377249|C10AX1301|Repatha|stl|140|mg|6|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|169853|217357|lyfalmen|||1|6|0|84,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||169853||169853|217357||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GPH|0|0|1|100|DKK|8279|6593|lyfalmen|V0182|3774|1|42|0|7,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Valacíklóvír||3769||3769|6593||1 377640|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|23210|32426|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||23210||23210|32426||1 378432|L01XX4701|Zydelig|filmhtfl|100|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|449654|565351|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||449654||449654|565351||2 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1560|3552|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1560||1560|3552||1 378543|N03AX1606|Pregabalin Mylan|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5309|4061|lyfalmen|V0687|3099|2|56|0|28,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||1930||1930|4061||2 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|12910|19174|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húðlyf-Diclofenacum||12910||12910|19174||1 378870|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|þpakki|12,5+50 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1391|3319|lyfalmen|V0937|3319|1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1391||1391|3319||1 379158|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.02.2015||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1097|2915|lyfalmen|V0677|2304|1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1097||1097|2915||1 379173|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|9400|7323|lyfalmen|V0830|7323|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4300||4300|7323||2 379419|B02BD0205|Elocta|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|150588|193396|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||150588|193396||3 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|121643|157397|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||121643|157397||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|92774|120411|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíð||92774||92774|120411||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|104028|135489|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíð||104028||104028|135489||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|134346|173196|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíð||134346||134346|173196||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|113966|147849|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||113966||113966|147849||1 379796|N04BC0406|Ropinirole Portfarma|forðatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4602|6147|lyfalmen|V0532|6147|2|84|0|28,0000|Alvogen|Alvogen|Rópíníról||3445||3445|6147||1 379875|N05BA0105|Stesolid|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|1765|3834|lyfalmen|||2|12,5|0|2,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||1765||1765|3834|28.02.2018|1 379883|N05BA0105|Stesolid|eþ-lausn|10|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|GRP|0|0|1|100|DKK|2516|4868|lyfalmen|||2|12,5|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||2516||2516|4868||1 379945|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||N06AB06|01.09.2017||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|2311|2781|lyfalmen|||2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2781||1 380141|QN03AA0201|Phenoleptil|töflur|25|mg|100|stk|1|þpakki|handa hundum|QN03AA02|01.05.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2057|4043|vetalmen|||1|100|0||Dýraheilsa ehf|Le Vet B.V.|Phenobarbitalum||2057||2057|4043||2 380162|H01BA0201|Minirin|nefúði|0,1|mg/ml|5|ml|3|úðagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|16492|24105|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||16492||16492|24105||1 380374|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1282|3169|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1282||1282|3169||2 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|23317|32562|lyfalmen|V0653|32562|1|168|0|42,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||23317|32562||1 380621|D07AD0101|Dermovat|smyrsli|0,5|mg/g|30|g|1|túpa||D07AD01|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|474|2057|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||||474|2057||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|17988|19986|lyfalmen|V0195|19986|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||13500||13500|19986||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|þpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|4338|4887|lyfalmen|V0902|4887|2|30|0|30,0000|Alvogen|ratiopharm GmbH|Memantín||2530||2530|4887||2 380922|D07AB0201|Locoid|húðlausn|1|mg/ml|30|ml|1|glas||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|482|2068|lyfalmen|V0912|2068|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||482||482|2068||1 381120|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 381231|QP54AA0501|Stronghold|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2502|4312|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2502||2502|4312||2 381589|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.06.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|35475|47939|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||35475|47939||1 381794|V03AC0301|Exjade|filmhtfl|360|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|261667|331547|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||261667||261667|331547||1 382162|N04BC0406|Ropinirole Portfarma|forðatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6310|8743|lyfalmen|V0533|8743|2|84|0|56,0000|Alvogen|Alvogen|Rópíníról||5331||5331|8743||1 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kælt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|0|100|NOK|4907|8159|lyfalmen|||0|98|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Simvastatín||||4907|8159||3 382657|B02BD0205|Elocta|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|112941|146574|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||112941|146574||3 382764|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3981|6884|lyfalmen|||2|120|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3981||3981|6884||1 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4857|8090|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||4857||4857|8090||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|þpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1016|1751|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1016||1016|1751|28.02.2018|2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis Group PTC ehf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1127|2956|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1127||1127|2956||1 383445|J05AG0101|Viramune|forðatfl|400|mg|30|stk|1|þpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|31276|42628|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||31276||31276|42628||1 384064|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|56|stk|1|þpakki|hart|A02BC01|01.06.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2373|1955|lyfalmen|V0006|1095|2|56|0|56,0000|Alvogen|ratiopharm GmbH|Ómeprazól||400||400|1955||2 384125|A10BK0301|Jardiance|filmhtfl|10|mg|30|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|5541|9032|lyfalmen|||1|30|0|17,1400|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||5541||5541|9032||1 384716|D01AE1504|Terbinafin Actavis|krem|10|mg/g|15|g|1|túpa||D01AE15|01.09.2015||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|15|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Terbínafín|||||||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5989|9648|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5989||5989|9648||1 386133|H01CB0501|Signifor|sts|60|mg|1|hgl|1|pakki||H01CB05|01.10.2015||R|0|0|0|0|0|1|NEL|0|0|0|100|DKK|334077|421605|lyfsjukr|||1|1|0|50,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||334077||334077|421605||1 386959|C03DA0406|Eplerenon Alvogen|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|12114|9713|lyfalmen|V0111|8287|2|100|0|100,0000|Alvogen|Alvogen|Eplerenón||6036||6036|9713||1 387012|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|3|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|6836|10814|lyfalmen|V0670|10814|1|15|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||6836||6836|10814||1 387263|L01BA0402|Pemetrexed W&H|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.06.2016||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|117433|152161|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Pemetrexed||117433||117433|152161||2 387579|N05BA1206|Alprazolam Krka|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|732|2342|lyfalmen|V0308|2342|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||681||681|2342||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|91881|119281|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||91881||91881|119281||1 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4549|8801|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4549||4549|8801|| 387884|C01CA0701|Dobutamin Medical|irþ|12,5|mg/ml|20|ml|5|lykjur||C01CA07|01.10.2016||R|0|0|0|0|0|1|DIC|0|0|0|100|IKR|6709|10639|lyfsjukr|||2|100|0|2,5000|LYFIS ehf|Medical ehf|Dobutamin||6709||6709|10639||2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TSA|0|0|0|100|XEU|5307|8709|lyfalmen|||2|98|0|49,0000|Alvogen|Teva Sweden AB|Montelúkast||5307||5307|8709||2 388068|A07DA0601|Truberzi|filmhtfl|100|mg|56|stk|1|þpakki||A07DA06|01.08.2017||R|1|0|0|1|0|0|AIP|0|0|0|100|XEU|14005|20681|lyfalmen|||2|56|0||Actavis ehf|Allergan Pharmaceuticals Ltd.|Eluksadólín||||14005|20681||1 388198|L01XE0901|Torisel|irþ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|118823|153890|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||118823||118823|153890||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2262|4518|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma|Blöndur||2262||2262|4518||2 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|2468|4802|lyfalmen|||1|30|0||Icepharma hf|Aspen Pharma|Blöndur||2468||2468|4802||2 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|MAR|0|0|0|100|IKR|||lyflausa|||0|2|0||Icepharma hf|Aspen Pharma|Blöndur|||||||2 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.01.2017||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|8144|12614|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||8144||8144|12614||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|MAR|0|0|0|100|DKK|4443|7520|lyfalmen|||1|20|0||Icepharma hf|Aspen Pharma|Blöndur||4443||4443|7520||2 388587|V03AF0101|Uromitexan|töflur|400|mg|10|stk|1|glas||V03AF01|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|23094|32280|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Mesna||||23094|32280||2 388836|H05BX0102|Cinacalcet WH|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|53301|25441|lyfalmen|V0722|24065|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||17463||17463|25441||2 388898|S01ED5116|Taptiqom|augndr|||0,3|ml|90|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|7725|12038|lyfalmen|||1|27|0|90,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||7725||7725|12038||2 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|2022|4188|lyfalmen|V0410|4188|1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||2022||2022|4188||2 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|1439|3386|lyfalmen|||1|84|0|84,0000|Icepharma hf|Meda AB|Noretísterón og östrógen||1439||1439|3386||2 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|634|2278|lyfalmen|V0128|2278|1|84|0|84,0000|Icepharma hf|Meda AB|Estradíól||634||634|2278||2 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|MEA|0|0|0|100|DKK|438|2008|lyfalmen|||1|84|0|42,0000|Icepharma hf|Meda AB|Estradíól||438||438|2008||2 389294|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|þpakki||N03AX21|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|6498|10349|lyfalmen|||0|84|1|19,0000|Distica|Distica - óskráð lyf|Retigabín||||6498|10349||1 389330|L01BC5901|Lonsurf|filmhtfl|28,19|mg|60|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|351245|442957|lyfsjukr|||1|60|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||351245|442957||2 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|668|2324|lyfalmen|V0367|1514|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||668||668|2324||1 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|2584|3650|lyfalmen|V0267|3650|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||1631||1631|3650||2 389453|J01CE0207|Fenoximetylpenicillin EQL Pharma|filmhtfl|800|mg|14|stk|1|þpakki||J01CE02|01.01.2018||R|0|0|0|0|0|0|EQL|0|0|1|100|IKR|450|1955|lyfalmen|V0928|1955|2|14|0|5,6000|LYFIS ehf|EQL Pharma AB|Fenoxýmetýlpenicillín||400||400|1955||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|35436|47890|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||35436|47890||2 389944|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|13586|20105|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13586||13586|20105||1 390699|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|64974|85249|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||64974||64974|85249||1 390878|N06BA0202|Attentin|töflur|20|mg|30|stk|1|þpakki||N06BA02|01.08.2017||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|12127|18097|lyfalmen|||1|30|0|40,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Dexamfetamine ||||12127|18097||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|5140|8480|lyfalmen|V0429|4301|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||5140||5140|8480||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2190|4419|lyfalmen|V0037|2631|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2190||2190|4419||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|18453|26804|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||18453|26804||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|8820|13545|lyfalmen|V0196|5636|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||8820||8820|13545||1 391354|B02BX0501|Revolade|filmhtfl|50|mg|28|stk|1|þpakki||B02BX05|01.08.2016||R|1|1|0|1|0|1|NEL|0|1|0|100|DKK|211736|269447|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Eltrombópag||211736||211736|269447||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|213052|167935|lyfsjukr|||2|30|0||Alvogen|Accord Healthcare Limited|Imatiníb||130116||130116|167935||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|1725|3779|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||1725||1725|3779||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|þpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|441|2012|lyfalmen|V0545|2012|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||441||441|2012||1 392024|G04BE0311|Revastad|filmhtfl|20|mg|100|stk|1|þpakki||G04BE03|01.11.2017||R|0|0|0|1|0|1|ASR|0|0|0|100|IKR|45000|59986|lyfsjukr|||2|100|0|40,0000|LYFIS ehf|STADA Arzneimittel AG|Síldenafíl||45000||45000|59986||2 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010|31.12.2017|R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|149813|192432|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||149813||149813|192432||2 392390|S01XA1802|Ikervis|augndr|1|mg/ml|0,3|ml|30|sk-ílá|fleyti, stakskammtar|S01XA18|01.02.2016||R|0|0|0|1|0|0|SAO|0|0|0|100|XEU|11459|17177|lyfalmen|||1|9|0||Icepharma hf|Santen Oy|Ciclosporin||11459||11459|17177||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3609|5292|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2824||2824|5292||1 392438|N07XX0901|Tecfidera|hylki|120|mg|14|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|22125|31054|lyfsjukr|||1|14|0|3,5000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||22125||22125|31054||2 393248|C10AA0107|Simvastatin LYFIS|filmhtfl|20|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2250|2231|lyfalmen|V0109|2123|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Simvastatín||600||600|2231||2 393642|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3381||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|með breyttan losunarhraða|H02AB09|01.01.2013||R|1|0|0|0|G|0|BVB|0|0|1|100|DKK|56639|74707|lyfalmen|||1|50|0|33,3300|Lyfjaver ehf|Shire Services BVBA|Hýdrókortisón||56639||56639|74707||3 393939|S01EE0403|Travoprost Portfarma|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|USD|1658|3537|lyfalmen|V0669|3537|2|2,5|0|25,0000|Alvogen|Alvogen|Travóprost||1549||1549|3537||1 394139|D01BA0207|Terbinafin Medical Valley|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.08.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|1648|3153|lyfalmen|V0123|3153|2|28|0|28,0000|Acare ehf|Medical Valley Invest AB|Terbínafín||1270||1270|3153||2 395077|V03AC0301|Exjade|filmhtfl|90|mg|90|stk|1|þpakki||V03AC03|01.06.2017||R|1|1|0|1|0|0|NEL|0|0|0|100|DKK|65438|85836|lyfalmen|||1|90|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||65438||65438|85836||1 395175|A10BJ0202|Saxenda|stl|6|mg/ml|3|ml|5|lyfjap|lausn,áfylltur lyfjapenni|A10BJ02|01.09.2017||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|31751|43229|lyfalmen|||1|15|0|75,0000|Vistor hf|Novo-Nordisk A/S|Liraglutide||31751||31751|43229||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|áf.spr|nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|117793|151698|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||117061||117061|151698||1 395539|C10BA0501|Atozet|filmhtfl|50|mg|30|stk|1|þpakki|10 mg + 40 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|5067|8379|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||5067||5067|8379||1 395732|C09CA0305|Valsartan ratiopharm|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3710|2781|lyfalmen|V0679|2781|2|98|0|196,0000|Alvogen|ratiopharm GmbH|Valsartan||1000||1000|2781||2 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|14419|21251|lyfalmen|V0356|21251|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||14419||14419|21251||3 395954|V08CA0101|Magnevist|stl|0,5|mmol/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007|31.12.2017|R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|139418|179504|lyfsjukr|||1|300|0||Icepharma hf|Bayer AB|Gadópentetat||139418||139418|179504||2 396120|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|1|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|3922|6803|lyfalmen|||2|60|0|30,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||3922||3922|6803||1 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|þpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3209|5822|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3209||3209|5822||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|16874|32184|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||16874||16874|32184||2 396841|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2300|1955|lyfalmen|V0006|1095|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|1955||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4457|8626|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||4457||4457|8626||1 397353|N03AX1603|Pregabalin Krka|hylki|75|mg|100|stk|1|glas||N03AX16|01.04.2017||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|4186|3745|lyfalmen|V0686|3745|2|100|0|25,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1700||1700|3745||2 397458|N03AX1209|Gabapentin Sandoz|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|1994|2487|lyfalmen|V0250|1985|2|100|0|16,6667|Artasan ehf|Sandoz A/S|Gabapentín||786||786|2487||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|21338|30059|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||21338||21338|30059||2 397520|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.08.2015||R|0|0|0|0|0|0|BFP|0|0|1|100|IKR|1686|3470|lyfalmen|V0337|3470|2|30|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1500||1500|3470||1 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|4322|7354|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||4322||4322|7354||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|24853|34504|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||24853||24853|34504||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lægemidler A/S|Natríumpicosúlfat|||||5735||1 398565|N06AA0907|Amitriptilyn Abcur|filmhtfl|10|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|623|2088|lyfalmen|V0923|2088|2|100|0|13,3333|Icepharma hf|Abcur AB|Amitriptýlín||496||496|2088||2 398719|J07AE0102|Dukoral|mixtúra|||3|ml|1|pakki||J07AE01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|8584|13220|lyfalmen|||0|3|1||Parlogis hf|Parlogis - óskráð lyf|cholera, inactivated, whole cell||||8584|13220||2 398759|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|16108|13609|lyfalmen|V0622|13466|2|90|0|162,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||8867||8867|13609||1 399039|R03DX0901|Nucala|sts|100|mg|1|hgl|1|pakki||R03DX09|01.06.2016||R|0|0|0|1|0|1|GSD|0|1|0|100|DKK|148771|191136|lyfsjukr|||1|1|0|27,7700|Vistor hf|GlaxoSmithKline Trading Services Ltd.|Mepolizumab||148771||148771|191136||1 399309|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.08.2015||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|25006|34698|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||25006|34698||1 399482|B02BD0101|Octaplex|irs|1000|ae|1|hgl|1|hgl|+leysir,lausn|B02BD01|01.02.2018||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|65405|85794|lyfsjukr|||1|1|0||Vistor hf|Octapharma AB|Storkuþættir lX,ll,Vll,X||65405||65405|85794||1 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|477|2061|lyfalmen|V0225|1965|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||477||477|2061||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GPH|0|0|0|100|DKK|2140|2692|lyfalmen|V0244|2330|1|56|0|9,3333|Vistor hf|GlaxoSmithKline Pharma A/S|Lamótrigín||935||935|2692||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|7149|11245|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||7149||7149|11245||1 399825|L01XE3301|Ibrance|hylki|75|mg|21|stk|1|þpakki||L01XE33|01.02.2017||R|1|0|0|1|0|1|PHH|0|1|0|100|DKK|441577|555305|lyfsjukr|||1|21|0||Icepharma hf|Pfizer Limited|Palbociclib||441577||441577|555305||1 399904|M01AH0502|Coxient|filmhtfl|30|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2440|3139|lyfalmen|V0824|2853|2|28|0|14,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1260||1260|3139||1 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNP|0|0|1|100|XEU|974|2746|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||974||974|2746||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|TCA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur||||||31.12.2017|1 400134|J05000001|Symtuza|filmhtfl|30|mg|30|stk|1|glas|800+150+200+10 mg|J05|01.03.2018||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|100803|131478|lyfsjukr|||1|30|0||Vistor hf|Janssen-Cilag International N.V.|Darunavir, Kobicistat, Emtricitabin, Tenofoviralafenamid||100803||100803|131478||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2142|4353|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2142||2142|4353||1 400244|B03AC0005|Ferinject|irl|50|mg/ml|20|ml|1|hgl||B03AC|01.08.2016||R|0|1|0|0|G|0|VIF|0|0|1|100|CHF|43327|57870|lyfalmen|||1|20|0|10,0000|Vistor hf|Vifor France SA|Járn, stungulyf||43327||43327|57870||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|177|1649|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||177||177|1649||1 400422|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|461|2039|lyfalmen|V0913|2039|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||461||461|2039||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|305|1825|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||305||305|1825||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|153|1616|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||153||153|1616||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|4271|7284|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||4271||4271|7284||1 400574|N07XX0901|Tecfidera|hylki|240|mg|56|stk|1|þpakki||N07XX09|01.12.2014||R|0|0|0|1|0|1|BIB|0|1|0|100|XEU|149386|191901|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Dimethyl fumarate||149386||149386|191901||2 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|1848|2631|lyfalmen|V0037|2631|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||891||891|2631||2 401403|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|702|2038|lyfalmen|V0173|2038|2|2|0|3,3300|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||460||460|2038||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|þpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|7627|11903|lyfalmen|V0459|10331|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||7627||7627|11903||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|653|2304|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||653||653|2304||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|958|2724|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||958||958|2724||1 402038|N06AB0313|Fluoxetin WH|hylki|20|mg|28|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|457|2034|lyfalmen|V0038|1825|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||457||457|2034||2 402203|D07AC1302|Ovixan|húðlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1117|2942|lyfalmen|V0952|2942|2|100|0||Vistor hf|Galenica AB|Mómetasón||1117||1117|2942||1 402673|N06BX1301|Raxone|filmhtfl|150|mg|180|stk|1|glas||N06BX13|01.05.2016||R|1|0|0|1|0|1|SPD|0|0|0|100|DKK|721327|903236|lyfsjukr|||1|180|0|30,0000|Vistor hf|Santhera Pharmaceuticals GmbH|Idebenone||721327||721327|903236||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1575|3096|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1575||1575|3096||1 402873|N06DA0302|Exelon (Lyfjaver)|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|11155|16759|lyfalmen|V0349|16137|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||11155||11155|16759||3 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|3991|3483|lyfalmen|V0552|3483|2|30|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||1510||1510|3483||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5185|10007|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||5185||5185|10007||1 403856|L01BA0108|Methotrexate Pfizer|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|29292|40119|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||29292|40119||1 403956|A12CB0101|Solvezink|freyðit|45|mg|100|stk|1|glas||A12CB01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6075|7213|lyfalmen|||0|100|1|8,0000|Parlogis hf|Parlogis - óskráð lyf|zinc sulfate||4220||4220|7213||2 403966|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|áf.spr||B01AX05|01.11.2015||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|14690|21624|lyfalmen|||1|6|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||14690||14690|21624||2 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar samsetningar|||||2422||2 404491|B01AD0201|Actilyse|sts/irs|20|mg|1|stk|1|hgl||B01AD02|01.12.2017||R|0|0|0|0|0|1|OSK|0|0|0|100|DKK|22198|31146|lyfsjukr|||0|1|1||Distica|Distica - óskráð lyf|Alteplasi||||22198|31146||1 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|52310|69232|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||52310||52310|69232||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|953|2717|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||953||953|2717||1 404832|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||36|stk|1|þpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|542|2151|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||542||542|2151||2 404997|A10BJ0301|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BJ03|01.10.2013||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|8249|12759|lyfalmen|||1|2|0|1,5000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||8249||8249|12759||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|þpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|1398|3329|lyfalmen|||2|100|0|100,0000|Alvogen|ratiopharm GmbH|Hýdróklórtíazíð og kalíumsparandi lyf||1398||1398|3329||2 405129|QP54AA0501|Stronghold|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|2506|4319|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2506||2506|4319||2 405168|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.06.2015||L|0|0|0|0|0|0|FKA|0|0|0|100|DKK|||lyfalmen|||0|400|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||2306||1 405220|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|98|stk|1|þpakki||A02BC04|01.04.2017||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|2436|3882|lyfalmen|V0467|3882|2|98|0|49,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3882||2 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|14760|21721|lyfalmen|||1|5|0||Vistor hf|GlaxoSmithKline Pharma A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||14760||14760|21721||1 405647|C05BB0201|Aethoxysklerol|stl|30|mg/ml|2|ml|5|lykjur||C05BB02|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|3302|5950|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Polidocanol||||3302|5950||1 405677|J01DD0401|Rocephalin|irþ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|2891|5384|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||2891||2891|5384||2 405823|C10BA0501|Atozet|filmhtfl|90|mg|90|stk|1|þpakki|10 mg + 80 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|14541|21419|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||14541||14541|21419||1 405998|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|60|stk|1|þpakki||A10BA02|01.11.2014||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|389|1940|lyfalmen|V0502|1940|2|60|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||389||389|1940||1 406106|C10AX1401|Praluent|stl|150|mg/ml|1|ml|6|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|167260|214132|lyfalmen|||1|6|0|166,6667|Vistor hf|Sanofi-aventis groupe|Alirocumab||167260||167260|214132||1 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15711|23030|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||15711||15711|23030||1 406356|L01XX4601|Lynparza|hylki|50|mg|448|stk|1|pakki|4 x 112 hylki|L01XX46|01.07.2016||R|0|0|0|1|0|0|AZA|0|1|0|100|SEK|585823|734707|lyfalmen|||1|448|0||Vistor hf|AstraZeneca AB|Olaparib||585823||585823|734707||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|47384|63002|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||47384||47384|63002||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|54613|72145|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||54613||54613|72145||1 406678|N04BA0210|Sinemet 12,5/50|töflur|62,5|mg|100|stk|1|glas|12,5+50 mg|N04BA02|01.10.2015||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1391|3319|lyfalmen|V0937|3319|1|100|0|8,3300|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1391||1391|3319||1 407043|B03BA0102|Betolvex|filmhtfl|1|mg|100|stk|1|glas||B03BA01|01.10.2016||L|1|0|0|0|G|0|GRP|0|0|1|100|XEU|||lyfalmen|||2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Cyanocobalamin|||||3911||1 407423|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|10|hgl|1|pakki|+leysir 30 ml x 10 hgl, dreifa|QJ01CE90|01.02.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|14642|27949|vetalmen|||0|10|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|||||14642|27949||2 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|133|1588|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||133||133|1588||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|273|1781|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||273||273|1781||1 408102|B01AF0301|Lixiana|filmhtfl|60|mg|100|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|27151|37411|lyfalmen|||1|100|0|100,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||27151||27151|37411||1 408145|B01AF0101|Xarelto|filmhtfl|2,5|mg|100|stk|1|þpakki|stakskammtaþynna|B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|13483|19963|lyfalmen|||1|100|0|12,5000|Icepharma hf|Bayer AG|Rivaoxaban||13483||13483|19963||2 408156|A10BB0904|Zodediab|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.03.2015||R|1|0|0|0|G|0|IPC|0|0|0|100|IKR|2744|3194|lyfalmen|V0020|1873|2|90|0|45,0000|Alvogen|Alvogen IPco S.á.r.l.|Glíklazíð||1300||1300|3194||1 408266|N05BA1206|Alprazolam Krka|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1548|3176|lyfalmen|V0310|3176|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1287||1287|3176||2 408675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.07.2017||R|0|0|0|0|0|0|GAN|0|0|0|100|XEU|3777|6604|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíð||3777||3777|6604||2 408909|N06BA0903|Atomoxetin Medical Valley|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8449|8623|lyfalmen|V0813|7494|2|28|0|6,3000|Acare ehf|Medical Valley Invest AB|Atomoxetín||5244||5244|8623||2 409019|QP54AA0501|Stronghold|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2599|4480|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2599||2599|4480||2 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PLS|0|0|1|100|DKK|3051|5604|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||3051||3051|5604||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2892|5385|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||2892||2892|5385||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|7413|11608|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||7413||7413|11608||1 409547|C09DX0401|Entresto|filmhtfl|200|mg|168|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|50487|66926|lyfalmen|V0728|66926|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||50487||50487|66926||1 409720|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.04.2017||R|1|1|0|0|G|0|GRP|0|0|0|100|XEU|13663|14962|lyfalmen|||2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||9850||9850|14962||1 409745|N05AX1302|Xeplion|stl|100|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|49428|65587|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||49428||49428|65587||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|6009|9676|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||6009||6009|9676||1 409809|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|18|stk|1|þpakki||N02CC01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|5650|4433|lyfalmen|V0234|4433|2|18|0|36,0000|Vistor hf|Bluefish Pharmaceuticals AB|Súmatriptan||2200||2200|4433||1 409927|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13682|20237|lyfalmen|V0651|20237|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13682||13682|20237||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|3074|5636|lyfalmen|V0196|5636|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||3074||3074|5636||2 410077|N02CC0402|Maxalt Smelt|frþ.tfl|5|mg|6|stk|1|þpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|2687|5103|lyfalmen|V0620|4798|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||2687||2687|5103||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|2936|4889|lyfalmen|||2|100|0|133,3300|Vistor hf|Orion Corporation|Spírónólaktón||2531||2531|4889||1 410383|N04BB0102|Symmetrel|hylki|100|mg|60|stk|1|pakki||N04BB01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4630|5999|lyfalmen|||0|60|1|30,0000|Parlogis hf|Parlogis - óskráð lyf|amantadine||3338||3338|5999||2 410469|L04AB0202|Remsima|irþ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|HUN|0|1|0|100|DKK|42944|57386|lyfsjukr|||2|1|0|26,6700|Vistor hf|Celltrion Healthcare Hunary Kft|Infliximab||42944||42944|57386|31.01.2018|1 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1383|3308|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1383||1383|3308||1 410649|C09CA0305|Valsartan ratiopharm|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|0|0|RTH|0|0|0|100|IKR|672|2330|lyfalmen|||2|14|0|7,0000|Alvogen|ratiopharm GmbH|Valsartan||672||672|2330||2 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|484|2071|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||484||484|2071||2 411034|N06AA0907|Amitriptilyn Abcur|filmhtfl|25|mg|100|stk|1|glas||N06AA09|01.12.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|848|2334|lyfalmen|V0510|2334|2|100|0|33,3333|Icepharma hf|Abcur AB|Amitriptýlín||675||675|2334||2 411076|N05AD0301|Buronil|húðuðtfl|25|mg|100|stk|1|glas||N05AD03|01.12.2014||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1206|3065|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1206||1206|3065||1 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RTH|0|0|1|100|XEU|346|1852|lyfalmen|V0230|1852|2|100|0|16,6667|Alvogen|ratiopharm GmbH|Paracetamól||325||325|1852||2 411324|N06AX2107|Duloxetine Mylan|sþ-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1331|2418|lyfalmen|V0692|2275|2|28|0|14,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||736||736|2418||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|5139|8478|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||5139||5139|8478||2 411466|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|8924|12671|lyfalmen|V0829|12671|2|100|0|22,2200|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||8185||8185|12671||2 411616|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|4258|5165|lyfalmen|V0624|3759|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||2732||2732|5165||1 411751|N03AX0901|Lamictal|töflur|100|mg|56|stk|1|pakki||N03AX09|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|2659|5065|lyfalmen|||0|56|1||Distica|Distica - óskráð lyf|Lamótrigín||||2659|5065||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|18855|27357|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Lamívúdín||18855||18855|27357||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyfalmen|V0554|1823|2|1|0|0,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól|||||2199||1 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|4916|8171|lyfalmen|||1|6|0|6,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Súmatriptan||4916||4916|8171||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|15569|21934|lyfalmen|V0183|17111|1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||14915||14915|21934||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|2443|4767|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||2443||2443|4767||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|2461|4837|vetalmen|||0|100|0||Vistor hf|Merial|||2461||2461|4837||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|3905|7579|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||3905||3905|7579||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|81580|106253|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||81580||81580|106253||2 412555|N04BD0201|Azilect|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.06.2016||R|0|0|0|0|G|0|TEE|0|0|0|100|NOK|41207|55189|lyfalmen|V0711|17234|1|112|0|112,0000|Actavis Pharmaceuticals Iceland ehf.|Teva. B.V.|Rasagilín||41207||41207|55189||1 412581|N05AX1302|Xeplion|stl|75|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|42201|56446|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||42201||42201|56446||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2430|4750|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||2430||2430|4750||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2507|4856|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||2507||2507|4856||2 413116|N02BE0122|Dolorin|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.12.2017||L|1|0|0|0|0|0|WEH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Williams & Halls efh|Williams & Halls ehf|Paracetamól|||||||2 413220|V03AB1703|Methylthioninium chloride Proveblue|stl|5|mg/ml|10|ml|5|lykjur||V03AB17|01.05.2015||R|0|0|0|0|0|1|ROP|0|0|0|100|DKK|26678|36813|lyfsjukr|||1|50|0||Williams & Halls efh|Provepharm SAS|Metýltíónín||26678||26678|36813||2 413671|B01AC2701|Uptravi|filmhtfl|1400|mcg|60|stk|1|pakki||B01AC27|01.07.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|SEK|515692|647483|lyfsjukr|||0|60|1||Distica|Distica - óskráð lyf|Selexipagum||||515692|647483||1 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|þpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414424|N06AA0907|Amitriptilyn Abcur|filmhtfl|50|mg|100|stk|1|glas||N06AA09|01.10.2017||R|1|0|0|0|G|0|ABC|0|0|0|100|SEK|1231|3099|lyfalmen|||2|100|0|66,6666|Icepharma hf|Abcur AB|Amitriptýlín||1231||1231|3099||2 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|||lyfalmen|||0|1,5|1||Parlogis hf|Parlogis - óskráð lyf|Lyf til berklarannsókna||||||30.11.2017|2 414592|L03AX1301|Copaxone|stl|40|mg/spr|12|áf.spr|1|pakki||L03AX13|01.11.2015||R|0|0|0|1|0|1|TEI|0|0|0|100|NOK|101515|132363|lyfsjukr|||1|12|0|24,0000|Actavis Pharmaceuticals Iceland ehf.|Teva Pharmaceuticals Limited|Glatíramer acetat||101515||101515|132363||1 414661|L01DC0302|Mitomycin medac|duft|40|mg|1|hgl|1|pakki|+ leysir fyrir þvagblöðrulausn|L01DC03|01.03.2017||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|32993|44800|lyfsjukr|||1|1|0||Williams & Halls efh|medac Gesellschaft|Mitomycin||32993||32993|44800||2 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1012|2798|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíð||1012||1012|2798||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|971|2741|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||971||971|2741||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|þpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1632|3651|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1632||1632|3651||1 415368|C02KX0501|Adempas|filmhtfl|2,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|161061|206422|lyfsjukr|||1|42|0|23,3300|Vistor hf|Bayer AG|Riociguatum||161061||161061|206422||1 415635|N05AX1303|TREVICTA|stl|263|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|110988|144145|lyfalmen|||1|1|0|105,2000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||110988||110988|144145||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.02.2012||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|6447|6180|lyfalmen|V0253|6180|2|100|0|33,3300|Alvogen|Pharmathen S.A.|Levetíracetam||3469||3469|6180||1 416371|QM01AE9001|Quadrisol|hlaup|100|mg/ml|30|ml|1|spr|f. hesta|QM01AE90|01.04.2015||R|0|0|0|0|0|0|VCL|0|0|0|100|DKK|1504|2956|vetalmen|||0|30|0||Icepharma hf|VETCOOL BV.|Vedaprófen||1504||1504|2956||2 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|7520|8230|lyfalmen|V0088|2242|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og þvagræsilyf||4959||4959|8230||1 416589|N03AX1604|Brieka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3996|2558|lyfalmen|V0686|2097|2|56|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||838||838|2558||1 416628|N03AA0302|Primidon ERA|töflur|250|mg|100|stk|1|pakki||N03AA03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|10803|16274|lyfalmen|||0|100|1|20,0000|Distica|Distica - óskráð lyf|primidone||||10803|16274||1 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3438|6137|lyfalmen|||1|300|0|15,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Ranitidín||3438||3438|6137||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2289|4555|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2289||2289|4555||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|800|2506|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||800||800|2506||2 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|1|1|0|1|0|1|VIH|0|0|0|100|DKK|30861|42103|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Abacavír||30861||30861|42103||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|PHH|0|1|0|100|DKK|78719|102634|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||78719||78719|102634||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|25526|35356|lyfalmen|V0460|35356|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||25526|35356||1 418119|N05AX1207|Lemilvo|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|4384|4704|lyfalmen|V0682|4502|2|56|0|18,6670|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||2397||2397|4704||1 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|1|0|1|0|1|BIO|0|0|0|100|DKK|106674|138780|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||106674||106674|138780||3 418731|A07EC0201|Mesasal|eþ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNP|0|0|0|100|XEU|4801|8013|lyfalmen|V0014|7566|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4801||4801|8013||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2187|4415|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2187||2187|4415||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|7317|11476|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7317||7317|11476||1 419385|J01FA0901|Klacid|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.03.2017||R|1|0|0|0|0|0|DUT|0|0|1|100|DKK|3480|5592|lyfalmen|V0116|4812|1|14|0|14,0000|Icepharma hf|BGP Products AB|Klaritrómýcín||3042||3042|5592||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|39426|52936|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||39426||39426|52936||1 419828|N06BA0406|Medikinet CR|hylki|5|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|2854|5333|lyfalmen|||2|30|0|5,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||2854||2854|5333||2 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|31590|43025|lyfalmen|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||31590||31590|43025||3 419937|A16AA0401|Cystagon|hylki|50|mg|100|stk|1|glas||A16AA04|01.10.2016||R|1|0|0|1|0|0|ORP|0|0|0|100|XEU|10861|16354|lyfalmen|||1|100|0|2,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||10861||10861|16354||3 419945|D07AD0101|Dermovat|húðlausn|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|537|2144|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||537||537|2144||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9552|14552|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||9552||9552|14552||1 420176|J05AR1801|Genvoya|filmhtfl|||30|stk|1|glas|150mg+150mg+200mg+10mg|J05AR18|01.07.2016||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|126381|163290|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Elvitegravír, kóbísistat, emtrícítabín og tenófóvír alafenam||126381||126381|163290||2 420209|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|100|stk|1|þpakki|hart|A02BC01|01.08.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4359|1955|lyfalmen|V0006|1955|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Ómeprazól||400||400|1955||2 420510|J01CA0413|Amoxin|mixtduft|100|mg/ml|60|ml|1|glas||J01CA04|01.01.2016||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|2242|2644|lyfalmen|V0479|2644|2|60|0|6,0000|Alvogen|ratiopharm GmbH|Amoxicillín||900||900|2644||2 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|1021|2810|lyfalmen|V0036|2447|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1021||1021|2810||1 421729|N06BA0407|Metylfenidat Actavis|forðatfl|36|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|13070|12529|lyfalmen|V0624|12529|2|100|0|120,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||8082||8082|12529||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|26807|51029|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||26807||26807|51029||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TVA|0|0|1|100|XEU|1772|3193|lyfalmen|V0458|2919|2|100|0|100,0000|Alvogen|Teva B.V.|Deslóratadín||1299||1299|3193||2 421962|A06AB0202|Toilax|sþ-tfl|5|mg|25|stk|1|glas||A06AB02|01.12.2016||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 422022|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.11.2017||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1095|2912|lyfalmen|V0922|2912|1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1095||1095|2912||1 422115|N02AA0506|Oxikodon Depot Actavis|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|480|2066|lyfalmen|V0596|2064|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||480||480|2066||1 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2420|4736|lyfalmen|V0049|2996|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||2420||2420|4736||1 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3979|6882|lyfalmen|V0054|4480|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||3979||3979|6882||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|50693|67187|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||50693||50693|67187||2 422545|B02BD0205|Elocta|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2018||R|0|0|0|1|0|1|SAB|0|0|0|100|DKK|37647|50686|lyfsjukr|||1|1|0||Swedish Orphan Biovitrum A/S|SwedishOrphan Biovitrum AB (publ)|Storkuþáttur VIII||||37647|50686||3 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.03.2016||R|0|0|0|0|0|0|LVE|0|0|0|100|NOK|5282|8675|lyfalmen|||0|100|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Brómókriptín||||5282|8675||3 422738|G03GA0503|Bemfola|stl|75|ae|0,125|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|2448|4774|lyfalmen|||1|0,125|0|1,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||2448||2448|4774||3 422937|B01AF0101|Xarelto|filmhtfl|2,5|mg|56|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|7568|11822|lyfalmen|||1|56|0|7,0000|Icepharma hf|Bayer AG|Rivaoxaban||7568||7568|11822||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|2555|4922|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||2555|4922||2 423414|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 423703|S01GA5101|Antistina-Privin|augndr|||10|ml|1|pakki|0,25 mg/ml + 5 mg/ml|S01GA51|01.08.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4289|7308|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Nafazólín í blöndum með öðrum efnum||||4289|7308||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|17318|25241|lyfsjukr|||2|1200|0|15,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||17318||17318|25241||1 423859|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.09.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|DKK|4656|7813|lyfalmen|V0373|4266|1|15|0|75,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||4656||4656|7813||2 424114|V08CA0101|Magnevist|stl|0,5|mmol/ml|10|ml|5|áfspr|röntgenskuggaefni|V08CA01|01.06.2017|31.12.2017|R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|23237|32460|lyfsjukr|||1|50|0||Icepharma hf|Bayer AB|Gadópentetat||23237||23237|32460||2 424811|L01BB0503|Fludarabin Actavis|stl/irþ|25|mg/ml|2|ml|1|hgl|lausn|L01BB05|01.03.2018||R|0|0|0|1|0|1|GPA|0|0|0|100|XEU|15423|22633|lyfsjukr|||2|2|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||15423||15423|22633||1 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|370|1914|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||370||370|1914||2 425282|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|POF|0|1|0|100|DKK|116404|93032|lyfsjukr|||2|60|0||Alvogen|Alvogen|Imatiníb||71127||71127|93032||1 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.08.2011|31.12.2017|R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3388|6068|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3388||3388|6068||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1271|3154|lyfalmen|V0213|2838|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Lósartan||1271||1271|3154||1 425943|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.06.2016||R|1|0|0|0|G|0|TTT|0|0|0|100|SEK|12586|18728|lyfalmen|||1|100|0|33,3300|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||12586||12586|18728||2 426511|A11CC0402|Rocaltrol|hylki|0,25|mcg|100|stk|1|glas||A11CC04|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6721|10656|lyfalmen|||0|100|1|25,0000|Parlogis hf|Parlogis - óskráð lyf|calcitriol||||6721|10656||2 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|485|2072|lyfalmen|||1|20|0|5,0000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||485||485|2072||2 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|871|2604|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||871||871|2604||2 427030|J05AR0602|Padviram|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.03.2018||R|1|1|0|1|0|1|SHS|0|0|0|100|DKK|94281|122317|lyfsjukr|||2|30|0|30,0000|Artasan ehf|Sandoz A/S|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||||94281|122317||1 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|þpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Alvogen|Alvogen IPco S.á.r.l.|Íbúprófen|||||||1 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|6733|10672|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||6733||6733|10672||1 427308|J01AA0212|Doxycyklin EQL Pharma|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.03.2018||R|1|0|0|0|0|0|LYF|0|0|1|100|IKR|817|2529|lyfalmen|||2|10|0|10,0000|LYFIS ehf|LYFIS ehf|Doxýcýklín||817||817|2529||2 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|5693|9241|lyfalmen|V0658|9241|1|7,5|0|75,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||5693||5693|9241||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|SNP|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Natríum pícósúlfat|||||3175||1 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|þpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2180||1 428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.03.2015|28.02.2018|R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|33771|45784|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||33771|45784||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|25104|34822|lyfalmen|||3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||25104||25104|34822||2 429093|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|glas|með skammtadælu|G03CA03|01.06.2016||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|962|2729|lyfalmen|V0129|2729|2|64|0||Vistor hf|Takeda Oy|Estradíól||962||962|2729||1 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2813|5277|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2813||2813|5277||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|76498|99825|lyfsjukr|||1|105|0|14,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||76498||76498|99825||1 429584|N06BA0902|Atomoxetin Actavis|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10180|8623|lyfalmen|V0812|7494|2|28|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||5244||5244|8623||1 429815|N02AJ0602|Parkodin forte|filmhtfl|530|mg|200|stk|1|pakki|þp 30+500 mg|N02AJ06|01.02.2018||R|2|0|1|0|0|0|GPA|0|0|1|100|XEU|3161|5756|lyfalmen|||2|200|0|66,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||3161||3161|5756||1 429875|G03GA0503|Bemfola|stl|225|ae|0,375|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|8088|12537|lyfalmen|||1|0,375|0|3,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||8088||8088|12537||3 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1687|3727|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1687||1687|3727||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4525|8755|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4525||4525|8755||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|76617|99975|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||76617||76617|99975||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|þpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|15691|5533|lyfalmen|V0184|5533|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||2999||2999|5533||2 430458|M01AH0503|Coxerit|filmhtfl|90|mg|98|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|8900|8009|lyfalmen|V0831|7717|2|98|0|147,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||4798||4798|8009||2 430507|A07EA0601|Entocort|endaþ.dr|2|mg|7|stk|1|þpakki|samsett pk|A07EA06|01.06.2016||R|0|0|0|0|G|0|TTT|0|0|0|100|SEK|4924|8182|lyfalmen|||1|7|0|7,0000|Icepharma hf|Tillotts Pharma GmbH|Búdesóníð||4924||4924|8182||2 430729|A11DA0101|Tiacur|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|18217|26479|lyfalmen|||1|10|0|10,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||18217|26479||2 430839|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|50|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|50|0|16,6600|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|þpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|786|2068|lyfalmen|V0173|2038|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||482||482|2068||1 430868|L04AA0601|Cellcept|mixtúra|200|mg/ml|110|g/fl|1|fl||L04AA06|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|DKK|72545|94825|lyfalmen|||0|110|1|55,0000|Parlogis hf|Parlogis - óskráð lyf|Mýcófenólsýra||||72545|94825||2 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|939|2697|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||939||939|2697||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúði|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|7764|12091|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||7764||7764|12091||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|1120|2946|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1120|2946||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|þpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PLS|0|0|1|100|DKK|2908|5407|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||2908||2908|5407||1 431930|N06BA0406|Medikinet CR|hylki|60|mg|30|stk|1|þpakki|með breyttan losunarhraða|N06BA04|01.01.2015||R|1|1|1|0|0|0|PUT|0|0|0|100|IKR|11696|17503|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Medice Arzneimittel Putter GmbH|Metýlfenídat||11696||11696|17503||2 431978|L04AA3301|Entyvio|irþ|300|mg|1|hgl|1|pakki||L04AA33|01.07.2016||R|0|1|0|1|0|1|TPA|0|1|0|100|DKK|293780|371487|lyfsjukr|||1|1|0|55,5600|Vistor hf|Takeda Pharma A/S|Vedolizumab||293780||293780|371487||1 431985|D07XC0101|Diprosalic|húðlausn|||100|ml|1|glas|0,5 mg/ml+20 mg/ml|D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1642|3665|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||1642||1642|3665||1 432410|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|0|0|KNM|0|0|0|100|IKR|4900|3332|lyfalmen|V0693|3332|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||1400||1400|3332||2 432482|N03AX1211|Gabapentin PCD|hylki|400|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|2200|2644|lyfalmen|V0251|2644|2|120|0|26,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||900||900|2644||2 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|DKK|29522|40410|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||29522|40410||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|pakki||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|2490|4894|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||2490||2490|4894||2 433126|N02BE0102|Panodil Brus|freyðit|500|mg|20|stk|1|þpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||2083||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|9435|14391|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||9435||9435|14391||1 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1988|4141|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||1988||1988|4141||1 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4369|7418|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||4369||4369|7418||1 433666|J02AC0401|Noxafil|sþ-tfl|100|mg|96|stk|1|þpakki||J02AC04|01.11.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|369384|465517|lyfsjukr|||1|96|0|32,0000|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||369384||369384|465517||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BAB|0|0|0|100|DKK|137280|176845|lyfsjukr|||1|150|0||Icepharma hf|Bayer AB|Gadóbútról||137280||137280|176845||2 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TAB|0|0|0|100|XEU|4470|2432|lyfalmen|V0490|2432|2|98|0|98,0000|Alvogen|Teva Pharma B.V.|Montelúkast||746||746|2432||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|60010|91837|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||56971||56971|91837||1 434353|QM01AE9104|Canicaral vet|töflur|160|mg|100|stk|1|þpakki||QM01AE91|01.09.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|15098|28814|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||15098||15098|28814||2 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6670|10586|lyfalmen|||1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíð||6670||6670|10586||1 434576|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3272|3882|lyfalmen|V0010|3882|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1800||1800|3882||2 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|639|2284|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||639||639|2284||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|4610|7750|lyfalmen|||1|1|0|0,6000|Icepharma hf|Meda AB|Adrenalín tartrat||4610||4610|7750||2 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|5301|8701|lyfalmen|||1|1|0|0,3000|Icepharma hf|Meda AB|Adrenalín tartrat||5301||5301|8701||2 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|XEU|8135|12602|lyfalmen|V0315|5245|1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||8135||8135|12602||2 434967|A16AX1401|Galafold|hylki|123|mg|14|stk|1|þpakki|Hart|A16AX14|01.05.2017||R|0|0|0|1|0|1|AMI|0|0|0|100|DKK|1989633|2480653|lyfsjukr|||1|14|0|28,0000|Vistor hf|Amicus Therapeuticks UK Ltd.|Migalastat||1989633||1989633|2480653||1 435072|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.10.2017||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|11457|17174|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||11457||11457|17174||1 435107|L04AA0401|Thymoglobuline|irs|25|mg|1|stk|1|pakki||L04AA04|01.08.2016||R|0|0|0|0|0|1|PCO|0|0|0|100|NOK|25718|35598|lyfsjukr|||0|1|1||Distica|Distica - óskráð lyf|Antithymocyte immunoglobulin||||25718|35598||1 435151|R06AX2706|Flynise|filmhtfl|5|mg|100|stk|1|þpakki||R06AX27|01.10.2015||L|1|0|0|0|G|0|GRP|0|0|1|100|IKR|||lyfalmen|V0458|2919|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín|||||3754||1 435728|N06AX1105|Mirtazapin Bluefish|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BFP|0|0|0|100|IKR|5573|9076|lyfalmen|||2|96|0|144,0000|Vistor hf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|9076||1 436010|L01AA0901|Levact|irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|172549|220710|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||172549||172549|220710||2 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúði|0,15|mg/sk|2,5|ml|1|úðagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|34166|46283|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lægemidler A/S|Desmópressín||34166||34166|46283||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|886|2624|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||886||886|2624||1 436618|H01AC0112|Genotropin Miniquick|stl|0,2|mg|7|spr|1|pakkar||H01AC01|01.12.2015||R|0|0|0|1|0|1|PCO|0|0|0|100|IKR|12812|19039|lyfsjukr|||0|7|1||Distica|Distica - óskráð lyf|Sómatrópín||||12812|19039||1 436647|A16AA0402|Procysbi|hylki|25|mg|60|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|58064|76510|lyfsjukr|||1|60|0|0,7500|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||58064||58064|76510||3 436669|J02AC0106|Fungyn|hylki|150|mg|2|stk|1|þpakki|hart|J02AC01|01.06.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|523|2125|lyfalmen|V0555|2125|2|2|0|1,5000|Alvogen|Alvogen|Flúkónazól||523||523|2125||1 436717|H01AC0112|Genotropin Miniquick|stl|0,4|mg|7|spr|1|pakki||H01AC01|01.07.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|DKK|23504|32798|lyfsjukr|||0|7|1||Distica|Distica - óskráð lyf|Sómatrópín||||23504|32798||1 436733|H01AC0112|Genotropin Miniquick|stl|0,6|mg|7|spr|1|pakkar||H01AC01|01.10.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|DKK|37162|50073|lyfsjukr|||0|7|1||Distica|Distica - óskráð lyf|Sómatrópín||||37162|50073||1 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|644|2291|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||644||644|2291||1 437223|V10XX0301|Xofigo|stl|1100|kBq/ml|6|ml|1|hgl||V10XX03|01.06.2015||R|0|0|0|1|0|1|FIN|0|1|0|100|DKK|508753|638853|lyfsjukr|||1|6|0||Icepharma hf|Bayer AG|radium-223 dichloride||508753||508753|638853||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|þpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Alvogen|ratiopharm GmbH|Deslóratadín|||||||2 437763|A10BD2001|Synjardy|filmhtfl|1005|mg|180|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|16680|24363|lyfalmen|V0712|24363|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||16680||16680|24363||1 437767|N03AG0102|Orfiril|sþ-tfl|150|mg|100|stk|1|glas||N03AG01|01.08.2015||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|933|2689|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||933||933|2689||1 437935|L01AA0901|Levact|irþ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|49607|65813|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||49607||49607|65813||2 438084|QM05BA0201|Osphos|stl|51|mg/ml|1|hgl|1|pakki|handa hestum|QM05BA02|01.12.2016||R|0|0|0|0|0|0|HRA|1|0|0|100|XEU|18807|35851|vetalmen|||0|1|0||Vistor hf|Dechra Limited|Clodronic acid||18807||18807|35851||1 438353|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|1728|3783|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||1728||1728|3783||1 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|1741|3801|lyfalmen|||1|10|0||Vistor hf|Novartis Healthcare A/S|Hýdrókortisón og sýkingalyf||1741||1741|3801||1 438428|N02AE0101|Bupremyl|forðapl|5|mcg/klst|4|stk|1|skpoki||N02AE01|01.03.2018||R|0|0|1|0|G|0|MYL|0|0|0|100|SEK|1113|2937|lyfalmen|V0943|2937|2|4|0|16,6700|Icepharma hf|Mylan AB|Búprenorfín||1113||1113|2937||2 438591|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.06.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1429|3372|lyfalmen|V0820|3372|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1429||1429|3372||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|þpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|5273|3965|lyfalmen|V0605|3535|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||1860||1860|3965||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|þpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|191560|244354|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||191560||191560|244354||2 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|130344|168218|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||130344||130344|168218||1 439089|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.11.2016||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4438|7513|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og Felodipin||4438||4438|7513||1 439548|L01XE0104|Imatinib Mylan|filmhtfl|100|mg|120|stk|1|þpakki||L01XE01|01.02.2017||R|1|0|0|1|0|1|MYL|0|1|0|100|SEK|137046|84764|lyfsjukr|||2|120|0||Icepharma hf|Mylan AB|Imatiníb||64590||64590|84764||2 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|16940|24721|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||16940||16940|24721||1 439672|N06AX2106|Duloxetin W&H|sþ-hylki|30|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|45218|13269|lyfalmen|||2|500|0|250,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||8620||8620|13269||2 439680|A10BJ0101|Byetta|stl|10|mcg/sk|60|skammtar|1|penni|lausn|A10BJ01|01.10.2015||R|0|0|0|0|0|0|AZA|0|0|0|100|SEK|12174|18161|lyfalmen|||1|60|0|40,0000|Vistor hf|AstraZeneca AB|Exenatide||12174||12174|18161||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1911|4035|lyfalmen|V0658|3080|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||1911||1911|4035||1 439766|N06BA0902|Atomoxetin Actavis|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|14252|18325|lyfalmen|V0818|18325|2|28|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||12293||12293|18325||1 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1113|2696|lyfalmen|V0163|2297|1|70|0|5,6000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||938||938|2696||1 440410|N05AX1303|TREVICTA|stl|350|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|143548|184641|lyfalmen|||1|1|0|140,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||143548||143548|184641||1 440652|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.02.2016||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3115|5692|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3115||3115|5692||2 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1116|2941|lyfsjukr|||2|10|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||1116||1116|2941||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|1760|3827|lyfsjukr|||2|10|0|3,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||1760||1760|3827||1 440731|N05AX1209|Aripiprazole Sandoz|töflur|30|mg|56|stk|1|þpakki||N05AX12|01.04.2016|28.02.2018|R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|11905|17791|lyfalmen|||2|56|0|112,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||11905||11905|17791||1 441191|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|5,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|898|2641|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||898||898|2641||1 441312|N07BA0151|Nicorette Cooldrops|munnstfl|4|mg|80|stk|1|pakki|4 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|80|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|833|2551|lyfalmen|V0046|2177|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||833||833|2551||1 441410|J01AA0211|Doxyferm|sts|20|mg/ml|5|ml|5|hgl||J01AA02|01.03.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|4803|8016|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Doxýcýklín||||4803|8016||2 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|95786|124220|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||95786||95786|124220||2 441642|P03AC0401|Nix|krem|0,5|%|30|g|1|pakki||P03AC04|01.07.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|5154|8499|lyfalmen|||0|30|1||Distica|Distica - óskráð lyf|Permetrín||||5154|8499||1 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|þpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|831|2549|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer AB|Noretísterón||831||831|2549||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|þpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2110|2871|lyfalmen|V0283|2871|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1065||1065|2871||2 442586|N03AX1608|Pregabalina Tecnigen|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|1654|1910|lyfalmen|V0685|1508|2|56|0|4,6667|Williams & Halls efh|Williams & Halls ehf|Pregabalín||367||367|1910||2 442678|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|65749|86230|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||65749||65749|86230||3 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|þpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|9044|13853|lyfalmen|V0460|11785|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||9044|13853||1 443025|A10BB0905|Gliclatim|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.08.2017||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2500|3745|lyfalmen|V0020|3745|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||1700||1700|3745||2 443122|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1144|2980|lyfalmen|V0560|2946|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1144||1144|2980||2 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|hgl|1|pakki|dæla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|2658|5063|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||2658||2658|5063||1 443325|H04AA0103|GlucaGen|sts|1|mg|10|hgl|1|pakki|leysir, lausn|H04AA01|01.07.2016||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|21095|29751|lyfalmen|||1|10|0|10,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||21095||21095|29751||1 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|19470|28203|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||19470||19470|28203||1 443374|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|3989|6895|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Levómeprómazín||||3989|6895||1 443586|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.12.2016||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|20066|28450|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||20066||20066|28450||3 443861|N06AB0311|Fluoxetin Mylan|hylki|20|mg|30|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|837|2338|lyfalmen|V0038|1955|2|30|0|30,0000|Icepharma hf|Mylan AB|Flúoxetín||678||678|2338||2 443903|N06AB0311|Fluoxetin Mylan|hylki|20|mg|100|stk|1|glas||N06AB03|01.11.2015||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1552|3145|lyfalmen|V0039|2601|2|100|0|100,0000|Icepharma hf|Mylan AB|Flúoxetín||1264||1264|3145||2 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|2475|4812|lyfalmen|V0116|4812|2|14|0|14,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||2475||2475|4812||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|NVO|0|0|0|100|DKK|6350|10145|lyfalmen|||1|20|0|10,0000|Vistor hf|N.V. Organon|Asenapíne||6350||6350|10145||1 444098|L04AX0306|Metojectpen|stl|15|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2436|4758|lyfalmen|||1|1|0|6,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2436||2436|4758||2 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|745|2430|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||745||745|2430||2 444285|J01CF0104|Dicloxacillin Bluefish|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.01.2017||R|0|0|0|0|0|0|BFP|0|0|1|100|IKR|1686|3470|lyfalmen|V0337|3470|2|30|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Díkloxacillín||1500||1500|3470||1 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|0|0|0|0|0|0|DAN|0|0|0|100|DKK|2475|4812|lyfalmen|V0061|2997|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||2475||2475|4812||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|18153|26391|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||18153||18153|26391||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|1707|3754|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1707||1707|3754||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|2018|4182|lyfalmen|||2|100|0|33,3300|Alvogen|ratiopharm Oy|Betahistín||2018||2018|4182||2 444722|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.07.2016||R|0|0|0|0|G|0|GPA|0|0|1|100|XEU|770|2465|lyfalmen|V0677|2304|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón||770||770|2465||1 444765|A05AA0207|Ursochol|hylki|250|mg|100|stk|1|þpakki||A05AA02|01.11.2014||R|1|0|0|0|G|0|IRO|0|0|0|100|XEU|4360|7406|lyfalmen|||2|100|0|33,3300|Artasan ehf|Orifarm Generics A/S|Úrsódeoxýkól sýra||4360||4360|7406||1 444932|B02BD0208|Afstyla|sts|2000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|139439|179530|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||139439||139439|179530||2 445022|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|180|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|14503|21367|lyfalmen|V0705|21367|1|180|0|90,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||14503||14503|21367||1 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|3983|6887|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og flútícason||3983||3983|6887||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1626|3643|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1626||1626|3643||1 445418|N05AX1210|Aripiprazol Medical Valley|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|7019|4502|lyfalmen|V0684|4502|2|56|0|56,0000|Acare ehf|Medical Valley Invest AB|Aripiprazól||2250||2250|4502||2 445580|H05BX0105|Cinacalcet Accord|filmhtfl|90|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|ARD|0|0|0|100|SEK|42607|25786|lyfalmen|V0722|24065|2|28|0|42,0000|Artasan ehf|Accord Healthcare Limited|Cinacalcet||17714||17714|25786||0 445692|D07CA0103|Terra-Cortril|smyrsli|||15|g|1|pakki||D07CA01|01.10.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|1493|3460|lyfalmen|||0|15|1||Distica|Distica - óskráð lyf|Hýdrókortisón og sýklalyf||||1493|3460||1 445705|A10AE0406|Toujeo [SoloStar]|stl|300|ein/ml|1,5|ml|3|pennar|áfylltir lyfjapennar|A10AE04|01.10.2015||R|0|1|0|0|G|0|SDH|0|0|0|100|XEU|5090|8411|lyfalmen|||1|4,5|0|33,7500|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||5090||5090|8411||1 446268|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|4034|6957|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer AB|Nífedipín||||4034|6957||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|13758|20341|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíð||13758||13758|20341||1 447040|N06AX2105|Duloxetin Krka|sþ-hylki|60|mg|100|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|9820|5809|lyfalmen|V0694|5302|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||3200||3200|5809||2 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|9544|14541|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||9544||9544|14541||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|5474|8939|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5474||5474|8939||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|6722|10657|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||6722||6722|10657||1 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PLS|0|0|1|100|DKK|8309|12841|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8309||8309|12841||1 447596|C07AG0205|Carveratio|töflur|25|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2887|5379|lyfalmen|V0948|5121|2|100|0|66,6700|Alvogen|ratiopharm GmbH|Carvedílól||2887||2887|5379||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|2836|5308|lyfalmen|||2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||2836||2836|5308||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|1974|4122|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer AB|Nífedipín||||1974|4122||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.09.2013|31.12.2017|L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1649|3675|lyfalmen|V0202|3260|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||1649||1649|3675||1 448821|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|100|stk|1|þpakki||C10AA07|01.02.2017||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6031|9706|lyfalmen|V0214|9706|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6031||6031|9706||2 448897|C09DX0401|Entresto|filmhtfl|100|mg|168|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|50487|66926|lyfalmen|V0727|66926|1|168|0|84,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||50487||50487|66926||1 449125|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|þpakki||N06AB06|01.03.2016|28.02.2018|R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|3278|4158|lyfalmen|||2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|4158||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|907|2653|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||907||907|2653||1 449485|N03AX1603|Pregabalin Krka|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|3475|2505|lyfalmen|V0686|2097|2|56|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||799||799|2505||2 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|820|2534|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||820||820|2534||2 449647|N05AH0414|Quetiapin Hexal|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|3852|6346|lyfalmen|V0275|6346|2|100|0|12,5000|Artasan ehf|Hexal A/S|Quetíapín||3590||3590|6346||1 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|GRP|0|0|0|100|DKK|4173|7149|lyfsjukr|||2|10|0|8,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Benzýlpenicillín||4173||4173|7149||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|2740|5176|lyfalmen|||1|10|0|5,0000|Icepharma hf|Bayer AG|Rivaoxaban||2740||2740|5176||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|3843|7461|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||3843||3843|7461||2 450054|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.12.2014||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|974|2746|lyfalmen|||1|30|0|30,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól||974||974|2746||2 450080|R05DA0701|Noskapin|töflur|25|mg|50|stk|1|glas||R05DA07|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|4742|7932|lyfalmen|||0|50|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|noscapine||||4742|7932||2 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|106855|139005|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||106855||106855|139005||1 450413|V03AB3701|Praxbind|stl/irl|2,5|g|50|ml|2|hgl||V03AB37|01.05.2016||R|0|0|0|0|0|1|BOE|0|0|0|100|DKK|317447|400922|lyfsjukr|||1|100|0||Vistor hf|Boehringer Ingelheim International GmbH|Idarucizumab||317447||317447|400922||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|1988|3449|lyfalmen|V0313|2704|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||1485||1485|3449||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|6950|11979|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||6950||6950|11979||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|16924|24699|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíð||||16924|24699||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003|31.12.2017|R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|29963|40967|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||29963||29963|40967||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|38605|51898|lyfalmen|||1|1|0|30,0800|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||38605||38605|51898||1 451378|H02AB0607|Prednisolon Actavis|töflur|10|mg|25|stk|1|glas||H02AB06|01.12.2016||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|592|2220|lyfalmen|||2|25|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Prednisólón||592||592|2220||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003|31.12.2017|R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|33312|45203|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||33312||33312|45203||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003|31.12.2017|R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44417|59249|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíð||44417||44417|59249||2 451751|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|7199|11314|lyfalmen|V0610|11314|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||7199||7199|11314||1 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|AEP|0|0|0|100|DKK|36074|48697|lyfalmen|||1|100|0||Icepharma hf|Aspen Pharma Trading Limited|Búsúlfan||36074||36074|48697||2 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|Trimb Healthcare AB|Ketókónazól|||||||1 452215|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.12.2016||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|Omega Pharma Nordic AB|Pencíklóvír|||||||1 452258|R03AK1101|Flutiform|innúðal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|6518|10376|lyfalmen|||1|120|0|60,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||6518||6518|10376||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8836|15230|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||8836||8836|15230||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|2000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||5720||1 452500|L01XE3801|Cotellic|filmhtfl|20|mg|63|stk|1|þpakki|3 x 21|L01XE38|01.02.2016||R|1|0|0|1|0|1|RRL|0|1|0|100|DKK|767621|960813|lyfsjukr|||1|63|0||Icepharma hf|Roche Registration Limited|Cobimetinib||||767621|960813||2 452594|A02BC0403|Rabeprazol Krka|sþ-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2781|lyfalmen|V0010|2218|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2781|| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|7615|11886|lyfalmen|||1|3000|0||Icepharma hf|Meda AB|Imikvímóð||7615||7615|11886||2 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|6526|10387|lyfsjukr|||1|100|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||6526||6526|10387||2 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1100|2919|lyfalmen|V0597|2440|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1100||1100|2919||2 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3300|5947|lyfalmen|V0598|4608|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||3300||3300|5947||2 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2102|4298|lyfalmen|V0584|3131|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2102||2102|4298||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1167|2011|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1167||1167|2011||1 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6335|10124|lyfalmen|V0585|6079|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||6335||6335|10124||2 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|3537|6273|lyfalmen|V0586|4686|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||3537||3537|6273||2 453515|N03AX1211|Gabapentin PCD|hylki|300|mg|120|stk|1|þpakki|hart|N03AX12|01.07.2017||R|1|1|0|0|G|0|PDA|0|0|0|100|IKR|1800|2382|lyfalmen|V0250|2382|2|120|0|20,0000|LYFIS ehf|PharmaCoDane ApS|Gabapentín||710||710|2382||2 453559|N03AX1604|Brieka|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1713|1993|lyfalmen|V0685|1508|2|56|0|4,6667|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||427||427|1993||1 453560|L04AX0501|Esbriet|filmhtfl|267|mg|63|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|88442|114932|lyfalmen|V0920|114932|1|63|0|7,0000|Icepharma hf|Roche Registration Limited|Pírfenidon||||88442|114932||2 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|11815|17667|lyfalmen|V0587|11644|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||11815||11815|17667||2 453731|N06AX1613|Venlafaxin Medical Valley|forðatfl|225|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3500|5396|lyfalmen|V0916|5396|2|100|0|225,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||2900||2900|5396||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|2181|4407|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2181||2181|4407||1 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|0|100|NOK|3456|6162|lyfalmen|||0|98|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Simvastatín||||3456|6162||3 454442|QH01BB0204|Oxytobel|stl|10|ae/ml|50|ml|12|hgl||QH01BB02|01.11.2015||R|0|0|0|0|0|0|Bel|1|0|0|100|DKK|4206|8150|vetalmen|||0|600|0||Icepharma hf|Bela-Pharma GmbH & CO KG|Oxytocin||4206||4206|8150||2 454659|N05AH0414|Quetiapin Hexal|forðatfl|150|mg|100|stk|1|þpakki||N05AH04|01.09.2017||R|1|1|0|0|G|0|SSA|0|0|0|100|DKK|5793|9378|lyfalmen|V0910|9378|2|100|0|37,5000|Artasan ehf|Hexal A/S|Quetíapín||5793||5793|9378||1 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8962|13740|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||8962||8962|13740||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|30553|35715|lyfalmen|V0342|6692|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||25810||25810|35715||1 454819|N02BE0115|Paracet|eþ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|WAS|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group PTC ehf|Weifa AS|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|OPH|0|0|0|100|DKK|44448|59288|lyfsjukr|||1|1|0||Artasan ehf|Novartis Europharm Ltd|Tópótecan||44448||44448|59288||1 454882|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.05.2017||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|331492|418390|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||331492||331492|418390||2 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|910|1789|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||910||910|1789||1 454973|J01FA1007|Azithromycin STADA|filmhtfl|500|mg|3|stk|1|þpakki||J01FA10|01.06.2017||R|1|0|0|0|0|0|ASR|0|0|1|100|IKR|800|2038|lyfalmen|V0174|2038|2|3|0|5,0000|LYFIS ehf|STADA Arzneimittel AG|Azitrómýcín||460||460|2038||2 455171|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|3841|6692|lyfsjukr|||1|4000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||3841||3841|6692||1 455223|J05AR0303|Emtricitabine/Tenofovir disoproxil Krka|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.08.2017||R|0|1|0|1|0|1|KNM|0|0|0|100|IKR|50000|66310|lyfsjukr|||2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Tenófóvír dísóproxíl og emtrícítabín||||50000|66310||2 455266|A10BD2001|Synjardy|filmhtfl|1012,5|mg|60|stk|1|þpakki|12,5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5663|9199|lyfalmen|V0713|8121|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||5663||5663|9199||1 455325|L04AX0601|Imnovid|hylki|2|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1088546|1359953|lyfsjukr|||1|21|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1088546||1088546|1359953||2 455492|G04BE0310|Sildenafil LYFIS|filmhtfl|50|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|8916|6635|lyfalmen|V0143|6635|2|24|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3800||3800|6635||2 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|525|2128|lyfalmen|||2|10|0|10,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||525||525|2128||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|707|2378|lyfalmen|||2|15|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||707||707|2378||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|GRP|0|0|1|100|XEU|1454|3406|lyfalmen|||2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Doxýcýklín||1454||1454|3406||1 456171|L01XE0302|Varlota|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.08.2017||R|1|0|0|1|0|1|ALO|0|1|0|100|XEU|221892|282079|lyfsjukr|||2|30|0||Alvogen|Alvogen Malta Operations(ROW)Ltd.|Erlótiníb||221892||221892|282079||1 456734|C07AB0704|Bisbetol|filmhtfl|10|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2740|5176|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||2740||2740|5176||2 456795|L01XE3501|Tagrisso|filmhtfl|80|mg|30|stk|1|þpakki||L01XE35|01.09.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|SEK|711411|890903|lyfsjukr|||0|30|1||Distica|Distica - óskráð lyf|Osimertinib||||711411|890903||1 456895|N05AH0206|Clozapin Medical|töflur|100|mg|100|stk|1|þpakki||N05AH02|01.06.2015||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|5264|5259|lyfalmen|V0277|5231|2|100|0|33,3300|Medical ehf|Medical ehf|Klózapín||2800||2800|5259||2 457112|N06BA0902|Atomoxetin Actavis|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10195|8623|lyfalmen|V0816|7494|2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||5244||5244|8623||1 457204|L02AE0307|Reseligo|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.05.2016||R|0|0|0|1|G|0|IPC|0|0|0|100|SEK|42485|46698|lyfalmen|V0451|46698|2|1|0|83,7200|Alvogen|Alvogen IPco S.á.r.l.|Góserelín||34494||34494|46698||1 457232|A07DA0601|Truberzi|filmhtfl|75|mg|56|stk|1|þpakki||A07DA06|01.08.2017||R|1|0|0|1|0|0|AIP|0|0|0|100|XEU|14005|20681|lyfalmen|||2|56|0||Actavis ehf|Allergan Pharmaceuticals Ltd.|Eluksadólín||||14005|20681||1 457359|N01BB0204|Lidokain Mylan|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.09.2016||R|0|0|0|0|0|0|MHS|0|0|1|100|XEU|1252|3128|lyfalmen|V0561|3128|2|100|0||Icepharma hf|Mylan Hospital AS|Lídókaín||1252||1252|3128||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|PHH|0|0|0|100|DKK|5506|8983|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsaðir fjórgildi A,C,Y,W-135 og fl.||5506||5506|8983||1 457692|L04AX0307|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2483|4823|lyfalmen|||1|0,45|0|9,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2483||2483|4823||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|GRP|0|0|0|100|XEU|2154|2156|lyfalmen|V0003|2156|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||546||546|2156||1 457991|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.08.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8836|15230|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||8836||8836|15230||2 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|907|2653|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||907||907|2653||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|FIN|0|1|0|100|DKK|321176|405560|lyfsjukr|||1|84|0||Icepharma hf|Bayer AG|Regorafenib||321176||321176|405560||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1045|2843|lyfalmen|V0577|2485|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1045||1045|2843||1 458491|C05AA0801|Doloproct|eþ-krem|||30|g|1|túpa||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1082|2894|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1082||1082|2894||2 458666|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|100587|131209|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||||100587|131209||3 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|8336|11855|lyfalmen|V0653|11629|1|60|0|15,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||7592||7592|11855||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|775070|970077|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||775070||775070|970077||1 459242|L03AB1301|Plegridy|stl|||2|áf.spr|1|pakki|63 og 94 mcg|L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|75918|99091|lyfsjukr|||1|2|0|17,6400|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||75918||75918|99091||2 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|679|2339|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||679||679|2339||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|1243|3116|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1243||1243|3116||1 459447|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|16810|32062|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||16810||16810|32062||2 459812|N05AH0411|Quetiapine Teva|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|2267|2194|lyfalmen|V0284|2194|2|100|0|6,2500|Alvogen|Teva Sweden AB|Quetíapín||573||573|2194||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|1281|3168|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Tranexamsýra||1281||1281|3168||2 460062|L01AA0902|Bendamustine Accord|st/irþ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.01.2016||R|0|0|0|1|0|1|ACC|0|1|0|100|DKK|113034|146690|lyfsjukr|||2|500|0||Artasan ehf|Accord Healthcare Limited|Bendamústín||113034||113034|146690||1 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|þpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|6522|10382|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||6522||6522|10382||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|194327|247795|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||194327||194327|247795||2 460632|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.03.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|5968|4156|lyfalmen|V0144|3800|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1999||1999|4156||1 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|pakki||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|4422|8560|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||4422||4422|8560||2 461035|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|98|stk|1|glas||N02AA05|01.08.2015||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|3892|6762|lyfalmen|V0585|6079|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||3892||3892|6762||1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|69126|90501|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||69126||69126|90501||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|442840|556876|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||442840||442840|556876||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyfalmen|V0554|1823|2|1|0|0,7500|Alvogen|ratiopharm GmbH|Flúkónazól|||||1823||2 461441|L04AX0601|Imnovid|hylki|4|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1122206|1401817|lyfsjukr|||1|21|0|28,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1122206||1122206|1401817||2 461641|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.09.2015||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|267136|338349|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||267136||267136|338349||1 461731|N02AJ0601|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02AJ06|01.01.1989||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|202|1683|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||202||202|1683||1 461774|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr||M09AX01|01.08.2015||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|5750|9319|lyfalmen|V0209|9319|2|2|0|5,7222|Vistor hf|Takeda Pharma A/S|Natríumhýalúrónat||5750||5750|9319||1 461917|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982|31.12.2017|R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|343|1877|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||343||343|1877||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982|31.12.2017|R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|382|1931|lyfalmen|||1|25|0||Vistor hf|GlaxoSmithKline Pharma A/S|Klóbetasól||382||382|1931||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BAB|0|0|0|100|DKK|2275|4536|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer AB|Nífedipín||||2275|4536||2 462069|C05BB0201|Aethoxysklerol|stl|5|mg/ml|2|ml|5|lykjur||C05BB02|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|2511|4861|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Polidocanol||||2511|4861||1 462070|A10BK0101|Forxiga|filmhtfl|10|mg|98|stk|1|þpakki||A10BK01|01.09.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|15711|23030|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||15711||15711|23030||1 462093|C05BB0201|Aethoxysklerol|stl|10|mg/ml|2|ml|5|lykjur||C05BB02|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|2725|5156|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Polidocanol||||2725|5156||1 462302|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|3454|6159|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||3454||3454|6159||1 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|XEU|4688|3786|lyfalmen|V0605|3607|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Memantín||1730||1730|3786||2 463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|þpakki||N03AX21|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|7326|11488|lyfalmen|||0|84|1|19,0000|Distica|Distica - óskráð lyf|Retigabín||||7326|11488||1 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|43147|57643|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||43147|57643||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1728|3783|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1728||1728|3783||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratoires Expanscience|Glúkósamín|||||||2 463956|R02AX0102|Strefen Orange Sukkerfri|sogtfl|8,75|mg|16|stk|1|þpakki||R02AX01|01.11.2016||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|16|0|3,1800|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Flurbiprofen|||||||1 464164|N02BE0101|Panodil|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464226|C07AG0205|Carveratio|töflur|12,5|mg|100|stk|1|þpakki||C07AG02|01.06.2015||R|0|0|0|0|G|0|RTH|0|0|0|100|IKR|2478|4816|lyfalmen|V0947|4571|2|100|0|33,3300|Alvogen|ratiopharm GmbH|Carvedílól||2478||2478|4816||2 464326|L01XX1905|Onivyde|irþ|5|mg/ml|10|ml|1|hgl||L01XX19|01.04.2017||R|0|0|0|1|0|1|ALT|0|0|0|100|DKK|84405|109826|lyfsjukr|||1|10|0||Lyfjaver ehf|Baxalta Innovations GmbH|Írinótekan||84405||84405|109826||3 464335|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|10917|16431|lyfalmen|V0718|16431|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||10917||10917|16431||1 464545|L01XX0502|Hydroxyurea medac|hylki|500|mg|100|stk|1|þpakki||L01XX05|01.01.2016||R|0|0|0|1|G|0|WIL|0|0|0|100|XEU|7562|11813|lyfalmen|||1|100|0||Williams & Halls efh|medac Gesellschaft|Hýdroxýkarbamíð||7562||7562|11813||2 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|þpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSA|0|0|1|100|IKR|1713|3763|lyfalmen|||2|14|0|7,0000|Alvogen|Teva Sweden AB|Klaritrómýcín||1713||1713|3763||2 464751|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 464762|R01AD0904|Mometasone Actavis|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.12.2016||L|0|0|0|0|G|0|GPA|0|0|1|100|XEU|||lyfalmen|V0677|2304|2|140|0|35,0000|Actavis Group hf|Actavis Group PTC ehf|Mómetasón|||||2675||1 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.10.2011||R|0|0|0|0|G|0|GRP|0|0|0|100|DKK|1445|3394|lyfalmen|V0376|2737|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1445||1445|3394||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|941|1849|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||||941|1849||1 465307|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|1536|3519|lyfalmen|||1|98|0|49,0000|Icepharma hf|BGP Products ApS|Verapamíl||1536||1536|3519||2 465333|L04AX0307|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L04AX03|01.12.2012||R|0|0|0|0|G|0|WIL|0|0|0|100|SEK|2751|5191|lyfalmen|||1|0,6|0|12,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2751||2751|5191||2 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|994|1955|lyfalmen|V0038|1955|2|30|0|30,0000|Alvogen|ratiopharm GmbH|Flúoxetín||400||400|1955||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2763|2601|lyfalmen|V0039|2601|2|100|0|100,0000|Alvogen|ratiopharm GmbH|Flúoxetín||869||869|2601||2 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|496|2088|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||496||496|2088||1 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1545|3531|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||1545||1545|3531||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|þpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1024|2814|lyfalmen|V0545|2012|1|63|0|84,0000|Icepharma hf|Bayer AB|Levónorgestrel og ethinylestradíól||||1024|2814||2 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1171|3017|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1171||1171|3017||1 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|4059|6992|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4059||4059|6992||1 466278|L01XC1401|Kadcyla|irþ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|224152|284889|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||224152||224152|284889||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|15643|22936|lyfalmen|||1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíð||15643||15643|22936||1 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2178|4403|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2178||2178|4403||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|5923|9557|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||5923||5923|9557||1 466588|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.02.2017||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 466610|N02BE0120|Paracetamol Sandoz|filmhtfl|500|mg|30|stk|1|þpakki||N02BE01|01.03.2016||L|1|0|0|0|0|0|SHS|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Artasan ehf|Sandoz A/S|Paracetamól|||||||1 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|3582|6335|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||3582||3582|6335||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir þrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466739|C09DX0401|Entresto|filmhtfl|200|mg|56|stk|1|þpakki|97 + 103 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|16829|24568|lyfalmen|V0728|22309|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||16829||16829|24568||1 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MEA|0|0|0|100|DKK|2625|5018|lyfalmen|V0063|4344|1|100|0|50,0000|Icepharma hf|Meda AB|Móklóbemíð||2625||2625|5018||2 466902|N02BE0122|Dolorin|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.12.2017||R|1|0|0|0|0|0|WEH|0|0|1|100|IKR|325|1852|lyfalmen|||2|100|0|16,6666|Williams & Halls efh|Williams & Halls ehf|Paracetamól||325||325|1852||2 467189|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|5588|6052|lyfalmen|V0622|4489|2|30|0|54,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3376||3376|6052||1 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5122|8455|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||5122||5122|8455||2 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|11493|17224|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||11493||11493|17224||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|þpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4923|8181|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrogen||4923||4923|8181||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|21870|30731|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21870||21870|30731||1 467756|A10BJ0301|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BJ03|01.10.2013||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|8249|12759|lyfalmen|||1|2|0|2,0000|Vistor hf|Sanofi-aventis groupe|Lixisenatide||8249||8249|12759||1 467810|J01DI0201|Zinforo|irþ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|67082|87916|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||67082||67082|87916||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|345|1880|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||345||345|1880||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|4892|5929|lyfalmen|V0317|3516|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3287||3287|5929||1 468103|H05BX0104|Cinacalcet Mylan|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.11.2016||R|1|0|0|0|0|0|ASD|0|0|0|100|SEK|12701|11407|lyfalmen|V0720|11407|2|28|0|14,0000|Icepharma hf|Mylan S.A.S.|Cinacalcet||7267||7267|11407||2 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|5956|5903|lyfalmen|V0318|4602|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3268||3268|5903||1 468537|QP54AA0501|Stronghold|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.12.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|1861|3208|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||1861||1861|3208||2 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|4936|9535|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||4936||4936|9535||2 468932|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5799|9387|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||5799||5799|9387||1 468996|A02BC0402|Rabeprazol Actavis|sþ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|IKR|2661|5068|lyfalmen|V0467|3961|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2661||2661|5068||1 469086|A10BD2001|Synjardy|filmhtfl|1005|mg|60|stk|1|þpakki|5mg/1000mg|A10BD20|01.01.2016||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|5663|9199|lyfalmen|V0712|8121|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og empagliflozin||5663||5663|9199||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|2577|4952|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||2577||2577|4952||1 469422|G03AB0501|Gracial|töflur|||66|stk|1|þpakki|Þp 3 * (15+7 stk)|G03AB05|01.08.2015||R|0|0|0|0|0|0|AEP|0|0|0|100|DKK|1978|4127|lyfalmen|||1|66|0|66,0000|Icepharma hf|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||1978||1978|4127||2 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|6132|9845|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||6132||6132|9845||1 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4508|7610|lyfalmen|V0228|7610|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||4508||4508|7610||2 469847|M01AH0106|Celecoxib Actavis|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|1991|2631|lyfalmen|V0037|2631|2|20|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||891||891|2631||1 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3697|6493|lyfalmen|V0227|5998|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||3697||3697|6493||2 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|2271|4531|lyfalmen|V0226|4520|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||2271||2271|4531||2 470148|N06BA0404|Methylphenidate Sandoz|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|5559|6048|lyfalmen|V0622|4489|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||3373||3373|6048||1 470315|J05AF0703|Virofob|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.01.2017||R|1|1|0|1|0|1|IPC|0|0|0|100|DKK|40466|47427|lyfsjukr|||2|30|0|30,0000|Alvogen|Alvogen IPco S.á.r.l.|Tenófóvír dísóproxíl||35070||35070|47427||1 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GPH|0|0|0|100|DKK|3273|5910|lyfalmen|||1|120|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||3273||3273|5910||1 470397|N05CM1801|Dexdor|irþ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|21531|30303|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||21531||21531|30303||1 470471|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|áf.spr||B01AX05|01.01.2016||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|4917|8173|lyfalmen|||1|5|0|10,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||4917||4917|8173||2 470591|B05XA1401|Glycophos|irl|216|mg/ml|20|ml|10|hgl||B05XA14|01.02.2017||R|0|0|0|0|0|1|PCO|0|0|0|100|DKK|3586|6341|lyfsjukr|||0|200|1||Distica|Distica - óskráð lyf|Sodium Glycerophosphate||||3586|6341||1 471550|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.10.2017||R|1|0|0|0|G|0|MEA|0|0|1|100|SEK|696|2363|lyfalmen|V0917|2363|1|30|0|15,0000|Icepharma hf|Meda AB|Fenýlprópanólamín||696||696|2363||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|3772|7327|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||3772||3772|7327||1 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1491|3457|lyfalmen|V0048|2254|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1491||1491|3457||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|þpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|2340|4626|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2340||2340|4626||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|7698|12000|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||7698||7698|12000||1 472984|S01EC5401|Simbrinza|augndr|12|mg/ml|5|ml|1|glas|10 + 2 mg/ml|S01EC54|01.01.2015||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2323|4602|lyfalmen|V0670|3605|1|5|0||Vistor hf|Novartis Europharm Ltd|Brimoníð og brinzolamið||2323||2323|4602||1 473213|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.07.2016||R|0|0|0|0|G|0|ATN|0|0|1|100|DKK|1149|2986|lyfalmen|||1|5|0|5,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Ketórólak||1149||1149|2986||2 473957|L04AB0102|Benepali|stl|50|mg|4|áf-penni|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAM|0|1|0|100|XEU|107195|139428|lyfsjukr|||2|4|0|28,5800|Biogen Idec Ltd.|Samsung Bioepis UK Ltd.|Etanercept||107195||107195|139428||2 473968|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.11.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|3949|6840|lyfalmen|V0921|6840|1|30|0||Vistor hf|LEO Pharma A/S|Takrólímus||3949||3949|6840||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MEA|0|0|0|100|DKK|8811|13532|lyfsjukr|||1|400|0||Icepharma hf|Meda AB|Dextran||8811||8811|13532||2 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|þykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|GPA|0|0|0|100|XEU|5242|8620|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5242||5242|8620||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474120|N03AX1604|Brieka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|6643|3365|lyfalmen|V0687|3099|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||1424||1424|3365||1 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000|31.12.2017|L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474411|C07AB0703|Emconcor|töflur|10|mg|100|stk|1|pakki||C07AB07|01.03.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3420|6112|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|bisoprolol||||3420|6112||2 474608|QB03AC0001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|24088|45870|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíð||24088||24088|45870||2 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|633|2276|lyfalmen|V0266|2272|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||633||633|2276||2 474855|N07BC0202|Metadon Abcur|töflur|10|mg|20|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|863|2593|lyfalmen|||1|20|0|8,0000|Icepharma hf|Abcur AB|Metadón||863||863|2593||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|GRP|0|0|0|100|IKR|1100|2919|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2919||1 475491|N02AJ0602|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AJ06|01.04.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|497|2089|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||497||497|2089||1 475533|N02AJ0602|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AJ06|01.04.1992||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|627|2268|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||627||627|2268||1 475669|N03AX1603|Pregabalin Krka|hylki|50|mg|56|stk|1|þpakki||N03AX16|01.01.2018||R|1|0|0|0|0|0|KNM|0|0|0|100|IKR|2904|3607|lyfalmen|||2|56|0|9,3333|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1600||1600|3607||2 475705|QN02AF0104|Torphadine vet.|stl|10|mg/ml|10|ml|1|hgl|lausn|QN02AF01|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5789|11153|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Bútorfanóltartrat||||5789|11153||0 475715|N02AJ0602|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AJ06|01.04.1992||R|1|0|1|0|0|0|GPA|0|0|1|100|IKR|1364|3282|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1364||1364|3282||1 475862|A02BC0110|Omeprazol ratiopharm|sþ-hylki|20|mg|28|stk|1|þpakki|hart|A02BC01|01.04.2015||L|1|0|0|0|0|0|RTH|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Alvogen|ratiopharm GmbH|Ómeprazól|||||||2 476249|QJ01CA0403|Amoxibactin vet.|töflur|250|mg|100|stk|1|þpakki||QJ01CA04|01.12.2016||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|5695|10975|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5695||5695|10975||2 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|52444|69401|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||52444|69401||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|fyrir eimgjafa|R03AC02|01.04.1992||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1003|2785|lyfalmen|||1|20|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Salbútamól||1003||1003|2785||1 476873|B05BA0314|Glucos Baxter Viaflo|irl|100|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3699|6496|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||||3699|6496||2 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|13958|20617|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||13958||13958|20617||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|þpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|3610|6374|lyfalmen|V0934|5534|1|12|0|3,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Prógúaníl í blöndum||3610||3610|6374||1 477099|L04AA3201|Otezla|filmhtfl|||27|stk|1|þpakki|10+20+30 mg upphafs.pkn|L04AA32|01.05.2016||R|1|0|0|1|0|1|CLC|0|1|0|100|XEU|46880|62364|lyfsjukr|||1|27|0||Celgene AB|Celgene Europe Limited|Apremilast||46880||46880|62364||2 477201|L04AB0102|Benepali|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.10.2017||R|0|1|0|1|0|1|SAM|0|1|0|100|XEU|107195|139428|lyfsjukr|||2|4|0|28,5800|Biogen Idec Ltd.|Samsung Bioepis UK Ltd.|Etanercept||107195||107195|139428||2 477295|N05AH0413|Quetiapin ratiopharm|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|28055|11089|lyfalmen|V0272|10891|2|100|0|75,0000|Alvogen|Teva Pharma B.V.|Quetíapín||7036||7036|11089||2 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyfalmen|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3307||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja|dreifa|H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|582|2206|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||582||582|2206||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FKA|0|0|0|100|IKR|||lyfalmen|||0|200|0||Vistor hf|Fresenius Kabi AB|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||3307||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|424|1878|lyfalmen|V0500|1873|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||344||344|1878||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|6010|11573|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||6010||6010|11573||2 478993|M01AH0502|Coxient|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|1954|3074|lyfalmen|V0825|2789|2|28|0|28,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1213||1213|3074||1 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|20524|29029|lyfalmen|||2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||20524||20524|29029||2 479703|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.07.2017||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|831|2549|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||831||831|2549||1 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|96958|125703|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||96958||96958|125703||1 480454|QN05CM1802|Sileo|munnh.hl|0,1|mg/ml|3|ml|1|spr||QN05CM18|01.01.2017||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2611|5124|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2611||2611|5124||2 480519|C09CA0604|Kairasec|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3804|5259|lyfalmen|V0080|5259|2|98|0|196,0000|Acare ehf|Medical Valley Invest AB|Candesartan||2800||2800|5259||2 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GPH|0|0|0|100|DKK|10388|15703|lyfalmen|||1|100|0|50,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Bupropionum||10388||10388|15703||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|590|2217|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||590||590|2217||1 481374|C01CA0201|Isuprel|stl|0,2|mg/ml|1|ml|5|lykjur||C01CA02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2859|5340|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Isoprenaline||||2859|5340||2 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|3751|6568|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Olodaterol||3751||3751|6568||1 481506|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.03.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|5778|6890|lyfalmen|V0681|5614|2|30|0|27,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||3985||3985|6890||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|þpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|206|1688|lyfalmen|V0055|1688|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||206||206|1688||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BAB|0|0|0|100|DKK|12907|19170|lyfalmen|||1|4|0|55,5600|Icepharma hf|Bayer AB|Testósterón||12907||12907|19170||2 482457|N02BA5102|Treo|freyðit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MEA|0|0|1|100|DKK|||lyflausa|||0|20|0|3,3333|Icepharma hf|Meda AB|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole|||||||2 482751|QJ01DB0101|Cefabactin vet.|töflur|500|mg|100|stk|1|þpakki||QJ01DB01|01.03.2018||R|0|0|0|0|0|0|BVL|1|0|0|100|IKR|6458|12423|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Cefalexin||||6458|12423||0 483104|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|54449|71937|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||54449||54449|71937||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|26288|36319|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer AG|Rivaoxaban||||26288|36319||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|5222|8592|lyfsjukr|||1|400|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||5222||5222|8592||2 483477|A02BC0403|Rabeprazol Krka|sþ-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1470|2781|lyfalmen|V0467|2218|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2781||2 483485|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|15|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44741|59659|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||44741||44741|59659||2 483540|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2017||R|0|0|0|0|G|0|DAN|0|0|0|100|XEU|4040|6966|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4040||4040|6966||2 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|5382|8813|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||5382||5382|8813||1 483711|S01ED5114|Latanoprost/Timolol Alvogen|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1574|3571|lyfalmen|V0374|3571|2|2,5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||1574||1574|3571||1 483903|N06DX0109|Marbodin|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.07.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|2486|4827|lyfalmen|V0902|4561|2|28|0|28,0000|LYFIS ehf|STADA Arzneimittel AG|Memantín||2486||2486|4827||2 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|þpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|805|2513|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíð||805||805|2513||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|þpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|GPA|0|0|1|100|XEU|230|1721|lyfalmen|V0055|1688|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||230||230|1721||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995|31.12.2017|R|0|0|0|1|0|1|FER|0|0|0|100|DKK|44451|59292|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||44451||44451|59292||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|4364|7412|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríð||4364||4364|7412||1 484271|L01XE3101|Ofev|hylki|150|mg|60|stk|1|þpakki||L01XE31|01.07.2016||R|0|0|0|1|0|0|BOE|0|0|0|100|DKK|295092|373119|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International GmbH|Nintedanib||295092||295092|373119||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|106940|139110|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||106940||106940|139110||1 484618|A01AD0201|Andolex|munnskol|1,5|mg/ml|300|ml|1|glas|lausn|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|991|2769|lyfalmen|||1|300|0|50,0000|Icepharma hf|Meda AB|Benzýdamín||991||991|2769||2 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|8220|12719|lyfalmen|||1|30|0|15,0000|Icepharma hf|Bayer AG|Rivaoxaban||8220||8220|12719||2 484721|L04AD0201|Advagraf|forðahlk|3|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|40237|53962|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||40237||40237|53962||1 484846|A10AE0601|Tresiba|stl|100|ae/ml|3|ml|5|áfpen|FlexTouch|A10AE06|01.12.2016||R|0|1|0|0|G|0|NAS|0|0|0|100|DKK|7917|12302|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulin degludec||7917||7917|12302||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1134|2966|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1134||1134|2966||2 485067|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.01.2016||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|8325|12863|lyfalmen|V0714|12863|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8325||8325|12863||2 485304|C02KX0501|Adempas|filmhtfl|2|mg|84|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|324443|409623|lyfsjukr|||1|84|0|37,3300|Vistor hf|Bayer AG|Riociguatum||324443||324443|409623||1 485549|R03AK0705|Bufomix Easyhaler|innönddu|329|mcg/sk|60|skammtar|3|innö.t|320+9 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|11557|17312|lyfalmen|||2|180|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||11557||11557|17312||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|64970|85244|lyfsjukr|||1|30|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Dolutegravír||64970||64970|85244||1 486750|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486821|N06BA0404|Methylphenidate Sandoz|forðatfl|18|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|10356|12301|lyfalmen|V0691|12301|2|90|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7916||7916|12301||1 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|436|2005|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||436||436|2005||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|HES|0|0|1|100|DKK|480|2066|lyfalmen|||1|5|0||Vistor hf|Novartis Healthcare A/S|Dexametasón||480||480|2066||1 487105|L01XE2801|Zykadia|hylki|150|mg|150|stk|1|þpakki|3 x 50|L01XE28|01.05.2017||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|662811|830458|lyfsjukr|||1|150|0||Vistor hf|Novartis Europharm Ltd|Ceritinib||662811||662811|830458||1 487361|H02AB0910|Hydrokortison Orion|töflur|10|mg|100|stk|1|þpakki||H02AB09|01.11.2015||R|0|0|0|0|G|0|ARN|0|0|1|100|DKK|2114|4315|lyfalmen|||2|100|0|33,3300|Vistor hf|Orion Corporation|Hýdrókortisón||2114||2114|4315||1 487650|N04BD0204|Rasagiline Mylan|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|21883|23305|lyfalmen|V0711|17234|2|112|0|112,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||15911||15911|23305||2 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|26178|36180|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||26178||26178|36180||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|43932|58635|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||43932||43932|58635||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|23445|30180|lyfalmen|V0453|30180|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíð||21434||21434|30180||2 487827|M01AB0517|Diclomex|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RTH|0|0|1|100|IKR|1033|2231|lyfalmen|V0469|2231|2|100|0|50,0000|Alvogen|ratiopharm GmbH|Díklófenak||600||600|2231||2 487961|QC01CE9001|Vetmedin vet.|tuggutfl|5|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|7267|13957|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||7267||7267|13957||1 488152|G04BE0807|Tadalafil Mylan|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|SEK|3503|5113|lyfalmen|V0924|4598|2|4|0|4,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||2694||2694|5113||2 488255|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|870|2602|lyfalmen|V0575|2389|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín||870||870|2602||2 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|222677|283055|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||222677||222677|283055||1 488730|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|5550|9044|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||5550||5550|9044||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|1|1|0|1|G|0|GRP|0|0|0|100|DKK|8881|13629|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||8881||8881|13629||1 488813|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 489050|N06AX1105|Mirtazapin Bluefish|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BFP|0|0|0|100|IKR|2178|2919|lyfalmen|V0331|2919|2|96|0|96,0000|Vistor hf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2919||1 489081|B01AC2701|Uptravi|filmhtfl|1200|mcg|60|stk|1|pakki||B01AC27|01.01.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|SEK|500336|628385|lyfsjukr|||0|60|1||Distica|Distica - óskráð lyf|Selexipagum||||500336|628385||1 489085|N06BA0407|Metylfenidat Actavis|forðatfl|27|mg|100|stk|1|glas||N06BA04|01.08.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|14153|18713|lyfalmen|V0681|18713|2|100|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||12575||12575|18713||1 489149|G03GA0503|Bemfola|stl|150|ae|0,25|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|5280|8672|lyfalmen|||1|0,25|0|2,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||5280||5280|8672||3 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|71555|93573|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||71555|93573||1 489264|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.09.2017||L|0|0|0|0|0|0|OEL|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón|||||||1 489348|N05AX1209|Aripiprazole Sandoz|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.04.2016||R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|7369|11548|lyfalmen|V0684|4502|2|56|0|56,0000|Artasan ehf|Sandoz GmbH|Aripiprazól||7369||7369|11548||1 490198|N03AX1606|Pregabalin Mylan|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.11.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|5717|4843|lyfalmen|V0688|4635|2|56|0|42,0000|Mylan AB|Generics (UK) Ltd.|Pregabalín||2498||2498|4843||2 490417|G03FB0504|Evorel Sequi|forðapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1678|3715|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1678||1678|3715||1 490425|G03FA0104|Evorel Conti|forðapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|1554|3544|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1554||1554|3544||1 490510|G03CX0103|Tibolon Orifarm|töflur|2,5|mg|84|stk|1|þpakki|3 x 28 stk|G03CX01|01.11.2014||R|0|0|0|0|G|0|IRO|0|0|0|100|XEU|3865|6725|lyfalmen|V0133|6725|2|84|0|84,0000|Artasan ehf|Orifarm Generics A/S|Tíbólón||3865||3865|6725||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|3327|5984|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3327||3327|5984||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|8577|9056|lyfalmen|V0112|2781|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5559||5559|9056||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|10471|12058|lyfalmen|V0113|2781|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7740||7740|12058||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12295|14850|lyfalmen|V0114|2781|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9768||9768|14850||1 491230|J05AP5501|Epclusa|filmhtfl|500|mg|28|stk|1|glas|400 mg + 100 mg|J05AP55|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|2057327|2564846|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvír og Velpatasvír||2057327||2057327|2564846||2 491237|L02BX0301|Zytiga|filmhtfl|500|mg|56|stk|1|þpakki||L02BX03|01.12.2017||R|0|0|0|0|0|1|JCI|0|1|0|100|SEK|305935|386604|lyfsjukr|||1|56|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Abírateron||305935||305935|386604||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|107301|139559|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||107301|139559||1 491593|M05BX0402|XGEVA|stl|120|mg|1,7|ml|1|hgl|lausn|M05BX04|01.01.2018||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|36088|48714|lyfsjukr|||1|1,7|0|618,1818|Vistor hf|Amgen Europe B.V.|Denosúmab||36088||36088|48714||1 491695|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|0|0|GGE|0|0|0|100|SEK|1933|3314|lyfalmen|V0693|3110|2|28|0|28,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||1387||1387|3314||2 491753|C10AC0103|Questran Loc|mixtduft|4|g|50|skpokar|1|pakki||C10AC01|01.12.2014||R|0|0|0|0|0|0|BBB|0|0|0|100|DKK|2976|5501|lyfalmen|||1|50|0|14,2800|Vistor hf|Bristol-Myers Squibb AB|Kólestýramín||||2976|5501||1 492114|J07BB0205|Influvac|stl|||0,5|ml|1|áfspr|með nál|J07BB02|01.08.2017||R|0|0|0|0|0|0|PGB|0|0|0|100|DKK|691|2356|lyfalmen|||1|0,5|0||Icepharma hf|BGP Products ApS|Inflúensa, hreinsaðir mótefnavakar||691||691|2356||2 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|þpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|436310|548754|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd|Bósútíníb||436310||436310|548754||1 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2396|4703|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2396||2396|4703||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|þpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5517|8999|lyfalmen|V0002|5259|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||5517||5517|8999||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492815|C10BA0501|Atozet|filmhtfl|20|mg|90|stk|1|þpakki|10 mg + 10 mg|C10BA05|01.03.2015||R|0|0|0|0|0|0|MLD|0|0|0|100|DKK|13822|20430|lyfalmen|||1|90|0||Vistor hf|Merck Sharp & Dohme Limited|Atorvastin og ezetimibe||13822||13822|20430||1 492917|QD07XB0201|Dermanolon|húðúði|19,47|mg/ml|75|ml|1|úðaílá|1,77+17,7 mg/ml|QD07XB02|01.11.2017||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|2758|5403|vetalmen|||0|75|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Triamcinolon||||2758|5403||2 493113|R02AA0306|Strepsils Jordbær Sukkerfri|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493173|N06BA0902|Atomoxetin Actavis|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10187|8623|lyfalmen|V0813|7494|2|28|0|6,3000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||5244||5244|8623||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|1|0|0|G|0|PAC|0|0|1|100|DKK|22129|31059|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||22129||22129|31059||1 493226|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|14|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|14|0|14,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 493313|G04BD0704|Tolterodin Actavis|forðahlk|2|mg|100|stk|1|þpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1262|3142|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||1262||1262|3142||1 493496|N05AX1303|TREVICTA|stl|175|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|77782|101449|lyfalmen|||1|1|0|70,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||77782||77782|101449||1 493534|L01XC2401|Darzalex|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC24|01.06.2017||R|0|1|0|0|0|1|JCI|0|1|0|100|SEK|57921|76329|lyfsjukr|||1|5|0||Vistor hf|Janssen-Cilag International N.V.|Daratumumab||57921||57921|76329||1 493888|C09CA0107|Losartan Medical Valley|filmhtfl|12,5|mg|98|stk|1|þpakki||C09CA01|01.10.2017||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|1455|2781|lyfalmen|V0213|2781|2|98|0|24,5000|Acare ehf|Medical Valley Invest AB|Lósartan||1000||1000|2781||2 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|948|2710|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||948||948|2710||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2729|5161|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2729||2729|5161||1 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|58782|77418|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||58782||58782|77418||2 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|146956|188879|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||146956||146956|188879||2 494474|J02AC0106|Fungyn|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.10.2017||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1250|2066|lyfalmen|V0551|2066|2|7|0|1,7500|Alvogen|Alvogen|Flúkónazól||480||480|2066||1 494533|G04BE0807|Tadalafil Mylan|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|GEN|0|0|0|100|SEK|7799|9370|lyfalmen|V0145|9195|2|8|0|16,0000|Icepharma hf|Generics UK Ltd|Tadalafíl||5787||5787|9370||2 494559|D10AF0101|Dalacin|húðfl|10|mg/ml|60|ml|1|glas|fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PLS|0|0|0|100|DKK|1793|3873|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1793||1793|3873||1 494578|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|GRP|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól|||||||1 494667|J07BC0203|Vaqta|stl|50|ein|1|ml|1|áfspr||J07BC02|01.02.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3745|6560|lyfalmen|||0|1|1||Distica|Distica - óskráð lyf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||||3745|6560||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|1789|3867|lyfalmen|V0128|2278|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1789||1789|3867||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2601|4985|lyfalmen|V0410|4188|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2601||2601|4985||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2176|4277|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|Magnesíum súlfat||2176||2176|4277||2 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1447|3397|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1447||1447|3397||1 494885|A16AA0402|Procysbi|hylki|75|mg|250|stk|1|glas||A16AA04|01.04.2016||R|0|1|0|1|0|1|RAP|0|0|0|100|XEU|725802|908801|lyfsjukr|||1|250|0|9,3700|Raptor Pharmaceuticals Europe B.V.|Raptor Pharmaceuticals Europe B.V.|Mecaptamín||725802||725802|908801||3 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|NAA|0|0|1|100|DKK|17406|6416|lyfalmen|V0384|4488|1|15|0|7,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||3641||3641|6416||1 495692|N05AX1211|Aripiprazole Mylan Pharma|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|SEK|8158|6908|lyfalmen|V0683|4502|2|56|0|37,3300|Icepharma hf|Pharmathen S.A.|Aripiprazól||3998||3998|6908||2 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|4837|8063|lyfalmen|||1|28|0|28,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||4837||4837|8063||1 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|||lyfalmen|||1|20|0|5,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Zanamivír||||||30.11.2017|1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|27510|37865|lyfalmen|||3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||27510||27510|37865||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3625|7048|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3625||3625|7048||2 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|414|1975|lyfalmen|||2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||414||414|1975||1 496935|N02AG0201|Ketogan|eþ-stíll|||10|stk|1|pakki|10 + 50 mg|N02AG02|01.07.1994||R|0|0|1|0|G|0|PLS|0|0|0|100|DKK|371|1916|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||371||371|1916||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|670|2327|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||670||670|2327||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|156153|98487|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||75440||75440|98487||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|þpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|196032|249916|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||196032||196032|249916||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|2557|4924|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||2557||2557|4924||1 497286|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1153|2320|lyfalmen|V0056|2320|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2320||1 497290|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.01.2016||R|1|0|0|0|0|0|GRP|0|0|0|100|NOK|5210|4057|lyfalmen|||1|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||1927||1927|4057||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|491|2081|lyfalmen|V0448|2081|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||491||491|2081||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|979|2752|lyfalmen|V0449|2752|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Enalapríl||979||979|2752||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|998|2779|lyfalmen|||2|5|0|16,6667|Alvogen|Alvogen|Dorzólamíð||998||998|2779||1 498051|A10BX0204|Repaglinide Krka|töflur|2|mg|120|stk|1|þpakki||A10BX02|01.11.2014||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2300|4571|lyfalmen|V0472|4571|2|120|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2300||2300|4571||2 498481|N05AX1210|Aripiprazol Medical Valley|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2016||R|1|1|0|0|G|0|VAL|0|0|0|100|IKR|12534|4502|lyfalmen|V0683|4502|2|56|0|37,3300|Acare ehf|Medical Valley Invest AB|Aripiprazól||2250||2250|4502||2 498552|QN01AX9401|AQUI-S vet.|baðþ|540|g/líter|1000|ml|1|glas||QN01AX94|01.06.2016||R|0|0|0|0|0|0|SAS|0|0|0|100|NOK|61563|99240|veteldis|||0|1000|0||Vistor hf|Scan Aqua AS|Isoeugenol||61563||61563|99240||1 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13443|19908|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||13443||13443|19908|28.02.2018|1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|13114|19455|lyfalmen|V0609|11030|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||13114||13114|19455||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|15334|22511|lyfalmen|V0610|11314|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||15334||15334|22511||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|19791|28645|lyfalmen|V0718|16431|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||19791||19791|28645||1 499070|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013|28.02.2018|R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|837|2557|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníð||837||837|2557||1 499079|N02AB0101|Ketogan Novum|stl|5|mg/ml|1|ml|5|hgl||N02AB01|01.12.2015||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|754|2443|lyfalmen|||0|5|1||Distica|Distica - óskráð lyf|Ketómebídón||||754|2443||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|7672|11965|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AG|Rivaoxaban||||7672|11965||2 499436|R03AK1101|Flutiform|innúðal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|MUP|0|0|0|100|DKK|4969|8244|lyfalmen|||1|120|0|30,0000|Icepharma hf|Mundipharma A/S|Formóteról og flútikasón||4969||4969|8244||2 499462|M05BA0606|Ibandronic acid WH|irþ|2|mg|2|ml|1|hgl|lausn|M05BA06|01.03.2018||R|0|1|0|1|0|1|WEH|0|0|0|100|IKR|7722|11360|lyfsjukr|||2|2|0|0,3333|Williams & Halls efh|Williams & Halls ehf|Íbandrónsýra||7233||7233|11360||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|þpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LUN|0|0|0|100|DKK|9032|13837|lyfalmen|||1|28|0|56,0000|Vistor hf|H. Lundbeck A/S|Vortioxetín||9032||9032|13837||1 500041|G03DA0203|Provera|töflur|5|mg|40|stk|1|þpakki||G03DA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|874|2608|lyfalmen|||0|40|1|40,0000|Distica|Distica - óskráð lyf|Medroxýprógesterón||||874|2608||1 500402|C07AB0214|Bloxazoc|forðatfl|25|mg|100|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|900|2079|lyfalmen|V0050|2079|2|100|0|15,8300|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||490||490|2079||2 500481|J05AR1701|Descovy|filmhtfl|210|mg|30|stk|1|glas|200+10 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|58212|76697|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|emtricitabine og tenofovir alafenamide||58212||58212|76697||2 500512|D07AC0401|Synalar|hlaup|0,25|mg/g|30|g|1|túpa||D07AC04|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|951|2714|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Flúócínólón||951||951|2714||2 500997|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|pakki||N07CA01|01.09.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|3582|6335|lyfalmen|||0|84|1||Parlogis hf|Parlogis - óskráð lyf|Betahistín||||3582|6335||2 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|þpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|4087|4189|lyfalmen|||2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||2023||2023|4189||2 501278|G04BD1201|Betmiga|forðatfl|25|mg|30|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|4688|7857|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||4688||4688|7857||1 501364|N06BA0403|Ritalin Uno|hylki|60|mg|30|stk|1|glas||N06BA04|01.11.2015||R|1|1|1|0|0|0|HES|0|0|0|100|DKK|11551|17304|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||11551||11551|17304||1 501660|B01AF0101|Xarelto|filmhtfl|2,5|mg|168|stk|1|þpakki||B01AF01|01.04.2015||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|22360|31351|lyfalmen|||1|168|0|21,0000|Icepharma hf|Bayer AG|Rivaoxaban||22360||22360|31351||2 501735|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2250|4502|lyfalmen|V0434|4129|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2250||2250|4502||2 502349|G04BE0313|Sildenafil Medical Valley|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.03.2018||R|1|0|0|0|0|0|VAL|0|0|0|100|IKR|2900|3470|lyfalmen|V0143|3317|2|12|0|12,0000|Acare ehf|Medical Valley Invest AB|Síldenafíl||1500||1500|3470||2 502647|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|30|stk|1|þpakki|með br. losunarhraða|G04CA02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|1774|3847|lyfalmen|V0926|3847|2|30|0|30,0000|Medical ehf|Medical ehf|Tamsúlósín||1774||1774|3847||2 502888|N07BC0202|Metadon Abcur|töflur|10|mg|100|stk|1|þpakki||N07BC02|01.03.2016||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|3578|6330|lyfalmen|||1|100|0|40,0000|Icepharma hf|Abcur AB|Metadón||3578||3578|6330||2 502904|A10BK0101|Forxiga|filmhtfl|10|mg|28|stk|1|þpakki||A10BK01|01.11.2015||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|4862|8097|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozin||4862||4862|8097||1 502956|A11DA0101|Tiacur|stl|25|mg/ml|2|ml|5|lykjur||A11DA01|01.09.2015||R|0|0|0|0|0|0|ABC|0|0|0|100|SEK|11436|17145|lyfalmen|||1|10|0|5,0000|Icepharma hf|Abcur AB|Thiamine (vit B1)||||11436|17145||2 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|16581|24227|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||16581||16581|24227||1 503266|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17653|25703|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17653||17653|25703||1 503406|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.12.2015||R|0|0|0|0|G|0|ZEN|0|0|0|100|SEK|4166|7139|lyfalmen|||1|60|0|30,0000|Vistor hf|AstraZeneca AB|Aclídínumbrómíð||4166||4166|7139||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6070|9760|lyfalmen|||3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||6070||6070|9760||2 503645|A06AH0101|Relistor|stl|12|mg|0,6|ml|1|hgl||A06AH01|01.10.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|5522|9005|lyfalmen|||0|0,6|1||Distica|Distica - óskráð lyf|Metýlnaltrexónbrómíð||||5522|9005||1 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SPP|0|0|0|100|XEU|3404|6090|lyfsjukr|||1|250|0||Williams & Halls efh|Sanquin Plasma Product|Albúmín||3404||3404|6090||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|1309|2267|lyfalmen|V0494|2093|2|90|0|180,0000|Actavis Group hf|Actavis hf|Glímepíríð||626||626|2267||1 504120|R03AL0301|ANORO|innönddu|77|mcg/sk|30|skammtar|1|innö.t|55+22 mcg|R03AL03|01.11.2014||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|5671|9210|lyfalmen|||1|30|0||Vistor hf|Glaxo Group Limited|Vilanterol og umeclidinium bromide||5671||5671|9210||1 504169|G04BE0302|Revatio|mixtduft|10|mg/ml|112|ml|1|glas||G04BE03|01.04.2016||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|30058|41088|lyfsjukr|||1|112|0|22,4000|Icepharma hf|Pfizer Limited|Síldenafíl||30058||30058|41088||1 504502|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.09.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|480|2066|lyfalmen|V0914|2066|1|30|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||480||480|2066||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|þpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|919|2670|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||919||919|2670||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|þpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|11091|21212|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||11091||11091|21212||1 505095|N06AX1613|Venlafaxin Medical Valley|forðatfl|150|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|3100|3057|lyfalmen|V0335|2741|2|100|0|150,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1200||1200|3057||2 505647|N07BA0147|Nicorette QuickMist|munnhúði|1|mg/sk|300|skammtar|1|fl|2 x 150 úðaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|1429|3372|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1429||1429|3372||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|2855|5335|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||2855||2855|5335||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PLS|0|0|0|100|DKK|6514|10371|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||6514||6514|10371||1 506036|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17653|25703|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17653||17653|25703||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|þpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2027|4195|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2027||2027|4195||2 506431|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|3961|5496|lyfalmen|V0145|4598|2|4|0|8,0000|Artasan ehf|Sandoz A/S|Tadalafíl||2972||2972|5496||1 506756|M01AH0504|Etoricoxib Krka|filmhtfl|90|mg|100|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|12000|7874|lyfalmen|V0831|7874|2|100|0|150,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||4700||4700|7874||2 506809|N05AX1207|Lemilvo|töflur|5|mg|100|stk|1|glas||N05AX12|01.03.2016||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|8699|10367|lyfalmen|V0682|8039|2|100|0|33,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||6511||6511|10367||1 506963|C01EB2101|Rapiscan|stl|400|mcg|5|ml|1|hgl||C01EB21|01.01.2018||R|0|0|0|1|0|1|RAS|0|0|0|100|NOK|6461|10298|lyfsjukr|||1|5|0||Icepharma hf|Rapidscan Pharma Solutions EU Ltd.|Regadenoson||6461||6461|10298||2 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1952|4092|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||1952||1952|4092||1 507269|J01MA1401|Avelox|töflur|400|mg|7|stk|1|pakki||J01MA14|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|DKK|6554|10426|lyfalmen|||0|7|1||Parlogis hf|Parlogis - óskráð lyf|moxifloxacin||||6554|10426||2 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|102259|133289|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||102259||102259|133289||1 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.12.2013||R|1|0|0|0|G|0|RHA|0|0|0|100|IKR|3105|5679|lyfalmen|||2|100|0|66,6700|Alvogen|ratiopharm Oy|Betahistín||3105||3105|5679||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1546|3533|lyfalmen|V0092|3533|2|100|0|66,6600|Vistor hf|Orion Corporation|Spírónólaktón||1546||1546|3533||1 507916|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.08.2015||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|742|2426|lyfalmen|||1|5|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||742||742|2426||1 508350|N03AX1603|Pregabalin Krka|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.03.2015||R|1|0|0|0|0|0|KNM|0|0|0|100|XEU|5729|3329|lyfalmen|V0687|3099|2|56|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Pregabalín||1398||1398|3329||2 508589|J02AC0102|Candizol|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.02.2015||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|612|2125|lyfalmen|V0555|2125|2|2|0|1,5000|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||523||523|2125||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4047|7848|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4047|7848||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3646|7088|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||3646||3646|7088||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10803|20666|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||10803||10803|20666||2 508921|L01CD0401|Jevtana|irþ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SGB|0|1|0|100|XEU|469305|589791|lyfsjukr|||1|1|0||Vistor hf|Sanofi-aventis groupe|Cabazitaxel||469305||469305|589791||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|7561|11812|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||7561||7561|11812||1 509127|QG02CB0301|Finilac|mixtúra|50|mcg/ml|15|ml|1|glas||QG02CB03|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5425|10463|vetalmen|||0|15|0||Dýraheilsa ehf|Le Vet B.V.|Kabergólín||||5425|10463|31.01.2018|2 509359|N06AX1611|Duofaxin|forðatfl|75|mg|28|stk|1|þpakki||N06AX16|01.07.2015||R|1|0|0|0|0|0|MEV|0|0|0|100|DKK|873|2476|lyfalmen|V0336|2476|2|28|0|21,0000|Vistor hf|MediLink A/S|Venlafaxín||778||778|2476||1 509486|R06AA0401|Tavegyl|stl|2|ml|5|lykjur|1|pakki||R06AA04|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|1426|3368|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Klemastín||||1426|3368||2 509496|S01XA1202|Bepanthen|augnsm|50|mg/g|5|g|1|túpa||S01XA12|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|510|2107|lyfalmen|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Dexpantenól||||510|2107||2 509504|QJ51CR0201|Clavubactin vet.|töflur|312,5|mg|100|stk|1|þpakki|250 mg+ 62,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|5785|11146|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||5785||5785|11146||2 509577|G03HB0102|Diane mite|töflur|||63|stk|1|þpakki||G03HB01|01.06.2013||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|1743|3804|lyfalmen|V0134|3112|1|63|0|84,0000|Icepharma hf|Bayer AB|Cýpróterón og östrógen||1743||1743|3804||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VIH|0|0|0|100|DKK|35816|48370|lyfsjukr|||1|60|0|30,0000|Vistor hf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||35816||35816|48370||1 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|68160|89279|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||68160|89279||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|13179|19544|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||13179||13179|19544||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|19728|28559|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||19728||19728|28559||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|32359|43998|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||32359||32359|43998||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|50014|66328|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||50014||50014|66328||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|381|1929|lyfalmen|V0601|1778|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíð||381||381|1929||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|130703|168665|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||130703|168665||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3299|4485|lyfalmen|V0445|4485|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Fínasteríð||2238||2238|4485||1 510982|H03AA0201|Liothyronin|töflur|20|mcg|100|stk|1|glas||H03AA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|3097|5668|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|liothyronine sodium||3097||3097|5668||1 511263|N02AJ0602|Parkodin forte|filmhtfl|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AJ06|01.12.2017||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|627|2268|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||627||627|2268||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2132|4339|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2132||2132|4339||1 511506|L01DB0106|Doxorubicin medac|irþ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.08.2017||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|2093|4286|lyfsjukr|||2|25|0||Williams & Halls efh|medac Gesellschaft|Doxórúbicín||||2093|4286||2 511688|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|þpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|12859|19104|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) með prógestógen||12859||12859|19104||2 512608|B05XA3101|Peditrace|irþ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4162|7133|lyfsjukr|||1|100|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar í blöndum með öðrum efnum||4162||4162|7133||1 512918|M01AH0504|Etoricoxib Krka|filmhtfl|120|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|3400|4433|lyfalmen|V0827|4433|2|30|0|60,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||2200||2200|4433||2 513133|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1826|2320|lyfalmen|V0057|2320|2|100|0|200,0000|Vistor hf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|2320||1 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|þpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|836|2123|lyfalmen|V0109|2123|2|100|0|66,6700|Vistor hf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|2123||1 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|MAR|0|0|1|100|IKR|||lyflausa|||0|35|0||Icepharma hf|Aspen Pharma|Lídókaín|||||||2 513312|A02BC0510|Eradizol|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.06.2017||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|28|0|18,6600|Alvogen|Alvogen|Esómeprazól|||||||1 513391|QJ51CR0201|Clavubactin vet.|töflur|62,5|mg|100|stk|1|þpakki|50 mg + 12,5 mg|QJ51CR02|01.03.2015||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2789|5462|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet B.V.|Amoxillinum og ensim hemill||2789||2789|5462||2 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|þpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|NVO|0|0|0|100|DKK|21899|30768|lyfalmen|||1|60|0|15,0000|Vistor hf|N.V. Organon|Asenapíne||21899||21899|30768||1 513494|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|þpakki||QM01AH92|01.11.2014||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2131|4188|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2131||2131|4188||2 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1677|3296|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og beta-laktamasa hemill||1677||1677|3296||2 514090|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.06.2015||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|4158|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|4158||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1304|3200|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1304||1304|3200||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|þpakki|hart|N06BA09|01.07.2013||R|1|1|0|0|0|0|DAN|0|0|0|100|XEU|14462|21310|lyfalmen|V0818|18325|1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||14462|21310||2 514870|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|30|stk|1|þpakki||N06AX21|01.05.2015||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2131|2437|lyfalmen|V0692|2437|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||750||750|2437||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PLS|0|0|0|100|IKR|3507|4668|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4668||1 515094|QR06AB0401|Histodine|stl|10|mg/ml|100|ml|1|hgl|lausn|QR06AB04|01.03.2018||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|2756|5399|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|Chlorphenamine maleate||||2756|5399||0 515399|G03GA0503|Bemfola|stl|300|ae|0,5|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|10627|16032|lyfalmen|||1|0,5|0|4,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||10627||10627|16032||3 516182|L01BC5901|Lonsurf|filmhtfl|28,19|mg|20|stk|1|þpakki|20 mg + 8,19 mg|L01BC59|01.09.2016||R|0|0|0|1|0|1|LLS|0|1|0|100|DKK|117082|151724|lyfsjukr|||1|20|0||Icepharma hf|Les Laboratoires Servier|Trifluridine í samsetningum||||117082|151724||2 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|4256|6451|lyfsjukr|||1|10|0|1,0000|Alvogen|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||3666||3666|6451||1 516630|D06BX0201|Picato|hlaup|500|mcg/g|0,47|g|2|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|15104|22194|lyfalmen|||1|0,94|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||15104|22194||1 516972|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|30|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|7836|8975|lyfalmen|V0384|8975|2|30|0|15,0000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||5500||5500|8975||1 517693|N05AH0413|Quetiapin ratiopharm|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.05.2015||R|1|1|0|0|G|0|TAB|0|0|0|100|IKR|18600|9087|lyfalmen|V0273|8793|2|100|0|50,0000|Alvogen|Teva Pharma B.V.|Quetíapín||5581||5581|9087||2 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2340|4626|lyfalmen|V0462|3592|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2340||2340|4626||1 517728|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.01.2015||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|26030|35993|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíð||26030||26030|35993||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2547|4911|lyfalmen|V0471|3653|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2547||2547|4911||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2739|5175|lyfalmen|V0472|3428|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníð||2739||2739|5175||1 517824|C01CA0302|Noradrenalin Abcur|irþ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|25600|35449|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||25600||25600|35449||2 517914|QI09AL0001|Suvaxyn Circo+MH RTU|stl|||100|ml|1|hgl|fleyti|QI09AL|01.01.2017||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8149|14046|vetorma|||0|100|0||Icepharma hf|Zoetis Belgium S.A.|Mycoplasma hyopneumoniae, Recombinat Porcine Circovirus||8149||8149|14046||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|þpakki||R06AX22|01.06.2012|31.12.2017|L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518224|N04BD0202|Rasagilin Krka|töflur|1|mg|112|stk|1|þpakki||N04BD02|01.01.2016||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23524|17234|lyfalmen|V0711|17234|2|112|0|112,0000|LYFIS ehf|Krka d.d. Novo mesto|Rasagilín||11500||11500|17234||2 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|885|2623|lyfalmen|||1|20|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||885||885|2623||1 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki|með breyttan losunarhraða|M01AB05|01.11.2000||R|1|0|0|0|G|0|GRP|0|0|1|100|DKK|3654|6434|lyfalmen|||1|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díklófenak||3654||3654|6434||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|MBV|0|0|0|100|DKK|1651|3677|lyfalmen|V0590|2722|1|84|0|84,0000|Vistor hf|Merck Sharp & Dohme B.V.|Desógestrel||1651||1651|3677||1 518341|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 518750|A02BC0508|Esomeprazol Actavis|sþ-tfl|20|mg|28|stk|1|þpakki||A02BC05|01.01.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|1003|2785|lyfalmen|V0004|2785|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1003||1003|2785||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|þpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|15253|22399|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||15253||15253|22399||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|MEA|0|0|1|100|DKK|795|2499|lyfalmen|||1|125|0|3,1250|Icepharma hf|Meda AB|Fenoxýmetýlpenicillín||795||795|2499||2 519061|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|G|0|BAB|0|0|1|100|IKR|||lyfalmen|V0362|1863|1|100|0|100,0000|Icepharma hf|Bayer AB|Lóratadín|||||8646||2 519070|M01AE0116|Ibuprofen Bril|filmhtfl|600|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|792|2121|lyfalmen|V0564|2061|2|100|0|50,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||520||520|2121||2 519112|QJ01EW1002|Equibactin vet.|pasta|400|mg|45|g|1|áfspr|333,3 + 66,7 mg|QJ01EW10|01.03.2016||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|2463|4841|vetalmen|||0|45|0||Dýraheilsa ehf|Le Vet B.V.|||||2463|4841||2 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3164|5760|lyfalmen|||2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíð||3164||3164|5760||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|AEP|0|0|1|100|DKK|1190|3043|lyfalmen|||1|100|0|2,5000|Icepharma hf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1190||1190|3043||2 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|5750|9319|lyfalmen|V0209|9319|2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||5750||5750|9319||1 520029|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|4526|3961|lyfalmen|V0515|3929|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||1857||1857|3961||1 520104|C07BB0701|Bisbetol Plus|filmhtfl|17,5|mg|100|stk|1|þpakki|5+12,5 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|2136|4345|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||2136||2136|4345||2 520160|J01XA0108|Vancomycin Actavis|st/irþ|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.03.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|712|1843|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||318||318|1843||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|18606|27014|lyfalmen|||1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||18606|27014||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|14189|20935|lyfalmen|V0143|3317|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14189||14189|20935||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|4617|7760|lyfalmen|V0144|1267|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4617||4617|7760||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PLS|0|0|0|100|DKK|12775|18988|lyfalmen|V0144|3800|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||12775||12775|18988||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|1225|2368|lyfalmen|V0056|2320|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||700||700|2368||1 520546|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2016||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|9731|14799|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||9731||9731|14799||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|GPA|0|0|0|100|IKR|2163|2368|lyfalmen|V0057|2320|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Amlódipín||700||700|2368||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|þpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|SEK|258|1760|lyfalmen|||1|30|0|7,5000|Icepharma hf|Meda AB|Orfenadrín í blöndum||258||258|1760||2 520903|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.2016||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.12.2015||R|0|0|0|1|0|1|PCO|0|0|0|100|IKR|12998|19295|lyfsjukr|||0|100|1||Distica|Distica - óskráð lyf|Hýdroxýkarbamíð||||12998|19295||1 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|7663|14709|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|Prókaínpenicillín í blöndum með öðrum sýklalyfjum||7663||7663|14709||1 522327|N03AX1604|Brieka|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.10.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|7281|4818|lyfalmen|V0688|4635|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Pregabalín||2480||2480|4818||1 522427|L03AB1301|Plegridy|stl|125|mcg|2|áf-penni|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|97002|125758|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||97002||97002|125758||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|138096|177860|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||138096||138096|177860||1 523043|N02AJ0602|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AJ06|01.11.1998||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|982|2757|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||982||982|2757||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|4031|3683|lyfalmen|V0285|3470|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1655||1655|3683||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|plglas||S01XA20|01.05.1998||L|0|0|0|0|G|0|HEG|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1823||1 523350|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+áfyllt sprauta, með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|151223|194186|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||151223||151223|194186||1 523355|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.09.2017||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1352|2518|lyfalmen|V0144|1267|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||809||809|2518||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|þpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|260147|329657|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||260147||260147|329657||1 523773|QD06AA0201|Animed vet.|húðúði|2,45|% w/w|211|ml|1|úðaílá||QD06AA02|01.06.2016||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1098|2158|vetalmen|||0|211|0||Dýraheilsa ehf|aniMedica GmbH|Chlortetracycline||1098||1098|2158||2 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNP|0|0|1|100|XEU|1235|3105|lyfalmen|V0903|2759|1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1235||1235|3105||1 523967|N02AA0506|Oxikodon Depot Actavis|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|GRP|0|0|0|100|XEU|1254|3131|lyfalmen|V0584|3131|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1254||1254|3131||1 523977|N03AF0104|Tegretol|eþ-stíll|250|mg|5|stk|1|pakki||N03AF01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1898|4017|lyfalmen|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Karbamazepín||||1898|4017||2 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|294|1810|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||294||294|1810||1 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1733|3790|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1733||1733|3790||1 524257|L02BB0401|Xtandi|hylki|40|mg|112|stk|1|þpakki||L02BB04|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|386789|487164|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||386789||386789|487164||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|þpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7643|6408|lyfalmen|V0010|3882|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6408||1 524351|L01XX2401|Oncaspar|stl/irl|750|ein/ml|5|ml|1|hgl||L01XX24|01.10.2016||R|0|0|0|1|0|1|ALT|0|0|0|100|SEK|186944|238613|lyfsjukr|||1|5|0||Lyfjaver ehf|Baxalta Innovations GmbH|Pegaspargase||186944||186944|238613||3 524367|N06AB0313|Fluoxetin WH|hylki|20|mg|98|stk|1|þpakki|Hart|N06AB03|01.07.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1122|2949|lyfalmen|V0039|2549|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Flúoxetín||1122||1122|2949||2 524678|B01AC0902|Flolan|sts|0,5|mg|1|hgl|1|pakki||B01AC09|01.03.2016||R|0|0|0|0|0|1|LVE|0|0|0|100|NOK|20523|29028|lyfsjukr|||0|1|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Epoprostenol||||20523|29028|31.01.2018|3 524937|N05AX1209|Aripiprazole Sandoz|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.04.2016|28.02.2018|R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|15158|22268|lyfalmen|||2|56|0|37,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||15158||15158|22268||1 524981|D11AX2101|Mirvaso|hlaup|3|mg/g|30|g|1|túpa||D11AX21|01.03.2016||R|0|0|0|0|0|0|GAL|0|0|0|100|XEU|6015|9684|lyfalmen|||1|30|0||Icepharma hf|Galderma International|Brimonidine||6015||6015|9684||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|þpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|555|2169|lyfalmen|||1|100|0|25,0000|Icepharma hf|Meda AB|Orfenadrín í blöndum||555||555|2169||2 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993|31.12.2017|R|1|0|0|0|G|0|TCA|0|0|1|100|XEU|3859|6716|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||3859||3859|6716||1 525219|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|11157|21338|vetalmen|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||11157||11157|21338||2 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|27179|37446|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer AG|Rivaoxaban||||27179|37446||2 525857|B05XA0103|Kaliumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|4291|7311|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Kalíumklóríð||4291||4291|7311||1 525865|B05XA0303|Natriumklorid B.Braun|irþ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|3907|6783|lyfsjukr|||2|1000|0||Actavis Group hf|B.Braun Melsungen AG|Natríumklóríð||3907||3907|6783||1 525945|J01MA0205|Ciprofloxacin Villerton|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.02.2016||R|0|0|0|0|0|1|VIN|0|0|0|100|DKK|2043|4217|lyfsjukr|||2|1000|0|4,0000|Icepharma hf|Villerton Invest SA|Cíprófloxacín||||2043|4217||2 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4770||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|RAU|0|0|0|100|IKR|||lyfalmen|||0|1000|0||Actavis Group hf|B.Braun Melsungen AG|Leysi- og þynningarvökvar, þ.m.t. skolvökvar|||||4832||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3225|5844|lyfalmen|V0435|5844|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3225||3225|5844||2 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|4921|8178|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4921||4921|8178||1 526521|C03DA0404|Kalspar|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2015||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|12124|8364|lyfalmen|V0111|8287|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Eplerenón||5056||5056|8364||2 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|1|0|0|G|0|DEA|0|0|0|100|XEU|3119|5698|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3119||3119|5698||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|þpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|GRP|0|0|1|100|IKR|||lyfalmen|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||1961||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNP|0|0|0|100|XEU|9947|15096|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||9947||9947|15096||1 527453|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|glas||N03AX14|01.04.2015||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|12326|5703|lyfalmen|V0516|5697|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3123||3123|5703||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1171|3017|lyfalmen|||1|5|0||Vistor hf|Novartis Europharm Ltd|Emedastín||1171||1171|3017||1 527685|M01AH0503|Coxerit|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3000|3024|lyfalmen|V0825|2789|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1176||1176|3024||2 527714|N05AX1303|TREVICTA|stl|525|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.11.2016||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|209862|267117|lyfalmen|||1|1|0|210,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||209862||209862|267117||1 527914|QS02CA0103|Saniotic vet.|eyrnadr|||20|ml|1|glas|fyrir hundi og ketti|QS02CA01|01.08.2015||R|0|0|0|0|0|0|RPG|0|0|0|100|XEU|1444|2838|vetalmen|||0|20|0||Icepharma hf|Richter Pharma AG|||1444||1444|2838||2 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|794|2177|lyfalmen|V0046|2177|2|100|0|33,3333|Vistor hf|Orion Corporation|Spírónólaktón||561||561|2177||1 528214|N04BC0505|Oprymea|forðatfl|0,52|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|8816|13539|lyfalmen|V0635|13539|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||8816||8816|13539||2 528241|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.12.2016||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2755||1 528267|A02BC0501|Nexium|sþ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8584|5789|lyfalmen|V0011|4773|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3185||3185|5789||1 528311|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|100|stk|1|þpakki||M01AE01|01.11.2016||R|1|0|0|0|G|0|BLL|0|0|1|100|IKR|590|1954|lyfalmen|V0562|1869|2|100|0|33,3300|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen||399||399|1954||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|1694|3737|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||1694||1694|3737||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|innö.t|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|NOK|4864|8100|lyfalmen|V0356|7084|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||4864||4864|8100||3 528584|A07EC0202|Pentasa|forðatfl|1|g|60|stk|1|þpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|5441|8894|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lægemidler A/S|Mesalazín (5-amínósalicýlsýra)||5441||5441|8894||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|þpakki||N02CC04|01.02.2018||R|0|0|0|0|G|0|RTH|0|0|0|100|XEU|3700|4842|lyfalmen|V0621|4842|2|18|0|18,0000|Alvogen|ratiopharm GmbH|Rizatriptan||2497||2497|4842|| 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PLS|0|0|0|100|DKK|54273|71715|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||54273||54273|71715||1 529787|L01XC1801|KEYTRUDA|irþ|50|mg|1|hgl|1|pakki||L01XC18|01.10.2015||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|224736|285616|lyfsjukr|||1|1|0||Vistor hf|Merck Sharp & Dohme Limited|Pembrolizumab||224736||224736|285616||1 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|10352|lyfalmen|||2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|10352||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530172|J05AP0901|Exviera|filmhtfl|250|mg|56|stk|1|þpakki||J05AP09|01.10.2015||R|1|0|0|1|0|1|ABV|0|1|0|100|DKK|135703|174884|lyfsjukr|||1|56|0|28,0000|Vistor hf|AbbVie Ltd.|Dasabuvir||135703||135703|174884||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|5485|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6075||1 530255|M01AH0504|Etoricoxib Krka|filmhtfl|30|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2488|3057|lyfalmen|V0824|3057|2|30|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1200||1200|3057||2 530322|B01AC0602|Hjarta-Aspirín|sþ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1290|2535|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1290||1290|2535||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2260|4516|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2260||2260|4516||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|5032|8331|lyfsjukr|||1|10000|0||Vistor hf|Fresenius Kabi AB|Kolvetni||5032||5032|8331||1 531611|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.04.2015||R|0|0|0|0|0|1|STI|0|0|0|100|NOK|3563|6309|lyfsjukr|||1|5|0|3,3333|Lyfjaver ehf|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||3563||3563|6309||3 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|533|2139|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||533||533|2139||1 532707|N04BD0203|Rasagilin WH|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.05.2016||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|36667|16115|lyfalmen|V0711|15388|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Rasagilín||10687||10687|16115||2 532821|L01XX3203|Bortezomib W&H|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.02.2016||R|0|1|0|1|0|1|WEH|0|1|0|100|XEU|93179|120923|lyfsjukr|||2|1|0||Williams & Halls efh|Williams & Halls ehf|Bortezomíb||93179||93179|120923||2 532881|C07BB0701|Bisbetol Plus|filmhtfl|35|mg|100|stk|1|þpakki|10+25 mg|C07BB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|3843|6694|lyfalmen|||2|100|0||Williams & Halls efh|Williams & Halls ehf|Bisoprolol og Thiazides||3843||3843|6694||2 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1639|3661|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||1639||1639|3661||2 533048|N06BA0407|Metylfenidat Actavis|forðatfl|54|mg|100|stk|1|glas||N06BA04|01.07.2017||R|1|1|1|0|0|0|GPA|0|0|0|100|XEU|16008|14962|lyfalmen|V0622|14962|2|100|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Metýlfenídat||9850||9850|14962||1 533147|B02BD0208|Afstyla|sts|3000|ae|1|hgl|1|pakki|leysir, lausn|B02BD02|01.03.2018||R|0|0|0|1|0|1|CSB|0|1|0|100|SEK|209159|266242|lyfsjukr|||1|1|0||Icepharma hf|CSL Behring GmbH|Storkuþáttur VIII||209159||209159|266242||2 533489|A03AB0201|Robinul|stl|0,2|mg/ml|10|lykjur|1|pakki||A03AB02|01.03.2018||R|0|0|0|0|0|1|LDR|0|0|0|100|DKK|2498|4843|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|glycopyrronium||2498||2498|4843||2 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986|28.02.2018|R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1437|3383|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1437||1437|3383||1 533779|A02BC0111|Omeprazol Pensa|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534024|N04BD0101|Eldepryl|töflur|5|mg|100|stk|1|glas||N04BD01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|3889|6758|lyfalmen|||0|100|1|100,0000|Distica|Distica - óskráð lyf|Selegilín||||3889|6758||1 534141|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|100|stk|1|glas||A02BC01|01.10.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2216|2060|lyfalmen|V0006|1955|2|100|0|100,0000|Artasan ehf|Sandoz A/S|Ómeprazól||476||476|2060||1 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|17903|26047|lyfalmen|||1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||17903||17903|26047||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|þpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|PHH|0|0|0|100|DKK|46454|61825|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||46454||46454|61825||1 534497|QJ01CA0402|Vetrimoxin L.A.|stl|150|mg/ml|100|ml|1|hgl||QJ01CA04|01.11.2014||R|0|0|0|0|0|0|CES|0|0|0|100|XEU|2376|4670|vetalmen|||0|100|0||Icepharma hf|Ceva Sante Animale|||2376||2376|4670||2 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7576|5534|lyfalmen|V0117|5534|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3000||3000|5534||2 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|4395|7454|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||4395||4395|7454||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1777|3851|lyfalmen|V0092|3533|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1777||1777|3851||1 535685|M01AH0503|Coxerit|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|3200|3024|lyfalmen|V0826|2853|2|28|0|42,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||1176||1176|3024||2 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 535777|N06AX2108|Aritavi|sþ-hylki|30|mg|28|stk|1|glas||N06AX21|01.12.2015||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|1343|2360|lyfalmen|V0692|2275|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Duloxetín||694||694|2360||1 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|317|1841|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||317||317|1841||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|331|1861|lyfalmen|||1|10|0|25,0000|Vistor hf|Novartis Healthcare A/S|Pílókarpín||331||331|1861||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|23622|32947|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||23622||23622|32947||1 536384|N03AX1609|Pregabalin Sandoz GmbH|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.02.2016||R|1|0|0|0|0|0|SDG|0|0|0|100|DKK|5371|6352|lyfalmen|V0687|3099|2|56|0|28,0000|Artasan ehf|Sandoz GmbH (Kundl)|Pregabalín||3594||3594|6352||1 536460|N05AX1302|Xeplion|stl|150|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|76869|100294|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||76869||76869|100294||1 536682|J02AC0106|Fungyn|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.01.2018||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12324|lyfalmen|V0419|12230|2|28|0|28,0000|Alvogen|Alvogen|Flúkónazól||7933||7933|12324||1 536712|N05AX1209|Aripiprazole Sandoz|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.04.2016|28.02.2018|R|1|1|0|0|G|0|HSS|0|0|0|100|DKK|2658|5063|lyfalmen|||2|28|0|9,3300|Artasan ehf|Sandoz GmbH|Aripiprazól||2658||2658|5063||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2198|4430|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||2198||2198|4430||2 536875|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.07.2016||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|6993|11030|lyfalmen|V0609|11030|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||6993||6993|11030||1 536963|D06BX0201|Picato|hlaup|150|mcg/g|0,47|g|3|túpur||D06BX02|01.02.2016||R|0|0|0|0|G|0|LBB|0|0|1|100|DKK|14939|21967|lyfalmen|||1|1,41|0||Vistor hf|LEO Laboratories Ltd.|Ingenol mebutate||||14939|21967||1 537029|N06BA0404|Methylphenidate Sandoz|forðatfl|36|mg|90|stk|1|glas||N06BA04|01.11.2016||R|1|1|1|0|0|0|SHS|0|0|0|100|DKK|13611|11410|lyfalmen|V0624|11276|2|90|0|108,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7269||7269|11410||1 537111|J05AR1701|Descovy|filmhtfl|225|mg|30|stk|1|glas|200+25 mg|J05AR17|01.10.2016||R|0|0|0|1|0|1|GIL|0|0|0|100|DKK|58212|76697|lyfsjukr|||1|30|0||Gilead Sience Sweden AB|Gilead Science International Limited|emtricitabine og tenofovir alafenamide||58212||58212|76697||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúðir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|4902|8152|lyfsjukr|||1|7500|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||4902||4902|8152||1 537600|C07AG0207|Carvedilol STADA|töflur|3,125|mg|30|stk|1|þpakki||C07AG02|01.03.2018||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|1500|3470|lyfalmen|||2|30|0|2,5000|LYFIS ehf|STADA Arzneimittel AG|Carvedílól||1500||1500|3470||2 537842|N05AH0206|Clozapin Medical|töflur|25|mg|500|stk|1|glas||N05AH02|01.12.2017||R|1|0|0|0|G|0|MED|0|0|0|100|IKR|14000|13380|lyfalmen|||2|500|0|41,6666|Medical ehf|Medical ehf|Klózapín||8700||8700|13380||2 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|||0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2166||1 537908|V03AF0101|Uromitexan|töflur|400|mg|20|stk|1|glas||V03AF01|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|41201|55181|lyfsjukr|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Mesna||||41201|55181||2 538138|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.11.2015||R|1|0|0|0|0|0|GRP|0|0|0|100|XEU|5514|8994|lyfalmen|||2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||5514||5514|8994||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|þpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSF|0|0|0|100|SEK|87877|114217|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd*|Interferón beta-1a||87877||87877|114217||2 538555|L04AX0306|Metojectpen|stl|12,5|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2360|4653|lyfalmen|||1|1|0|5,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2360||2360|4653||2 538696|C09CA0305|Valsartan ratiopharm|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.02.2015||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|2682|2781|lyfalmen|V0678|2781|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan||1000||1000|2781||2 538713|R03BB0701|Incruse|innönddu|55|mcg|30|skammtar|1|innö.t|afmældir skammtar|R03BB07|01.10.2015||R|0|0|0|0|G|0|RGO|0|0|0|100|DKK|4096|7043|lyfalmen|||1|30|0|30,0000|Vistor hf|Glaxo Group Limited|Umeclidiniumbrómið||4096||4096|7043||1 538757|S01LA0401|Lucentis|stl|10|mg/ml|1|áf.spr|1|pakki|lausn|S01LA04|01.12.2017||R|0|1|0|1|0|1|OSK|0|0|0|100|DKK|97577|126486|lyfsjukr|||0|1|1||Distica|Distica - óskráð lyf|Ranibizumab||||97577|126486||1 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNP|0|0|0|100|XEU|7359|11534|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||7359||7359|11534||1 539385|L01XC1701|OPDIVO|irþ|10|mg/ml|4|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|68836|90134|lyfsjukr|||1|4|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||68836||68836|90134||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|1|100|DKK|621|2260|lyfalmen|||2|25|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||621||621|2260||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|GRP|0|0|0|100|DKK|650|2300|lyfalmen|||2|100|0|20,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Díazepam||650||650|2300||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539906|N06BA0903|Atomoxetin Medical Valley|hylki|60|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8449|8623|lyfalmen|V0816|7494|2|28|0|21,0000|Acare ehf|Medical Valley Invest AB|Atomoxetín||5244||5244|8623||2 539965|N05BA0901|Frisium|töflur|10|mg|50|stk|1|þpakki||N05BA09|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|1745|3807|lyfalmen|||0|50|1|25,0000|Distica|Distica - óskráð lyf|clobazam||1745||1745|3807||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1421|3361|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1421||1421|3361||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|17355|25292|lyfsjukr|||1|2958|0||Vistor hf|Fresenius Kabi AB|Blöndur||17355||17355|25292||1 540133|H05BX0102|Cinacalcet WH|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|36232|14956|lyfalmen|V0721|14463|2|28|0|28,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||9845||9845|14956||2 540220|S01FA5601|MYDRANE|stl|||20|lykjur|1|pakki|0,2+3,1+10 mg/ml|S01FA56|01.10.2017||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|18767|27236|lyfsjukr|||1|20|0||Vistor hf|Laboratories THEA|Tropikamid í blöndum||18767||18767|27236||1 540648|N05AX1207|Lemilvo|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|7375|4704|lyfalmen|V0684|4502|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||2397||2397|4704||1 540709|N04BD0204|Rasagiline Mylan|töflur|1|mg|28|stk|1|þpakki||N04BD02|01.11.2016||R|0|0|0|0|G|0|ASD|0|0|0|100|SEK|5777|8320|lyfalmen|V0726|7739|2|28|0|28,0000|Icepharma hf|Mylan S.A.S.|Rasagilín||5024||5024|8320||2 540823|L01XA0103|Cisplatin Teva|irþ|1|mg/ml|100|ml|1|hgl||L01XA01|01.07.2016||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|14571|21460|lyfsjukr|||2|100|1||Parlogis hf|Parlogis - óskráð lyf|Cisplatín||14571||14571|21460||2 540958|L04AX0401|Revlimid|hylki|2,5|mg|21|stk|1|þpakki|hart|L04AX04|01.09.2015||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|577528|724390|lyfsjukr|||1|21|0|5,2500|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||||577528|724390||2 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|þpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541846|C02KX0501|Adempas|filmhtfl|0,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|161061|206422|lyfsjukr|||1|42|0|4,6700|Vistor hf|Bayer AG|Riociguatum||161061||161061|206422||1 542068|R01AA0504|Rhinox|nefdr|0,1|mg/ml|20|stk|1|pakki||R01AA05|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|472|2055|lyfalmen|||0|20|1||Distica|Distica - óskráð lyf|Oxýmetazólín||||472|2055||1 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|4647|7801|lyfsjukr|||2|800|0|3,3300|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||4647||4647|7801||1 542434|N05AX1208|Aripiprazol W&H|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|4384|4595|lyfalmen|V0682|4502|2|56|0|18,6670|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||2318||2318|4595||2 542474|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|túpa|með skammtadælu|G03CA03|01.03.2017||R|0|0|0|0|G|0|TAT|0|0|0|100|DKK|962|2729|lyfalmen|V0129|2729|2|64|0||Vistor hf|Takeda Oy|Estradíól||962||962|2729||1 542634|N05AX1207|Lemilvo|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.10.2015||R|1|1|0|0|G|0|GPA|0|0|0|100|XEU|6113|4773|lyfalmen|V0683|4502|2|56|0|37,3300|Actavis Group hf|Actavis Group PTC ehf|Aripiprazól||2447||2447|4773||1 542744|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|1000|ml|10|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6003|9667|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||6003|9667||2 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|þpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNP|0|0|0|100|XEU|752|2440|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||752||752|2440||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|13073|19399|lyfalmen|||1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||13073|19399||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|3007|2861|lyfalmen|V0203|2860|2|12|0|84,0000|Vistor hf|Bluefish Pharmaceuticals AB|Alendrónsýra||1058||1058|2861||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|890|2630|lyfalmen|V0373|1422|2|5|0|25,0000|Alvogen|Alvogen|Tímólól í blöndum||890||890|2630||1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|58345|76865|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||58345|76865||2 543663|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|20|stk|1|pakki||N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|20|0|1,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|MEA|0|0|0|100|DKK|||lyflausa|||0|250|0|21,7857|Icepharma hf|Meda AB|Semen psyllii (ispaghula)|||||||2 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|0|0|0|0|0|0|OME|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|Vistor hf|Omega Pharma Nordic AB|Oxýmetazólín|||||||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|2978|3564|lyfalmen|V0143|3317|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||1569||1569|3564||2 544374|L01XX4701|Zydelig|filmhtfl|150|mg|60|stk|1|glas||L01XX47|01.07.2016||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|449654|565351|lyfsjukr|||1|60|0||Gilead Sience Sweden AB|Gilead Science International Limited|Idelalisib||449654||449654|565351||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|213080|271119|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í æð||213080||213080|271119||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|þpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|10287|15564|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||10287||10287|15564||1 544571|G04BE0808|Tadalafil Sandoz|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|6914|10018|lyfalmen|V0145|9195|2|8|0|16,0000|Artasan ehf|Sandoz A/S|Tadalafíl||6258||6258|10018||1 545090|N04BC0505|Oprymea|forðatfl|2,1|mg|100|stk|1|þpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|27126|37379|lyfalmen|V0636|37379|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||27126||27126|37379||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|208788|261642|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||205460||205460|261642||2 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|þpakki||G03HB01|01.10.2012||R|0|1|0|0|0|0|RTH|0|0|0|100|XEU|1337|3112|lyfalmen|V0134|3112|2|63|0|84,0000|Alvogen|ratiopharm GmbH|Cýpróterón og östrógen||1240||1240|3112||2 545554|M01AE0116|Ibuprofen Bril|filmhtfl|200|mg|20|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|730|2410|lyfalmen|||1|15|0||Vistor hf|GlaxoSmithKline Pharma A/S|Múpírócín||730||730|2410||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|692|2357|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||692||692|2357||1 545827|R06AD0203|Prometazin Actavis|filmhtfl|25|mg|100|stk|1|þpakki||R06AD02|01.07.2017||R|1|1|0|0|G|0|VBA|0|0|1|100|XEU|1048|2759|lyfalmen|V0903|2759|2|100|0|100,0000|Actavis Group PTC ehf|Actavis BV|Prómetazín||984||984|2759||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1690|3731|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1690||1690|3731||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23926|33332|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||23926||23926|33332||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|19290|27956|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||19290||19290|27956||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|24067|33510|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||24067||24067|33510|| 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|20446|28930|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||20446||20446|28930||1 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1 546151|A02BC0510|Eradizol|sþ-tfl|20|mg|14|stk|1|þpakki||A02BC05|01.10.2015||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||2|14|0|9,3300|Alvogen|Alvogen|Esómeprazól|||||||1 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|GPA|0|0|1|100|XEU|1002|2784|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis Group PTC ehf|Paracetamól||1002||1002|2784||1 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|16122|23595|lyfalmen|||0|56|1|37,0000|Parlogis hf|Parlogis - óskráð lyf|Ísókarboxasíð||16122||16122|23595||2 546549|N07XX0601|Nitoman|töflur|25|mg|112|stk|1|þpakki||N07XX06|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|32258|43870|lyfalmen|||0|112|1|28,0000|Parlogis hf|Parlogis - óskráð lyf|tetrabenazine||32258||32258|43870||2 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|þpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RTH|0|0|0|100|IKR|3218|2368|lyfalmen|V0580|2368|2|98|0|98,0000|Alvogen|ratiopharm GmbH|Valsartan og þvagræsilyf||700||700|2368||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|GRP|0|0|0|100|IKR|3338|4657|lyfalmen|V0010|3961|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2363||2363|4657||1 546947|N05AX1211|Aripiprazole Mylan Pharma|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|SEK|8158|6908|lyfalmen|V0682|4502|2|56|0|18,6600|Icepharma hf|Pharmathen S.A.|Aripiprazól||3998||3998|6908||2 547054|A07EC0203|Pentasa Sachet|forðakyr|4|g|30|pokar|1|pakki||A07EC02|01.04.2017||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|11926|17820|lyfalmen|||1|30|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||11926||11926|17820||1 547094|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|100|ml|20|glös|lausn|B05BB01|01.01.2018||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|2767|5213|lyfsjukr|||2|2000|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||2767||2767|5213||2 547519|N03AX1209|Gabapentin Sandoz|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.12.2015||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|2615|2868|lyfalmen|V0251|2203|2|100|0|22,2200|Artasan ehf|Sandoz A/S|Gabapentín||1063||1063|2868||1 547589|L01AA0301|Alkeran|stl|50|mg|1|stk|1|glas||L01AA03|01.10.2017||R|0|0|0|1|0|1|LDR|0|0|0|100|DKK|15271|22424|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Melphalan||15271||15271|22424||2 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||5241||1 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|DKK|7648|11932|lyfsjukr|||1|100|0|0,3800|Vistor hf|Glaxo Group Limited|Eptifibatíð||7648||7648|11932||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|RGO|0|0|0|100|DKK|2459|4789|lyfsjukr|||1|10|0|0,1000|Vistor hf|Glaxo Group Limited|Eptifibatíð||2459||2459|4789||1 547925|B05BB0214|Plasmalyte Glucos|irl|50|mg/ml|500|ml|20|pokar||B05BB02|01.09.2015||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8349|12896|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar í blöndum með kol­vetnum||||8349|12896||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|FIN|0|0|0|100|DKK|84485|109927|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer AG|Interferón beta-1b||84485||84485|109927||2 548136|C07AB0704|Bisbetol|filmhtfl|5|mg|100|stk|1|þpakki||C07AB07|01.01.2017||R|0|0|0|0|G|0|WEH|0|0|0|100|IKR|1370|3291|lyfalmen|||2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|bisoprolol||1370||1370|3291||2 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|438|2008|lyfalmen|V0951|2008|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||438||438|2008||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|með rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|HES|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Novartis Healthcare A/S|Gervitár og aðrar óvirkar samsetningar|||||1958||1 548722|N06AX2107|Duloxetine Mylan|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.10.2015||R|0|0|0|0|G|0|GGE|0|0|0|100|SEK|6964|6624|lyfalmen|V0694|5196|2|98|0|98,0000|Mylan AB|Generics (UK) Ltd.|Duloxetín||3792||3792|6624||2 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|1|0|1|BAA|0|0|0|100|SEK|125922|162719|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||125922||125922|162719||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|6398|10211|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||6398||6398|10211||1 549550|D08AC0203|Klorhexidin Fresenius Kabi|húðlausn|0,5|mg/ml|125|ml|1|fl||D08AC02|01.02.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|156|1620|lyfalmen|||0|125|1||Distica|Distica - óskráð lyf|Klórhexidín||||156|1620||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|þpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|FIN|0|0|0|100|DKK|26288|36319|lyfalmen|||1|98|0|73,5000|Icepharma hf|Bayer AG|Rivaoxaban||||26288|36319||2 550111|S01AA0102|Oftan Chlora|augnsm|10|mg/g|3,5|g|1|túpa||S01AA01|01.02.2018||R|0|0|0|0|G|0|SAO|0|0|1|100|XEU|414|1649|lyfalmen|V0936|1649|2|3,5|0||Icepharma hf|Santen Oy|Klóramfeníkól||177||177|1649||2 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|GPA|0|0|1|100|IKR|1250|2066|lyfalmen|V0551|2066|2|7|0|1,7500|Actavis Group hf|Actavis Group PTC ehf|Flúkónazól||480||480|2066||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|þpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|2518|4871|lyfalmen|V0471|4871|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníð||2518||2518|4871||2 551043|B01AC0701|Persantin|húðuðtfl|100|mg|100|stk|1|þpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1365|3284|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||1365||1365|3284||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6449|10281|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||6449||6449|10281||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|3900|6773|lyfalmen|||1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||3900||3900|6773||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|1315|3215|lyfalmen|||1|1|0|2,6667|Icepharma hf|Meda AB|Tríamcínólón||1315||1315|3215||2 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MEA|0|0|1|100|DKK|2105|4302|lyfalmen|||1|100|0|50,0000|Icepharma hf|Meda AB|Nabúmeton||2105||2105|4302||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1812|2183|lyfalmen|V0466|2183|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2183||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2691|3873|lyfalmen|V0467|2218|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3873||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1355|1434|lyfalmen|V0003|1078|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1434||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2821|2183|lyfalmen|V0003|2156|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|2183||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|5587|3873|lyfalmen|V0010|2218|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3873||1 551969|S01EE0106|Latanoprost Mylan|augndr|50|mcg/ml|2,5|ml|3|glös||S01EE01|01.04.2017||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|1369|2737|lyfalmen|V0376|2737|2|7,5|0|75,0000|Icepharma hf|Mylan AB|Latanóprost||968||968|2737||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1383|3308|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1383||1383|3308||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|13121|21151|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||13121||13121|21151||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2547|4911|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||2547||2547|4911||1 553076|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|50|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|149136|191590|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||149136||149136|191590||2 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|þpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|8541|13161|lyfalmen|V0237|13161|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||8541|13161||1 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|2746|5185|lyfalmen|V0237|4387|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||2746||2746|5185||1 553684|N06BA0904|Atomoxetine Sandoz|hylki|10|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9168|7494|lyfalmen|V0812|7494|2|28|0|3,5000|Artasan ehf|Sandoz A/S|Atomoxetín||4424||4424|7494||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|þpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|442840|556876|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||442840||442840|556876||1 553818|A11CC0301|Etalpha|dropar|2|mcg/ml|20|ml|1|glas||A11CC03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|10993|16536|lyfalmen|||0|20|1||Distica|Distica - óskráð lyf|Alfakalsídól||||10993|16536||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAR|0|1|0|100|SEK|34295|46447|lyfsjukr|||1|1|0||Icepharma hf|Bayer AG|Storkuþáttur VIII||||34295|46447||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|7636|14658|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|Selen blöndur||7636||7636|14658||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|5256|5750|lyfalmen|V0029|5719|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||3157||3157|5750||1 554720|L04AX0601|Imnovid|hylki|3|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1105438|1380962|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1105438||1105438|1380962||2 554721|J01XA0108|Vancomycin Actavis|st/irþ|1000|mg/hgl|1|hgl|1|pakki||J01XA01|01.07.2016||R|0|0|0|0|0|1|GPA|0|0|0|100|XEU|1235|2174|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Actavis Group PTC ehf|Vankómýcín||559||559|2174||1 555196|L04AC1001|Cosentyx|stl|150|mg|2|áf-penni|1|pakki||L04AC10|01.07.2015||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|129479|167143|lyfsjukr|||1|2|0|30,0000|Vistor hf|Novartis Europharm Ltd|Secukinumab||129479||129479|167143||1 555235|N05AB0303|Peratsin|húðuðtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1415|3353|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||1415||1415|3353||1 555268|N05AB0303|Peratsin|húðuðtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1969|4115|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||1969||1969|4115||1 555292|N05AB0303|Peratsin|húðuðtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|COR|0|0|0|100|DKK|1007|2791|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1007||1007|2791||1 555385|R01AD0903|Mometason Evolan|nefúði|50|mcg/sk|140|skammtar|3|úðagl||R01AD09|01.02.2017||R|0|0|0|0|G|0|EVO|0|0|1|100|IKR|3000|3470|lyfalmen|||2|420|0|105,0000|LYFIS ehf|Evolan Pharma AB|Mómetasón||1500||1500|3470||2 555572|S01XA2201|JETREA|stþ|0,5|mg/hgl|0,2|ml|1|hgl||S01XA22|01.12.2014||R|0|1|0|1|0|1|THO|0|0|0|100|USD|362485|456937|lyfsjukr|||1|0,2|0||Vistor hf|ThromboGenics NV|Ocriplasmínum||362485||362485|456937||1 555864|G04BD0804|Solifenacin Actavis|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.03.2015|31.12.2017|R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|11408|14583|lyfalmen|||2|90|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Sólífenacín||9574||9574|14583||1 556242|QD07XB0202|Recicort|eyrnadr|||20|ml|1|dropaí|1,77+17,7 mg/ml|QD07XB02|01.12.2017||R|0|0|0|0|0|0|BVL|0|0|0|100|IKR|1328|2610|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet B.V.|Triamcinolon||||1328|2610||2 556377|R01AD0903|Mometason Evolan|nefúði|50|mcg/sk|140|skammtar|1|úðagl||R01AD09|01.06.2016||L|0|0|0|0|G|0|EVO|0|0|1|100|IKR|||lyfalmen|V0677|2304|2|140|0|35,0000|LYFIS ehf|Evolan Pharma AB|Mómetasón|||||2304||2 556694|C10AX1401|Praluent|stl|150|mg/ml|1|ml|2|áfpen|lausn í áf.lyfjapenna|C10AX14|01.02.2016||R|0|0|0|0|0|0|SGB|0|0|0|100|XEU|58078|76527|lyfalmen|||1|2|0|55,5556|Vistor hf|Sanofi-aventis groupe|Alirocumab||58078||58078|76527||1 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|16193|23693|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|Merck AB|Sómatrópín||16193||16193|23693||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3859|6716|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3859||3859|6716||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|7524|11761|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7524||7524|11761||1 557073|N06BA0903|Atomoxetin Medical Valley|hylki|25|mg|28|stk|1|þpakki|hart|N06BA09|01.06.2017||R|1|1|0|0|0|0|VAL|0|0|0|100|XEU|8449|8623|lyfalmen|V0814|8623|2|28|0|8,7500|Acare ehf|Medical Valley Invest AB|Atomoxetín||5244||5244|8623||2 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|Artasan ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|þpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2271|4316|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2115||2115|4316||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|þpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|194252|247702|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||194252|247702||1 558892|N07BA0151|Nicorette Cooldrops|munnstfl|2|mg|160|stk|1|pakki|8 x 20 stykki|N07BA01|01.07.2016||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|160|0|10,6700|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 558954|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.01.2017||R|0|0|0|0|0|1|BBV|0|0|0|100|SEK|41321|55333|lyfsjukr|||1|5|0|0,4000|Vistor hf|Janssen-Biologics B.V.|Abciximab||41321||41321|55333||1 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|1|100|IKR|534|2140|lyfalmen|||0|20|1|3,0000|Parlogis hf|Parlogis - óskráð lyf|Tramadól||||534|2140||2 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1178|3026|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1178||1178|3026||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíð|||||||2 559618|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|3696|6492|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||3696||3696|6492||1 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|HEG|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar samsetningar|||||1757||1 560085|L01CD0105|Abraxane|irs|5|mg/ml|100|mg|1|hgl||L01CD01|01.05.2016||R|0|0|0|1|0|1|CLC|0|1|0|100|XEU|38676|51988|lyfsjukr|||1|100|0||Celgene AB|Celgene Europe Limited|Paklítaxel||38676||38676|51988||2 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|HCA|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1134|2966|lyfalmen|||1|4,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||1134||1134|2966||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|4266|7277|lyfalmen|||1|100|0|2,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Acíklóvír||4266||4266|7277||1 560435|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.05.2017||L|1|0|0|0|0|0|BAB|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Icepharma hf|Bayer AB|Lóratadín|||||||2 560466|S01XA2010|Sincon|augndr|||60|stk|1|pakki||S01XA20|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|3777|6604|lyfalmen|||0|60|1||Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||||3777|6604||1 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|77703|101349|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||77703||77703|101349||1 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|357431|450651|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||357431||357431|450651||1 560682|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.09.2017||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|213052|167935|lyfsjukr|||2|30|0||Alvogen|Accord Healthcare Limited|Imatiníb||130116||130116|167935||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|POF|0|1|0|100|DKK|116404|93032|lyfsjukr|||2|60|0||Alvogen|Alvogen|Imatiníb||71127||71127|93032||1 561022|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1289|3179|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1289||1289|3179||2 561780|C02KX0501|Adempas|filmhtfl|1,5|mg|42|stk|1|þpakki||C02KX05|01.12.2014||R|1|0|0|1|0|1|BRE|0|1|0|100|DKK|161061|206422|lyfsjukr|||1|42|0|14,0000|Vistor hf|Bayer AG|Riociguatum||161061||161061|206422||1 562014|C09BA0201|Darazið|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|GRP|0|0|0|100|XEU|1316|2729|lyfalmen|V0098|2337|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og þvagræsilyf||962||962|2729||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|PHH|0|0|0|100|DKK|39417|52925|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Storkuþáttur IX||39417||39417|52925||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|án rotvarnarefnis|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|3536|6272|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||3536||3536|6272||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|211653|269344|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||211653||211653|269344||3 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|RGO|0|1|0|100|DKK|68136|89249|lyfsjukr|||1|1|0|16,0000|Vistor hf|Glaxo Group Limited|Belimumab||68136||68136|89249||1 563184|A10BD1101|Jentadueto|filmhtfl|1002,5|mg|60|stk|1|þpakki|2,5mg/1000mg|A10BD11|01.11.2015||R|0|0|0|0|G|0|BOE|0|0|0|100|DKK|4787|7994|lyfalmen|V0705|7122|1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International GmbH|Metforminum og linagliptinum||4787||4787|7994||1 563192|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|10|ml|10|áfspr|lausn,áf.spr.|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|29827|40795|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||29827||29827|40795||2 563213|D07AC1702|Flutivate|krem|0,05|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1794|3874|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1794||1794|3874||1 563285|N06BA0904|Atomoxetine Sandoz|hylki|18|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|9168|7494|lyfalmen|V0813|7494|2|28|0|6,3000|Artasan ehf|Sandoz A/S|Atomoxetín||4424||4424|7494||1 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995|31.01.2018|R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|501|2094|lyfalmen|||1|30|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||501||501|2094||1 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PLS|0|0|0|100|DKK|1093|2909|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1093||1093|2909||1 563527|H05BX0102|Cinacalcet WH|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2016||R|1|0|0|0|0|0|WEH|0|0|0|100|XEU|19789|12185|lyfalmen|V0720|11407|2|28|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Cinacalcet||7832||7832|12185||2 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2731|5164|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2731||2731|5164||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2831|5302|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2831||2831|5302||2 563653|A10BB1203|Glimepirid Bluefish|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|1326|2093|lyfalmen|V0494|2093|2|90|0|180,0000|Vistor hf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2093||1 563730|QJ01CE9003|Penethaone vet.|sts|5|m.ae/hgl|1|hgl|1|pakki|+leysir|QJ01CE90|01.03.2016||R|0|0|0|0|0|0|DIV|0|0|0|100|IKR|1486|2921|vetalmen|||0|1|0||Dýraheilsa ehf|Divasa-Farmavic S.A.|||||1486|2921||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|367398|463047|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótið disapartate||367398||367398|463047||1 563799|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.03.2018||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1446|3395|lyfalmen|V0949|3395|1|100|0||Vistor hf|LEO Pharma A/S|Hýdrókortisón bútýrat||1446||1446|3395||1 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|IKR|10463|18034|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||10463||10463|18034||2 563905|J02AC0106|Fungyn|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.01.2017||L|1|0|0|0|0|0|GOV|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Alvogen|Alvogen ehf|Flúkónazól|||||||1 563918|N02AA0505|Oxycodone ratiopharm|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RTH|0|0|0|100|XEU|530|2064|lyfalmen|V0596|2064|2|28|0|1,8600|Alvogen|ratiopharm GmbH|Oxýcódon||479||479|2064||2 564229|C03CA0406|Torem|töflur|5|mg|100|stk|1|þpakki||C03CA04|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|3313|5965|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|torasemide||3313||3313|5965||2 564270|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.12.2015||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|17696|25762|lyfsjukr|||1|1|0||Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||17696||17696|25762||3 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|817|2529|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||817||817|2529||1 564918|A02BC0113|Omeprazol Sandoz|sþ-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.10.2015||L|1|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyflausa|||2|28|0|28,0000|Artasan ehf|Sandoz A/S|Ómeprazól|||||||1 565046|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|pokar|Kabipac|B05BB01|01.11.2015||R|0|0|0|0|0|1|FKA|0|0|0|100|DKK|2090|4282|lyfsjukr|||1|5000|0||Vistor hf|Fresenius Kabi AB|Elektrólýtar||2090||2090|4282||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565400|N05AH0411|Quetiapine Teva|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2014||R|1|0|0|0|G|0|TSA|0|0|0|100|IKR|7600|6265|lyfalmen|V0286|6265|2|100|0|50,0000|Alvogen|Teva Sweden AB|Quetíapín||3531||3531|6265||2 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|ATN|0|0|0|100|DKK|8325|12863|lyfalmen|V0714|12863|1|100|0|50,0000|Pharmanovia A/S|Atnahs Pharma UK Ltd|Olsalazín||8325||8325|12863||1 565625|M01AE0102|Ibufen|mixtúra|20|mg/ml|100|ml|1|glas||M01AE01|01.08.2016||L|0|0|0|0|0|0|GPA|0|0|1|100|IKR|||lyflausa|||0|100|0|1,6700|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 565685|QA04AD9001|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.04.2015||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6852|13170|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||6852|13170||2 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|19421|28136|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lægemidler A/S|Terlípressín||19421||19421|28136||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1308|3205|lyfalmen|V0444|2162|1|5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Brinzólamíð||1308||1308|3205||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.07.2014|28.02.2018|R|0|0|0|0|0|0|GPA|0|0|0|100|XEU|2437|4759|lyfalmen|||2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2437||2437|4759||1 566786|A06AX0201|Relaxit|eþ-stíll|||12|stk|1|pakki||A06AX02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|1724|3778|lyfalmen|||0|12|1||Distica|Distica - óskráð lyf|carbon dioxide producing drugs||||1724|3778||1 566794|A06AX0201|Relaxit|eþ-stíll|||20|stk|1|pakki||A06AX02|01.03.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|15385|22581|lyfalmen|||0|20|1||Distica|Distica - óskráð lyf|carbon dioxide producing drugs||||15385|22581||1 566853|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.10.2017||R|0|0|0|0|G|0|OEL|0|0|1|100|DKK|1624|3640|lyfalmen|V0918|3640|1|10|0||Vistor hf|LEO Pharma A/S|Takrólímus||1624||1624|3640||1 566873|N05BB0102|Allerzine|filmhtfl|25|mg|100|stk|1|þpakki||N05BB01|01.09.2017||R|0|1|0|0|0|0|IPC|0|0|1|100|SEK|876|2319|lyfalmen|V0907|2319|2|100|0|33,3333|Alvogen|Alvogen IPco S.á.r.l.|Hýdroxýzín||664||664|2319||1 566924|R03AK0705|Bufomix Easyhaler|innönddu|164,5|mcg/sk|120|skammtar|3|innö.t|160+4,5 mcg/sk|R03AK07|01.11.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|11722|17539|lyfalmen|||2|360|0|90,0000|Vistor hf|Orion Corporation|Formóteról og budesonide||11722||11722|17539||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|148637|190970|lyfsjukr|||1|84|0||Vistor hf|Novartis Europharm Ltd|Labatinibum||148637||148637|190970||1 567126|A09AA0207|Creon 25.000|töflur|300|mg|100|stk|1|glas||A09AA02|01.07.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|12393|18463|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Hvatablöndur (lípasi, próteasi o.s.frv.)||||12393|18463||2 567332|C10AA0508|Lipistad|filmhtfl|40|mg|100|stk|1|þpakki||C10AA05|01.01.2017||R|1|0|0|0|G|0|ASR|0|0|0|100|IKR|3587|2781|lyfalmen|V0114|2781|2|100|0|200,0000|LYFIS ehf|STADA Arzneimittel AG|Atorvastatín||1000||1000|2781||2 567338|G04BD1201|Betmiga|forðatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13682|20237|lyfalmen|V0651|20237|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13682||13682|20237||1 567400|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.06.2015||L|0|0|0|0|G|0|AEP|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Icepharma hf|Aspen Pharma Trading Limited|Estríól|||||2872||2 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|1|0|0|G|0|ALK|0|0|1|100|DKK|4594|7728|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||4594|7728||1 567461|D07AC1702|Flutivate|smyrsli|0,005|%|100|g|1|túpa||D07AC17|01.12.2017||R|0|0|0|0|G|0|GPH|0|0|1|100|DKK|1707|3754|lyfalmen|||1|100|0||Vistor hf|GlaxoSmithKline Pharma A/S|Flútíkasón||1707||1707|3754||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2165|4385|lyfalmen|V0291|2231|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||2165||2165|4385||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|AEP|0|0|0|100|DKK|2181|4407|lyfalmen|||1|100|0|33,3333|Icepharma hf|Aspen Pharma Trading Limited|Labetalól||2181||2181|4407||2 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|4194|7178|lyfalmen|V0292|3470|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||4194||4194|7178||1 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 567802|L04AX0501|Esbriet|filmhtfl|267|mg|252|stk|1|þpakki||L04AX05|01.11.2017||R|1|1|0|1|0|0|RRL|0|0|0|100|DKK|301586|381196|lyfalmen|V0919|381194|1|252|0|28,0300|Icepharma hf|Roche Registration Limited|Pírfenidon||||301586|381196||2 567805|M01AE0116|Ibuprofen Bril|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.11.2016||L|1|0|0|0|0|0|BLL|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Williams & Halls efh|Bristol Laboratories Limited|Íbúprófen|||||||2 567837|G04BE0808|Tadalafil Sandoz|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.01.2018||R|1|0|0|0|0|0|SHS|0|0|0|100|DKK|6709|10639|lyfalmen|V0935|10639|2|28|0|14,0000|Artasan ehf|Sandoz A/S|Tadalafíl||6709||6709|10639||1 567980|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 568478|M01AH0502|Coxient|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|ALO|0|0|1|100|IKR|2191|3074|lyfalmen|V0826|2853|2|28|0|42,0000|Alvogen|Alvogen Malta Operations(ROW)Ltd.|Etoríkoxíb||1213||1213|3074||1 568708|N06AX1613|Venlafaxin Medical Valley|forðatfl|75|mg|100|stk|1|glas||N06AX16|01.10.2017||R|0|0|0|0|G|0|VAL|0|0|0|100|IKR|2800|2919|lyfalmen|V0334|2741|2|100|0|75,0000|Acare ehf|Medical Valley Invest AB|Venlafaxín||1100||1100|2919||2 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|815|2527|lyfalmen|||1|3|0||Vistor hf|GlaxoSmithKline Pharma A/S|Mupirocin||815||815|2527||1 568812|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|4413|7479|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||4413||4413|7479||1 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|2296|2807|lyfalmen|V0058|2231|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1019||1019|2807||1 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|3096|3926|lyfalmen|V0059|2644|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Felódipín||1832||1832|3926||1 569174|M01AH0503|Coxerit|filmhtfl|120|mg|7|stk|1|þpakki||M01AH05|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|1|100|IKR|850|2052|lyfalmen|V0827|1034|2|7|0|14,0000|Williams & Halls efh|Williams & Halls ehf|Etoríkoxíb||470||470|2052||2 569257|J05AR1301|Triumeq|filmhtfl|950|mg|30|stk|1|glas|50+600+300 mg|J05AR13|01.12.2014||R|0|1|0|1|0|1|VIH|0|0|0|100|DKK|105757|137639|lyfsjukr|||1|30|0||Vistor hf|ViiV Healthcare UK Ltd|Abacavír, dolutegravír og lamivudín||105757||105757|137639||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|8817|13541|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíð||8817||8817|13541||2 569422|A02BC0114|Omeprazol Medical Valley|sþ-hylki|40|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|4800|2781|lyfalmen|V0001|2781|2|100|0|200,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||1000||1000|2781||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|12178|18167|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||12178||12178|18167||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|14005|20681|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||14005||14005|20681||1 569514|N06AX2105|Duloxetin Krka|sþ-hylki|30|mg|100|stk|1|þpakki||N06AX21|01.02.2017||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|4602|7186|lyfalmen|||2|100|0|50,0000|LYFIS ehf|Krka d.d. Novo mesto|Duloxetín||4200||4200|7186||2 570258|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.11.2015||R|1|0|0|1|0|0|BFP|0|0|0|100|IKR|5269|8657|lyfalmen|V0657|7940|2|30|0|10,0000|Vistor hf|Bluefish Pharmaceuticals AB|Modafinil||5269||5269|8657||1 570272|C10AA0104|Simvastatin Alvogen|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2017||R|1|0|0|0|G|0|GOV|0|0|0|100|IKR|1780|2653|lyfalmen|V0110|2368|2|100|0|133,3333|Alvogen|Alvogen ehf|Simvastatín||907||907|2653||1 570421|L04AX0306|Metojectpen|stl|10|mg|1|áf-penni|1|pakki||L04AX03|01.05.2016||R|0|0|0|0|G|0|WIL|0|0|0|100|XEU|2261|4517|lyfalmen|||1|1|0|4,0000|Williams & Halls efh|medac Gesellschaft|Metótrexat||2261||2261|4517||2 570649|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|þpakki|25+100 mg|N04BA02|01.02.2018||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|1645|3669|lyfalmen|V0938|3669|1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||1645||1645|3669||1 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|2684|5263|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||2684||2684|5263||1 571063|R06AX2707|Dasselta|filmhtfl|5|mg|30|stk|1|þpakki||R06AX27|01.09.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|650|2024|lyfalmen|V0908|2024|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Deslóratadín||450||450|2024||2 571158|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|15|stk|1|þpakki||A04AA01|01.12.2015||R|1|0|0|0|G|0|BFP|0|0|1|100|IKR|2770|5218|lyfalmen|V0384|4488|2|15|0|7,5000|Vistor hf|Bluefish Pharmaceuticals AB|Ondansetrón||2770||2770|5218||2 571181|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.2015||R|0|0|0|1|0|1|CHI|0|0|0|100|DKK|65526|85948|lyfsjukr|||1|1,5|0|0,7500|Chiesi Farmaceutici SpA|Chiesi Farmaceutici SpA|Náttúrulegir fosfólípíðar||65526||65526|85948||1 571285|L01XE1301|Giotrif|filmhtfl|40|mg|28|stk|1|þpakki||L01XE13|01.05.2016||R|0|0|0|1|0|1|BOE|0|1|0|100|DKK|235113|298522|lyfsjukr|||1|28|0||Vistor hf|Boehringer Ingelheim International GmbH|Afatiníb||235113||235113|298522||1 571358|L01XC1501|Gazyvaro|irþ|1000|mg|1|hgl|1|pakki||L01XC15|01.02.2015||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|431870|543232|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Obinutuzumab||431870||431870|543232||2 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 572422|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|63234|83049|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||63234||63234|83049||1 572697|R06AE0706|Zensitin|filmhtfl|10|mg|100|stk|1|þpakki||R06AE07|01.01.2018||L|1|0|0|0|G|0|WEH|0|0|1|100|IKR|||lyfalmen|V0575|2389|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Cetirizín|||||2602||2 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|þpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|GPA|0|0|0|100|IKR|5070|3833|lyfalmen|V0245|3804|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||1764||1764|3833||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|2965|5486|lyfalmen|V0464|4006|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Tímólól í blöndum||2965||2965|5486||1 573382|J05AP5101|Harvoni|filmhtfl|490|mg|28|stk|1|glas|400 mg + 90 mg|J05AP51|01.09.2015||R|1|0|0|1|0|1|GIL|0|0|0|100|DKK|1995966|2488530|lyfsjukr|||1|28|0||Gilead Sience Sweden AB|Gilead Science International Limited|Sofosbuvir og ledipasvir||||1995966|2488530||2 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|68988|90326|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||68988||68988|90326||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|SEK|12674|18849|lyfsjukr|||1|10|0|2,5000|Icepharma hf|Pfizer ApS|Meropenem||12674||12674|18849||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|10|hgl|1|pakki||J01DH02|01.10.1995||R|0|0|0|0|0|1|PLS|0|0|0|100|SEK|20779|29352|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Pfizer ApS|Meropenem||20779||20779|29352||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|þpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4348|4105|lyfalmen|V0144|3800|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||1962||1962|4105||2 574086|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.09.2016||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17198|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17198||2 574357|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|500|stk|1|glas||N06AX21|01.01.2016||R|2|0|0|0|G|0|WEH|0|0|0|100|XEU|||lyfalmen|||2|500|0|500,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||||||30.11.2017|2 574423|L01XC1301|Perjeta|irþ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|330805|417536|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||330805||330805|417536||2 574510|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.07.2016||R|0|0|0|0|G|0|NAA|0|0|1|100|DKK|8178|12661|lyfalmen|||1|50|0|2,5000|Artasan ehf|Novartis Healthcare A/S|Ondansetrón||8178||8178|12661||1 574597|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.11.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|1921|2282|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||637||637|2282|31.12.2017|1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|6100|6147|lyfalmen|V0322|2889|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||3445||3445|6147||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|3611|2298|lyfalmen|V0152|2298|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||649||649|2298||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PLS|0|0|0|100|DKK|10994|6147|lyfalmen|V0323|4075|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||3445||3445|6147||1 575484|L01AA0903|Bendamustine medac|st/irþ|2,5|mg/ml|100|mg|1|hgl|lausn|L01AA09|01.03.2018||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|31617|43059|lyfsjukr|||2|100|0||Williams & Halls efh|medac Gesellschaft|Bendamústín||31617||31617|43059||2 575504|B02BD0801|NovoSeven|sts|8|mg|1|hgl|1|pakki|+áfyllt sprauta með leysi|B02BD08|01.10.2015||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|682173|854539|lyfsjukr|||1|1|0||Vistor hf|Novo-Nordisk A/S|Storkuþáttur VIIa||682173||682173|854539||1 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1070|2066|lyfalmen|V0159|2066|2|20|0|10,0000|Alvogen|ratiopharm GmbH|Amoxicillín||480||480|2066||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1285|2368|lyfalmen|V0160|2368|2|30|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||700||700|2368||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|þpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RTH|0|0|1|100|IKR|1392|2437|lyfalmen|V0158|2437|2|20|0|15,0000|Alvogen|ratiopharm GmbH|Amoxicillín||750||750|2437||2 575919|N04BA0303|Levodopa+Carbidopa+Entacapona WH|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.07.2017||R|1|0|0|0|G|0|WEH|0|0|0|100|IKR|9646|14682|lyfalmen|V0900|14682|2|100|0|33,3300|Williams & Halls efh|Williams & Halls ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||9646||9646|14682||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.12.2010||R|0|0|0|0|G|0|GPA|0|0|0|100|IKR|945|1867|lyfalmen|V0243|1642|2|42|0|3,5000|Actavis Group hf|Actavis Group PTC ehf|Lamótrigín||336||336|1867||1 576123|L04AX0601|Imnovid|hylki|1|mg|21|stk|1|þpakki||L04AX06|01.04.2016||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|1071729|1339038|lyfsjukr|||1|21|0|7,0000|Celgene Europe ltd|Celgene Europe ltd|Pomalidómide||1071729||1071729|1339038||2 576518|QN05CM1803|Sedadex|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.03.2017||R|0|0|0|0|0|0|VEB|1|0|0|100|IKR|5680|10947|vetalmen|||2|10|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5680||5680|10947||2 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|8039|12470|lyfalmen|||1|25|0||Icepharma hf|Aspen Pharma Trading Limited|Merkaptópúrín||8039||8039|12470||2 576797|V03AE0205|Sevelamercarbonat Stada|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.10.2017||R|1|0|0|0|0|0|ASR|0|0|0|100|IKR|13500|12141|lyfalmen|V0680|12141|2|180|0|22,5000|LYFIS ehf|STADA Arzneimittel AG|Sevelamer||7800||7800|12141||2 577135|C09DX0401|Entresto|filmhtfl|100|mg|56|stk|1|þpakki|49 + 51 mg|C09DX04|01.04.2016||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|16829|24568|lyfalmen|V0727|22309|1|56|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartan og sacubitril||16829||16829|24568||1 577441|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.12.2016||R|0|0|0|1|0|0|LDR|0|0|0|100|DKK|3928|6811|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Própafenón||||3928|6811||2 577682|N06BA0904|Atomoxetine Sandoz|hylki|80|mg|28|stk|1|þpakki|hart|N06BA09|01.10.2017||R|1|1|0|0|0|0|SHS|0|0|0|100|DKK|12646|9994|lyfalmen|V0817|9994|2|28|0|28,0000|Artasan ehf|Sandoz A/S|Atomoxetín||6240||6240|9994||1 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|9495|14474|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||9495||9495|14474||2 578261|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.07.2015||R|0|0|0|0|0|0|PLS|0|0|0|100|USD|3427|6122|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer ApS|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||3427||3427|6122||1 578368|V08CA0201|CLARISCAN|stl|0,5|mmol/ml|100|ml|10|glas|lausn|V08CA02|01.10.2017||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|298272|377074|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Gadoteric acid||298272||298272|377074||2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5545|9557|vetorma|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||5545||5545|9557||2 578794|A06AB0202|Toilax|sþ-tfl|5|mg|100|stk|1|glas||A06AB02|01.12.2016||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|544|2154|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||544||544|2154||1 579037|G03CA5701|Premarina|töflur|625|mcg|84|stk|1|þpakki||G03CA57|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1834|3929|lyfalmen|||0|84|1|84,0000|Parlogis hf|Parlogis - óskráð lyf|conjugated estrogens||||1834|3929||2 579043|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|þpakki||H02AB02|01.06.2016||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|15688|22998|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||15688||15688|22998||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|888|2627|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||888||888|2627||1 579171|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.01.2016||R|1|0|0|0|G|0|PGB|0|0|0|100|DKK|2025|4192|lyfalmen|||1|98|0|98,0000|Icepharma hf|BGP Products ApS|Verapamíl||2025||2025|4192||2 579240|L01XC1701|OPDIVO|irþ|10|mg/ml|10|ml|1|hgl||L01XC17|01.06.2016||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|171739|219702|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Nivolumab||171739||171739|219702||1 579796|N02AJ0602|Parkodin forte|filmhtfl|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AJ06|01.02.2018||R|1|0|1|0|0|0|GPA|0|0|1|100|IKR|1364|3282|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Group PTC ehf|Kódein og Paracetamól||1364||1364|3282||1 579864|C07AB0214|Bloxazoc|forðatfl|100|mg|30|stk|1|þpakki||C07AB02|01.05.2017||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|800|2506|lyfalmen|||2|30|0|20,0000|LYFIS ehf|Krka d.d. Novo mesto|Metóprólól||800||800|2506||2 579911|B01AF0301|Lixiana|filmhtfl|60|mg|30|stk|1|þpakki||B01AF03|01.11.2016||R|1|1|0|0|G|0|OPE|0|0|0|100|DKK|8145|12616|lyfalmen|||1|30|0|30,0000|Vistor hf|Daiichi Sankyo Europe GmbH|Edoxaban||8145||8145|12616||1 579932|C03DA0406|Eplerenon Alvogen|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|POF|0|0|0|100|DKK|3132|3255|lyfalmen|V0107|2781|2|30|0|15,0000|Alvogen|Alvogen|Eplerenón||1344||1344|3255||1 579972|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.05.2015||R|1|0|0|0|0|0|BFP|0|0|0|100|IKR|11539|8287|lyfalmen|V0111|8287|2|100|0|100,0000|Vistor hf|Bluefish Pharmaceuticals AB|Eplerenón||5000||5000|8287||2 580042|C05AA0801|Doloproct|eþ-stíll|||10|stk|1|þpakki||C05AA08|01.02.2015||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|590|2217|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||590||590|2217||2 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|þpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6781|10738|lyfalmen|||1|14|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||6781||6781|10738||1 580144|L01CD0203|Docetaxel Kabi|irþ|20|mg/ml|8|ml|1|hgl|lausn|L01CD02|01.01.2016||R|0|0|0|1|0|1|PLC|0|0|0|100|DKK|5980|9636|lyfsjukr|||1|8|0||Icepharma hf|Fresenius Kabi Oncology Plc.|Docetaxel||5980||5980|9636||2 580699|H01BA0208|NOCDURNA|frþ.tfl|25|mcg|30|stk|1|þpakki||H01BA02|01.04.2017||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|2960|5479|lyfalmen|||1|30|0|1,8750|Vistor hf|Ferring Lægemidler A/S|Desmópressín||2960||2960|5479||1 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1308|3205|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1308||1308|3205||2 581417|S01ED5116|Taptiqom|augndr|||0,3|ml|30|Sk-ílá|15mcg/ml + 5mg/ml|S01ED51|01.07.2015||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|2575|4949|lyfalmen|||1|9|0|30,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||2575||2575|4949||2 581661|N02CC0403|Rizatriptan Portfarma|munndr.t|5|mg|6|stk|1|þpakki||N02CC04|01.01.2015||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2822|4798|lyfalmen|V0620|4798|2|6|0|3,0000|Alvogen|Alvogen|Rizatriptan||2465||2465|4798||1 581792|L02BB0305|Bicalutamide Alvogen|filmhtfl|150|mg|90|stk|1|þpakki||L02BB03|01.11.2016||R|0|0|0|0|G|0|GOV|0|0|0|100|IKR|33214|15169|lyfalmen|V0421|15169|2|90|0|270,0000|Alvogen|Alvogen ehf|Bíkalútamíð||10000||10000|15169||1 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|11385|21770|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||11385||11385|21770||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|1911|4035|lyfalmen|V0669|3537|1|2,5|0|25,0000|Vistor hf|Novartis Europharm Ltd|Travóprost||1911||1911|4035||1 582034|QM01AC0608|Novaquin|mixtúra|15|mg/ml|125|ml|1|glas|dreifa|QM01AC06|01.03.2018||R|0|0|0|0|0|0|VEB|0|0|0|100|IKR|4185|8110|vetalmen|||0|125|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||||4185|8110||0 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|17287|25199|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||17287||17287|25199||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|33830|45858|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||33830||33830|45858||2 582122|G03GA0503|Bemfola|stl|450|ae|0,75|ml|1|penni||G03GA05|01.01.2015||R|0|0|0|1|G|0|FBA|0|0|0|100|SEK|14463|21312|lyfalmen|||1|0,75|0|6,0000|Finox Biotech AG|Finox Biotech AG|Follitrópín alfa||14463||14463|21312||3 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|DAN|0|1|0|100|XEU|67659|88645|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||67659||67659|88645||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19763|28607|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||19763||19763|28607||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|22671|31745|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||22671||22671|31745||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|51479|68181|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||51479||51479|68181||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|20097|28489|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||20097||20097|28489||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|MEC|0|1|0|100|SEK|27490|37840|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|Merck AB|Sómatrópín||27490||27490|37840||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PLS|0|0|0|100|DKK|1616|3629|lyfalmen|V0376|912|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1616||1616|3629||1 583126|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 583195|C10AC0201|Lestid|töflur|1|g|120|stk|1|pakki||C10AC02|01.07.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|23404|32672|lyfalmen|||0|120|1||Distica|Distica - óskráð lyf|Colestipol||23404||23404|32672||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|41056|54998|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||41056||41056|54998||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|782|2481|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||782||782|2481||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|69334|90764|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||69334||69334|90764||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21966|30853|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||21966||21966|30853||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|35145|47522|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||35145||35145|47522||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|65897|86417|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||65897||65897|86417||2 583806|G04BE0310|Sildenafil LYFIS|filmhtfl|100|mg|24|stk|1|þpakki||G04BE03|01.09.2016||R|0|0|0|0|0|0|LYF|0|0|0|100|IKR|10000|7599|lyfalmen|V0144|7599|2|24|0|48,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||4500||4500|7599||2 583916|B05BB0122|Natriumklorid B. Braun|irl|9|mg/ml|250|ml|10|pokar|lausn|B05BB01|01.02.2018||R|0|0|0|0|0|1|RAU|0|0|0|100|XEU|1467|3424|lyfsjukr|||2|2500|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1467||1467|3424||2 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|14645|21562|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||14645||14645|21562||1 584208|L04AC0101|ZINBRYTA|stl|150|mg|1|áf-penni|1|pakki||L04AC01|01.01.2017||R|0|1|0|1|0|1|BIB|0|0|0|100|XEU|189729|242077|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Biogen Idec Ltd|Daclizumab||189729||189729|242077||2 585359|L01XC1801|KEYTRUDA|irþ|25|mg/ml|4|ml|1|hgl||L01XC18|01.07.2017||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|420701|529341|lyfsjukr|||1|4|0||Vistor hf|Merck Sharp & Dohme Limited|Pembrolizumab||420701||420701|529341||1 585516|A10BK0301|Jardiance|filmhtfl|25|mg|90|stk|1|þpakki||A10BK03|01.07.2015||R|1|0|0|0|G|0|BOE|0|0|0|100|DKK|16359|23921|lyfalmen|||1|90|0|128,5700|Vistor hf|Boehringer Ingelheim International GmbH|Empagliflozin||16359||16359|23921||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|4779|7983|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||4779||4779|7983||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|3522|6253|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||3522||3522|6253||1 585692|A02BC0114|Omeprazol Medical Valley|sþ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.07.2016||R|1|0|0|0|G|0|VAL|0|0|0|100|IKR|2500|1955|lyfalmen|V0006|1955|2|100|0|100,0000|Acare ehf|Medical Valley Invest AB|Ómeprazól||400||400|1955||2 585754|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|áf.spr||B01AX05|01.09.2017||R|0|0|0|0|G|0|AEP|0|0|0|100|DKK|9783|14870|lyfalmen|||1|4|0|20,0000|Icepharma hf|Aspen Pharma Trading Limited|Fondaparinux||9783||9783|14870||2 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|3302|5950|lyfalmen|||1|1|0||Vistor hf|GlaxoSmithKline Pharma A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3302||3302|5950||1 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|24356|33876|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||24356||24356|33876||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|LEM|0|0|0|100|XEU|11181|16794|lyfsjukr|||2|800|0|10,0000|Actavis Group PTC ehf|B.Braun Melsungen AG|Gentamícín||11181||11181|16794||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|þpakki|hart hylki+innönd.tæki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|299013|377995|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||299013||299013|377995||1 586312|C10AX1301|Repatha|stl|140|mg|2|áf-penni|1|pakki||C10AX13|01.10.2016||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|55326|73047|lyfalmen|||1|2|0|28,0000|Vistor hf|Amgen Europe B.V.|Evolocumab||55326||55326|73047||1 586797|N06BA0902|Atomoxetin Actavis|hylki|40|mg|28|stk|1|þpakki|hart|N06BA09|01.03.2017||R|1|1|0|0|0|0|GPA|0|0|0|100|XEU|10195|8623|lyfalmen|V0815|7494|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Atomoxetín||5244||5244|8623||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|þpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BSM|0|0|0|100|DKK|23317|32562|lyfalmen|V0652|32562|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||23317|32562||1 587112|M01AH0106|Celecoxib Actavis|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.12.2014||R|1|0|0|0|G|0|GPA|0|0|1|100|XEU|3536|5636|lyfalmen|V0196|5636|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Celekoxíb||3074||3074|5636||1 587176|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 587522|L04AB0601|Simponi|stl|100|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.11.2014||R|0|1|0|1|0|1|JAN|0|1|0|100|DKK|125808|162577|lyfsjukr|||1|1|0|60,2400|Vistor hf|Janssen Biologics B.V.|Golimumab||125808||125808|162577||1 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|GPA|0|0|0|100|XEU|3659|6441|lyfalmen|V0095|6441|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og þvagræsilyf||3659||3659|6441||1 587931|N03AX1002|Taloxa|töflur|600|mg|100|stk|1|þpakki||N03AX10|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|NOK|34745|47016|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|felbamate||||34745|47016||1 587958|C09CA0604|Kairasec|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.2017||R|1|0|0|0|0|0|VAL|0|0|0|100|XEU|3587|5259|lyfalmen|V0081|5259|2|98|0|98,0000|Acare ehf|Medical Valley Invest AB|Candesartan||2800||2800|5259||2 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1498|3467|lyfalmen|||0|5|1||Distica|Distica - óskráð lyf|Nedókrómíl||||1498|3467||1 588195|N05AX1208|Aripiprazol W&H|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2016||R|0|1|0|0|G|0|WEH|0|0|0|100|XEU|16341|4595|lyfalmen|V0683|4502|2|56|0|37,3300|Williams & Halls efh|Williams & Halls ehf|Aripiprazól||2318||2318|4595||2 588227|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+30 áf.spr.m.leysi|H01AX01|01.10.2017||R|0|0|0|1|0|1|PIZ|0|0|0|100|DKK|578380|725450|lyfsjukr|||1|30|0|60,0000|Icepharma hf|Pfizer Ltd|Pegvisómant||578380||578380|725450||1 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1536|3519|lyfalmen|||1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1536||1536|3519||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNP|0|0|0|100|XEU|6238|9991|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||6238||6238|9991||1 588669|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|þpakki||N03AX22|01.01.2015||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|17653|25703|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||17653||17653|25703||1 588767|A10BB0905|Gliclatim|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.08.2017||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2000|3194|lyfalmen|V0020|1873|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíð||1300||1300|3194||2 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|GPA|0|0|0|100|XEU|7396|5490|lyfalmen|V0282|5455|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2968||2968|5490||1 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|NEL|0|1|0|100|DKK|516713|648753|lyfsjukr|||1|120|0||Vistor hf|Novartis Europharm Ltd|Dabrafeníb||516713||516713|648753||1 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|USD|5731|9293|lyfalmen|||0|7,5|1||Parlogis hf|Parlogis - óskráð lyf|Lyf við vörtum og líkþornum||||5731|9293||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|9302|14208|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||9302||9302|14208||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|114923|149039|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||114923||114923|149039||1 590135|C10AA0107|Simvastatin LYFIS|filmhtfl|10|mg|100|stk|1|glas||C10AA01|01.12.2016||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|1693|2093|lyfalmen|V0108|2093|2|100|0|33,3400|LYFIS ehf|LYFIS ehf|Simvastatín||500||500|2093||2 590252|G04BE0312|Granpidam|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.01.2018||R|1|0|0|1|0|1|ACC|0|0|0|100|XEU|32943|44737|lyfsjukr|||2|90|0|36,0000|Artasan ehf|Accord Healthcare Limited|Síldenafíl||32943||32943|44737||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|TCA|0|0|0|100|XEU|2422|2790|lyfalmen|V0041|2790|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1006||1006|2790||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|133225|171802|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||133225||133225|171802||1 590947|H05BX0105|Cinacalcet Accord|filmhtfl|60|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|ARD|0|0|0|100|SEK|28678|14669|lyfalmen|V0721|14463|2|28|0|28,0000|Artasan ehf|Accord Healthcare Limited|Cinacalcet||9637||9637|14669||0 591260|N06DA0302|Exelon (Lyfjaver)|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|10235|15492|lyfalmen|V0347|15492|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||10235||10235|15492||3 591405|L04AA2901|Xeljanz|filmhtfl|5|mg|56|stk|1|þpakki||L04AA29|01.12.2017||R|0|1|0|1|0|1|PHH|0|1|0|100|DKK|96424|125027|lyfsjukr|||1|56|0|28,0000|Icepharma hf|Pfizer Limited|Tofacitinib||96424||96424|125027||2 591418|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.01.2018||R|0|0|0|0|0|0|MAR|0|0|1|100|DKK|1636|3657|lyfalmen|V0561|3128|1|100|0||Icepharma hf|Aspen Pharma|Lídókaín||1636||1636|3657||2 591540|J01CR0202|Augmentin|töflur|625|mg|21|stk|1|þpakki|500+125 mg|J01CR02|01.09.2015||R|0|0|0|0|0|0|GPH|0|0|1|100|DKK|1203|3061|lyfalmen|V0168|2549|1|21|0|10,0000|Vistor hf|GlaxoSmithKline Pharma A/S|Amoxicillín og beta-laktamasa hemill ||1203||1203|3061||1 592378|D08AC0201|Hibiscrub|húðlausn|40|mg/ml|500|ml|1|glas||D08AC02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|1671|3705|lyfalmen|||0|500|1||Distica|Distica - óskráð lyf|Klórhexidín||||1671|3705||1 592418|M01AH0504|Etoricoxib Krka|filmhtfl|60|mg|30|stk|1|þpakki||M01AH05|01.08.2017||R|1|0|0|0|G|0|KNM|0|0|1|100|IKR|2308|2988|lyfalmen|V0825|2988|2|30|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Etoríkoxíb||1150||1150|2988||2 592498|QC09CA0701|Semintra|mixtúra|4|mg/ml|30|ml|1|glas|fyrir ketti|QC09CA07|01.04.2016||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|3004|5870|vetalmen|||1|30|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Telmisartanum||3004||3004|5870||1 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|þpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|GEB|0|0|0|100|XEU|585047|715871|lyfsjukr|||1|30|0||Vistor hf|Genzyme Europe B.V.|Vandetaníb||570678||570678|715871||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|408|1966|lyfalmen|V0238|798|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||408||408|1966||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|719|2395|lyfalmen|V0238|2395|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||719||719|2395||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1053|2854|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1053||1053|2854||2 593438|N06AX2106|Duloxetin W&H|sþ-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.08.2015||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|6109|6226|lyfalmen|V0694|5196|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Duloxetín||3503||3503|6226||2 594099|A10BB1203|Glimepirid Bluefish|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.12.2016||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|919|2093|lyfalmen|V0023|2093|2|90|0|135,0000|Vistor hf|Bluefish Pharmaceuticals AB|Glímepíríð||500||500|2093||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MEA|0|0|1|100|DKK|14829|21816|lyfalmen|||1|12|0|32,0000|Icepharma hf|Meda AB|Tríamcínólón||14829||14829|21816||2 595198|G04BD1201|Betmiga|forðatfl|25|mg|90|stk|1|þpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|13682|20237|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||13682||13682|20237||1 595653|J01CR0205|Spectracillin|filmhtfl|1000|mg|10|stk|1|þpakki|875+125 mg|J01CR02|01.01.2017||R|0|0|0|0|0|0|WEH|0|0|1|100|IKR|752|1978|lyfalmen|V0169|1594|2|10|0|8,7500|Williams & Halls efh|Williams & Halls ehf|Amoxicillín og beta-laktamasa hemill ||416||416|1978||2 595966|B02BD0207|ReFacto AF|sts|250|ae|1|áf.spr|1|pakki|+leysir|B02BD02|01.11.2014||R|0|0|0|1|0|1|PIZ|0|1|0|100|DKK|18433|26776|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Ltd|Storkuþáttur VIII||18433||18433|26776||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GPH|0|0|0|100|DKK|453|2028|lyfalmen|||1|0,5|0||Vistor hf|GlaxoSmithKline Pharma A/S|Inflúensa, hreinsaðir mótefnavakar||453||453|2028|31.01.2018|1 596031|J01FF0101|Dalacin|mixt.kyr|15|mg/ml|80|ml|1|glerfl||J01FF01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3450|6154|lyfalmen|||0|80|1||Parlogis hf|Parlogis - óskráð lyf|Klindamýcín||||3450|6154||2 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|43703|58346|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||43703|58346||1 596523|QP52AC5501|Drontaste|töflur|344|mg|2|stk|1|þpakki|150+144+50 mg|QP52AC55|01.10.2017||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|873|1505|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|Febantel, Pyrantelembonat,Prazikvantel||873||873|1505||2 596881|N05CM1801|Dexdor|irþ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|13457|19927|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||13457||13457|19927||1 597041|R06AX2702|Aerius (Lyf og heilsa)|filmhtfl|5|mg|90|stk|1|þpakki||R06AX27|01.06.2016||R|1|0|0|0|G|0|HOL|0|0|1|100|NOK|2684|5099|lyfalmen|V0458|2627|3|90|0|90,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||2684||2684|5099||2 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PLS|0|0|1|100|DKK|1406|3340|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1406||1406|3340||1 597433|L01XC1101|Yervoy|stþ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|509051|639224|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||509051||509051|639224||1 597565|L03AB1301|Plegridy|stl|125|mcg|2|áf.spr|1|pakki||L03AB13|01.07.2015||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|97002|125758|lyfsjukr|||1|2|0|28,0900|Icepharma hf|Biogen Idec Ltd|Peginterferón beta-1a||97002||97002|125758||2 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|TRI|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Trimb Healthcare AB|Ekónazól|||||||1 597814|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.01.2018||R|1|0|0|0|G|0|BFP|0|0|0|100|XEU|1976|2505|lyfalmen|V0089|2505|2|98|0|98,0000|Vistor hf|Bluefish Pharmaceuticals AB|Lósartan og þvagræsilyf||799||799|2505||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|1987|4140|lyfalmen|||1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíð||1987||1987|4140||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNP|0|0|1|100|XEU|295|1811|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||295||295|1811||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RTH|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Alvogen|ratiopharm GmbH|Íbúprófen|||||||2 598908|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|þpakki||N07BA01|01.12.2016||L|0|0|0|0|0|0|SDF|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|GlaxoSmithKline Consumer Healthcare A/S|Nikótín|||||||1 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||2011||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|þpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PIZ|0|1|0|100|DKK|487439|612345|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd|Axitinib||487439||487439|612345||1 599176|L01XA0303|Oxaliplatin Actavis|irþ|5|mg/ml|20|ml|1|hgl|lausn|L01XA03|01.03.2018||R|0|0|0|1|0|1|GRP|0|0|0|100|XEU|4631|7779|lyfsjukr|||2|20|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Oxalíplatín||4631||4631|7779||1 599248|QC01CE9001|Vetmedin vet.|tuggutfl|1,25|mg|100|stk|1|þpakki|fyrir hunda|QC01CE90|01.04.2017||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|2859|5595|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pimobendan||2859||2859|5595||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|3512|6833|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||3512||3512|6833|31.01.2018|2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og aðrar óvirkar samsetningar|||||2260|| 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|24121|33578|lyfalmen|||1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||24121|33578||1 599531|H05BX0105|Cinacalcet Accord|filmhtfl|30|mg|28|stk|1|þpakki||H05BX01|01.02.2018||R|1|0|0|0|0|0|ARD|0|0|0|100|SEK|15513|11911|lyfalmen|V0720|11407|2|28|0|14,0000|Artasan ehf|Accord Healthcare Limited|Cinacalcet||7633||7633|11911||0 599737|N05AX1211|Aripiprazole Mylan Pharma|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2017||R|1|1|0|0|G|0|MAT|0|0|0|100|SEK|8158|6908|lyfalmen|V0684|4502|2|56|0|56,0000|Icepharma hf|Pharmathen S.A.|Aripiprazól||3998||3998|6908||2 599883|N06AX1610|Venlafaxine Bluefish|forðahlk|75|mg|100|stk|1|þpakki|hart|N06AX16|01.05.2015||R|1|0|0|0|G|0|BFP|0|0|0|100|IKR|2859|3194|lyfalmen|V0334|2741|2|100|0|75,0000|Vistor hf|Bluefish Pharmaceuticals AB|Venlafaxín||1300||1300|3194||1 655392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|pakki||J04AK01|01.10.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4095|7041|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Pýrazínamíð||||4095|7041||1 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.04.2016||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|3316|5969|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráð lyf|Amfetamín||||3316|5969||1 692980|N05CH0103|Melatonin|töflur|3|mg|100|stk|1|pakki||N05CH01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|4744|7935|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Melatonin||||4744|7935||1 751350|V03AB0003|Succicaptal|hylki|200|mg|15|stk|1|pakki||V03AB|01.03.2016||R|0|0|0|0|0|0|LVE|0|0|1|100|DKK|52113|68983|lyfalmen|||0|15|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|lyf gegn eitrunum||||52113|68983||3 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|1024|2814|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Bíótín||||1024|2814||2 801234|A06AB0204|Custodiol|lausn|1|poki|1000|ml|6|pokar||A06AB02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|DKK|302525|292138|lyfsjukr|||0|6000|1||Parlogis hf|Parlogis - óskráð lyf|Bisakódýl||229980||229980|292138||2 801591|N01AF0001|Brevimytal|sts|500|mg|1|hgl|1|pakki||N01AF|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2424|4741|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Barbiturates, Plain||||2424|4741||2 801940|C02DA0101|Proglicem|töflur|25|mg|100|stk|1|pakki||C02DA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|6238|9991|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|diazoxide||||6238|9991||1 806901|M01AB0505|Voltaren|eþ-stíll|12,5|mg|10|stk|1|pakki||M01AB05|01.12.2017||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|752|2440|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Díklófenak||||752|2440||1 860004|N06AX0602|Nefazodone|töflur|100|mg|60|stk|1|glas||N06AX06|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|NOK|14869|21871|lyfalmen|||0|60|1|15,0000|Distica|Distica - óskráð lyf|nefazodone||||14869|21871||1 862112|C01CA0105|Thomasin|töflur|25|mg|100|stk|1|glas||C01CA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|2772|5220|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráð lyf|etilefrine||||2772|5220||1 910572|S01BA0701|Flucon|augndr|0,1|%|5|ml|1|glas||S01BA07|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|1603|3611|lyfalmen|||0|5|1||Distica|Distica - óskráð lyf|fluorometholone||||1603|3611||1 911798|V04CX0004|Verdye|sts|25|mg|5|hgl|1|pakki||V04CX|01.08.2016||R|0|0|0|0|0|1|PCO|0|0|0|100|XEU|49224|65329|lyfsjukr|||0|5|1||Distica|Distica - óskráð lyf|Önnur sjúkdómsgreiningarefni||||49224|65329||1 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|þpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|1966|4111|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráð lyf|Dómíperídón||1966||1966|4111||1 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|998|2779|lyfalmen|||0|3,5|1||Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||||998|2779||1 926975|A06AD0301|Magnesium Peroxíd|duft|15|%|1|kg|1|pakki||A06AD03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|21438|30185|lyfalmen|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|magnesium peroxide||||21438|30185||1 928294|C01CA1701|Gutron|töflur|2,5|mg|100|stk|1|glas||C01CA17|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4436|6883|lyfalmen|||0|100|1|8,0000|Parlogis hf|Parlogis - óskráð lyf|midodrine||3980||3980|6883||2 936734|C01DA0212|Nitrolingual|spray|400|mcg|1|fl|1|pakki||C01DA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|1138|2971|lyfalmen|||0|1|1|32,0000|Distica|Distica - óskráð lyf|Glýcerýltrínítrat||||1138|2971||1 937980|C01CA2403|Adrenalin|stl|0,1|mg|10|ml|1|dæla||C01CA24|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2580|4956|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Adrenalín tartrat||||2580|4956||2 938368|V03AB0101|Kraaksirap|mixtúra|100|mg/g|60|ml|1|fl||V03AB01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|7320|11480|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|Ipecacuanha||||7320|11480||2 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|16359|23921|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Papaverín||||16359|23921||2 938582|P01AX0501|Mepacrin|stl|10|mg/ml|50|ml|1|hgl||P01AX05|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|10254|15519|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Mepacrine||||10254|15519||2 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|60053|65510|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Pentósan pólýsúlfat natríum||49367||49367|65510||2 938665|A12CX0001|K-Phos Neutral|töflur|||100|stk|1|glas||A12CX00|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|9783|14870|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Málmlyf ýmisleg||||9783|14870||2 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|GBP|11092|16672|lyfalmen|||0|10|1|100,0000|Distica|Distica - óskráð lyf|Prógesterón||||11092|16672||1 942468|A04AD0510|Vogalene - Distica|hylki|15|mg|20|stk|1|þpakki||A04AD05|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|6645|10551|lyfalmen|||0|20|1|20,0000|Distica|Distica - óskráð lyf|Metópímazín||||6645|10551||1 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|4803|7279|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráð lyf|Kortisón||4268||4268|7279||1 944852|A06AX0102|Glycerol infant|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|545|2155|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Glýceról||545||545|2155||2 944985|A06AX0103|Glycerol adult|eþ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|2319|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Glýceról||664||664|2319||2 945404|H03AA0202|Thyrotardin|sts|100|mcg|1|hgl|1|pakki||H03AA02|01.10.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|10456|15797|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|liothyronine sodium||||10456|15797||2 945503|B02BC0001|Thrombin Topical (Bovine)|vefjalyf|5000|ae|1|hgl|1|pakki|5 ml leysir|B02BC|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|15163|22275|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Lyf til að minnka staðbundna blæðingu||||15163|22275||2 945529|V04CC0301|Kinevac|stl|5|mcg|10|hgl|1|pakki||V04CC03|01.06.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|167023|213837|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Sincalide||||167023|213837||2 945785|H02AB1301|Calcort|töflur|6|mg|100|stk|1|glas||H02AB13|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|5690|9237|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráð lyf|deflazacort||||5690|9237||1 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4561|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|4561||1 946163|V03AB1901|Anticholium|stl|0,4|mg/ml|5|ml|5|lykjur||V03AB19|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|10623|16026|lyfsjukr|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Physostigmine||||10623|16026||2 946246|G04BX0601|Phenazopyridin|töflur|100|mg|100|stk|1|glas||G04BX06|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|36025|48635|lyfalmen|||0|100|1|17,0000|Parlogis hf|Parlogis - óskráð lyf|phenazopyridine||||36025|48635||2 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1340|3249|lyfalmen|||0|50|1|25,0000|Parlogis hf|Parlogis - óskráð lyf|Koffeín||||1340|3249||2 947252|H03AA0109|L-Thyroxin|stl|0,5|mg/ml|5|ml|1|glas||H03AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|12046|13777|lyfalmen|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Levótýroxínnatríum||8989||8989|13777||2 947260|D08AX0002|Monsel'S Ferric|lausn|||500|ml|1|stk||D08AX|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|10373|15682|lyfsjukr|||0|500|1||Parlogis hf|Parlogis - óskráð lyf|Ýmis sótthreinsandi lyf||||10373|15682||2 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|7418|11615|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráð lyf|Kortisón||7418||7418|11615||2 947997|B01AD0401|Urokinase|sts|10000|ae|1|hgl|1|pakki||B01AD04|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|6532|10396|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Urokinase||||6532|10396||2 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1702|3748|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Dexametasón||||1702|3748||2 948622|A07BA0106|Actidose M/Sorbitoli|mixtúra|25|g|120|ml|1|fl||A07BA01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4235|7234|lyfalmen|||0|120|1||Parlogis hf|Parlogis - óskráð lyf|Lyfjakol||||4235|7234||2 948630|R03CA0201|Efedrin|töflur|15|mg|28|stk|1|glas||R03CA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4560|7681|lyfalmen|||0|28|1|8,0000|Parlogis hf|Parlogis - óskráð lyf|Efedrínhýdróklóríð||||4560|7681||2 949159|N04BB0103|PK Merz|töflur|100|mg|100|stk|1|pakki||N04BB01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|11829|17686|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráð lyf|amantadine||||11829|17686||1 949620|G03DA0401|Utrogest|hylki|100|mg|30|stk|1|pakki||G03DA04|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|1995|4151|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Prógesterón||||1995|4151||2 949638|H02AB0606|Prednisolone|freyðit|5|mg|30|stk|1|pakki||H02AB06|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2110|4309|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Prednisólón||||2110|4309||2 949737|A11DA0104|Vitamin B1|stl|50|mg/ml|2|ml|5|lykjur||A11DA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|580|2203|lyfalmen|||0|10|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Thiamine (vit B1)||||580|2203||2 949828|C03AA0401|Diuril|mixtúra|50|mg/ml|237|ml|1|glerfl||C03AA04|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|19475|28210|lyfalmen|||0|237|1||Parlogis hf|Parlogis - óskráð lyf|Chlorothiazide||||19475|28210||2 949969|L01XB0102|Natulan|hylki|50|mg|50|stk|1|pakki||L01XB01|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|65885|86402|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|procarbazine||||65885|86402||2 950403|A07BA0105|Actidose Aqua|mixtúra|25|g|120|ml|1|fl||A07BA01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4350|7392|lyfalmen|||0|120|1||Parlogis hf|Parlogis - óskráð lyf|Lyfjakol||||4350|7392||2 950528|D05BA0202|Meladinine|töflur|10|mg|50|stk|1|pakki||D05BA02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|10320|15609|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|methoxsalen||||10320|15609||2 950635|J01CE0805|Tardocillin|stl|1,2|millj ae|4|ml|1|pakki||J01CE08|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|4838|8064|lyfsjukr|||0|4|1||Parlogis hf|Parlogis - óskráð lyf|benzathine benzylpenicillin||||4838|8064||2 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|1335|3242|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Dexametasón||||1335|3242||2 950982|P01BD0101|Daraprim|töflur|25|mg|30|stk|1|pakki||P01BD01|01.12.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2960|5479|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Pyrimethamine||||2960|5479||2 951287|J01CA0101|Ampicillin|sts|1|g|10|hgl|1|pakki||J01CA01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|4465|7551|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Ampicillín||||4465|7551||2 951336|N02AA0107|Morfinmixtura|mixtúra|10|mg/5ml|100|ml|1|glas||N02AA01|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|482|2068|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||||482|2068||2 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|4726|7279|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráð lyf|Hýdrókortisón||4268||4268|7279||1 951641|J01EC0201|Sulfadiazin|töflur|500|mg|100|stk|1|pakki||J01EC02|01.02.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7234|11362|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Sulfadiazine||||7234|11362||2 951964|R03DA0503|Aminophylline|stl|25|mg/ml|10|ml|10|lykjur||R03DA05|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|11626|17407|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|aminophylline||||11626|17407||2 952251|J01CA0101|Ampicillin|sts|500|mg|10|hgl|1|pakki||J01CA01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2871|5357|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Ampicillín||||2871|5357||2 952424|V04CX0003|Patentblau|stl|2,5|%|2|ml|5|lykjur||V04CX|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|50928|67484|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Önnur sjúkdómsgreiningarefni||||50928|67484||2 952516|S01EC0101|Diamox|sts|500|mg|1|hgl|1|pakki||S01EC01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|1921|4049|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Acetazólamíð||||1921|4049||2 952532|D05AD0201|Oxsoralene|hylki|10|mg|50|stk|1|pakki||D05AD02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|5936|9575|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Methoxsalen||||5936|9575||2 952574|B05XA0304|Natriumklorid|irl|0,45|%|500|ml|10|stk|VIAFLEX|B05XA03|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|7051|11110|lyfsjukr|||0|5000|1||Parlogis hf|Parlogis - óskráð lyf|Natríumklóríð||||7051|11110||2 952623|L01BB0302|Thioguanin-GSK|töflur|40|mg|25|stk|1|pakki||L01BB03|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|40641|48479|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|tioguanine||35902||35902|48479||2 952631|C01CA0402|Dopamin Fresenius|irþ|40|mg/ml|5|ml|10|lykjur||C01CA04|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|9867|14986|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Dópamín||||9867|14986||2 952699|H03AA0102|L-Thyroxin Henning|töflur|100|mcg|100|stk|1|glas||H03AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|980|2754|lyfalmen|||0|100|1|67,0000|Parlogis hf|Parlogis - óskráð lyf|Levótýroxínnatríum||||980|2754||2 952722|J01AA0802|Minocyclin|hylki|100|mg|50|stk|1|pakki||J01AA08|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5743|9310|lyfalmen|||0|50|1|25,0000|Parlogis hf|Parlogis - óskráð lyf|minocycline||||5743|9310||2 952772|N07AX0301|Evoxac|hylki|30|mg|100|stk|1|pakki||N07AX03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|103000|134210|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|cevimeline ||||103000|134210||2 952897|C03CC0101|Edecrin|töflur|25|mg|100|stk|1|pakki||C03CC01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|84806|110333|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Etacrínsýra||||84806|110333||2 953051|V03AB0601|Natrium Thiosulfat|stl|10|%|10|ml|5|lykjur||V03AB06|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2052|4229|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Thiosulfate||||2052|4229||2 953366|C04AX0202|Dibenzyran|hylki|10|mg|100|stk|1|þpakki||C04AX02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|21759|30591|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|phenoxybenzamine||||21759|30591||2 953431|J04AB0203|Rifadin|mixtúra|20|mg/ml|120|ml|1|glas||J04AB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1836|3932|lyfalmen|||0|120|1|4,0000|Parlogis hf|Parlogis - óskráð lyf|Rífampicín||||1836|3932||2 953613|H03AA0501|Armour Thyroid|töflur|60|mcg|100|stk|1|pakki||H03AA05|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|11649|17439|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|thyroid gland preparations ||||11649|17439||2 954083|N06AA0201|Tofranil|töflur|25|mg|100|stk|1|glas||N06AA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|3772|6597|lyfalmen|||0|100|1|25,0000|Distica|Distica - óskráð lyf|imipramine||||3772|6597||1 954364|N06AX0501|Trazedone|töflur|50|mg|100|stk|1|pakki||N06AX05|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1855|2991|lyfalmen|||0|100|1|17,0000|Parlogis hf|Parlogis - óskráð lyf|trazodone||1152||1152|2991||2 954421|C03CA0112|Furosemide|mixtúra|10|mg/ml|60|ml|1|pakki||C03CA01|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2673|5084|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|Fúrósemíð||||2673|5084||2 954463|G03XA0102|Danol|hylki|100|mg|60|stk|1|pakki||G03XA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6252|10010|lyfalmen|||0|60|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|danazol||||6252|10010||2 954471|A07EA0201|Colifoam|eþ-froða|100|mg/g|20,8|g|1|sett||A07EA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7483|11705|lyfalmen|||0|20,8|1|14,0000|Parlogis hf|Parlogis - óskráð lyf|hydrocortisone||||7483|11705||2 954497|G03XA0102|Danol|hylki|200|mg|60|stk|1|pakki||G03XA01|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6780|10737|lyfalmen|||0|60|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|danazol||6780||6780|10737||2 954629|N05AB0206|Lyogen|töflur|1|mg|50|stk|1|pakki||N05AB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2060|4240|lyfalmen|||0|50|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|fluphenazine||||2060|4240||2 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|99112|128427|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||99112||99112|128427||2 954934|S01KA0202|Sic Ophtal|augndr|3,2|mg/ml|10|ml|3|glös||S01KA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1466|3423|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|hypromellose||||1466|3423||2 955239|A11GA0107|Vitamin C|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|680|2341|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Askorbínsýra||||680|2341||2 955528|J04AC0103|Isozid|töflur|100|mg|100|stk|1|pakki||J04AC01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1895|4013|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Ísóníazíð||||1895|4013||2 955578|A03AA0401|Duspatalin|töflur|135|mg|50|stk|1|glas||A03AA04|01.12.2015||R|0|0|0|0|G|0|LDR|0|0|0|100|IKR|2283|4547|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Mebeverín||||2283|4547||2 955601|N04AA0104|Trihexyphenidyl|töflur|2|mg|84|stk|1|glas||N04AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4092|7037|lyfalmen|||0|84|1|17,0000|Parlogis hf|Parlogis - óskráð lyf|trihexyphenidyl||||4092|7037||2 955643|C03DA0101|Aldactone|stl|20|mg/ml|10|ml|10|stk||C03DA01|01.02.2016||R|0|0|0|0|G|0|LDR|0|0|0|100|IKR|6780|10737|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Spírónólaktón||||6780|10737||2 955825|V03AC0202|Ferriprox|töflur|500|mg|100|stk|1|pakki||V03AC02|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|38897|52267|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|deferiprone||||38897|52267||2 956005|N05BA0604|Tavor|stl|2|mg|10|lykja|1|þpakki||N05BA06|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|9866|14984|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Lórazepam||||9866|14984||2 956104|A11DA0106|Vitamin B1 ratiopharm|töflur|200|mg|100|stk|1|pakki||A11DA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1958|3781|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Thiamine (vit B1)||1726||1726|3781||2 956352|R03AB0003|Racepinephrine|innönd.l|2,25|%|0,5|ml|30|hgl||R03AB|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|9783|14870|lyfalmen|||0|15|1||Parlogis hf|Parlogis - óskráð lyf|Non-Selective Beta-Adrenoreceptor Agonists||||9783|14870||2 956427|N01AH0602|Ultiva|sts|2|mg|5|hgl|1|pakki||N01AH06|01.02.2016||R|0|0|1|0|0|1|LDR|0|0|0|100|IKR|9563|14567|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Remífentaníl||||9563|14567||2 956534|N02CX0201|Catapresan|töflur|100|mcg|100|stk|1|þpakki||N02CX02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2968|5490|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Klónidín||||2968|5490||2 956609|N03AA0205|Phenobarbital|stl|200|mg/ml|1|ml|10|hgl|og leysir|N03AA02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|19623|28414|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Fenemal||||19623|28414||2 956667|B05CB0201|Sodium Citrate|mixtúra|300|mmol/L|30|ml|10|stk||B05CB02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|12694|18877|lyfsjukr|||0|300|1||Parlogis hf|Parlogis - óskráð lyf|Natríum citrate||||12694|18877||2 956899|H03BA0202|Propycil|töflur|50|mg|100|stk|1|glas||H03BA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3959|6854|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráð lyf|propylthiouracil||||3959|6854||2 957178|R05CB0201|Bisolvon|töflur|8|mg|50|stk|1|þpakki||R05CB02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2168|4389|lyfalmen|||0|50|1|17,0000|Distica|Distica - óskráð lyf|bromhexine||||2168|4389||1 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|22216|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|22216||2 957665|A12BA0102|Kalíum Klórið - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2996|4997|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríð||2610||2610|4997||2 957714|N07BC0203|Metadone mixtúra|mixtúra|1|mg/ml|500|ml|1|fl||N07BC02|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|0|100|GBP|3154|5746|lyfalmen|||0|500|1||Parlogis hf|Parlogis - óskráð lyf|Metadón||||3154|5746||2 957764|A11CC0501|Dekristol|hylki|20000|ae|50|stk|1|pakki||A11CC05|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4345|7385|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|colecalciferol||||4345|7385||2 957855|A11HA0205|Vitamin B6 Hevert (pyridoxin)|töflur|100|mg|100|stk|1|glas||A11HA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1584|3585|lyfalmen|||0|100|1|63,0000|Parlogis hf|Parlogis - óskráð lyf|Pýrídoxín||||1584|3585||2 957871|L01DA0101|Cosmegen|sts|500|mcg|1|hgl|1|pakki||L01DA01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|16458|24058|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Dactinomycin||||16458|24058||2 957889|N07AB0101|Miostat|stl|0,01|%|1,5|ml|12|lykjur||N07AB01|01.01.2017||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|30576|41743|lyfsjukr|||0|18|1||Parlogis hf|Parlogis - óskráð lyf|Carbacholum||||30576|41743||2 958621|D05AA0005|Exorex|áburður|1|%|250|ml|1|fl||D05AA|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5458|8917|lyfalmen|||0|250|1||Parlogis hf|Parlogis - óskráð lyf|Tjörur||||5458|8917||2 958704|A09AA0214|Viokase|töflur|800|ae|100|stk|1|pakki||A09AA02|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|36881|49717|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Hvatablöndur (lípasi, próteasi o.s.frv.)||||36881|49717||2 958829|A06AD0002|Miralax|lausnduf|||238|g|1|stauk||A06AD00|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2093|4286|lyfalmen|||0|238|1||Parlogis hf|Parlogis - óskráð lyf|Hægðalyf með osmótíska verkun||||2093|4286||2 958928|R06AA0202|Diphenhydramin|stl|50|mg/ml|1|ml|25|stk||R06AA02|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5996|7853|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Dífenhýdramín||4685||4685|7853||2 958936|M01AB0108|Liometacen|stl|50|mg|6|lykjur|1|pakki||M01AB01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2365|4660|lyfalmen|||0|6|1||Parlogis hf|Parlogis - óskráð lyf|Indómetacín||||2365|4660||2 958986|V03AF0401|Isovorin|töflur|7,5|mg|30|stk|1|pakki||V03AF04|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7884|12256|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Kalsíumlevófólínat||||7884|12256||2 959059|N04BC0901|Neupro - Parlogis|forðapl|4|mg/sólh|28|stk|1|pakki||N04BC09|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|30156|33372|lyfalmen|||0|28|1|19,0000|Parlogis hf|Parlogis - óskráð lyf|rotigotine||23958||23958|33372||2 959067|A12CA0103|Natriumklorid|töflur|600|mg|100|stk|1|glas||A12CA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3047|4337|lyfalmen|||0|100|1|60,0000|Parlogis hf|Parlogis - óskráð lyf|natríum klóríð||2130||2130|4337||2 959075|C10AD0202|Niacin|forðatfl|500|mg|90|stk|1|þpakki||C10AD02|01.04.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|49761|66008|lyfalmen|||0|90|1||Parlogis hf|Parlogis - óskráð lyf|nicotinic acid||||49761|66008||2 959116|N05AA0107|Chlorpromazin mixtúra|mixtúra|5|mg/ml|150|ml|1|fl||N05AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|940|2699|lyfalmen|||0|150|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||||940|2699||2 959124|N05AA0107|Chlorpromazin mixtúra|mixtúra|20|mg/ml|150|ml|1|fl||N05AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1598|3604|lyfalmen|||0|150|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||||1598|3604||2 959314|A16AA0103|Biocarn|mixtúra|303,03|mg/ml|50|ml|1|fl||A16AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5397|8833|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|levocarnitine||||5397|8833||2 959372|G03CA0103|Ethinyl Estradiol|töflur|50|mcg|15|stk|1|pakki||G03CA01|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|2586|4006|lyfalmen|||0|15|1|30,0000|Parlogis hf|Parlogis - óskráð lyf|Ethinýl estradíól||1890||1890|4006|31.12.2017|2 959398|N06BC0102|Caffeine Citrate|stl|25|mg/ml|2|ml|10|stk||N06BC01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3175|5321|lyfsjukr|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Koffeín||2845||2845|5321||2 959497|N05AA0110|Largactil|stl|25|mg/ml|2|ml|10|stk||N05AA01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2565|4935|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||||2565|4935||2 959835|N03AD0103|Ethosuximide|hylki|250|mg|56|stk|1|pakki||N03AD01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|36199|48855|lyfalmen|||0|56|1|11,0000|Distica|Distica - óskráð lyf|ethosuximide||||36199|48855||1 959885|N05AA0111|Chlorpromazine Almus|töflur|50|mg|28|stk|1|þpakki||N05AA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1403|3336|lyfalmen|||0|28|1|5,0000|Distica|Distica - óskráð lyf|chlorpromazine||||1403|3336||1 960486|G04BX1301|Rimso-50 Parlogis|lausn|50|%|50|ml|1|hgl||G04BX13|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|77314|100857|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|dimethyl sulfoxide||||77314|100857||2 960585|J06BB0405|Hepatect|stl|50|ae/ml|40|ml|1|hgl||J06BB04|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|269000|275263|lyfsjukr|||0|40|1||Parlogis hf|Parlogis - óskráð lyf|hepatitis B immunoglobulin||216412||216412|275263||2 960642|J06BB0405|Hepatect|stl|50|ae/ml|10|ml|1|hgl||J06BB04|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|87837|114166|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|hepatitis B immunoglobulin||||87837|114166||2 960692|A05AA0205|Ursofalk mixtúra|mixtúra|50|mg/ml|250|ml|1|flaska||A05AA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7170|11274|lyfalmen|||0|250|1||Parlogis hf|Parlogis - óskráð lyf|Úrsódeoxýkól sýra||||7170|11274||2 960717|C10AA0301|Pravastatin|töflur|40|mg|100|stk|1|pakki||C10AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3140|5727|lyfalmen|||0|100|1|133,0000|Parlogis hf|Parlogis - óskráð lyf|Pravastatín||||3140|5727||2 960791|A05AA0202|Ursofalk|hylki|500|mg|100|stk|1|pakki||A05AA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|16100|23565|lyfalmen|||0|100|1|67,0000|Parlogis hf|Parlogis - óskráð lyf|Úrsódeoxýkól sýra||||16100|23565||2 960981|N05AC0203|Thioridazin|töflur|25|mg|100|stk|1|pakki||N05AC02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1543|3529|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|thioridazine||||1543|3529||1 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|6983|11016|lyfalmen|||0|30|1|30,0000|Distica|Distica - óskráð lyf|Megestról||||6983|11016||1 961062|G02CB0401|Norprolac|töflur|0,075|mg|30|stk|1|glas||G02CB04|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|7378|11560|lyfalmen|||0|30|1|30,0000|Distica|Distica - óskráð lyf|quinagolide||||7378|11560||1 961252|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|10643|16054|lyfalmen|||0|100|1|13,0000|Distica|Distica - óskráð lyf|Brómókriptín||||10643|16054||1 961369|S01XA2021|Bion Tears - Parlogis|augndr|||0,4|ml|28|sk-hyl||S01XA20|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2203|4437|lyfalmen|||0|11,2|1||Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||||2203|4437||2 961468|C01DA0811|Isoket|irl|0,1|%|10|ml|10|stk||C01DA08|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3233|5855|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Ísósorbíð dínítrat||||3233|5855||2 961484|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1924|4053|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Prómetazín||||1924|4053||2 961509|S01XA1801|Restasis|augndr|0,05|%|0,4|ml|30|lykjur||S01XA18|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|21760|30592|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Ciclosporin||||21760|30592||2 961591|H02AB0906|Hydrocortisone Galen|töflur|10|mg|20|stk|1|þpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1607|3617|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||1607||1607|3617||2 961608|H02AB0905|Hydrocortisone|töflur|10|mg|25|stk|1|glas||H02AB09|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1000|2781|lyfalmen|||0|25|1|8,0000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||1000||1000|2781||2 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3990|6897|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||3990||3990|6897||2 961781|A03AB0201|Robinul|stl|0,2|mg/ml|5|lykjur|1|pakki||A03AB02|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3473|6185|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|glycopyrronium||||3473|6185|28.02.2018|2 961830|C08DA0109|Verapamil|stl|2,5|mg/ml|2|ml|5|hgl|5 mg/2 ml|C08DA01|01.08.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|650|2300|lyfalmen|||2|10|1||Parlogis hf|Parlogis - óskráð lyf|Verapamíl||||650|2300||2 961955|V04CD0501|Ghrh Ferring|sts|50|mcg|1|ml|5|lykjur|Frostþurrkað duft og leysir|V04CD05|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|124434|160868|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Somatorelin||||124434|160868||2 961997|D04AA0101|Anthisan|krem|2|%|25|g|1|túpa||D04AA01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1874|3984|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Thonzylamine||||1874|3984||2 962044|S01XA0304|NACL 5% Dispersa|augndr|400|mg|10|ml|1|glas||S01XA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2712|5138|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|sodium chloride, hypertonic||||2712|5138||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1803|3887|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1803||1803|3887||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1154|2993|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1154||1154|2993||2 962458|C01EB1002|Adenosine|stl|5|mg/ml|10|ml|1|hgl||C01EB10|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6616|10511|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Adenósín||||6616|10511||2 962474|A07AA0601|Humatin|hylki|250|mg|28|stk|1|þpakki||A07AA06|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|16470|24074|lyfalmen|||0|28|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|paromomycin||||16470|24074||2 962482|C01CE0201|Milrinone Lactate|stl|1|mg/ml|10|ml|10|hgl|áfylltur penni|C01CE02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|36159|31917|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Milrinone||22807||22807|31917||2 962763|A07AA1101|Normix|töflur|200|mg|12|stk|1|þpakki||A07AA11|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3153|5745|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|rifaximin||||3153|5745||2 963159|D08AC0501|Lavasept|þykkni|200|mg/ml|2|ml|5|stk||D08AC05|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|14427|21262|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Polihexanide||||14427|21262||2 963307|N02AA0102|Morfin|töflur|30|mg|100|stk|1|pakki||N02AA01|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|8764|13468|lyfalmen|||0|100|1|30,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||||8764|13468||2 963323|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr||J07BA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|14209|20962|lyfalmen|||0|0,5|1||Parlogis hf|Parlogis - óskráð lyf|Japönsk heilabólguveira óvirk||||14209|20962||2 963381|N05AD0801|Dehydrobenzperidol|stl|2,5|mg|1|ml|10|hgl||N05AD08|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|7974|12380|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Droperidol||||7974|12380||2 963456|L01AD0401|Zanosar|stl|1|g|20|ml|1|pakki||L01AD04|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|73744|96342|lyfsjukr|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Streptozocin||||73744|96342||2 963498|L01DB0101|Adriamycin|sts|50|mg|1|hgl|1|pakki||L01DB01|01.12.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|16791|19082|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Doxórúbicín||12843||12843|19082||2 963521|N06AF0301|Nardil|töflur|15|mg|100|stk|1|glas||N06AF03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|6131|9844|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|phenelzine||||6131|9844||1 963547|M01AC0101|Felden|hylki|20|mg|30|stk|1|pakki||M01AC01|01.06.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|GBP|2038|4210|lyfalmen|||0|30|1||Distica|Distica - óskráð lyf|Piroxicamum||||2038|4210||1 964058|M04AA0301|Uloric|töflur|80|mg|30|stk|1|glas||M04AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|39066|52481|lyfalmen|||0|30|1|30,0000|Parlogis hf|Parlogis - óskráð lyf|febuxostat||||39066|52481||2 964082|C02AB0102|Aldomet|töflur|500|mg|30|stk|1|pakki||C02AB01|01.02.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2656|5061|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Methyldopa||||2656|5061||2 964115|R06AX0202|Periactin-Martindale|töflur|4|mg|30|stk|1|þpakki||R06AX02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2200|4433|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|cyproheptadine||||2200|4433||2 964123|M03AC1101|Nimbex|stl|5|mg|2,5|ml|5|lykjur||M03AC11|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|4554|7673|lyfsjukr|||0|12,5|1||Parlogis hf|Parlogis - óskráð lyf|Cisatracurium ||||4554|7673||2 964131|C05AX0001|Anoheal|krem|2|%|30|g|1|pakki||C05AX|01.03.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|18840|27336|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Staðbundinnar notkunar við gyllinæð og sprungum||||18840|27336||2 964214|S01BA0104|Dexa-Sine|augndr|1|mg/ml|0,4|ml|50|sk-hyl||S01BA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|7790|12127|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Dexametasón||||7790|12127||2 964248|A03BA0303|Hyoscine|stl|0,4|mg/ml|1|ml|10|lykjur||A03BA03|01.04.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|11094|16675|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|hyoscyamine||||11094|16675||2 964298|M01AB0110|Indo-CT|eþ-stíll|50|mg|50|stk|1|pakki||M01AB01|01.10.2017||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2300|4571|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Indómetacín||||2300|4571||2 964339|N03AG0106|Depakote (DAC)|töflur|500|mg|100|stk|1|glas||N03AG01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6563|10438|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Valpróínsýra||||6563|10438||2 964355|M04AA0301|Uloric|töflur|40|mg|30|stk|1|glas||M04AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|49523|65707|lyfalmen|||0|30|1|15,0000|Parlogis hf|Parlogis - óskráð lyf|febuxostat||||49523|65707||2 964363|H03AA0108|Tirosint|hylki|0,05|mg|50|stk|1|glas||H03AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3006|5542|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Levótýroxínnatríum||||3006|5542||2 964438|C10AA0303|Pravastatin Ratiopharm|töflur|20|mg|100|stk|1|pakki||C10AA03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|5205|8569|lyfalmen|||0|100|1|67,0000|Distica|Distica - óskráð lyf|Pravastatín||||5205|8569||1 964503|N06AA0906|Saroten|töflur|10|mg|100|stk|1|pakki||N06AA09|01.05.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|546|2156|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Amitriptýlín||||546|2156||1 964561|L01CB0102|EPOSIN|stl|20|mg/ml|25|ml|10|lykjur||L01CB01|01.01.2016||R|0|0|0|0|0|1|PCO|0|0|0|100|IKR|37135|50039|lyfsjukr|||0|250|1||Distica|Distica - óskráð lyf|Etoposíð||||37135|50039||1 964686|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|9342|14263|lyfalmen|||0|50|1||Distica|Distica - óskráð lyf|saccharomyces boulardii||||9342|14263||1 964694|C07AA0701|Sotacor|töflur|80|mg|30|stk|1|þpakki||C07AA07|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1797|3878|lyfalmen|||0|30|1|15,0000|Distica|Distica - óskráð lyf|Sótalól||||1797|3878||1 964727|C01EB1002|Adenosine|stl|5|mg/ml|50|ml|10|stk||C01EB10|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|99128|128447|lyfalmen|||0|500|1||Parlogis hf|Parlogis - óskráð lyf|Adenósín||||99128|128447||2 964735|N01BB5205|Lidokain/Nafzolin|stl|34,17|mg/ml|30|ml|1|hgl|(34 mg+0,17 mg)/ml|N01BB52|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3297|5943|lyfsjukr|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Lídókaín í blöndum||||3297|5943||2 964769|A02BB0101|Cytotec|töflur|0,1|mg|60|stk|1|þpakki||A02BB01|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|||lyfalmen|||0|60|1|15,0000|Parlogis hf|Parlogis - óskráð lyf|Mísóprostól||||||30.11.2017|2 964777|G03FB0904|Öestronara|töflur|2|mg|84|stk|1|pakki||G03FB09|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|XEU|5452|8909|lyfalmen|||0|84|1||Parlogis hf|Parlogis - óskráð lyf|levonorgestrel and estrogen||||5452|8909||2 964826|J02AX0101|Ancotil|töflur|500|mg|100|stk|1|pakki||J02AX01|01.07.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|14953|21986|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Flucytosine||||14953|21986||2 964842|B05CB0101|Sodium Chloride|irl|3|%|500|ml|24|pokar|VIAFLEX|B05CB01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|31278|42631|lyfsjukr|||0|12000|1||Parlogis hf|Parlogis - óskráð lyf|Natríumklóríð||||31278|42631||2 964848|J02AA0105|Fungizone|irl|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.07.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2167|4388|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Amfóterícín||2167||2167|4388||2 964876|C10AA0301|Pravastatin|töflur|20|mg|100|stk|1|pakki||C10AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1743|3804|lyfalmen|||0|100|1|67,0000|Parlogis hf|Parlogis - óskráð lyf|Pravastatín||||1743|3804||2 964892|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|16096|23559|lyfalmen|||0|10|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|Granisetrón||||16096|23559||2 964909|M01AE0201|Miranax|töflur|550|mg|10|stk|1|glas||M01AE02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1350|3263|lyfalmen|||0|10|1|11,0000|Parlogis hf|Parlogis - óskráð lyf|Naproxen||||1350|3263||2 964925|P01BA0301|Primaquine|töflur|26,3|mg|100|stk|1|pakki||P01BA03|01.03.2017||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|37612|50642|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Primaquine||||37612|50642||2 964941|A03FA0116|Metoclopramide HCL|mixtúra|1|mg/ml|150|ml|1|pakki||A03FA01|01.06.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|4622|7767|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráð lyf|Metóklópramíð||||4622|7767||2 964967|N03AD0104|Petnidan|hylki|250|mg|100|stk|1|þpakki||N03AD01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7498|11725|lyfalmen|||0|100|1|20,0000|Parlogis hf|Parlogis - óskráð lyf|ethosuximide||||7498|11725||2 964975|A11EA0009|Multivit B forte|stl|||2|ml|5|lykjur||A11EA|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1780|3855|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|B-komplex, óblandað öðrum efnum||||1780|3855||2 964991|C09BA0802|Inhibace Plus|töflur|5|mg|28|stk|1|þpakki||C09BA08|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6251|10009|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|cilazapril and diuretics||||6251|10009||2 965006|J04AB0204|Eremfat|sts/irs|300|mg|1|hgl|1|pakki||J04AB02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|1418|3357|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Rífampicín||||1418|3357||2 965056|A16AA0104|Carnitin|töflur|333|mg|200|stk|1|glas||A16AA01|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|0|100|DKK|14140|20867|lyfalmen|||0|200|1|33,0000|Lyfjaver ehf|Lyfjaver - óskráð lyf|levocarnitine||||14140|20867||3 965345|J01BA0101|Kemicetine|stl|100|mg/ml|10|ml|1|hgl||J01BA01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3231|5852|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Chloramphenicol||||3231|5852||2 965478|J05AD0101|Foscavir|irl|24|mg/ml|250|ml|1|pakkar||J05AD01|01.03.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|37294|50240|lyfsjukr|||0|250|1||Parlogis hf|Parlogis - óskráð lyf|foscarnet||||37294|50240||2 965535|C09AA0212|Renitec|töflur|5|mg|98|stk|1|pakki||C09AA02|01.10.2017||R|0|0|0|0|0|0|LVE|0|0|0|100|NOK|1698|3742|lyfalmen|||0|98|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|Enalapríl||||1698|3742||3 965543|S01XA2101|Cystadrops 0,55%|augndr|0,55|%|5|ml|1|glas||S01XA21|01.12.2015||R|0|0|0|0|0|0|LVE|0|0|0|100|XEU|151953|195094|lyfalmen|||0|5|1||Lyfjaver ehf|Lyfjaver - óskráð lyf|mercaptamine ||||151953|195094||3 965626|P02CA0301|Zentel|töflur|400|mg|3|stk|1|þpakki||P02CA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2982|5509|lyfalmen|||0|3|1|3,0000|Parlogis hf|Parlogis - óskráð lyf|albendazole||||2982|5509||2 965642|C02AC0103|Catapres|stl|0,15|mg/ml|1|ml|5|stk||C02AC01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|874|2366|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|clonidine||698||698|2366||2 965676|J01FA0104|Abboticin|sts|1|g|1|hgl|1|pakki||J01FA01|01.01.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|1380|3304|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Erýtrómýcín||||1380|3304||2 965684|L01AD0101|Carmubris|duft|100|mg|1|stk|1|pakki||L01AD01|01.01.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|225504|286571|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Carmustine ||||225504|286571||2 965692|A07EC0103|Sulfasalazin|mixtúra|||500|ml|1|glas||A07EC01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|12901|19162|lyfalmen|||0|500|1||Parlogis hf|Parlogis - óskráð lyf|Súlfasalazín||||12901|19162||2 965759|N06AA0401|Anafranil|stl|25|mg|2|ml|5|stk||N06AA04|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1330|3236|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Klómípramín||||1330|3236||2 965816|L01CB0201|Vumon|sts|50|mg/ml|5|ml|10|hgl||L01CB02|01.03.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|30828|42061|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Tenípósíð||||30828|42061||2 965907|C10AB0502|Fenofibrate|hylki|100|mg|100|stk|1|pakki||C10AB05|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1673|3708|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|fenofibrate||||1673|3708||1 965923|S01FA0104|Atropin Pos 0,5%|augndr|0,5|%|10|ml|1|glas||S01FA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1046|2845|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|atropine||||1046|2845||1 965981|N06BX0306|Piracetam mixtúra|mixtúra|333|mg/ml|300|ml|1|fl||N06BX03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3107|5681|lyfalmen|||0|300|1||Distica|Distica - óskráð lyf|piracetam||||3107|5681||1 966062|N03AG0108|Dépakine|töflur|200|mg|40|stk|1|glas||N03AG01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1252|3128|lyfalmen|||0|40|1||Distica|Distica - óskráð lyf|Valpróínsýra||||1252|3128||1 966202|N03AB0208|Epinat|töflur|100|mg|100|stk|1|glas||N03AB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1269|3152|lyfalmen|||0|100|1|33,0000|Parlogis hf|Parlogis - óskráð lyf|Fenýtóín||||1269|3152||2 966294|V03AB0002|Natriumkalciumedetat|stl|100|mg/ml|10|ml|10|hgl||V03AB|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|25797|35698|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|lyf gegn eitrunum||||25797|35698||2 966369|N01BB0207|Versatis|plástur|5|%|30|stk|1|pakkar||N01BB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|26559|31750|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Lídókaín||22675||22675|31750||2 966393|N05AA0108|Chlorpromazine|töflur|25|mg|28|stk|1|þpakki||N05AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|590|2217|lyfalmen|||0|28|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||||590|2217|31.12.2017|2 966418|N05AA0108|Chlorpromazine|töflur|50|mg|28|stk|1|þpakki||N05AA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|670|2327|lyfalmen|||0|28|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||||670|2327|31.12.2017|2 966468|M04AB0103|Probecid|töflur|500|mg|50|stk|1|glas||M04AB01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2000|3903|lyfalmen|||0|50|1|25,0000|Parlogis hf|Parlogis - óskráð lyf|probenecid||1815||1815|3903||2 966492|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|16015|11480|lyfalmen|||0|98|1|98,0000|Parlogis hf|Parlogis - óskráð lyf|Eprosartan||7320||7320|11480||2 966559|H01AA0202|Synachten|stl|0,25|mg/ml|1|ml|10|stk||H01AA02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|29250|31180|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|tetracosactide||22225||22225|31180||2 966583|A12AA0303|Calcium Gluconate|stl|10|%|10|ml|1|pakki||A12AA03|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3125|5322|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|calcium gluconate||2846||2846|5322||2 966591|C01BB0102|LAT|hlaup|4|%|3|ml|1|túpa||C01BB01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4664|7824|lyfalmen|||0|3|1||Parlogis hf|Parlogis - óskráð lyf|Lídókaín||4664||4664|7824||2 966658|S01BA0501|Triesence|stl|40|mg/ml|1|ml|1|hgl||S01BA05|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|17436|25404|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Triamcinolone||||17436|25404||2 966682|C07AG0202|Dimitone|töflur|25|mg|56|stk|1|pakki||C07AG02|01.03.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|||lyfalmen|||0|56|1||Parlogis hf|Parlogis - óskráð lyf|Carvedílól||||||30.11.2017|2 966731|V03AB3301|Cyanokit|irs|5|g|1|hgl|1|pakki|duft og sett ekki leysir|V03AB33|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|113287|147004|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Hydroxocobalamin||||113287|147004||2 966757|N05AB0603|Modalina|töflur|1|mg|30|stk|1|glas||N05AB06|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1350|3263|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|trifluoperazine||||1350|3263||2 967408|L02AA0201|Estradurin|stl|80|mg|1|stk|1|pakkar||L02AA02|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|5287|8682|lyfalmen|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|polyestradiol phosphate||||5287|8682||2 967549|A12CB0102|Zinksulfat|irþ|4,4|mg/ml|10|ml|1|pakki||A12CB01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|9480|14453|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|zinc sulfate||||9480|14453||2 967565|A16AB0601|Sucraid|lausn|8500|ae/ml|118|ml|1|glas||A16AB06|01.12.2015||R|0|0|0|0|0|1|PCO|0|0|0|100|IKR|852487|1066362|lyfsjukr|||0|118|1||Distica|Distica - óskráð lyf|sacrosidase||||852487|1066362||1 967581|V03AB2401|Digifab|sts|40|mg|4|ml|1|hgl||V03AB24|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|190246|242720|lyfsjukr|||0|4|1||Parlogis hf|Parlogis - óskráð lyf|Digitalis Antitoxin||||190246|242720||2 967606|S01XA2102|Cysteamine|augndr|0,11|%|10|ml|1|glas||S01XA21|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|18917|27442|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|mercaptamine ||||18917|27442||2 967747|J05AB0104|Aciclovir|töflur|400|mg|56|stk|1|þpakki||J05AB01|01.05.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|GBP|1437|3383|lyfalmen|||0|56|1||Distica|Distica - óskráð lyf|Acíklóvír||||1437|3383||1 967755|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.2015||R|0|0|0|0|0|1|PCO|0|0|0|100|XEU|887|2626|lyfsjukr|||0|5|1|2,5000|Distica|Distica - óskráð lyf|Bíperíden||||887|2626||1 967771|N07CA0301|Sibelium|töflur|5|mg|60|stk|1|pakki||N07CA03|01.08.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4157|7127|lyfalmen|||0|60|1||Distica|Distica - óskráð lyf|Flunarizín||4157||4157|7127||1 967987|J01CA0418|Amoxicillin|sts|500|mg|10|hgl|1|pakki||J01CA04|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3645|6422|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Amoxicillín||||3645|6422||2 968042|D01AC0801|Fungoral|krem|2|%|30|g|1|túpa||D01AC08|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1253|3130|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Ketókónazól||||1253|3130||2 968068|D07XA0101|Widmer Pigmanorm|krem|||15|g|1|túpa||D07XA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2411|4723|lyfalmen|||0|15|1||Parlogis hf|Parlogis - óskráð lyf|Hydrocortisone||||2411|4723||2 968109|L04AA2501|Soliris|stl|10|mg/ml|30|ml|1|hgl||L04AA25|01.01.2016||R|0|0|0|1|0|1|LDR|0|0|0|100|XEU|||lyfsjukr|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Eculizumab ||||||30.11.2017|2 968167|C08DB0112|Diltiazem|stl|5|mg/ml|5|ml|5|stk||C08DB01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|30000|41014|lyfsjukr|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Diltíazem||||30000|41014||2 968183|M04AA0302|Adenuric|töflur|80|mg|28|stk|1|pakkar||M04AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7465|11680|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|febuxostat||||7465|11680||2 968216|L01AD0203|Ceenu|hylki|40|mg|20|stk|1|glas||L01AD02|01.12.2015||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|78470|102319|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|lomustine||||78470|102319||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|1598|3604|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1598||1598|3604||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|18870|27378|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|27378||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|11131|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|11131||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5436|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5436||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6429|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6429||2 968422|J01MA0101|Tarivid|töflur|200|mg|10|stk|1|pakki||J01MA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|GBP|2230|4474|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Ófloxacín||||2230|4474||1 968472|R03BA0109|Clenil Modulite|innúðal|100|mcg|200|skammtar|1|pakki||R03BA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4820|8039|lyfalmen|||0|200|1||Distica|Distica - óskráð lyf|beclometasone||||4820|8039||1 968498|C10AB0502|Fenofibrate|hylki|200|mg|100|stk|1|pakki||C10AB05|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4065|7000|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|fenofibrate||||4065|7000||1 968547|A11HA0206|Vitamin B6 (Pyridoxin)|stl|50|mg/ml|2|ml|5|lykjur||A11HA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|347|1883|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Pýrídoxín||||347|1883||1 968555|M01AB0109|Indomet ratiopharm|eþ-stíll|100|mg|50|stk|1|pakki||M01AB01|01.12.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|1439|3386|lyfalmen|||0|50|1||Distica|Distica - óskráð lyf|Indómetacín||||1439|3386||1 968571|N05AB0208|Modecate|stl|100|mg/ml|1|ml|5|lykjur||N05AB02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|10223|15476|lyfalmen|||0|5|1|5,0000|Distica|Distica - óskráð lyf|fluphenazine||||10223|15476||1 968604|A07DA0101|Reasec|töflur|2,5|mg|20|stk|1|pakki|2,5+0,025 mg|A07DA01|01.02.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3272|5909|lyfalmen|||0|20|1||Distica|Distica - óskráð lyf|Diphenoxylate||||3272|5909||1 968638|N05AA0112|Chlorpromazine Dr. Reddy´s|töflur|50|mg|28|stk|1|glas||N05AA01|01.05.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|1077|2887|lyfalmen|||0|28|1||Distica|Distica - óskráð lyf|chlorpromazine||||1077|2887||1 968993|C03CA0401|Torasemid|töflur|10|mg|100|stk|1|þpakki||C03CA04|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1097|2915|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|torasemide||||1097|2915||2 969008|L01AC0101|Tepadina|stl|100|mg|1|hgl|1|pakkar||L01AC01|01.02.2016||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|168652|215863|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Thiotepa||||168652|215863||2 969016|N03AG0102|Orfiril|stl|100|mg/ml|3|ml|5|lykjur||N03AG01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|7899|12277|lyfsjukr|||0|15|1||Parlogis hf|Parlogis - óskráð lyf|Valpróínsýra||||7899|12277||2 969066|A04AA0202|Granisetron|töflur|1|mg|10|stk|1|pakki||A04AA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|11435|17144|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Granisetrón||||11435|17144||2 969074|H01AA0202|Synachten|stl|0,25|mg/ml|1|ml|1|stk||H01AA02|01.12.2015||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3710|6511|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|tetracosactide||||3710|6511||2 969082|P01AB0201|Fasigyn|töflur|500|mg|4|stk|1|pakki||P01AB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1962|4105|lyfalmen|||0|4|1||Parlogis hf|Parlogis - óskráð lyf|tinidazole||||1962|4105||2 969149|H03BB0102|Carbimazol|töflur|5|mg|100|stk|1|þpakki||H03BB01|01.02.2014||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1380|3304|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráð lyf|Karbímazól||1380||1380|3304||2 969181|N02AA0111|Morfin "DAK"|töflur|10|mg|100|stk|1|pakki||N02AA01|01.05.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|2948|5463|lyfalmen|||0|100|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||2948||2948|5463||2 969206|N06BC0102|Caffeine Citrate|mixtúra|10|mg/ml|5|ml|1|pakki||N06BC01|01.01.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|7890|12265|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Koffeín||||7890|12265||2 969222|N01AH0201|Rapifen|stl|0,5|mg/ml|2|ml|5|stk||N01AH02|01.02.2016||R|0|0|1|0|0|1|LDR|0|0|0|100|IKR|1540|3525|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Alfentanil||||1540|3525||2 969248|J07BG0102|Verorab|bóluefni|||0,5|ml|1|spr||J07BG01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|9449|14411|lyfalmen|||0|0,5|1||Distica|Distica - óskráð lyf|Hundaæði, dauð veira||||9449|14411||1 969256|P01AX0601|Wellvone|mixtúra|||226|ml|1|fl||P01AX06|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|105485|137301|lyfalmen|||0|226|1||Parlogis hf|Parlogis - óskráð lyf|atovaquone||||105485|137301||2 969298|M03BA0202|Carisoprodol|töflur|350|mg|100|stk|1|pakki||M03BA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|8561|13188|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|carisoprodol||||8561|13188||2 969305|N02AB0308|Abstral Sublingval|töflur|400|mcg|30|stk|1|glas||N02AB03|01.12.2015||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|32900|44682|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Fentanýl||||32900|44682||2 969313|D10AD0103|Airol|krem|0,05|%|20|g|1|túpa||D10AD01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|870|2602|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Tretínóín||||870|2602||2 969339|N07CA0302|Flunarizine acis|hylki|5|mg|100|stk|1|glas||N07CA03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|2995|5527|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Flunarizín||||2995|5527||1 969446|C01CA0121|Effortil|töflur|5|mg|50|stk|1|pakki||C01CA01|01.12.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1437|3383|lyfalmen|||0|50|1||Distica|Distica - óskráð lyf|etilefrine||||1437|3383||1 969454|M01AB0520|Voltarol|eþ-stíll|12,5|mg|10|stk|1|pakki||M01AB05|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|||lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Díklófenak||||||30.11.2017|1 969462|C07AA0520|Propranolol ratiopharm|forðahlk|160|mg|90|stk|1|pakki||C07AA05|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|8980|13765|lyfalmen|||0|90|1||Distica|Distica - óskráð lyf|Própranólól||||8980|13765||1 969545|C08DB0111|Diltiazem Al|hylki|120|mg|100|stk|1|pakki||C08DB01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|2325|4605|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Diltíazem||||2325|4605||1 969579|A03FA0115|MCP Rathiopharm|eþ-stíll|10|mg|25|stk|1|pakki||A03FA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|1302|3197|lyfalmen|||0|25|1||Distica|Distica - óskráð lyf|Metóklópramíð||||1302|3197||1 969587|C01CA0120|Etilefrin Al|töflur|5|mg|50|stk|1|glas||C01CA01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|718|2393|lyfalmen|||0|50|1||Distica|Distica - óskráð lyf|etilefrine||||718|2393||1 969602|J07AH0901|Bexsero|stl|||0,5|ml|1|spr||J07AH09|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|15122|22219|lyfalmen|||0|0,5|1||Distica|Distica - óskráð lyf|meningococcus B, multicomponent vaccine ||||15122|22219||1 969701|V08DA0001|Sonovue|sts|25|mg|5|ml|1|pakki||V08DA00|01.07.2017||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|17982|26155|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Svovlhexafluorid||||17982|26155||2 969727|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|hgl||N04AA02|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|830|2506|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Bíperíden||800||800|2506||2 969743|C03CA0401|Torasemid|töflur|5|mg|100|stk|1|þpakki||C03CA04|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|986|2762|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|torasemide||||986|2762||2 969751|J06BB0301|Varitect|irl|25|ae/ml|20|ml|1|hgl||J06BB03|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|101375|132189|lyfsjukr|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Varicella/Zoster Immunoglobulin||||101375|132189||2 969769|J06BB0301|Varitect|irl|25|ae/ml|50|ml|1|hgl||J06BB03|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|247492|313918|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Varicella/Zoster Immunoglobulin||||247492|313918||2 969777|N02AA0111|Morfin "DAK"|töflur|10|mg|10|stk|1|þpakki||N02AA01|01.07.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|750|2437|lyfalmen|||0|10|1|1,0000|Parlogis hf|Parlogis - óskráð lyf|Morfín||750||750|2437||2 969785|A02AD0401|Steritalc|duft|4|g|4|stk|1|pakki||A02AD04|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|19241|27888|lyfsjukr|||0|4|1||Parlogis hf|Parlogis - óskráð lyf|Hydrotalcite||||19241|27888||2 969793|B02AB0101|Aprotinin|stl|10000|KIU/ml|50|ml|1|hgl||B02AB01|01.02.2016||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|20000|28366|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Aprotinin||||20000|28366||2 969818|A11HA0210|Vitamin B6 Hevert|stl|12,5|mg/ml|2|ml|5|lykjur||A11HA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|650|2300|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Pýrídoxín||||650|2300||2 969826|A11AA0301|Aquadeks|tuggutfl|||60|stk|1|glas||A11AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6589|10474|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|multivitamins and other minerals, incl. combinations ||||6589|10474||2 969842|R06AE0901|Xyzal Tab|töflur|5|mg|90|stk|1|pakki||R06AE09|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|7148|11243|lyfalmen|||0|90|1||Parlogis hf|Parlogis - óskráð lyf|levocetirizine||||7148|11243||2 969876|B01AD0101|Streptase|irs|250|ae|1|hgl|1|pakki||B01AD01|01.12.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|7862|12226|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Streptokinasum||||7862|12226||2 969925|H03AA0302|Tiroide Ibsa|töflur|95,4|mcg|25|stk|1|pakki||H03AA03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2890|5383|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|combinations of levothyroxine and liothyronine||||2890|5383||2 969933|B05XB0102|Medargin|skammtar|||30|stk|1|skpoki||B05XB01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3952|6844|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|arginine hydrochloride||||3952|6844||2 969941|V04CG3002|Amzoate|mixtúra|100|mg/ml|100|ml|1|flaska||V04CG30|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4750|7943|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|caffeine and sodium benzoate||||4750|7943||2 969959|P01BF0101|Riamet|töflur|140|mg|24|stk|1|pakki|20 +120 mg|P01BF01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7692|11992|lyfalmen|||0|24|1||Parlogis hf|Parlogis - óskráð lyf|Artemether and Lumefantrine||||7692|11992||2 969975|A11CC0502|D3 Vicotrat|stl|2,5|mg/ml|5|lykjur|1|pakki||A11CC05|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2802|5262|lyfalmen|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|colecalciferol||||2802|5262||2 970013|A01AD1102|Magical Mouthwash - forskriftarlyf|mixtúra|||100|ml|1|fl||A01AD11|01.04.2015||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3988|6894|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis lyf||3988||3988|6894||2 970039|C09AA0106|Captopril mixtúra - forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||C09AA01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15995|23420|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Kaptópríl||15995||15995|23420||2 970063|N07BB0401|Naltrexone Hydrochloride-forskriftarlyf|lausn|1|mg/ml|100|ml|1|fl||N07BB04|01.03.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1995|4151|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naltrexone||||1995|4151||2 970089|A09AA0212|Combizym|töflur|135|mg|60|stk|1|pakki||A09AA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4500|7599|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|Hvatablöndur (lípasi, próteasi o.s.frv.)||||4500|7599||2 970104|J02AB0203|Ketoconazole|töflur|200|mg|100|stk|1|pakki||J02AB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|23243|32468|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Ketókónazól||||23243|32468||2 970146|A07BB0002|Pepto-Bismol|töflur|262|mg|30|stk|1|glas||A07BB|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|975|2747|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Bismuth preparations||||975|2747||2 970196|L01CB0103|Eto Gry|irþ|20|mg/ml|5|ml|1|hgl||L01CB01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|8306|12837|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Etoposíð||||8306|12837||2 970203|J01GB0102|Tobi|innöndl|300|mg|56|lykjur|1|pakki||J01GB01|01.12.2015||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|536222|546747|lyfsjukr|||0|56|1||Parlogis hf|Parlogis - óskráð lyf|Tobramýcín||434696||434696|546747||2 970245|S01GA0501|Neosynephrin Pos|augndr|||10|ml|1|glas||S01GA05|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1561|3553|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|phenylephrine||||1561|3553||2 970287|B06AA0301|Hylase Dessau|sts|1500|ae|10|hgl|1|pakki||B06AA03|01.03.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|65533|85956|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Hyaluronidase||||65533|85956||2 970302|S01GA5501|Fenylefrin-Lidokain|stl|25|mg/ml|10|ml|1|hgl|15+10 mg|S01GA55|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|6990|11026|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Phenylephrine í samsetningum||||6990|11026||2 970352|R06AA5901|Diclegis|töflur|10|mg|100|stk|1|pakki||R06AA59|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|126171|163028|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Ddoxylamine í samsetningum||||126171|163028||2 970386|A02BA0115|Cimetidin Acis|töflur|400|mg|50|stk|1|glas||A02BA01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1512|3486|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|cimetidine||||1512|3486||2 970419|V04CG3002|Amzoate|stl|20|mg/ml|10|ml|10|stk||V04CG30|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|21397|30133|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|caffeine and sodium benzoate||||21397|30133||2 970427|N03AA0310|Primidon Holsten|töflur|250|mg|100|stk|1|pakki||N03AA03|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4058|6990|lyfalmen|||0|100|1|20,0000|Distica|Distica - óskráð lyf|primidone||||4058|6990||1 970477|C01DA0810|ISDN-ratiopharm|töflur|5|mg|100|stk|1|glas||C01DA08|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|659|2312|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Ísósorbíð dínítrat||||659|2312||1 970518|N03AX1002|Taloxa|töflur|600|mg|40|stk|1|þpakki||N03AX10|01.12.2015||R|0|0|0|1|0|0|PCO|0|0|0|100|XEU|17812|25921|lyfalmen|||0|40|1||Distica|Distica - óskráð lyf|felbamate||||17812|25921||1 970534|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.04.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|9408|14354|lyfalmen|||0|454|1||Distica|Distica - óskráð lyf|Pólýstýren súlfónat||||9408|14354||1 970542|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1711|3760|lyfalmen|||0|100|1|25,0000|Distica|Distica - óskráð lyf|Maprótilín||||1711|3760||1 970576|R01BA5205|Aerinaze|töflur|2,5|mg|20|stk|1|pakki||R01BA52|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2685|5101|lyfalmen|||0|20|1|10,0000|Distica|Distica - óskráð lyf|Pseudóefedrín í blöndum||||2685|5101||1 970584|C07AA0521|Propranolol Teva|forðatfl|160|mg|90|stk|1|glas||C07AA05|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|6153|9874|lyfalmen|||0|90|1||Distica|Distica - óskráð lyf|Própranólól||||6153|9874||1 970592|V04CL0023|Soluprick SQ, hafrar|lausn|||1|hgl|1|pakki||V04CL|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|12936|19210|lyfalmen|||0|1|1||Distica|Distica - óskráð lyf|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||||12936|19210||1 970609|N05AD0103|Haloperidol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1816|3904|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Halóperídól||||1816|3904||1 970633|N05AD0101|Haldol|mixtúra|2|mg/ml|100|ml|1|fl||N05AD01|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|1355|3270|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Halóperídól||||1355|3270||1 970659|N06AA0202|Imipramin|töflur|25|mg|100|stk|1|glas||N06AA02|01.12.2015||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1925|4054|lyfalmen|||0|100|1|25,0000|Distica|Distica - óskráð lyf|imipramine||||1925|4054||1 970683|N03AX0905|Lamotrigin|töflur|100|mg|100|stk|1|pakki||N03AX09|01.01.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4666|7827|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Lamótrigín||||4666|7827||1 970691|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|pakki||J01DC02|01.05.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|2467|4800|lyfalmen|||0|14|1||Distica|Distica - óskráð lyf|Cefúroxím||||2467|4800||1 970758|V06DD0010|L-Citrullin|hylki|500|mg|120|stk|1|pakki||V06DD|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|9130|13971|lyfalmen|||0|120|1||Parlogis hf|Parlogis - óskráð lyf|Amínósýrur, m.a. í samsetningu með pólypeptíðum||||9130|13971||2 970766|A16AX0302|Ammonaps|töflur|500|mg|250|stk|1|glas||A16AX03|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|123486|145077|lyfalmen|||0|250|1||Parlogis hf|Parlogis - óskráð lyf|sodium phenylbutyrate||111737||111737|145077||2 970774|S01EC0110|Glaupax|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6596|10484|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Acetazólamíð||||6596|10484||2 970782|P01AX1101|Alinia|töflur|500|mg|30|stk|1|pakki||P01AX11|01.04.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|315850|398936|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Nitazoxanide||||315850|398936||2 970831|J01XB0101|Colomycin|sts|1|millj ae|10|hgl|1|pakki||J01XB01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|7004|11045|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Colistin ||||7004|11045||2 970857|J01CR0502|Piperacillin Tazoba "REIG JOFRE"|irs|4,5|g|10|hgl|1|pakki|4 g/ 0,5 g|J01CR05|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|34228|18390|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Piperacillín og beta-laktamasa hemill||12340||12340|18390||2 970881|N04BC0901|Neupro - Parlogis|forðapl|2|mg/sólh|28|stk|1|pakki||N04BC09|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|20112|28508|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|rotigotine||||20112|28508||2 970899|C02CA0406|Doxazosin|töflur|4|mg|100|stk|1|pakki||C02CA04|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3923|6805|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Doxazósín||||3923|6805||2 970906|H03BB0210|Thiamazol|töflur|10|mg|100|stk|1|glas||H03BB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1764|3833|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|thiamazole||||1764|3833||2 970914|N05AN0110|Lithium Apogepha|töflur|295|mg|100|stk|1|glas||N05AN01|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2636|5033|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Litíum||||2636|5033||2 970948|N03AB0214|Epanutin mixtúra|mixtúra|||500|ml|1|glas||N03AB02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2231|4476|lyfalmen|||0|500|1||Parlogis hf|Parlogis - óskráð lyf|Fenýtóín||||2231|4476||2 970956|M01CC0102|Distamine|töflur|250|mg|100|stk|1|pakki||M01CC01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5060|8370|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Penicillamín||||5060|8370||2 970964|M01CC0102|Distamine|töflur|125|mg|100|stk|1|pakki||M01CC01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2857|5337|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Penicillamín||||2857|5337||2 970998|C03CA0405|Torasemide|töflur|50|mg|50|stk|1|þpakki||C03CA04|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1750|3814|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|torasemide||||1750|3814||2 971003|H01BA0101|Pressyn Ar|stl|20|ein/ml|2|ml|10|lykjur||H01BA01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|71087|92981|lyfsjukr|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Vasopressin (argipressin)||||71087|92981||2 971045|B01AC0901|Flolan Trockensub|stl|0,5|mg|50|ml|2|lykjur||B01AC09|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|18624|27039|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Epoprostenol||||18624|27039||2 971079|M01CC0103|Metalcaptase|töflur|300|mg|100|stk|1|pakki||M01CC01|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|11384|17074|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Penicillamín||||11384|17074||2 971152|D05BA0201|Meladinin|töflur|10|mg|30|stk|1|glas||D05BA02|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3250|5878|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|methoxsalen||||3250|5878||2 971178|R06AD0301|Torecan|töflur|6,5|mg|50|stk|1|þpakki||R06AD03|01.12.2015||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|4800|6242|lyfalmen|||0|50|1|10,0000|Parlogis hf|Parlogis - óskráð lyf|Tíetýlperazín||3514||3514|6242||2 971194|N06BA0201|Dexamphetamine sulphate|töflur|20|mg|100|stk|1|þpakki||N06BA02|01.01.2016||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|16600|24253|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Dexamfetamine ||||16600|24253||2 971201|N05AE0501|Latuda|töflur|37|mg|98|stk|1|glas||N05AE05|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|125544|162249|lyfalmen|||0|98|1||Parlogis hf|Parlogis - óskráð lyf|Lurasidone ||||125544|162249||2 971219|J01DH5102|Imipenem/Cilastin|duft|1000|mg|10|stk|1|pakki|500 / 500|J01DH51|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|32638|44351|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Imipenem og cilastatin||||32638|44351||2 971227|N05AE0501|Latuda|töflur|37|mg|28|stk|1|glas||N05AE05|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|16330|23882|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|Lurasidone ||||16330|23882||2 971243|V03AH0102|Proglycem|mixtúra|50|mg/ml|30|ml|1|glas||V03AH01|01.02.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|50480|66917|lyfalmen|||0|30|1|5,0000|Parlogis hf|Parlogis - óskráð lyf|diazoxide||50480||50480|66917||2 971251|P03AX0301|Prioderm|lausn|0,5|%|55|ml|1|pakkar||P03AX03|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1238|3109|lyfalmen|||0|55|1||Parlogis hf|Parlogis - óskráð lyf|Malatíón||||1238|3109||2 971269|H03AA0303|Thyroid Erfa|töflur|60|mg|100|stk|1|pakki||H03AA03|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|8960|13737|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|combinations of levothyroxine and liothyronine||||8960|13737||2 971277|S01AA0201|Aureomycin|augnsm|10|mg/g|5|g|1|túpa||S01AA02|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1952|4092|lyfalmen|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Chlortetracycline||||1952|4092||2 971285|A04AD0511|Vogalib|töflur|7,5|mg|8|stk|1|pakki||A04AD05|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2840|5314|lyfalmen|||0|8|1|8,0000|Parlogis hf|Parlogis - óskráð lyf|Metópímazín||||2840|5314||2 971293|A09AA0213|Viokace|töflur|10440|ae|100|stk|1|pakki||A09AA02|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|89558|116343|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Hvatablöndur (lípasi, próteasi o.s.frv.)||||89558|116343||2 971318|N01AH0602|Ultiva|sts|5|mg|5|hgl|1|pakki||N01AH06|01.02.2016||R|0|0|1|0|0|1|LDR|0|0|0|100|IKR|21722|30544|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Remífentaníl||||21722|30544||2 971326|N05CM0601|Propavan|töflur|25|mg|100|stk|1|glas||N05CM06|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|8722|13410|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Propiomazine ||||8722|13410||2 971334|M01AB0519|Diclofenac|eþ-stíll|25|mg|50|stk|1|pakki||M01AB05|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1135|2967|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Díklófenak||||1135|2967||2 971342|R03AC0204|Ventolin|töflur|2|mg|100|stk|1|pakki||R03AC02|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1319|3220|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Salbútamól||||1319|3220||2 971368|N02BA0112|ACETYLSALICYLSYRE|töflur|5|mg|100|stk|1|glas||N02BA01|01.01.2016||R|2|0|0|0|0|0|LDR|0|0|1|100|IKR|7891|12266|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Acetýlsalicýlsýra||||7891|12266||2 971376|N01BB0903|Ropivacain|stl|2|mg/ml|100|ml|5|plastl||N01BB09|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|8583|9736|lyfalmen|||0|500|1||Parlogis hf|Parlogis - óskráð lyf|Rópívakaín||6053||6053|9736||2 971384|N01BB0903|Ropivacain|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|4326|7359|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Rópívakaín||||4326|7359||2 971392|H02AB0803|Lederlon|stl|20|mg/ml|1|ml|10|stk||H02AB08|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|14791|21763|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Tríamcínólón||||14791|21763||2 971417|N05AA0106|Chlorpromazin|töflur|100|mg|28|stk|1|þpakki||N05AA01|01.01.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|690|2355|lyfalmen|||0|28|1|9,0000|Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||||690|2355|31.12.2017|2 971433|L01CB0103|Eto Gry|stl|20|mg/ml|25|ml|1|hgl||L01CB01|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|33683|45672|lyfsjukr|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Etoposíð||||33683|45672||2 971441|V03AB0401|Contrathion|stl|2|%|10|ml|10|hgl||V03AB04|01.02.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|37275|50216|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Pralidoxime||||37275|50216||2 971475|V08BA0106|E-Z-PAQUE|mixtúra|96|%|24|stk|1|pakki||V08BA01|01.11.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|34167|46285|lyfsjukr|||0|24|1||Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||||34167|46285||2 971483|C02DB0202|Hydralazine|töflur|25|mg|84|stk|1|pakki||C02DB02|01.08.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5143|6443|lyfalmen|||0|84|1||Parlogis hf|Parlogis - óskráð lyf|hydralazine||3660||3660|6443||2 971491|S01AD0302|Xorox|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.03.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1503|3474|lyfalmen|||0|4,5|1||Parlogis hf|Parlogis - óskráð lyf|Acíklóvír||||1503|3474||2 971524|L01CB0104|Etoposid|sts|20|mg/ml|25|ml|1|hgl||L01CB01|01.08.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|21190|24365|lyfsjukr|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Etoposíð||16681||16681|24365||2 971558|A14AA0701|DHEA|hylki|50|mg|100|stk|1|pakki||A14AA07|01.07.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3130|5713|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Prasteronum||3130||3130|5713||2 971582|C01BB0103|Lidocaine|irl|0,4|%|500|ml|15|hgl||C01BB01|01.03.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|40222|37454|lyfsjukr|||0|7500|1||Parlogis hf|Parlogis - óskráð lyf|Lídókaín||27185||27185|37454||2 971607|C01BC0302|Propafenon|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.03.2016||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|3301|5948|lyfalmen|||0|100|1|100,0000|Parlogis hf|Parlogis - óskráð lyf|Própafenón||||3301|5948||2 971623|L01DB0702|Mitoxantrone|irþ|2|mg/ml|10|ml|5|hgl||L01DB07|01.06.2016||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|124523|160979|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Mítoxantrón||||124523|160979||2 971631|A12BA0205|Acalka|töflur|1080|mg|100|stk|1|pakki||A12BA02|01.03.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|8120|12581|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|potassium citrate||||8120|12581||2 971649|V03AB2503|Flumazenil|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2016||R|0|0|0|0|0|1|PCO|0|0|0|100|GBP|2735|5169|lyfsjukr|||0|25|1||Distica|Distica - óskráð lyf|Flúmazeníl||||2735|5169||1 971673|G04BX1401|Priligy|töflur|60|mg|6|stk|1|pakki||G04BX14|01.04.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|8535|13152|lyfalmen|||0|6|1||Distica|Distica - óskráð lyf|Dapoxetinum||||8535|13152||1 971699|G03DA0405|Progesterone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.04.2016||R|0|0|0|1|0|0|PCO|0|0|0|100|GBP|22818|31930|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Prógesterón||||22818|31930||1 971706|C03CA0111|Frusol|mixtúra|55|mg/ml|150|ml|1|glas|50/5 mg/ml|C03CA01|01.04.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|6016|9685|lyfalmen|||0|150|1||Distica|Distica - óskráð lyf|Fúrósemíð||||6016|9685||1 971714|N05AA0112|Chlorpromazine Dr. Reddy´s|töflur|100|mg|28|stk|1|glas||N05AA01|01.05.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|1107|2929|lyfalmen|||0|28|1||Distica|Distica - óskráð lyf|chlorpromazine||||1107|2929||1 971748|R03CA0203|Ephedrine hydrochloride|töflur|15|mg|28|stk|1|pakki||R03CA02|01.07.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5564|9063|lyfalmen|||0|28|1|8,0000|Distica|Distica - óskráð lyf|Efedrínhýdróklóríð||||5564|9063||1 971756|N03AA0312|Primidone|töflur|50|mg|100|stk|1|pakki||N03AA03|01.07.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|28365|38946|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|primidone||28365||28365|38946||1 971764|R01BA5205|Aerinaze|töflur|2,5|mg|10|stk|1|pakki||R01BA52|01.08.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|GBP|1741|3801|lyfalmen|||0|10|1||Distica|Distica - óskráð lyf|Pseudóefedrín í blöndum||||1741|3801||1 971772|C01DA0213|Nitroderm TTS|forðapl|10|mg/sólh|30|stk|1|pakki||C01DA02|01.08.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|4060|6993|lyfalmen|||0|30|1||Distica|Distica - óskráð lyf|Glýcerýltrínítrat||||4060|6993||1 971821|N05CD0103|Dalmane|hylki|15|mg|30|stk|1|pakki||N05CD01|01.11.2016||R|0|0|0|0|0|0|PCO|0|0|1|100|GBP|2648|5050|lyfalmen|||0|30|1||Distica|Distica - óskráð lyf|Flúrazepam||||2648|5050||1 971847|N04BD0301|Xadago|töflur|50|mg|30|stk|1|pakki||N04BD03|01.12.2016||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|16244|23763|lyfalmen|||0|30|1||Distica|Distica - óskráð lyf|Safinamíð||||16244|23763||1 971863|A09AA0215|Kreon 25.000|töflur|300|mg|100|stk|1|pakki||A09AA02|01.03.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|9064|13881|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Hvatablöndur (lípasi, próteasi o.s.frv.)||||9064|13881||2 971871|A02BA0206|Ranitidin|stl|25|mg/ml|2|ml|5|hgl||A02BA02|01.03.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3550|6291|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Ranitidín||||3550|6291||2 971889|L01XX3901|Istodax|sts|10|mg/hgl|1|hgl|1|pakki||L01XX39|01.03.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|XEU|249189|316028|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Romídepsin||||249189|316028||2 971897|B03BA0501|Mekobalamine|stl|5|mg/ml|2|ml|10|lykjur||B03BA05|01.04.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|18286|26574|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Mecobalamin||||18286|26574||2 971912|C02AC0104|Catapresan|töflur|150|mcg|100|stk|1|þpakki||C02AC01|01.04.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2213|4451|lyfalmen|||0|100|1|33,0000|Parlogis hf|Parlogis - óskráð lyf|clonidine||||2213|4451||2 971954|N02BA0113|Aspirin|eþ-stíll|300|mg|12|stk|1|pakki||N02BA01|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|7380|11563|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Acetýlsalicýlsýra||||7380|11563||2 971962|C05BB0501|Sclerosing solution|stl|25|mg/ml|10|ml|10|hgl||C05BB05|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|28138|38659|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Phenol||||28138|38659||2 971988|H03AA0201|Liothyronin|sts|20|mcg|5|hgl|1|pakki||H03AA02|01.04.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|321618|406110|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|liothyronine sodium||||321618|406110||2 971996|L01AA0701|Ixoten|töflur|50|mg|50|stk|1|pakki||L01AA07|01.04.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|SEK|15130|22230|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Trofosfamide||||15130|22230||2 972001|N07BC0201|Metadon|stl|10|mg/ml|1|ml|10|lykjur||N07BC02|01.04.2016||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|4300|7323|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Metadón||||4300|7323||2 972019|C03XA0101|Samsca|töflur|15|mg|10|stk|1|pakki||C03XA01|01.04.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|155625|199661|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Tólvaptanum||||155625|199661||2 972027|A03AB0201|Robinul|stl|0,2|mg/ml|10|lykjur|1|pakki||A03AB02|01.04.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|1929|4060|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|glycopyrronium||||1929|4060|31.01.2018|2 972035|N06AB0801|Fluvoxamine|töflur|50|mg|100|stk|1|pakki||N06AB08|01.04.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2315|4591|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Fluvoxamine||||2315|4591||2 972043|N02BA0113|Aspirin|sts|500|mg|5|lykjur|1|pakki||N02BA01|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|7489|11713|lyfalmen|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Acetýlsalicýlsýra||||7489|11713||2 972051|A03AB0202|Cuvposa|mixtúra|0,2|mg/ml|473|ml|1|fl||A03AB02|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|88360|114828|lyfalmen|||0|473|1||Parlogis hf|Parlogis - óskráð lyf|glycopyrronium||||88360|114828||2 972069|A11AA0301|Aquadeks|mixtúra|||60|ml|1|fl||A11AA03|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|6593|10480|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|multivitamins and other minerals, incl. combinations ||||6593|10480||2 972085|N03AA0311|Primidon Holstein|töflur|250|mg|100|stk|1|pakki||N03AA03|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3548|5823|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|primidone||3210||3210|5823||2 972093|N03AX1210|Gabapentin|mixtúra|50|mg/ml|470|ml|1|pakki||N03AX12|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|20413|28889|lyfalmen|||0|470|1||Parlogis hf|Parlogis - óskráð lyf|Gabapentín||||20413|28889||2 972118|V08CA0801|Multihance|stl|334|mg/ml|10|ml|1|hgl|röntgenskuggaefni|V08CA08|01.05.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|18360|26676|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Gadobenic acid ||||18360|26676||2 972134|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|pakki||N07AA02|01.05.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7044|11100|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráð lyf|Pyridostigmin||||7044|11100|31.12.2017|2 972192|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|pakki||L01CB01|01.06.2016||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|23958|33372|lyfsjukr|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Etoposíð||||23958|33372||2 972209|C09AA0104|Captopril|töflur|1|mg|100|stk|1|pakki||C09AA01|01.07.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|16101|23566|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||16101||16101|23566||2 972241|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|pakki||N02CX02|01.06.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1066|2872|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Klónidín||||1066|2872||2 972267|J01AA0101|Demeclocycline|töflur|150|mg|100|stk|1|pakki||J01AA01|01.07.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|65744|86223|lyfalmen|||2|100|1|25,0000|Parlogis hf|Parlogis - óskráð lyf|Demeclocycline||65744||65744|86223||2 972291|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.07.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|847|2571|lyfalmen|||0|3,5|1||Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||847||847|2571||2 972316|J01XA0401|Xydalba|irs|500|mg|1|hgl|1|pakki||J01XA04|01.07.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|165100|197292|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|dalbavancin||153720||153720|197292||2 972332|J01XX0101|Fosfomycin|mixt.kyr|3|g|1|poki|1|pakki||J01XX01|01.08.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1292|3183|lyfalmen|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Fosfomycinum||||1292|3183||2 972358|J04AB0401|Mycobutin|hylki|150|mg|30|stk|1|pakki||J04AB04|01.08.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|28776|39466|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Rifabutin||||28776|39466||2 972407|V08BA0105|Barium Sulfate|töflur|648|mg|100|stk|1|pakki||V08BA01|01.10.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|76500|99827|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||||76500|99827||2 972415|J01XA0402|Dalvance|irs|500|mg|1|hgl|1|pakki||J01XA04|01.10.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|252960|320718|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|dalbavancin||||252960|320718||2 972423|L03AB0301|Imukin|stl|0,2|mg/ml|0,5|ml|6|hgl||L03AB03|01.10.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|110502|143541|lyfsjukr|||0|3|1||Parlogis hf|Parlogis - óskráð lyf|Interferon gamma||||110502|143541||2 972431|J01MA0202|Ciproxin|mixtúra|50|mg/ml|100|ml|1|fl||J01MA02|01.10.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5600|9113|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Cíprófloxacín||||5600|9113||2 972449|N04BD0106|Selegilin|töflur|10|mg|100|stk|1|pakki||N04BD01|01.10.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|11761|17593|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Selegilín||||11761|17593||2 972457|C10AC0401|Cholestagel|töflur|625|mg|180|stk|1|pakki||C10AC04|01.10.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|21700|30516|lyfalmen|||0|180|1||Parlogis hf|Parlogis - óskráð lyf|Colesevelamum||||21700|30516||2 972481|N07AA0102|Neostig|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.10.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|1027|2818|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Neostigmín||||1027|2818||2 972499|J01DH0204|Meropenem STADA|stl/irs|1|g/hgl|10|hgl|1|pakki|lausn|J01DH02|01.10.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|XEU|12916|19183|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Meropenem||||12916|19183||2 972506|G03GB02|Clomifen|töflur|50|mg|10|stk|1|þpakki||G03GB02|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|XEU|2165|4385|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Klómífen||||2165|4385||2 972514|J04AK0103|Pyrazinamide|töflur|500|mg|100|stk|1|pakki||J04AK01|01.10.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4162|7133|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Pýrazínamíð||||4162|7133||2 972522|D05AA0003|Polytar Scalp|sjampó|4|%|150|ml|1|fl||D05AA|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|930|2685|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráð lyf|Tjörur||||930|2685||2 972556|A04AA0202|Granisetron|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2416|4730|lyfalmen|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Granisetrón||||2416|4730||2 972572|V03AF0402|Lederfoline|töflur|5|mg|30|stk|1|pakki||V03AF04|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4040|6966|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Kalsíumlevófólínat||||4040|6966||2 972598|N05BE0109|Busp|töflur|5|mg|100|stk|1|pakki||N05BE01|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2737|5172|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Búspírón hýdróklóríð||||2737|5172||2 972605|N05BE0109|Busp|töflur|10|mg|100|stk|1|pakki||N05BE01|01.11.2016||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6572|10451|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Búspírón hýdróklóríð||||6572|10451||2 972613|C07AA0522|Propranolol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.12.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4874|8113|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráð lyf|Própranólól||||4874|8113||2 972621|P01AX1101|Alinia|mixtúra|20|mg/ml|60|ml|1|fl||P01AX11|01.12.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|60758|79917|lyfalmen|||0|60|1||Parlogis hf|Parlogis - óskráð lyf|Nitazoxanide||||60758|79917||2 972639|C08DB0112|Diltiazem|stl|5|mg/ml|5|ml|10|hgl||C08DB01|01.12.2016||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|8340|12884|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Diltíazem||||8340|12884||2 972746|V04CD0101|Metopirone|hylki|250|mg|50|stk|1|pakki||V04CD01|01.12.2016||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|58500|77061|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Metyrapone||||58500|77061||2 972845|L01AA0302|Melphalan|töflur|2|mg|25|stk|1|pakki||L01AA03|01.03.2017||R|0|0|0|1|0|0|PCO|0|0|0|100|GBP|9630|14660|lyfalmen|||0|25|1||Distica|Distica - óskráð lyf|Melphalan||||9630|14660||1 972887|L02AE0402|Decapetyl SR|stl|11,25|mg|1|stk|1|pakki||L02AE04|01.04.2017||R|0|0|0|1|0|1|PCO|0|0|0|100|XEU|67408|88328|lyfsjukr|||0|1|1||Distica|Distica - óskráð lyf|Triptórelín||||67408|88328||1 972936|J07BK0201|Zostavax|sts|||0,65|ml|1|spr||J07BK02|01.10.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|25374|35163|lyfalmen|||0|0,65|1||Distica|Distica - óskráð lyf|Hlaupabóla-ristilveira(veikluð)||||25374|35163||1 972994|V04CX0006|Osmohale|innönddu|635|mg|1|sett|1|pakki||V04CX|01.01.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|10030|15210|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Önnur sjúkdómsgreiningarefni||||10030|15210||2 973033|L04AX0103|Azathioprine|mixtúra|10|mg/ml|150|ml|1|pakki||L04AX01|01.01.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|21831|30682|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráð lyf|Azatíóprín||||21831|30682||2 973059|A12AA0701|Calcium Chloride|stl|5|mmol/ml|5|ml|10|lykjur||A12AA07|01.02.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|GBP|5366|8791|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Calcium Chloride||||5366|8791||2 973067|C01BB0201|Mexitil|hylki|50|mg|100|stk|1|pakki||C01BB02|01.02.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|11626|17407|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Mexiletinum||||11626|17407||2 973075|C01BB0201|Mexitil|hylki|100|mg|100|stk|1|pakki||C01BB02|01.02.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|15280|22436|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Mexiletinum||||15280|22436||2 973083|C02AB0101|Presinol|töflur|500|mg|100|stk|1|pakki||C02AB01|01.02.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5201|8564|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Methyldopa||||5201|8564||2 973091|C01CA1701|Gutron|töflur|2,5|mg|50|stk|1|pakki||C01CA17|01.03.2017||R|0|0|0|0|0|0|ARC|0|0|0|100|IKR|2400|4020|lyfalmen|||0|50|1||Acare ehf|Acare - óskráð lyf|midodrine||1900||1900|4020||2 973108|N04BB0104|Viregyt-K|hylki|100|mg|50|stk|1|glas||N04BB01|01.04.2017||R|0|0|0|0|0|0|ARC|0|0|0|100|IKR|3500|5396|lyfalmen|||0|50|1||Acare ehf|Acare - óskráð lyf|amantadine||2900||2900|5396||2 973116|S01XA2022|Methocel|augndr|2|%|30|g|1|pakki||S01XA20|01.03.2017||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|1830|3924|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar samsetningar||||1830|3924||2 973124|A03FA0101|Primperan|eþ-stíll|10|mg|10|stk|1|pakki||A03FA01|01.03.2017||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1046|2845|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Metóklópramíð||||1046|2845||2 973158|A05BA0001|Hepa Merz|mixtduft|6000|mg|30|pokar|1|pakki||A05BA|01.03.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|13013|19316|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Lifrarlyf||||13013|19316||2 973174|R06AB0201|Polaramin|töflur|2|mg|20|stk|1|pakki||R06AB02|01.03.2017||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1146|2982|lyfalmen|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Dexklórfeníramín||1146||1146|2982||2 973207|J01GB0103|Tobramycin|stl|40|mg/ml|2|ml|25|hgl||J01GB01|01.03.2017||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|12688|18869|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Tobramýcín||||12688|18869||2 973215|C08DA0109|Verapamil|töflur|80|mg|100|stk|1|pakki||C08DA01|01.08.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|961|2728|lyfalmen|||2|100|1||Parlogis hf|Parlogis - óskráð lyf|Verapamíl||||961|2728||2 973249|L04AA0601|Cellcept|hylki|250|mg|100|stk|1|pakki||L04AA06|01.03.2017||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|23787|33156|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Mýcófenólsýra||||23787|33156||2 973299|N03AD0104|Petnidan|mixtúra|50|mg/ml|250|ml|1|fl||N03AD01|01.04.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5466|8928|lyfalmen|||0|250|1||Parlogis hf|Parlogis - óskráð lyf|ethosuximide||||5466|8928||2 973306|N07AA0201|Mestinon|töflur|10|mg|100|stk|1|pakki||N07AA02|01.04.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2388|4692|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Pyridostigmin||||2388|4692|31.01.2018|2 973322|L01DC0301|Mito Medac|sts|20|mg|5|hgl|1|pakki||L01DC03|01.04.2017||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|138523|178391|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Mitomycin||||138523|178391||2 973398|C07AB0313|Tenormin|töflur|50|mg|100|stk|1|pakki||C07AB03|01.04.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|793|2496|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Atenólól||||793|2496|31.01.2018|2 973405|C01CA0202|Isoprenalina|stl|0,2|mg/ml|1|ml|5|hgl||C01CA02|01.05.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2859|5340|lyfsjukr|||0|5|1||Parlogis hf|Parlogis - óskráð lyf|Isoprenaline||||2859|5340||2 973439|A14AA0701|DHEA|hylki|10|mg|100|stk|1|pakki||A14AA07|01.05.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2017|4181|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Prasteronum||||2017|4181||2 973471|J04AK0202|EMB Fatol|töflur|400|mg|100|stk|1|pakki||J04AK02|01.06.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|5085|8404|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|ethambutol||||5085|8404||2 973504|C02DD0101|Nitroprussiat|sts|50|mg|1|hgl|1|pakki|+ leysir|C02DD01|01.06.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|3769|6593|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Nitroprusside||||3769|6593||2 973512|B01AE0302|Argatra|irþ|100|mg/ml|2,5|ml|1|hgl||B01AE03|01.06.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|34053|46140|lyfsjukr|||0|2,5|1||Parlogis hf|Parlogis - óskráð lyf|Argatrobanum||||34053|46140||2 973538|V03AB1602|Alcohol absolute|stl|100|%|5|ml|10|hgl||V03AB16|01.07.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|17462|25440|lyfsjukr|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Ethanol||||17462|25440||2 973554|J01CF0105|Dicloxacillin|hylki|250|mg|30|stk|1|pakki||J01CF01|01.07.2017||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|893|2634|lyfalmen|||2|30|1||Parlogis hf|Parlogis - óskráð lyf|Díkloxacillín||||893|2634||2 973562|C09DA0308|Diovan Comp 80/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.07.2017||R|1|0|0|0|0|0|LDR|0|0|0|100|IKR|5592|9102|lyfalmen|||0|98|1||Parlogis hf|Parlogis - óskráð lyf|Valsartan og þvagræsilyf||||5592|9102||2 973588|G03CA0322|Progynova|töflur|2|mg|84|stk|1|pakki||G03CA03|01.07.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1192|3046|lyfalmen|||0|84|1|84,0000|Parlogis hf|Parlogis - óskráð lyf|Estradíól||||1192|3046||2 973637|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|10|hgl||V04CF01|01.09.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|DKK|18976|27523|lyfalmen|||0|15|1||Parlogis hf|Parlogis - óskráð lyf|Lyf til berklarannsókna||||18976|27523||2 973679|N05AA0111|Chlorpromazine Almus|töflur|25|mg|28|stk|1|pakki||N05AA01|01.09.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|690|2355|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||690||690|2355||2 973736|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.09.2017||R|0|0|0|0|G|0|LDR|0|0|0|100|IKR|8273|12792|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Chlorambucíl||8273||8273|12792||2 973752|B01AD0401|Urokinase|sts|100000|ae|1|hgl|1|pakki||B01AD04|01.10.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|13242|19631|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Urokinase||||13242|19631||2 973819|C10AA0401|Lescol|filmhtfl|20|mg|28|stk|1|þpakki||C10AA04|01.08.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|3543|6282|lyfalmen|||0|28|1||Distica|Distica - óskráð lyf|Flúvastatín||3543||3543|6282||1 973827|R03BA0801|Alvesco|innúðal|80|mcg/sk|120|skammtar|1|pakkar||R03BA08|01.08.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|8484|13082|lyfalmen|||0|120|1||Distica|Distica - óskráð lyf|Ciclesóníð||||8484|13082||1 973869|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.09.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|DKK|16873|24629|lyfalmen|||0|56|1|37,0000|Distica|Distica - óskráð lyf|Ísókarboxasíð||16873||16873|24629||1 973877|N05AX1302|Xeplion|stl|25|mg|1|áf.spr|1|pakki|forðadreifa|N05AX13|01.09.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|SEK|23731|33085|lyfalmen|||0|1|1|10,0000|Distica|Distica - óskráð lyf|Paliperídón||||23731|33085||1 973918|N06AF0401|Parnate|töflur|10|mg|100|stk|1|pakki||N06AF04|01.10.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|16163|23652|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Tranylcypromín||||16163|23652||1 973926|C09XA0201|Rasilez|töflur|300|mg|98|stk|1|pakki||C09XA02|01.10.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|20053|28433|lyfalmen|||0|98|1||Distica|Distica - óskráð lyf|Aliskiren||||20053|28433||1 973934|C09XA0201|Rasilez|töflur|150|mg|98|stk|1|pakki||C09XA02|01.11.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|21014|29649|lyfalmen|||0|98|1||Distica|Distica - óskráð lyf|Aliskiren||||21014|29649||1 973992|N05AA0110|Largactil|töflur|25|mg|50|stk|1|pakki||N05AA01|01.11.2017||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1372|3293|lyfalmen|||0|50|1||Distica|Distica - óskráð lyf|chlorpromazine||||1372|3293||1 974007|N06AX1612|Venlafaxin|töflur|37,5|mg|56|stk|1|pakki||N06AX16|01.10.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|887|2626|lyfalmen|||0|56|1||Parlogis hf|Parlogis - óskráð lyf|Venlafaxín||||887|2626||2 974015|M03BC5101|Norgesic|töflur|||30|stk|1|pakki|35+450mg|M03BC51|01.12.2017||R|0|0|0|0|G|0|LDR|0|0|1|100|IKR|2892|5385|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Orfenadrín í blöndum||2892||2892|5385||2 974049|J04AC0104|Isoniazid|mixtúra|10|mg/ml|473|ml|1|fl||J04AC01|01.10.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|42284|56551|lyfalmen|||0|473|1||Parlogis hf|Parlogis - óskráð lyf|Ísóníazíð||||42284|56551||2 974065|G03BA0306|Testogel|hlaup|50|mg|30|skpokar|1|pakki||G03BA03|01.10.2017||R|0|0|0|0|G|0|LDR|0|0|0|100|IKR|6470|10310|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Testósterón||||6470|10310||2 974099|M01AB0111|Dolcidium|eþ-stíll|50|mg|12|stk|1|pakki||M01AB01|01.11.2017||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1208|3068|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráð lyf|Indómetacín||||1208|3068||2 974106|A07AA0907|Vancomycin|hylki|125|mg|28|stk|1|pakki||A07AA09|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|28207|38746|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|Vankómýcín||28207||28207|38746||2 974122|N05AA0110|Largactil|töflur|25|mg|50|stk|1|pakki||N05AA01|01.11.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2305|3015|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||1170||1170|3015||2 974148|N05AA0110|Largactil|töflur|100|mg|30|stk|1|pakki||N05AA01|01.11.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2305|4578|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|chlorpromazine||||2305|4578||2 974156|D08AC0502|Lavacept Konzentrat|þykkni|200|mg/ml|100|ml|1|stk||D08AC05|01.12.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|50505|66949|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Polihexanide||||50505|66949||2 974164|C07AB0314|Atenolol|töflur|25|mg|28|stk|1|pakki||C07AB03|01.11.2017||R|0|0|0|0|G|0|LDR|0|0|0|100|IKR|168|1636|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|Atenólól||||168|1636||2 974172|J01MA1201|Tavanic|irl|5|mg/ml|100|ml|1|stk||J01MA12|01.12.2017||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|8722|13410|lyfsjukr|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Levofloxacin||||8722|13410||2 974198|P01BC0201|Lariam|töflur|250|mg|8|stk|1|pakkar||P01BC02|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2962|5482|lyfalmen|||0|8|1||Parlogis hf|Parlogis - óskráð lyf|Meflókvín||||2962|5482||2 974205|J01CF0502|Flucloxacillin|sts/irs|250|mg|10|hgl|1|pakki||J01CF05|01.12.2017||R|0|0|0|0|0|1|ARC|0|0|0|100|GBP|3695|6491|lyfsjukr|||0|10|1||Acare ehf|Acare - óskráð lyf|Flúkloxacillín||||3695|6491||2 974213|J01CF0502|Flucloxacillin|sts/irs|500|mg|10|hgl|1|pakki||J01CF05|01.12.2017||R|0|0|0|0|0|1|ARC|0|0|0|100|GBP|6245|10001|lyfsjukr|||0|10|1||Acare ehf|Acare - óskráð lyf|Flúkloxacillín||||6245|10001||2 974221|J01CF0502|Flucloxacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF05|01.12.2017||R|0|0|0|0|0|1|ARC|0|0|0|100|GBP|12616|18770|lyfsjukr|||0|10|1||Acare ehf|Acare - óskráð lyf|Flúkloxacillín||||12616|18770||2 974239|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|pakki||G02AB01|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1126|2955|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Metýlergómetrín||1126||1126|2955||2 974247|A07EA0101|Prednisolon|eþ-stíll|20|mg|10|stk|1|pakki||A07EA01|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7666|11956|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Prednisolone||||7666|11956||2 974255|A07EA0101|Prednisolon|eþ-stíll|20|mg|10|stk|1|pakki||A07EA01|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7666|11956|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Prednisolone||||7666|11956||2 974263|C07AG0206|Carvedilol|töflur|25|mg|50|stk|1|pakki||C07AG02|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1330|3236|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Carvedílól||||1330|3236||2 974271|A08AB0101|Xenical|hylki|120|mg|84|stk|1|pakki||A08AB01|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|8162|12639|lyfalmen|||0|84|1||Parlogis hf|Parlogis - óskráð lyf|Orlístat||||8162|12639||2 974289|M04AB0301|Narcaricin mite|töflur|50|mg|100|stk|1|pakki||M04AB03|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1028|2820|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Benzbromarone||||1028|2820||2 974297|A07EB0102|Nalcrom|mixtúra|20|mg/ml|10|ml|50|lykjur||A07EB01|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|25509|35334|lyfalmen|||0|500|1||Parlogis hf|Parlogis - óskráð lyf|cromoglicic acid ||||25509|35334||2 974304|D05AA0004|Oxipor|húðlausn|5|%|112|g|1|stk||D05AA|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|3784|6613|lyfalmen|||0|112|1||Parlogis hf|Parlogis - óskráð lyf|Tjörur||||3784|6613||2 974619|N05BA0107|Diazepam|eþ-lausn|5|mg/2,5ml|2,5|ml|5|túpa||N05BA01|01.03.2018||R|0|0|0|0|0|0|OSK|0|0|1|100|GBP|1962|4105|lyfalmen|||0|12,5|1||Distica|Distica - óskráð lyf|Díazepam||1962||1962|4105||1 974627|C03DA0104|SpironolactonAL|töflur|50|mg|100|stk|1|pakki|laktósufrítt|C03DA01|01.02.2018||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1755|3821|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Spírónólaktón||1755||1755|3821||1 974643|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|pakki||C03DA01|01.03.2018||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|1476|3436|lyfalmen|||0|100|1||Distica|Distica - óskráð lyf|Spírónólaktón||1476||1476|3436||1 974669|N07BC5101|Suboxone|tungur.f|15|mg|30|stk|1|pakki|12+3 mg|N07BC51|01.03.2018||R|0|0|1|1|0|1|PCO|0|0|0|100|DKK|19548|28311|lyfsjukr|||0|30|1||Distica|Distica - óskráð lyf|Búprenorfín í blöndum||19548||19548|28311||1 974677|N07BC5101|Suboxone|tungur.f|2,5|mg|30|stk|1|pakki|2+0,5 mg|N07BC51|01.03.2018||R|0|0|1|1|0|1|PCO|0|0|0|100|DKK|3258|5889|lyfsjukr|||0|30|1||Distica|Distica - óskráð lyf|Búprenorfín í blöndum||3258||3258|5889||1 974685|N07BC5101|Suboxone|tungur.f|10|mg|30|stk|1|pakki|8+2 mg|N07BC51|01.03.2018||R|0|0|1|1|0|1|PCO|0|0|0|100|DKK|13032|19342|lyfsjukr|||0|30|1||Distica|Distica - óskráð lyf|Búprenorfín í blöndum||13032||13032|19342||1 974784|A01AC0001|Clobetasol propionate - forskriftarlyf|munnskol|0,5|mg/ml|300|ml|1|fl||A01AC|01.02.2018||R|0|0|0|0|0|0|PAR|0|0|1|100|IKR|3375|6050|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Corticosteroids for local oral treatment||||3375|6050||2 974883|P01AX0501|Mepacrin|töflur|100|mg|50|stk|1|pakki||P01AX05|01.12.2017||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|35462|47923|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Mepacrine||||35462|47923||2 974891|C01CA0603|Phenylephrine|stl|1|%|1|ml|10|hgl||C01CA06|01.01.2018||R|0|0|0|0|0|1|ABC|0|0|0|100|IKR|12236|18247|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Phenylephrin||||12236|18247||2 974908|G03CA0103|Ethinyl Estradiol|töflur|50|mcg|25|stk|1|pakki||G03CA01|01.12.2015||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|988|2765|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Ethinýl estradíól||||988|2765||2 974916|A05AA0401|Ocaliva|töflur|5|mg|30|stk|1|pakki||A05AA04|01.01.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|369657|465857|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Obeticholic acid||||369657|465857||2 974924|A05AA0401|Ocaliva|töflur|10|mg|30|stk|1|pakki||A05AA04|01.01.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|369657|465857|lyfalmen|||0|30|1||Parlogis hf|Parlogis - óskráð lyf|Obeticholic acid||||369657|465857||2 974932|J01FA0903|Klaricid|sts|500|mg|1|hgl|1|stk||J01FA09|01.01.2018||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|2105|4302|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Klaritrómýcín||2105||2105|4302||2 974958|M03CA0102|Ryanodex|stl|250|mg|20|ml|1|hgl||M03CA01|01.01.2018||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|452187|568501|lyfsjukr|||0|20|1||Parlogis hf|Parlogis - óskráð lyf|Dantrolene||452187||452187|568501||2 974966|C01DA0214|Transiderm nitro|forðapl|5|mg/sólh|100|stk|1|pakki||C01DA02|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|7373|11553|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Glýcerýltrínítrat||||7373|11553||2 975013|V03AB2101|Thysat|töflur|65|mg|10|stk|1|pakki||V03AB21|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2154|4370|lyfalmen|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Potassium iodide||||2154|4370||2 975021|M01AX2502|Structum|hylki|500|mg|240|stk|1|pakki||M01AX25|01.01.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|CHF|15093|22179|lyfalmen|||0|240|1||Parlogis hf|Parlogis - óskráð lyf|chondroitin sulfate||15093||15093|22179||2 975047|H02AB0404|Methylprednisolone|töflur|4|mg|100|stk|1|pakki||H02AB04|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3872|6734|lyfalmen|||1|100|1||Parlogis hf|Parlogis - óskráð lyf|Metýlprednisólón||||3872|6734||1 975055|C07AB0313|Tenormin|töflur|50|mg|50|stk|1|pakki||C07AB03|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2712|5138|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Atenólól||||2712|5138||2 975063|L01AD0103|Carmustine|sts|100|mg|1|hgl|1|pakki||L01AD01|01.02.2018||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|225504|286571|lyfsjukr|||0|1|1||Parlogis hf|Parlogis - óskráð lyf|Carmustine ||||225504|286571||2 975071|G03CA0103|Ethinyl Estradiol|töflur|1000|mcg|25|stk|1|pakki||G03CA01|01.02.2018||R|0|0|0|1|0|0|LDR|0|0|0|100|IKR|988|2765|lyfalmen|||0|25|1||Parlogis hf|Parlogis - óskráð lyf|Ethinýl estradíól||||988|2765||2 975089|H02AB0703|Lodotra|töflur|5|mg|100|stk|1|glas||H02AB07|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|21091|29746|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Prednisón||||21091|29746||2 975097|H02AB0206|Dexa|stl|10|mg/ml|10|ml|1|hgl||H02AB02|01.02.2018||R|0|0|0|0|0|1|LDR|0|0|0|100|IKR|5030|8328|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Dexametasón||5030||5030|8328||2 975229|A06AC0301|Inolaxol green|sk-pokar|4|g|50|pokar|1|pakki||A06AC03|01.02.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|2980|5507|lyfalmen|||0|50|1||Parlogis hf|Parlogis - óskráð lyf|Sterculia||2980||2980|5507||2 975237|C10AA0404|Fluvastatin|hylki|20|mg|28|stk|1|pakki||C10AA04|01.03.2018||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|715|2389|lyfalmen|||0|28|1||Parlogis hf|Parlogis - óskráð lyf|Flúvastatín||715||715|2389||2 975253|L01DB0702|Mitoxantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.03.2018||R|0|0|0|1|0|1|LDR|0|0|0|100|IKR|12645|18809|lyfsjukr|||0|10|1||Parlogis hf|Parlogis - óskráð lyf|Mítoxantrón||||12645|18809||2 975261|J01XE0104|Nifurantin|töflur|50|mg|100|stk|1|pakki||J01XE01|01.03.2018||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|2500|4846|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Nítrófúrantóín||2500||2500|4846||2 975378|M04AC0101|Colchicine|töflur|500|mcg|100|stk|1|pakki||M04AC01|01.03.2018||R|0|0|0|0|G|0|LDR|0|0|0|100|IKR|4239|7239|lyfalmen|||0|100|1||Parlogis hf|Parlogis - óskráð lyf|Kolkisín||4239||4239|7239||2 980005|C07AA0513|Propranolol hydrochloride-forskriftarlyf|mixtúra|2|mg/ml|100|ml|1|fl||C07AA05|01.12.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|4995|8280|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Própranólól||4995||4995|8280||2 980071|D07AD0102|Clobetazol in Dermazink - forskriftarlyf|lausn|50|mg|120|ml|1|fl||D07AD01|01.02.2017||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|16998|24801|lyfalmen|||0|120|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Klóbetasól||16998||16998|24801||2